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ABSTRACT 
Progressive Myoclonic Epilepsies (PME) are characterized by progressive neurological 
impairment with myoclonus, seizures and dementia.  In contradistinction, Familial Adult 
Myoclonic Epilepsy (FAME) is characterized by a benign course with rare seizures and 
cortical tremor.  Both conditions have neurophysiological features suggestive of a cortical 
origin for their myoclonus. 
This dissertation reports on a novel form of PME.  Many of those who were affected had no 
or minimal progression of their illness, low seizure frequency and were cognitively intact, 
suggestive of non-progressive disorders linked to the FAME loci.   
The majority of patients had features of cortical myoclonus, with generalized spike and wave 
discharges on electroencephalography, enlarged evoked potentials, enhanced C reflexes, 
and evidence of cortical excitability with magnetic stimulation.  However, there was evidence 
of cerebellar dysfunction both pathologically and on imaging. With regard to similar 
conditions, dentatorubral pallidoluysian atrophy and Unverricht-Lundborg syndrome were 
excluded by linkage analysis.  Similarly, linkage was not present for either the FAME 1 or 
FAME 2 loci. 
This syndrome is both clinically and genetically novel, and has a nosology which is difficult to 
characterize, in which the condition appears to lie on the spectrum between FAME and  
PME.  The dissociation between the pathological and radiological findings which suggest 
subcortical dysfunction, and the neurophysiological findings of cortical myoclonus is striking.   
Review of the literature associated with the neurophysiology of related conditions associated 
with PME and FAME suggests that: 
1. The assumption that generalized forms of myoclonic disorders represent multifocal 
forms of focal cortical discharges is an oversimplification. 
2. The dissociation between initial and later components of the evoked potential is less 
robust than is generally supposed, and that subcortical inputs may affect later 
components of the evoked potential. 
3. In a high proportion of cases the latency from cortical spike discharge to myoclonic 
jerk obtained with jerk locked averaging is incompatible with a cortical origin for the 
spike discharge. 
4. The proposal that myoclonus is a form of long latency reflex and that myoclonus 
represents a reflex arising from subclinical sensory input, is unproven. 
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OPSOMMING 
Progressiewe Miokloniese Epilepsie (PME) word gekenmerk deur progressiewe 
neurologiese agteruitgang met mioklonus, konvulsies en demensie. Daarenteen word 
Familiële Volwasse Miokloniese Epilepsie (FAME) gekenmerk deur 'n benigne verloop met 
ongereelde konvulsies en kortikale tremor. Beide entiteite het neurofisiologiese kenmerke 
suggestief van 'n kortikale oorsprong vir die mioklonus.   
Hierdie manuskrip beskryf 'n nuwe vorm van PME. Baie van die aangetaste persone toon 
geen of min agteruitgang van die siekte oor tyd nie, met 'n lae frekwensie van konvulsies en 
is kognitief intak, wat suggestief is van 'n nie-progressiewe siekte gekoppel aan die FAME 
loci.   
Die oorgrote meerderheid van pasiente het kenmerke van kortikale mioklonus gehad, met 
algemene spits en boog ontladings op elektroensefalografie, hoë amplitude ontlokte 
potensiale, versterkte C-reflekse, en tekens van kortikale eksiteerbaarheid met magnetiese 
stimulasie. Met neurobeelding en patologie was daar egter bewyse van serebellêre 
disfunksie. Soortgelyke toestande, naamlik dentatorubro-pallidoluysiese atrofie en 
Unverricht-Lundborg sindroom is uitgeskakel deur middel van koppelingsanalise. Koppeling 
met die FAME1 of FAME2 loci kon ook nie aangetoon word nie.   
Die sindroom is beide klinies sowel as geneties nuut en het 'n nosologie wat moeilik 
gekaraktiseer kan word. Dit wil voorkom of die siekte op 'n spektrum lê tussen FAME en 
PME. Die dissosiasie tussen die patologiese en radiologiese bevindinge, wat suggestief is 
van subkortikale disfunksie, en die neurofisiologiese bevindinge van kortikale mioklonus is 
opmerklik. 
’n Oorsig van die literatuur in verband met die neurofisiologie van toestande geassosieer 
met PME en FAME suggesteer die volgende: 
1. Die aanname dat algemene vorme van miokloniese toestande multifokale vorme van 
fokale kortikale ontladings verteenwoordig, is ’n oorvereenvoudiging. 
2. Die dissosiasie tussen inisiële en latere komponente van die ontlokte potensiaal is 
minder robuust as wat algemeen aanvaar word, en subkortikale invoer mag latere 
komponente van die ontlokte potensiaal beïnvloed. 
3. In ’n groot proporsie van gevalle is die latensie van kortikale spits ontlading tot 
miokloniese ruk, verkry deur “jerk locked averaging”, nie verenigbaar met  met ’n 
kortikale oorsprong vir die spits ontlading nie. 
4. Geen bewyse bestaan vir die teorie dat mioklonus ’n vorm van ’n lang latensie refleks 
is en dat mioklonus ’n refleks is wat ontstaan uit subkliniese sensoriese invoer nie.
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INTRODUCTION 
Although this thesis largely concerns the investigations of a novel form of myoclonus and 
epilepsy, the investigations of this condition have in turn generated a number of questions.  
In particular, they have raised concerns about the current classification of myoclonus and the 
basis on which this classification rests.  The disease entity itself largely falls on the spectrum 
between benign forms of myoclonus and more malignant conditions, such as the progressive 
myoclonic epilepsies (PME), and is currently termed Familial Adult Myoclonus Epilepsy type 
3 (FAME 3). 
 
Myoclonus and its causes occupy a remarkably distinctive place in the canon of neurological 
literature, and has featured prominently in the history of neurology.  For much of the 20th 
century there has been controversy regarding the origin of myoclonus.  Myoclonus is 
sometimes classified on the basis of the diseases or syndromes in which it is an obvious or 
striking manifestation of the illness.  Alternatively, classification may take place by means of 
neurophysiological techniques that attempt, in general, to make a quasi-anatomical 
diagnosis, for example, cortical and subcortical forms of myoclonus.  All classifications are 
imperfect, and to some extent these approaches resemble the fable of the three blind men 
examining the elephant and drawing various conclusions about the nature of the beast.  
Current classifications of myoclonus are typically based on the neurophysiology of 
myoclonus, but inherently also reflect the presumptive structural origin of myoclonus.  On the 
whole, the derivation of various anatomical levels to account for the production of myoclonus 
from electrophysiological findings is often trivial in that it adds little to the understanding of 
the pathophysiology, and may represent an oversimplification.  This thesis will try to 
demonstrate that the entity of myoclonus is highly complex, and not easily classifiable.   
 
Regarding the disease processes which cause myoclonus, a striking feature is the lack of 
uniformity in the wide range of associated pathologies, which include viral encephalitides, 
metabolic derangements, primary and secondary epilepsies and inherited 
neurodegenerative diseases.  Myoclonus is neither a disease process nor a syndrome, but is 
a phenomenon.  That this phenomenon is typically associated with diffuse derangements of 
the central nervous system is undoubtedly correct, but the multiplicity of causes results in 
classifications which are intuitively unattractive.   
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This thesis describes a novel form of epilepsy, characterised by the presence of generalized 
tonic-clonic seizures (GTCS), myoclonic jerks, and associated in some individuals with 
progressive neurological deficit, which we have termed FAME 31.  Two families were 
identified from the Western Cape Province of South Africa, and are of mixed ancestry, 
predominantly resulting from intermarriage between the original inhabitants of the area, the 
Khoi-San, and early settlers of European origin.  
 
FAME has autosomal dominant inheritance and often presents in early adulthood, as may 
PME.  However, in PME, dominant inheritance is only seen in dentatorubral pallidoluysian 
atrophy (DRPLA2, a single family with Kufs disease3 and mutations in the neuroserpin gene4.  
FAME was originally described in families from Japan and is characterized by myoclonic 
jerks in the arms and legs, tremulous finger movements, rare GTCS and has been linked to 
chromosome 8q245;6.  Families with a clinical phenotype similar to FAME have been 
described from Spain in which linkage to FAME 1 was excluded, indicating genetic 
heterogeneity7.  A similar condition, Autosomal Dominant Cortical Myoclonus and Epilepsy 
(ADCME), has features of a primary generalized seizure disorder, complex partial seizures 
and mental retardation in some patients, and maps to chromosome 2p11.1-q12.28, a locus 
termed FAME 2.  Three other families with FAME have been linked to the same region, but 
did not have mental retardation or complex partial seizures, suggesting that the disorders 
may be allelic9 10.  It has been proposed that FAME 1 is seen in Japanese families linked to 
8q24 and FAME 2 in European families linked to 2p11.1-q12.210.  However, a family from the 
Netherlands has been described in which the loci responsible for both FAME 1 and FAME 2 
were excluded11.   
 
The thesis outline is as follows: 
1. Background 
a. Review of myoclonus, its classification and related conditions. In particular, 
the historical context of the development of the current classification of 
myoclonus is presented. 
b. Review of the various known forms of PME to illustrate the differential 
diagnosis of progressive illnesses presenting with myoclonus, and 
establishing that FAME 3 is a novel entity. 
c. Review of the anatomical structures related to the generation of some of the 
neurophysiological manifestations of myoclonus, in order to establish the 
nature of anatomical connections related to the neurophysiological 
investigations of myoclonus and also the pathophysiology of myoclonus. 
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d. Review of the neurophysiology of myoclonus to serve as an introduction to 
the electrophysiological studies carried out in the group of affected individuals 
with FAME 3, and to illustrate the complexities of applying neurophysiological 
investigations in order to derive a classification of myoclonus. 
2. The methodology associated with the neurophysiological investigation, 
neuroradiology, neuropathology, genetics and nosology of FAME 3. 
3. Results of the findings in the two families of these investigations. 
4. Discussion of the results with relevance to FAME 3 as a unique entity, and its 
relevance to the classification of myoclonus. 
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AIMS AND PURPOSES 
The purpose of this study was to examine the following: 
1. To delineate the features of a family with a novel disease resembling a form of 
myoclonic epilepsy. 
2. To establish novelty of the disease by demonstrating lack of linkage to known loci 
associated with similar conditions. 
3. To ascertain the neurophysiological hallmarks of this disease with regard to the 
features of established forms of cortical and subcortical myoclonus. 
4. To review the existing literature and establish the nosology of this new syndrome 
within the existing categories of myoclonus. 
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1. OVERVIEW 
1.1 HISTORICAL NOTE 
 
In an article entitled “On convulsive tremor”, William A. Hammond12 referred to a publication 
by a Dr Pritchard, who in 182213, described, “under the name of Convulsive Tremor, an 
affection which, so far as I am aware, has not since been distinctly alluded to by any other 
author.  His attention was first directed to the matter by observing that in some epileptics fits 
of rigor or of tremor appeared to take the place of the ordinary paroxysm”12.  Pritchard 
described a patient in whom “all the muscles of the upper extremities…were constantly 
agitated by a convulsive movement, which was almost entirely confined to them”, the legs 
being spared.  Following blood letting and resultant syncope, “ the gluteal muscles were so 
greatly convulsed that by their action the patient was thrown up from his seat with the motion 
of a man sitting on a trotting horse”13. 
 
Hammond himself then went on to describe a 35 year old male who would on two or three 
occasions during the day “be seized with severe and unrestrainable muscle tremor, involving 
his head and all the muscles of the trunk and arms” 12.  There was an associated feeling of 
anxiety and it seems not unlikely, given the paroxysmal nature of the condition, that it was a 
form of conversion disorder, particularly since it was subsequently noted that the first attack 
had begun during sexual intercourse.  He was treated with potassium bromide and 
galvanism, the latter being able to dampen down a paroxysm which occurred during an 
office visit12.  Subsequently, Hammond noted that “my opinion was, and the success of the 
treatment abundantly justified the view, that the condition depended upon a disorder of the 
cerebellum”12. 
 
Myoclonus has been generally accepted to have its origin with a clinical description by 
Friedreich14.  He coined the term Paramyoclonus multiplex on the following basis: clonus 
refers to a quick movement, myo to muscle in order to distinguish it from an epileptic 
disorder, para indicated it was symmetrical and multiplex to the fact that there were multiple 
sites15.  Friedreich wished to distinguish this type of involuntary movement, which he 
believed to originate in the spinal cord from “clonic spasm”, which was thought at that time to 
come from the brain15.  The myoclonic jerks affected all muscles of the body except the face 
and occurred at different times14.  The frequency varied from 10-50 Hz and the movement 
was present at rest but accentuated with tactile or stretch stimuli and disappeared with 
voluntary movement and sleep14.  There was no history of epilepsy or family history14.  This 
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disorder may be described as essential myoclonus, although the lack of an effect of 
voluntary movement is puzzling16. 
 
More recently, the neurophysiological approach to myoclonus had its roots in France initially, 
and subsequently at the National Hospital in London, where A.M. Halliday and C.D. Marsden 
played a prominent role.  Shibasaki in Japan and Hallett at the National Institute of Health 
supplemented and expanded this work, giving rise to the concepts which remain the 
mainstay of classification at the present time.  
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1.2 DEFINITIONS 
 
Myoclonus refers to sudden, brief, shock-like involuntary movements caused by muscular 
contractions (positive myoclonus) or inhibitions (negative myoclonus) arising from the central 
nervous system17.  Myoclonic jerks are not associated with loss of consciousness and are 
frequently precipitated by stimuli such as movement, bright light or stress18 .  As has been 
pointed out by Symonds, voluntary movement is the most striking of the factors which 
exacerbate myoclonus19.  The myoclonic jerk typically occurs at the beginning of a 
movement and is exaggerated by “change from one movement to another”19.  It may be 
difficult to distinguish between rhythmical myoclonus and tremor20. 
 
The magnitude of myoclonus may vary tremendously, as may the body part involved and the 
rhythmicity of the movement: J.P.P. Bradshaw wrote in 1954 that the jerks are “arrhythmic 
and asynergic, involving portions of muscles, whole muscles or muscle groups…. the 
magnitude may be as small as the twitch of a fasciculation or, if the legs are affected, the 
patient may be thrown to the ground21. 
 
The diseases associated with myoclonus are heterogeneous.  It is a symptom common to 
many syndromes in which it may appear in a variety of forms, and it is the symptom 
complex, particularly the associated neurological features and course of the illness which 
may lead to diagnosis22. 
 
Two broad groups emerge: the first consisting of disorders where myoclonus is the 
presenting and major clinical feature, with neurological deficits appearing later, and a second 
group in which myoclonus is a part of a progressive encephalopathy, and may be 
overshadowed by other neurological features23.  
 
Myoclonus and epilepsy may occur as part of an encephalopathy with known pathology.  
The pathology may be progressive, as in certain neuronal storage diseases, in which case 
the illness might be termed a progressive myoclonic encephalopathy. The latter includes 
metabolic disorders such as the GM2 and GM1 gangliosidoses, Niemann-Pick disease and 
Krabbe's disease, and acquired disorders such as subacute sclerosing panencephalitis 
(SSPE).  Alternatively, the pathology may be static as after cerebral hypoxia or trauma, 
when the condition may be called static myoclonic encephalopathy16. 
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1.3 CLASSIFICATION 
Although myoclonus could be classified by pathophysiology, pharmacotherapy, or clinical 
phenomenology, the following classification is based on aetiology.  Further classifications, 
predominantly physiological, are discussed in section 1.8.1. 
Classification of Myoclonus (after Marsden et al.16) 
I. Physiologic myoclonus (normal subjects) 
(a) Sleep jerks (hypnic jerks) 
(b) Anxiety-induced 
(c) Exercise-induced 
(d) Hiccough  
(e) Benign infantile myoclonus with feeding 
II. Essential myoclonus (no known cause and no other gross neurologic deficit) 
(a) Hereditary (autosomal dominant) 
(b) Sporadic essential myoclonus  
(c) Periodic movements of sleep (nocturnal myoclonus) 
III. Epileptic myoclonus (seizures dominate and no encephalopathy, at least initially) 
(a) Fragments of epilepsy 
 Isolated epileptic myoclonic jerks 
 Epilepsia partialis continua 
 Idiopathic stimulus-sensitive myoclonus 
 Photosensitive myoclonus 
 Myoclonic absences in petit mal 
 (b) Childhood myoclonic epilepsies 
  Benign myoclonus of infancy 
  Infantile spasms 
  Myoclonic astatic epilepsy (Lennox-Gastaut) 
  Cryptogenic myoclonus epilepsy (Aicardi) 
(c) Juvenile myoclonic epilepsy 
(d) Progressive myoclonic epilepsy: Baltic myoclonus (Unverricht-Lundborg) 
IV. Symptomatic myoclonus (progressive or static encephalopathy dominates) 
 (a) Storage disease 
  Lafora body (LB) disease 
  Lipidoses, eg GM2 gangliosidosis, Tay-Sachs, Krabbe's 
  Ceroid-lipofuscinosis (Batten) 
  Sialidosis ("cherry-red spot") 
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(b) Spinocerebellar degenerations 
  Ramsay Hunt syndrome 
  Freidreich's ataxia 
  Ataxia telangiectasia 
 (c) Basal ganglia degenerations 
  Wilson's disease 
  Torsion dystonia 
  Hallervorden-Spatz disease 
  Progressive supranuclear palsy 
  Huntington's disease 
  Parkinson's disease 
 (d) Dementias 
  Creutzfeldt-Jakob disease 
  Alzheimer's disease 
 (e) Viral encephalopathies 
  Subacute sclerosing panencephalitis 
  Encephalitis lethargica 
  Arbo virus encephalitis 
  Herpes simplex encephalitis 
  Postinfectious encephalitis 
  Infantile polymyoclonus (neuroblastoma) 
 (f) Metabolic encephalopathies 
  Hepatic failure 
  Renal failure 
  Dialysis syndrome 
  Hyponatremia 
  Hypoglycemia 
  Infantile myoclonic encephalopathy (polymyoclonus) (± neuroblastoma) 
  Nonketotic hyperglycemia 
  Multiple carboxylase deficience  
  Biotin deficiency  
 (g) Toxic encephalopathies 
  Bismuth 
  Heavy-metal poisons 
  Methyl bromide 
  Drugs, including levodopa  
 (h) Physical encephalopathies 
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  Posthypoxia (lance-Adams) 
  Post-traumatic 
  Heat stroke 
  Electric shock 
  Decompression injury 
 (i) Focal CNS damage 
  Poststroke 
Postthalamotomy 
Tumor 
Trauma 
Olivodentate lesions (palatal myoclonus) 
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1.4 BENIGN FORMS OF MYOCLONUS  
1.4.1 ESSENTIAL MYOCLONUS 
Essential myoclonus refers to a disorder of unknown aetiology in which myoclonus 
classically occurs as the sole neurological abnormality17.  There is a normal life expectancy, 
and no seizure disorder or evidence of cerebellar dysfunction20.  
 
In general, the cases which have been described have been familial with an apparent 
autosomal dominant (AD) pattern of inheritance. The term ”esential myoclonus” is typically 
applied to sporadic cases.  When inherited, usually as an AD trait, the condition is termed 
“hereditary essential myoclonus”, and synonyms include familial myoclonia, essential familial 
myoclonus, and benign essential myoclonus24.  The jerks in hereditary essential myoclonus 
increase considerably with action and in stressful situations.  They characteristically involve 
the proximal upper limbs and neck, and are less prominent in the face and hands24.  
Dystonia may be a feature (see below 1.4.4). 
 
An early report was that of Pierce Clark, who in 1912, wrote that “the pathogenesis of 
essential myoclonus is now known to develop…either in the myoclonic’s own family or in 
collateral branches of the same family stock” 25.  Subsequently,  in 1933 Lindemulder 
recorded a family with myoclonus affecting three generations, which started in the second 
decade and predominantly affected the face and limbs.  
 
Daube described two families with benign hereditary myoclonus in four generations26, 
however, some patients had signs of more widespread neurological involvement.  In the 
proband, abnormal movements were first seen as he was learning to walk and feed himself.  
Most of the jerks occurred unpredictably on a background of voluntary movement. At age 18, 
the proband’s daughter developed irregular, uncontrollable jerking movements of her head 
and arms, and spilled drinks, wrote illegibly, and was unable to perform venipunctures.  In 
addition, a three-year-old grandson of the proband had the disorder in the same form and 
severity. In the second family, jerking movements were described as early as the second 
year and were particularly prominent when eating or drinking.  The movements were most 
frequent and intense in proximal muscles, affected by voluntary acitivity, and in a number of 
patients, they were predominantly unilateral.  The older and more severely involved patients 
had additional symptoms of motor function impairment.  These included intention tremor, 
unsteadiness of gait, slow alternating movements of the hands, jerky eye movements, and 
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speech impairment. Most of these symptoms were mild and progressed slowly with age.  
There was no intellectual impairment and no clinical or EEG evidence of a seizure disorder.   
Mahloudji27 reported a syndrome of hereditary myoclonus of benign type, reviewing the 
clinical findings in 6 members of a family.  The cardinal features of the disorder were 
myoclonus commencing in the first decade of life with a benign course, and a variable effect 
of voluntary movement.  There were no seizures and the EEG was normal.  The authors 
proposed the term hereditary essential myoclonus.  Diagnostic criteria for this condition 
included27: 
1. Onset of myoclonus in the first or second decade. 
2. Males and females equally affected. 
3. A benign course with normal lifespan, although variable severity. 
4. Dominant mode of inheritance. 
5. Absence of seizures, dementia, gross ataxia and other neurological deficits. 
6. Normal EEG. 
 
Fahn and Sjaastad reported on a large Norwegian family with essential myoclonus affecting 
19 individuals in four generations20.  Notable features were that one individual had dystonia 
and two had frequent eye blinks, which were likely to be a manifestation of blepharospasm; 
myoclonus was relieved to some extent by alcohol, and two individuals had complete 
remission of their myoclonus. 
 
Przuntek and Muhr described an eight generation family with an AD inheritance pattern in 
which there were 25 affected individuals with essential myoclonus who had a striking 
response to alcohol 28.  The myoclonus mostly affected the neck and arms, and usually 
started in adulthood, with a range from 4 to 34 years.  EEGs were normal in eight 
individuals.  Seven patients had a postural tremor of the hands in addition to myoclonus. 
 
Essential myoclonus can occur without a family history, and Bressman and Fahn described 
15 patients with this entity.  However, over half of these patients had either focal or 
segmental myoclonus, suggesting underlying cerebral pathology. The clinical findings were 
rather diverse, including cases of myoclonus with familial tremor, rhythmic myoclonus, (one 
of whom had palatal tremor, the other patient had rhythmic myoclonus of the arm, with 
postural tremor, and may have had cortical tremor), and four other patients with oscillating 
myoclonus, defined as “transient bursts of fairly regular contractions with a waxing and 
waning amplitude”.  The authors also stated that in two of their patients, who had 
predominantly arrhythmic contractions, myoclonus was regular at times, implying a 
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continuum between rhythmic and arrhythmic myoclonus.  Similarly in a review of myoclonus 
at the Mayo clinic, 19 out of 94 patients had essential myoclonus, of onset from 4 to 86 
years, and without progression and only one patient had a family history of myoclonus29.   
1.4.2 ESSENTIAL TREMOR AND MYOCLONUS  
Another area of nosological confusion is the combination of essential tremor and myoclonus, 
although it is by no means certain that the entity is really essential tremor.  The situation is 
exacerbated by the difficulty in distinguishing between rhythmical myoclonus and tremor20.  
Korten et al described a family with an AD pattern of inheritance who developed essential 
tremor and myoclonus30.  Seven members of the family had essential tremor, in four others 
there was tremor and myoclonus, and 12 had complex myoclonic jerks.  The index patient 
had spontaneous myoclonus in the arms, abdomen and back, and had rhythmic tremor of 
the hands, fingers and head at a frequency varying from 3-6 Hz.  
 
In the family with AD inherited essential myoclonus described by Przuntek and Muhr , seven 
patients had a postural tremor of the hands in addition to myoclonus31.  Similarly in the Mayo 
Clinic review of essential myoclonus, a boy is described with tremor of the hands associated 
with clumsiness and the subsequent development of ataxia, and a generalized spike and 
wave pattern on the EEG29. 
 
Many patients with myoclonus and tremor are likely to have cortical tremor, a diagnosis 
which can be determined by standard neurophysiological characteristics of cortical 
myoclonus, and which is discussed in greater detail in section 2.3.  
1.4.3. ALCOHOL AND ESSENTIAL MYOCLONUS 
In the families reported by Przuntek and Fahn20;28 alcohol reduced the severity of myoclonus, 
a feature which aids in distinguishing myoclonus from other movements such as dystonic 
tremor20, although essential tremor may also respond to alcohol. A similar response to 
alcohol has been reported with PME32.  Patients with hereditary essential myoclonus had 
rebound worsening on alcohol withdrawal. 
 
The condition termed “dominantly inherited myoclonic dystonia with dramatic response to 
alcohol”, was described by Quinn and Marsden in 1984 33.  Four families with an AD pattern 
of inheritance presented with childhood onset myoclonic dystonia involving the upper body 
and arms.  A similar family described by Kurlan also showed a response to alcohol34.  The 
condition has the following characteristics35: 
1. Onset in childhood. 
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2. Arms and neck affected predominantly. 
3. Movement disorder characterised by sudden, irregular “lightning-like” jerks. 
4. Jerks were both symmetrical and asymmetrical and synchronous and asynchronous 
5. Alcohol dramatically reduced the jerks (the response may be so dramatic as to be 
diagnostic24). 
6. Many patients had dystonia: torticollis, retrocollis, truncal spasms, dystonic posturing of 
arms, writer’s cramp. 
1.4.4 DYSTONIA AND MYOCLONUS 
Obeso et al studied the combination of myoclonus with dystonia in 14 patients36.  In most 
cases the same muscle groups were involved in both movements.  In all patients, voluntary 
muscle activity produced myoclonic jerking that was superimposed upon dystonic muscle 
spasms.  Dystonia was most prominent in proximal muscles of the neck and shoulder, 
whereas myoclonus was more obvious in distal muscles.  The myoclonus was irregular and 
usually in a segmental distribution.  Electrophysiology showed sustained dystonic 
contractions frequently recorded concomitantly with the jerks, with no features of cortical 
myoclonus.  The authors felt that the source of the jerks of myoclonic dystonia within the 
CNS was unknown, although, given that there were no features of cortical myoclonus, the 
jerks may have been subcortical in origin 36.    
 
Quinn and Marsden described familial myoclonic dystonia, with normal intellect and life 
expectancy, and inherited in an AD fashion24.  The topography of the movement was largely 
that of the upper body, with relative sparing of the face. The movements improved 
significantly with alcohol.  The patients were similar to those with benign essential 
myoclonus excepting for the presence of dystonia.  Kurlan has also reported a family having 
myoclonus or dystonia or both over three generations34.   
With regard to dystonia, of the reports described above in the section on essential 
myoclonus, three list features of dystonia: 
1. One of the family of Mahloudji had torticollis and facial grimacing27. 
2. In the family described by Przuntek and Muhr, ten individuals had myoclonus of the neck 
which induced symptoms of spasmodic torticollis31. 
3. In the family described by Fahn and Sjaastad, one individual had torticollis and two 
probably had blepharospasm 20. 
 
The topic was reviewed under the title of “Hereditary myoclonic dystonia, hereditary torsion 
dystonia and hereditary essential myoclonus: an area of confusion”35.  The authors noted the 
occurrence of dystonia with many of the cases of hereditary essential myoclonus, and 
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emphasized that hereditary essential myoclonus may be difficult to distinguish from 
hereditary myoclonic dystonia35. Families may be characterized by myoclonus, dystonia or 
tremor, or a combination of all three35. 
 
The issue as to the cause of essential myoclonus with or without dystonia has largely been 
resolved by the finding of a locus on chromosome 7q21 for myoclonus-dystonia (DYT11) 
mapped in a North-American family with typical features of essential myoclonus associated 
with dystonia37.  Subsequently, mutations in the epsilon-sarcoglycan gene were identified as 
causative for AD inherited myoclonus-dystonia38.  Mutations in this gene probably account 
for most cases of clinically typical myoclonus-dystonia39.  It is currently assumed that cases 
of essential myoclonus with essential tremor, with dramatic response to alcohol and with 
dystonia are all related to mutations in the epsilon-sarcoglycan gene39. 
1.4.5 OSCILLATING MYOCLONUS  
This entity was first reported by Fahn in 198140.  Three patients had sudden bursts of 
oscillating movements which then faded.  The movements were associated with ramp, but 
not ballistic movements, and involved the trunk and limbs. The EEG was normal and these 
patients would in other respects form part of the essential myoclonus group.   
A second report described oscillatory myoclonus in two patients with perinatal anoxia41.  The 
movements in the first case were described as “ sudden transient bursts of myoclonic 
jerks…present in both arms at rest, recurring in an irregular oscillatory fashion.” Posture or 
movement was associated with action myoclonus.  The oscillations were confirmed by 
electromyography (EMG) which showed silent periods interrupted irregularly by bursts of 
alternating activity in antagonist muscles at a frequency of 3-6 Hz.  The bursts lasted from 1 
to 60 seconds, and the duration of individual EMG discharges was from 60 to 120 msec.  
The authors emphasized that this form of myoclonus was not a tremor since it was irregular, 
transient and had an abrupt onset41.  The absence of features of cortical myoclonus 
suggested that this condition may have had a subcortical origin42. 
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1.5. RAMSAY-HUNT SYNDROME  
1.5.1 DESCRIPTION OF RHS 
In 1914, Ramsay-Hunt described Dyssynergia Cerebellaris Progressiva (DCP), a condition 
of generalized intention tremor, most obvious during voluntary movement, and associated 
with cerebellar signs43.  
 
Three cases were described, none of whom had a family history.  The tremor was described 
as coarse and irregular “atactiform shaking” on attempting any movement, and had a 
frequency of 3-5 Hz.  The onset of the cases was 23, 28 and 40 years43.    
 
DCP was reported as being similar to the intention tremor of multiple sclerosis and to 
essential tremor43.  Ramsay-Hunt commented “It is not improbable that some of the cases 
which are now grouped with the hereditary and essential tremors would show on closer 
examination the same progressive disturbances of the cerebellar function as to the cases 
which are the subject of this study”43.  He distinguished his cases of “progressive 
dyssynergia” from those of hereditary tremor since his cases had a movement disorder 
which was “not a true tremor but a synergic disturbance which is evident only when the 
extremity is in action, and consists of coarse irregular tremor-like movements in which the 
constant, vibratory characteristics of a true tremor is almost entirely lacking”43.  The article 
concluded by stating that the term ‘chronic progressive cerebellar tremor’ would be a 
reasonable appellation for the disorder described in this report43.   
 
Subsequently, in an article published in 1921 entitled “Dyssynergia Cerebellaris Myoclonica 
– Primary atrophy of the dentate system: Contribution to the pathology and symptomatology 
of the cerebellum”, Ramsay Hunt described six cases which combined the symptomatology 
of his previously described DCP with myoclonus and epilepsy (Table 1)44.  He therefore drew 
attention to the association of cerebellar disorders and epilepsy with myoclonus.  On the 
basis of the neuropathology he determined that the progressive dyssynergia was due to 
atrophy of the efferent dentate system of the cerebellum44. 
 
Of the six cases, four were described as having dyssynergia cerebellaris progressiva 
myoclonica and a pair of affected twins were described with the same entity in association 
with Friedreich’s ataxia44.   However, it is unlikely that they would have been diagnosed with 
Friedreich’s ataxia using current criteria45.  Furthermore, as pointed out by Berkovic, 
although there are some similarities, the neuropathology of these cases differs from that of 
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Friedreich’s ataxia by the presence, in most cases, of significant neuronal loss in the inferior 
olives and the absence of degeneration in the corticospinal tracts, and both clinical and 
pathological features fall within the spectrum of Myoclonus Epilepsy and Ragged-Red Fibers 
(MERRF)46. 
Table 1. Summary of Findings of Ramsay Hunt’s cases44 
Case Epilepsy Onset 
Myoclonus 
Onset Seizures Cerebellar signs 
Family 
history 
Cognition 
affected 
1 17 19 3-4/year Yes Probably 
no 
No 
2 10 7 6/year Yes No No 
3 12 12 Very rare Yes No Yes 
4 12 13 Weekly Mild clumsiness No No 
5 21 ? 21 Yes Marked Twin Yes 
6 19 ? Yes Marked Twin No (?) 
 
Case 1: This patient developed myoclonic epilepsy at age 17 years, followed by a 
progressive development of intention tremor with ataxia of the limbs and speech.  
Generalized tonic-clonic seizures occurred three to four times per year.   Myoclonus was at 
times so severe that he occasionally fell to the ground.  There was no family history. 
Case 2:  This patient developed myoclonic epilepsy at age 7 years with progressive ataxia 
involving the speech and limbs.  There was no family history of a similar condition.   She had 
approximately six generalized tonic-clonic seizures yearly.  The ataxia was progressive and 
myoclonus was often associated with voluntary movements.  There was moderate dementia 
present. 
Case 3: A patient aged 38 who had a history of myoclonic epilepsy for 26 years without any 
family history of illness.  Generalized tonic-clonic seizures began at the age of 12  years, 
followed shortly thereafter by myoclonic jerks which gradually increased in severity and 
frequency.  There was an associated dementing illness and signs of cerebellar disturbance. 
Case 4:  A female patient who developed myoclonic seizures at the age of 12, followed 
shortly thereafter by myoclonic jerks.  Subsequently her speech was involved and there was 
also a “slight tendency to myoclonic waves and twitching of the face.”  On examination there 
was mild ataxia in the arms. 
Cases 5 & 6: These cases were those of a pair of twins reported to have Friedreich’s ataxia.  
There was no family history.   
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Case 5: This patient developed generalized tonic-clonic seizures at the age of 21.  
Subsequently he developed myoclonic jerks and mild gait ataxia.  There was an associated 
mild to moderate dementia.  Myoclonic jerks were clearly brought out by mild voluntary 
movement.  Speech was said to have been typically scanning and there was a marked 
intention tremor of both arms and ataxia in the legs.  Reflexes were difficult to elicit in the 
upper limbs and absent in the legs, with flexor plantar reflexes.  No scoliosis was present but 
there was a tendency to pes cavus.  There was marked loss of “deep sensibility” of the legs 
with loss of position sense.  There was also loss of sensation in the hands and fingers.  
Case 6:  This patient’s illness began at the age of 19 and was similar to that of his sibling.  
Marked ataxia was present and reflexes were absent..  There was no pes cavus and 
sensation was normal. 
1.5.2 CONTROVERSIES CONCERNING THE RHS 
The combination of myoclonus, with cerebellar ataxia and seizures, as described by 
Ramsay-Hunt in 1921, came to be known as the Ramsay-Hunt syndrome (RHS)44. 
 
The definition of the syndrome varies greatly.  An early definition was that of Bonduelle, who 
in 1968 defined the condition as the association of hereditary spinocerebellar degeneration 
with myoclonus, and less commonly with “major or myoclonic epilepsy”22.  According to 
Berkovic the clinical presentation of the syndrome has been described as that of a slowly 
progressive cerebellar disorder beginning between the ages of 5 to 30, followed by 
myoclonus with infrequent tonic-clonic seizures in many cases47.  Some authors have 
regarded the condition as separate from the epilepsies, since convulsive seizures and 
epileptiform abnormalities on EEG have been considered to be rare48.  In contradistinction, 
Roger observed that a cardinal feature of RHS was an epileptic syndrome of myoclonic 
seizures, with or without tonic-clonic seizures and with associated EEG changes of 
paroxysmal epileptiform discharges precipitated by photic stimulation49.   
 
Increasing confusion regarding the term in the literature led some authors to consider its 
continued use to be inappropriate47.  Controversy was generated by a presentation at the 
1987 American Academy meeting by Berkovic, with a report entitled “Mitochondrial 
encephalomyopathies: A solution to the Enigma of the Ramsay Hunt syndrome”50.  Patients 
with RHS were reviewed and found to have mitochondrial disease.  The authors went on to 
state that RHS was no longer a useful diagnostic category, and that in their experience it 
was completely accounted for by mitochondrial encephalomyopathies.  In a subsequent 
review of the progressive myoclonic epilepsies, Berkovic pointed out that some patients with 
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PME may not have a clear diagnosis, but even in these, the use of the term RHS should be 
avoided, since it did not convey useful diagnostic or therapeutic information47. 
 
Subsequently, the debate was further defined by two opposing groups who put forward their 
views in the journal Movement Disorders 51 52.  Marsden and Obeso commenced the 
discussion in an article entitled “ The Ramsay Hunt syndrome is a useful clinical entity”51.  
They defined RHS as a triad of :  
1. severe myoclonus 
2. progressive ataxia 
3. mild epilepsy and cognitive change. 
 
In RHS the dominant feature was the myoclonus, with action myoclonus and stimulus-
sensitive myoclonus being characteristic 51. The authors went on to point out that a 
distinctive feature of RHS was a relatively infrequent occurrence of tonic-clonic seizures, 
which often responded well to treatment 51.  In their experience of 19 patients with the 
syndrome, most had fewer than one or two tonic-clonic seizures per year51.  In addition, they 
distinguished RHS from PME on the basis that progressive ataxia and dementia form part of 
the PME spectrum, whereas in RHS dementia is not found and intellectual change, if present 
at all, tends to be mild51.  Conditions which presented with RHS, and are not associated with 
dementia or epilepsy, included Unverricht-Lundborg Disease, later onset forms of neuronal 
ceroid lipofuscinosis (NCL), sialidosis, non-infantile Gaucher’s disease, syndromes of 
dentatorubral pallidoluysian atrophy (DRPLA) and the May-White Syndrome53as well as 
coeliac disease, Whipple’s disease and spino-cerebellar degenerations51.  The point was 
made that movement disorders experts saw patients predominantly with myoclonus, 
whereas the group from the Montreal Neurological Institute saw a different spectrum of 
disease in which epilepsy was more obvious51.  The utility of the RHS was in being a useful 
shorthand description of an easily recognized clinical syndrome with many causes51.  
 
In reply, the group from Montreal referred to the difficulty in separating myoclonus from 
ataxia, recalling that “The late Francis McNaughton (Professor of Neurology at Montreal) 
used to watch such patients for long periods attempting to decide whether their inability to 
eat with a fork was due to action myoclonus or to ataxia.  It was never possible to settle this 
question on clinical grounds”52.  They reported a review of 84 cases of PME seen at the 
Montreal Neurological Institute.  Diagnoses included Lafora Body disease, Unverricht-
Lundborg disease, NCL, renal failure action myoclonus syndrome and neuroaxonal 
dystrophy52.  Of the remainder (fifteen cases), the majority had evidence of mitochondrial 
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dysfunction demonstrated either by the presence of ragged red fibers on muscle biopsy, skin 
biopsy or biochemically52.  
 
The Montreal group was of the opinion that they were able to make a diagnosis in all their 
cases of PME, since all patients with RHS turned out to have mitochondrial disease.  
However they also noted that their experience was not shared by other centers: “ Why then 
is the Ramsay Hunt syndrome alive and well in London (and in Marseilles) whereas it has 
vanished in Montreal?”52.  The possibility was raised that other neurologists had difficulties 
with the specificity of diagnosis of Unverricht-Lundborg disease, which the Montreal group, in 
collaboration with Finnish groups, had studied extensively, forming the opinion that it was a 
specific, genetically determined entity, characterized by prominent myoclonus, infrequent 
seizures and minimal dementia52.  The implication was made that those cases of RHS 
without a mitochondrial cytopathy were likely to be suffering from Unverricht-Lundborg 
disease52. The Montreal group reiterated their opinion that it was possible to make a specific 
diagnosis in most patients with PME, and that RHS was therefore not a useful diagnostic 
entity52, and that although there was likely to be a residue of difficult cases which varied from 
center to center, “to say that they have the Ramsay-Hunt syndrome is no advance over 
saying that they have PME not further diagnosed”52.  The Montreal group concurred with the 
opinion of Marsden and Obeso that ascertainment bias affected the types of referrals seen, 
depending on whether the group saw primarily epilepsy or movement disorders. 
 
Harding summed up the opposing positions, emphasizing that the RHS was a useful entity 
as long as it was seen to be a syndrome and not a disease54.  In her opinion, there were 
undoubtedly cases with myoclonus, ataxia and occasional seizures without a known cause, 
and which were unlikely to have Unverricht-Lundborg disease54.   
 
In a rebuttal of the Montreal group’s position, Tassinari et al published a report entitled: 
“Dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome): a condition unrelated to 
mitochondrial encephalomyopathies”.  This condition was also known as “Mediterranean 
myoclonus” to distinguish it from Baltic myoclonus55.  In five patients the disease was 
inherited in an autosomal recessive (AR) pattern, and in the remainder was sporadic.  The 
patients had action myoclonus and generalized seizures, and a mild, slowly progressive 
cerebellar syndrome.  The mean age of onset was from 6 to 15 years, and EEG showed 
generalized spike-and-wave discharges with photosensitivity55.  Muscle biopsies were 
normal in these patients and did not show mitochondrial abnormalities55.  In reply, Berkovic 
and Andermann were of the opinion that the cases of Tassinari et al were identical to those 
described under the term Unverricht-Lundborg56.  Furthermore they stated that “the use of 
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the term “Ramsay Hunt syndrome” for such patients was historically inaccurate and 
diagnostically misleading56.  
 
In 1990, Marsden and Harding pointed out that patients with long-standing idiopathic 
epilepsy and myoclonic seizures may develop ataxia after many years, perhaps related to 
anticonvulsant therapy57.  They went on to discuss 30 patients with the RHS diagnosed at 
their institutions in Spain and the United Kingdom57.  A clinical diagnosis was made in 12 of 
the patients with RHS: mitochondrial disease was thought to be probable in five, based on 
their clinical features or pedigree data; five patients fulfilled the diagnostic criteria for 
Unverricht-Lundborg disease; and two patients had celiac disease57.  The remaining 18 
patients fell into three groups57.  Firstly, there were five patients who had the features of 
Unverricht-Lundborg disease, but their symptoms began too early or too late, or the course 
of the illness was atypical, for example, tonic-clonic seizures had not developed until after 
the age of 25 years57.  Secondly, there were three patients with onset in their late teens or 
20s with seizures, myoclonus, and ataxia who had normal EEGs, all of whom had normal 
muscle biopsy specimens57. Thirdly, there was an older group of patients, some with 
epileptic seizures, and some with parkinsonism, who appeared to have multi-system 
atrophy, with progressive ataxia and myoclonus, but without dementia57.  These data 
suggested that, even allowing leeway in diagnostic criteria for what were already poorly 
defined clinical entities (Unverricht-Lundborg disease and mitochondrial encephalopathy 
without histochemical or ultrastructural evidence of muscle involvement), a clinical or 
biochemically supported diagnosis could not be made in 43% of their cases with the 
syndrome of Ramsay Hunt57. 
 
Marsden et al reiterated that the discrepancies between their findings and those of the 
Montreal group arose primarily because of differences in ascertainment57.  The patients had 
been referred because of their group's interest in myoclonus, other movement disorders, and 
cerebellar ataxia, as opposed to epilepsy57.  As noted before, tonic-clonic seizures were not 
a major clinical problem, and some patients did not have seizures at all57.  When seizures 
did occur, they tended to be infrequent and easily controlled with anticonvulsant drugs57.  
Marsden et al emphasized that dementia is not a feature of RHS and that several disorders 
included in the differential diagnosis of progressive myoclonic epilepsy and studied by the 
Montreal group, such as Lafora body disease and NCL, would not present as RHS57.  
Finally, they expressed the opinion that the clinical and neurophysiological features of 
Unverricht-Lundborg syndrome were not specific, and that it could be as dangerous a clinical 
concept as the RHS57.  However, time and genetic studies would prove the last statement to 
be incorrect58. 
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Susequently the Marseilles consensus group published their findings on the classification of 
PME and related disorders in 199059.  A consensus was reached to discard the term 
Ramsay Hunt syndrome and to divide the patients into two broad syndromic categories, 
each of which demanded a specific approach to diagnosis (Figure 1) 59.  These two 
categories were the PMEs and the progressive myoclonic ataxias (PMAs).  It was noted that 
a specific diagnosis could usually be made in patients with PME, whereas the converse held 
true for PMA.  
 
The syndrome of PMA comprises myoclonus and progressive cerebellar ataxia with 
infrequent or absent epileptic seizures59.  Known causes of PMA syndromes include 
spinocerebellar ataxia, mitochondrial encephalopathies, celiac disease and some early 
presentations of disorders typically associated with a PME syndrome such as Unverricht-
Lundborg disease or the sialidoses.  It was emphasized that the terms PME and PMA 
represented syndromes and that they overlapped59. 
 
 
Figure 1. The relationship between PME and PMA (after Marseilles Consensus Group, 
1990). 
The findings of the consensus groups can be summarized as follows: 
1.5.2.1 Phenomenology 
In patients with moderate or severe action myoclonus, it was difficult or impossible to 
determine if cerebellar signs were present as well, unless the myoclonus could be controlled 
by drug therapy59.  The clinical characteristics of myoclonus in all the specific causes of the 
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PME syndrome were very similar.  Although the spectrum of severity of action myoclonus 
might vary in different diseases, the nature of the myoclonus would not enable a specific 
diagnosis to be reached.  The presence of spontaneous myoclonus, although a feature of 
more severe disease, would not contribute to the diagnosis59. 
1.5.2.2 Special Investigations59 
Generalized spike-wave discharges, photosensitivity, focal (especially posterior) epileptiform 
discharges, vertex spikes in rapid eye movement sleep, and giant somatosensory-evoked 
potentials (SEP) may be found in most of the disorders that cause the PME syndrome.  
Slowing of the background activity of the EEG occurs in all forms of PME, but is usually 
much more prominent and early in those diseases with diffuse neuronal damage or storage, 
compared with those diseases with restricted neuronal degeneration. 
1.5.2.3 Specific Diseases59 
In most parts of the world, five disease entities account for most of the cases of PME 
presenting to epilepsy clinics47 49.  These conditions are PME of Unverricht-Lundborg type, 
Lafora body disease, NCL, mitochondrial disorders, and the sialidoses.  A different spectrum 
of diseases is seen in movement disorder clinics where a common additional category, 
particularly among older patients, is a degenerative cerebellar syndrome of unknown cause60 
51
. 
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1.6 PROGRESSIVE MYOCLONUS EPILEPSIES 
The majority of the various disorders which comprise the PME syndrome are characterized 
by AR inheritance, with the major exception being disorders with mitochondrial inheritance.  
Rare forms of NCL, DRPLA, and the conditions known as FAME and Benign Adult Familial 
Myoclonus Epilepsy (BAFME) have AD inheritance.  The various forms of PME are reviewed 
and contrasted in this section. 
 
PME is characterized by myoclonus, tonic-clonic seizures and progressive neurologic 
dysfunction, particularly ataxia and dementia47.  Myoclonus in PME is typically fairly severe 
and often precipitated by posture, action and sensory stimulation in a wide range of 
modalities61.   
 
The symptoms and signs in patients with primary generalized epilepsy, particularly juvenile 
myoclonic epilepsy, may mimic those of the PME phenotype.  This is particularly true if 
toxicity arises from anticonvulsants, since the latter may cause ataxia, uncontrolled seizures 
and cognitive impairment47.  
 
PME also needs to be distinguished from other secondary generalized epileptic 
encephalopathies, such as the Lennox-Gastaut syndrome47.  These disorders are 
characterized by various forms of generalized seizures, including myoclonic seizures, but 
frequently have a fixed neurological deficit, and the illness may progress in some cases.  
PME can usually be distinguished from secondary generalized epileptic encephalopathies by 
a history of normal development followed by a relatively rapid progression of symptoms after 
the illness starts.   
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1.6.1 UNVERRICHT-LUNDBORG DISEASE 
The first form of PME to be described was that of Unverricht-Lundborg syndrome47.  The 
major manifestation of the disease is either myoclonus or generalized seizures, both typically 
manifesting at an average age of 10 to 11 years, with a range of onset of 6 to 15 years 62The 
characteristic clinical picture includes ataxia, intention tremor, dysarthria and emotional 
lability, with no or minimal dementia48;62 
Unverricht initially described the condition in 1891, and in 1903 and 1912 Lundborg 
described 17 patients from nine families with the same disease 63 62he term Baltic myoclonus 
arose because the descriptions, first by Unverricht, and then by Lundborg, were of families 
from Estonia and Eastern Sweden respectively, and many cases had also been reported 
from Finland (Figure 2), where the incidence is estimated to exceed 1 in 20 00064.  However, 
the disorder is not restricted to the Baltic region, and the term “Baltic myoclonus” has 
therefore fallen away.  Similarly, the term "progressive myoclonus epilepsy without Lafora 
bodies" is no longer used65.  
 
             
 
 
 
 
 
 
 
 
Figure 2. Distribution of 127 cases of Unverricht-Lundborg disease about the Baltic 
sea (Figure from Eldridge, 1983). 
Genton and Tassinari described a group of patients originating from the Western 
Mediterranean including a large number of Northern African subjects with typical features of 
Unverricht-Lundborg disease, with consanguinity present in 11 families66.  The authors 
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reported that this condition was less severe than Baltic myoclonus, and suggested that it be 
called Mediterranean myoclonus.  However, these conditions (Baltic and Mediterranean 
myoclonus) were subsequently shown to be genetically identical58;67. 
 
1.6.1.1 Diagnosis 
Unverricht-Lundborg disease has been clearly distinguished from PME of Lafora body 
type62.  The diagnosis is made on the following features: 
1. Stimulus-sensitive myoclonic jerks. 
2. Age at onset from 6-15 years. 
3. Generalized tonic-clonic seizures. 
4. Characteristic EEG. 
5. Progressive course. 
 
1.6.1.2 Inheritance 
The disorder has an AR inheritance pattern 62;68although there may be a dominant form of 
the condition69.  The high prevalence in Finland, with a heterozygote frequency estimated at 
one in 7064, as well as haplotype data, are compatible with a single ancestral founder 
mutation70.  Lundborg’s description was one of the first to detail recessive inheritance, and 
he published the names of the affected cases.  Subsequently, consanguineous marriages 
appear to have been avoided in Finland, one of the earliest and largest instances of group 
genetic counseling71.   
 
1.6.1.3 Myoclonus 
Myoclonus can be elicited by light, touch and other stimuli and is accentuated by voluntary 
movements72.  Descriptions vary: it is described by Bonduelle as exactly “resembling that of 
paramyoclonus multiplex; asynergistic, asynchronous partial muscular twitching, sometimes 
accompanied by fasciculation, rarely producing any motor effect and sometimes affecting the 
whole musculature”22.  Koskiniemi described the myoclonus developing from localised jerks 
to general shaking attacks sometimes leading to generalized seizures 72.  Myoclonus was 
reported to be most severe in the morning and jerks were said to be so severe that they 
caused the patient to fall to the ground or from a chair72.  With progression of the disease, 
myoclonus may become more severe, arrhythmic and asynchronous72.  The increased 
severity of myoclonus finally made patients unable to move unaided and rendered them 
bedridden and helpless towards the end of the second decade72.   
 
 40 
1.6.1.4 Clinical Manifestations 
Koskiniemi reviewed 93 cases, and found that in addition to myoclonus, gait ataxia with 
frequent falls was an early symptom.  All patients had cerebellar symptoms, with ataxia and 
intention tremor72.  Generally, ataxia developed a few years after disease onset, although 
Andermann states that ataxia may be mild and progress minimally65.  As is usual in many 
severe forms of myoclonus, the distinction between intention tremor and ataxia was 
occasionally impossible due to myoclonus72.  After six or seven years the patients were able 
to walk only with support or to move in a wheelchair, and two or three years later they were 
confined to bed72.  Difficulties with swallowing occurred in all patients during the final stage 
of the disease.  Speech became dysarthric early in the course of the disease72.  Horizontal 
nystagmus was found in seven of the cases examined by Koskiniemi et al72.  Several years 
after the appearance of the first symptoms, spasticity was found in 28 % and brisk reflexes in 
33 % 72. 
Intelligence quotients ranged from 55 to 129 and some patients had an IQ over 100 even 5 
to 10 years after the onset of disease72.  However, the estimated IQ at onset of disease was 
92, and this tended to deteriorate with time, with neuropsychological testing correlating well 
with the stage of disease 73.  Some patients developed hallucinations72.  
The average age at death was 24 years, about 14 years after the appearance of the first 
symptoms72.  On the other hand, sometimes the illlness stopped progressing after many 
years and these patients sometimes lived for up to 20 to 30 years after the beginning of the 
disease72.  Life expectancy of patients appears to be improving, probably because of better 
anti-epileptic drugs, and survival into adulthood is usual47.  Patients are not uniformtly 
affected and a study of 19 hospitalized patients suggested that severity did not depend on 
duration of disease, noting that most of the patients had been affected for more than 15 
years73.  
 
Unverricht-Lundborg disease may have had its relatively benign course altered by phenytoin 
so that the progression resembled that of Lafora body disease74.  Thus, lifespan was 
reported to have shortened and dementia become more frequent in phenytoin treated 
patients72, with average duration of survival being 14 years from onset. This report was 
based on 27 affected members of 15 families in the United States. Phenytoin was of no 
apparent benefit in all 26 patients who had taken it, and “in at least 9 patients death was 
associated with its administration”74.  In contrast, “8 individuals showed marked improvement 
in neurological and intellectual function once valproate sodium treatment was instituted”74.  
Mean survival in the phenytoin era of 14 years72 was contrasted with the age of the cases 
reported by Lundborg where five of the first six lived past the age of 50 years.  Similarly, 
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Iivanainen also noted that patients on phenytoin appeared to do less well than on other 
medications 75.   
 
1.6.1.5 Special Investigations  
Until the advent of genetic testing, diagnosis was clinical, and ancillary tests served only to 
exclude other disorders47, since there are no biochemical abnormalities specific to the 
disease65.  EEG shows generalized slowing with spike and wave discharges and marked 
photosensitivity61.  Skin biopsies have been reported to show membrane-bound vacuoles 
with clear contents in eccrine clear cells76.  Identification of affected individuals through 
genetic testing is now available. 
 
1.6.1.6  Pathology 
In patients exposed to phenytoin, which is associated with Purkinje cells loss, a case was 
reported with marked change in the cerebellum with reduction in the number of Purkinje cells 
and degenerative changes in the remaining Purkinje cells74 .  The molecular layer had a 
cribriform appearance and there was a glial response noted in some areas of the inner 
granular layer.  Koskiniemi reported diffuse Purkinje cell loss, with relative preservation of 
the dentate nucleus; some neuronal degeneration was noted in the medial thalamic nuclei62.  
Matthews et al reported on a case of PME without Lafora bodies and found a normal brain, 
excepting for almost complete Purkinje cell loss77.  Haltia reported detailed 
neuropathological findings in three patients: in addition to pronounced Purkinje cell loss, 
there was rarefaction and chromatolysis of neurons in cerebral cortex, subpial gliosis and 
rarefaction of myelin.  Severe neuronal loss was seen in the caudate nucleus, putamen and 
globus pallidus, as well as medial thalamus.  In the cerebellum, there was marked loss of 
basket fibers, fibrillary gliosis of the molecular layer, but only slight neuronal loss and 
degeneration of the dentate nuclei.  In the spinal cord, neurons of Clarke’s column showed 
chromatolysis78.   
 
1.6.1.7 Genetics 
The locus for Unverricht-Lundborg disease is at chromosome 21q22.367.  The gene symbol 
is CSTB, and the gene name is cystatin B; with EPM1 being a synonym.  The gene product 
is Cystatin B, a cysteine protease inhibitor79.  The genetics of the condition are remarkable in 
that the mutation comprises a dodecamer repeat, typically of 30-80 copies, which accounts 
for 90 % of known cases of Unverricht-Lundborg disease70;80.   
 
 42 
1.6.1.8 Epidemiology  
The disorder is commonest in Finland65, but patients have been described from Japan, Italy, 
France, Turkey, Sweden, the United States, and other countries65.   
 
1.6.1.9 Management 
The drugs of choice are the antimyoclonic agents valproic acid, clonazepam, and 
piracetam65.  Antiepileptic agents relatively easily control the generalized seizures, but  
myoclonus often proves difficult to control.  Unlike most forms of epilepsy, PME is best 
treated by polytherapy, including the three agents mentioned above, as indicated in a study 
by Obeso et al of patients with post-anoxic myoclonus and the Ramsay-Hunt syndrome 
(some of whom may have had Unverricht-Lundborg disease)81.  Zonisamide may be 
effective in the treatment of this form of progressive myoclonus epilepsy 82. Alcohol 
abolishes the myoclonus briefly32.  Treatment with N-acetylcysteine has resulted in 
improvement in seizure control and myoclonus, possibly based on its putative anti-oxidant 
effect 83.  
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1.6.2 LAFORA BODY DISEASE 
In 1911 Lafora & Glueck found amyloid-like inclusions in the neurons of patients with PME, 
establishing the pathological hallmark of the disease which bears Lafora’s name. The illness 
is characterized by the onset of generalized tonic-clonic seizures and/or myoclonus between 
the ages of 6 and 19 years84, typically around the 14th year of life61. Rapid and severe 
mental deterioration occurs, often with psychotic symptoms49.  Survival is short, and the 
mean age of death is 20 years, less than 2 to 10 years after onset85. 
 
1.6.2.1 Diagnosis 
There is a clearly distinguishable clinical pattern from Unverricht-Lundborg disease, with the 
major distinctions being: 
1. Later age of onset, and shorter duration of illness. 
2. Focal occipital seizures in half the cases and visual impairment86. 
3. Significant and progressive cognitive impairment 47. 
 
1.6.2.2 Inheritance 
Lafora body disease follows an AR pattern of inheritance 49. 
 
1.6.2.3 Myoclonus 
At first, as with many forms of PME, the myoclonic seizures can mimic juvenile myoclonic 
epilepsy.  The myoclonus is constant, and jerks may be massive and synchronous, usually 
limited to one or more muscle groups 87.  Jerks are also described as being asynchronous 
and asymmetrical85.  The myoclonic jerks are not associated with loss of consciousness and 
are aggravated by voluntary movement.  With progression, myoclonus increases in intensity 
and becomes quite severe and multifocal, precipitated by posture or action84.  
 
1.6.2.4 Clinical Manifestations 
Seizures are predominantly clonic, tonic-clonic and myoclonic49 and can be preceded by 
increasing myoclonus85.  Paroxysmal visual manifestations that are epileptic in nature may 
be an early sign of the disease88, and visual disturbance and blindness occur in a minority85.  
Dysarthria and cerebellar symptoms have been described frequently85.  After a few years, 
there may be a rapid onset of dementia, and some cases may present with dementia 68. 
A few cases of a possible adult-onset form of the disease with a more benign course have 
been described, with a 30 year course in one patient 89.  Although typical Lafora inclusion 
bodies were found in these cases, it is unclear if they represent the same disease.  Of note, 
in Lafora body disease, inclusions are found in the neuronal perikarya, and in late-onset 
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Lafora body disease there are inclusions in both axons and perikarya 89;90, a similar 
distribution to adult polyglucosan body disease91. 
 
1.6.2.5 Pathophysiology 
Lafora bodies have the properties of an acid mucopolysaccharide, are periodic acid-Schiff 
(PAS) positive, and are a polyglucosan protein complex 92. Polyglucosans are glucose 
polymers, similar to glycogen, but lacking its branched structure93.  The bodies vary in size 
from 1 to 30 µm in diameter, and cells may contain single or multiple bodies23.  Deposits 
generally appear free in the cytoplasm of neurons94.  The histological appearance is that of a 
concentric-lamellar target-like structure, with a basophilic core surrounded by a pale 
eosinophilic zone, containing dark radial stria 23.  At the electron microscope level, the 
bodies consist of filamentous and granular components, located in neuronal cell processes 
and perikarya 95 . 
 
There are similarities between Lafora bodies, corpora amylacea, deposits found in type IV 
glycogenosis and intra-axonal bodies seen with normal ageing 91.  The bodies have been 
found throughout the nervous system, with dentate nucleus, substantia nigra, thalamus, and 
pons being the main locations, and are also seen in the retina and spinal nerves 72. In 
addition, Lafora bodies are present in non-neuronal tissue, such as muscle and liver 96.   
 
A unique biochemical pathway of glycogen metabolism appears to exist: this is made up of 
laforin, E3 ubiquitin ligase, and three proteins which interact with laforin.  Laforin appears to 
bind polyglucosan accumulations and promotes their elimination97. 
 
1.6.2.6 Special Investigations 
Skin biopsies show Lafora bodies in the eccrine ducts of sweat glands98.  Biopsies from the 
axilla show bodies in the myoepithelial cells of the acini of the apocrine glands99.  However, 
biopsies from apocrine glands may be a source of confusion, since apocrine glands normally 
contain PAS positive inclusions 100.  
 
1.6.2.7 Pathology 
LBs are an intracytoplasmic inclusion of neurons, varying in size from 1-30 µm, with a 
variable number of inclusions per cell.  Typically on H & E staining there is a dense 
basophilic core and a pale periphery, with the centre staining intensely with Periodic-acid 
Schiff 96;101and Alcian blue101;102 Most other reports emphasize the presence of diffuse LBs 
and report moderate neuronal loss 89;102 103;104 
 45 
 
1.6.2.8 Genetics 
The gene locus is located at chromosome 6q24, and the gene is currently termed: Epilepsy, 
progressive myoclonus type 2A, with the gene symbol being EPM2A. The gene product is 
the laforin protein, which is characterized by a carbohydrate-binding domain and a tyrosine 
phosphatase domain105.  In addition, the EPM2B (also termed NHLRC1) gene has been 
recently identified, and encodes for the E3 ubiquitin ligase106.   
 
1.6.2.9 Epidemiology 
Lafora body disease is a rare disorder and there are no accurate estimates of its prevalence.  
In a review of PME from the Montreal Neurologic Institute, an epilepsy referral centre, 12 
(14.2%) of 84 patients with PME had Lafora body disease52. 
 
1.6.2.10 Management 
Control of seizures should be attempted with antimyoclonic drugs, especially valproic acid, 
clonazepam, and piracetam47.   
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1.6.3 CORTICAL TREMOR, FAME AND ADCME 
In 1990, Ikeda et al described the entity of cortical tremor for the first time in the Western 
literature107.  They reported two patients who had rare seizures and who had developed fine 
tremor in the 4th and 7th decades.   
 
1.6.3.1 Diagnosis 
Since 1990, a number of similar conditions have been described from Japan, typically 
characterized by a benign clinical course, with rare seizures, normal cerebellar function, 
absence of dementia and and associated with tremor108.  The tremor can be demonstrated to 
be of cortical origin, and represents a manifestation of cortical reflex myoclonus. 
These conditions include: 
1. “Cortical tremor” (reported by Ikeda in 1990107) 
2. “Benign adult familial myoclonus epilepsy (BAFME)” (reported by Kuwano in 1996 109 
) 
3. “Familial cortical myoclonic tremor” (reported by Terada in 1997108) 
4. “Familial cortical tremor with epilepsy” (FCTE) (reported by Okuma in 1997) 110 
5.  “Familial benign myoclonus epilepsy of adult onset” (reported by Okino in 1997111) 
6. “Familial adult myoclonic epilepsy (FAME)” (reported by Plaster in 1999) 
In addition, similar conditions have been described in European families, namely ADCME 
with complex partial and generalized seizures and Familial Cortical Tremor, Epilepsy and 
Mental Retardation8;112. 
 
1.6.3.2 Inheritance 
In Ikeda’s report, one of the patients had six siblings, of whom two had a similar tremor, 
indicating a possible AD condition107.  Terada et al described three pedigrees with AD 
inheritance108 and Okuma reported on a further Japanese family in which five members in 
three generations had a similar condition, and three further families in which the disorder 
was present in two successive generations110.  Kuwano reported five families, with age of 
onset between 18 and 50 years with AD inheritance109.  Plaster et al reported that AD 
inheritance was a criterion for FAME, and that penetrance was unusually high5.   
 
1.6.3.3 Myoclonus and Cortical Tremor 
Wilkins et al had previously published on a group of patients in an article entitled ‘Primary 
generalised epileptic myoclonus: a frequent manifestation of minipolymyoclonus of central 
origin”113.  However, since the distribution and latency of the recorded premovement 
discharge, Ikeda et al coined the term “cortical tremor” although the movement resembled 
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polyminimyoclonus.  The tremor was fine and shivering-like, brought out by outstretched 
posture and accentuated by action107   
In Okino’s report of 1997, rare seizures occurred, usually preceded by a worsening of 
myoclonic movements.  Examination showed “fine myoclonus in the distal portion of the 
upper limbs”in one patient, whose 81 year old mother was reported to have “marked 
generalized myoclonus” after a seizure111.  Okuma described “tremulous shivering-like 
movements” with posture-holding110. 
 
1.6.3.4 Clinical Manifestations 
Table 2 reporting radiological findings and Table 3 reporting results of linkage analysis are 
found on page 52 and 53 respectively.  Table 16 concerning progression of disease and 
Table 18 concerning clinical features are available on page 206 and 212 respectively. 
Ikeda’s initial report described two patients who had rare seizures and who had developed 
fine tremor in the 4th and 7th decades.  Seizures occurred twice in the older patient and the 
younger one had “several seizures every 1 to 2 years, especially when tired or tense”.  The 
tremor generalized prior to the seizure in both cases.  There were no cerebellar signs in 
either patient.  In one of the patients, “the involuntary movement was so severe that 
intensive medication was required to prevent generalized convulsion  (sic)”107.  
 
In familial benign myoclonus epilepsy of adult onset, three families with onset of illness 
between the third and fifth decades were reported111.  The illness was characterised by jerks 
in arms and eyelids, which were exacerbated by movement.  There was no dementia, 
cerebellar ataxia or other characteristic signs of PME.  However, one 64 year old patient had 
slowly progressive generalized myoclonus, and had suffered seizures several times over the 
two decades prior to admission.  At admission, he was mildly drowsy with generalized 
myoclonus.   
 
BAFME has also been associated with night-blindness and abnormalities on 
electroretinography.  Manabe reported a family in which a 34-year-old proband developed 
night-blindness at the age of 13 and tremulous finger movements three years later114.  On 
examination the only abnormal finding was that of fine tremor in the fingers and myoclonus 
in the arms and legs at rest.  In particular, the reflexes were normal and there was no 
dementia present.  MRI scan was normal.  The proband’s mother had myoclonus of the 
arms and legs when tired from the age of 30, and generalized seizures from age 33.  The 
proband’s sister had myoclonus in the arms and legs, and fine tremulous movements in the 
fingers114. 
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In 1997, there was a report by Terada et al, originating from the same group which had 
originally coined the term “cortical tremor”, and now termed “Familial Cortical Myoclonic 
Tremor”108.  The patients had ‘tremulous involuntary movements’ which were rhythmic and 
seen in both the upper and lower limbs, and were exacerbated by posture and action.  They 
had been previously diagnosed as having familial essential tremor.  In six patients from three 
families, tremor commenced at a mean of 37 years and gradually progressed.  Three 
patients had episodes of loss of consciousness, but these were extremely rare, “on one to 
three occasions throughout the clinical course”.  One patient had akinesia, rigidity and gait 
disturbance with a limited response to dopamine replacement, but otherwise the neurological 
examination was normal.  Terada et al proposed the following criteria for the condition108. 
1. AD inheritance. 
2. Adult onset. 
3. Slowly progressive, but mild clinical course. 
4. Relatively rhythmic small jerks predominantly involving the distal limbs, markedly 
enhanced during movement. 
5. Infrequent attacks of loss of consciousness. 
6. No other neruological findings (no dementia or ataxia). 
7. Electrophysiology of :  
7.1. Generalized EEG spikes, with photoparoxysmal response. 
7.2. Giant SEPs. 
7.3. Enhanced C-reflex. 
7.4. Cortical spikes on jerk locked averaging (JLA). 
7.5. Preservation of normal bereitschaftpotential (BP). 
 
Okuma described “Familial cortical tremor with epilepsy” in which the clinical features were 
“tremulous, shivering-like movements” and rare seizures110.  On standing the proband had 
rhythmic oscillations of the legs resembling orthostatic tremor.  He had a seizure three 
decades previously at the age of 25.  All of the four other members of the family who were 
described had a normal neurological examination with fine tremor of the fingers with posture 
holding.  CT and MRI of the brain were normal in the proband and his daughter.  Seizure 
onset occurred in the proband’s mother at 32 years, and in his daughter at 20, and in his son 
at age 32. 
 
In a second report by Okuma et al, three additional families with seven affected patients 
were described115.  The proband had a seizure at the age of 20 and had tremulous finger 
movements from that time.  At the age of 39, she was on anticonvulsants which controlled 
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the seizures, and when these were stopped myoclonus reappeared.  The tremor was not 
progressive and there was no evidence of corticospinal or cerebellar dysfunction. 
 
The entity of FAME was reported by Uyama in 1996116.  There were four families, with 27 
affected members presenting over three generations with high penetrance.  The following 
characteristics were noted 5: 
1. Adult onset at a mean age of 37.5 years. 
2. The course was benign, without associated ataxia or dementia. 
3. The condition had been only reported in Japan. 
4. The clinical features of FAME were myoclonic jerks in the arms and legs, tremulous 
finger movements and rare generalized tonic-clonic seizures (GTCS). 
5. Myoclonic jerks could be precipitated by fatigue, insomnia and photic stimuli. 
6. The EEG showed generalized spikes and polyspikes. 
 
In 1999, the FAME locus was mapped to chromosome 8q245 by Plaster et al.  BAFME was 
mapped to the same locus, termed the FAME 1 locus (8q23.3-q24.11) by Mikami et al. who 
used microsatellite markers to demonstrate a maximum multipoint LOD score of 5.42 in the 
interval between the markers D8S555 and D8S17796.  The authors of the latter report 
pointed out the following characteristics: 
1. Autosomal dominant inheritance, tremulous finger movements and myoclonus of 
extremities. 
2. Infrequent epileptic seizures. 
3. EEG showed polyspike and wave with marked photosensitivity. 
4. Features of cortical myoclonus were present, including enlarged SEPs, enhanced 
C reflexes and positive spikes preceding myoclonus. 
5. Benign nonprogressive course without cerebellar ataxia and dementia6.  
 
Mikami et al described a family with three affected generations and 17 affected patients6.  
The onset of tremulous movements in fingers or myoclonus of the extremities typically 
occurred at an average age of 30.5 years (range 18-45 years).  In half the patients 
myoclonus involved both arms and legs, and was restricted to the arms in the remainder.  
Seizures occurred infrequently, often less than four times throughout the lifespan of the 
patient.  Two of the 17 patients did not have generalised seizures.  No evidence of cerebellar 
ataxia of dementia was seen over an observation period of more than a decade.  CT 
demonstrated mild atrophy of the cerebral cortex in three patients.   
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Subsequently, a four-generation family with FAME was reported from Spain: ten living and 
three deceased family members had “involuntary rhythmic movements of the extremities”, 
the mean age of onset being 41 years7.  The movements were described as myoclonic, 
rather than tremulous.  Eight of the 13 had generalized tonic-seizures, the mean age of 
onset being 44.6 years.  EEG showed polyspike and wave discharges without 
photosensitivity, and electrophysiological findings were compatible with cortical myoclonus7. 
 
Van Rootselaar described a family from the Netherlands with FCTE117.  There were 13 
definite affected patients, and three probably affected.  The proband had finger twitching, 
tremor, and trembling of his legs, worsened by stress and after waking.  He had a 
kinesogenic tremor with superimposed myoclonus in his fingers and toes.  He had rare 
seizures.  Linkage was negative for the FAME 1 and 2 loci118. 
 
A European family was described by Elia et al. with cortical tremor, epilepsy and mental 
retardation, although mental retardation was present in only one individual112.  The family 
had a six generation pedigree with seven affected individuals and appears to have been 
transmitted only through the female line, suggesting a mitochondrial disorder.  Two 
individuals in the first generation only had finger tremor.  One patient had no seizures, and 
seizure onset was age five in two patients, and age 18 in another. Seizures were well 
controlled by Phenobarbital in two patients.  MRI scan showed mildly enlarged subarachnoid 
space and lateral ventricles in two patients, and was normal in a third. 
 
In 2001, Guerrini et al described a family from Tuscany of 11 individuals over five 
generations characterized by similarities to FAME but also having complex partial seizures8. 
The condition had linkage to chromosome 2p11.1-q12.2, and linkage to the locus for FAME 
was excluded.  This condition was termed ADCME8.  The features of the condition were: 
1. Onset in adulthood.  The age of onset of myoclonus range from 12 - 50 years, with a 
mean of 23 years and typically slightly preceded or commenced at the same time as the 
first GTCS.   
2. The course of the illness was not progressive. 
3. Distal, semi-continuous, rhythmic myoclonus resembling tremor of variable ampitude.  
Myoclonus of the hands was present at rest, but exacerbated by maintenance of posture.  
There were also isolated multifocal jerks of the arms proximally and intermittent 
myoclonus of eyelids.   
4. Of the eight family members, two had only one or two isolated GTCS, and three had 
seizures in remission on treatment, in two for 20 years. One had treatment resistant 
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GTCS, two had intractable complex partial seizures, and one had complex partial 
seizures that responded to treatment. 
5. Three patients had mild to moderate mental retardation and one borderline intellectual 
functioning, and in the remaining three patients intelligence was below average.   
6. EEG abnormalities included features of primary generalized epilepsy as well as 
frontotemporal or focal temporal spike discharges. 
 
Electrophysiological testing was compatible with myoclonus of cortical origin.  MRI imaging 
was normal.  This family had two phenotypes: a core syndrome of rhythmic myoclonus and 
GTCS, and a more severe phenotype associated with complex partial seizures.  It was 
proposed that this could have been the consequence of a gene causing widespread cortical 
hyperexcitability, but particularly involving the frontotemporal regions8. 
 
Two further Italian families were described with linkage to 2p11.1-q12.29.  These families 
had cortical tremor, and seizures were present in 40 % of one family and 60 % of the other, 
but were rare (one to five attacks) in those affected.  There was no dementia present, and 
neurological examination was normal apart from the presence of tremor.  This locus has 
been termed the FAME 2 locus. 
 
Subsequently, Striano et al reported a new BAFME pedigree, with possible linkage to the 
FAME 2 locus, since lod scores only reached 1.5510.  Seven with the condition had cortical 
tremor and GTCS was present in six.  MRI of the brain was normal in three patients.  The 
authors proposed that the condition was found worldwide, but genetically heterogenous, with 
Japanese families linked to the FAME 1 locus and European ones to the FAME 2 locus10.  
Similarly, Okuma and Mizuno pointed out that FAME, BAFME and familial cortical tremor 
were likely to be one entity119.   
 
FAME associated with migraine has been described in a five generation family from Turkey 
in which myoclonus started in the third or fourth decades120.  Generalised seizures were 
extremely uncommon, the only feature of note on examination was postural tremor of the 
hands, and both myoclonus and migraine were decreased by valproic acid120. 
 
1.6.3.5 Pathophysiology 
Since BAFME responds to sodium valproate and diazepam, and since GABA receptors are 
the site of action of these drugs, linkage studies of the DNA polymorphisms of the GABA 
receptors, GABARβ1, GABARβ3 and GABARα6 were performed.  However, the gene for 
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BAFME was not linked to a gene for the GABA receptors109.  Lack of neurodegeneration in 
FAME may suggest that the disorder is one of membrane excitability5. 
 
1.6.3.6 Special Investigations 
Neuroradiological findings are summed up in Table 2.  Predominanly, both CT and MRI are 
normal in a wide range of reports.  Mild cerebellar and cerebral atrophy have been noted 
relatively infrequently. 
Table 2. Neuroradiological findings in FAME and related families. 
 CT MRI 
Ikeda, 1990 
Periventricular lucency 
Moderate cerebral atrophy 
in patient aged 75. 
 
Okino, 1997  
Infarction in cerebellar 
hemisphere (patient 1). 
Normal (patient 3). 
Multiple lacunar infarctions 
(patient 4). 
Okuma, 1997  Normal (2) Normal 
Okuma, 1998  Normal Normal 
Plaster, 1999 Normal Normal 
Elia, 1998  
Mild enlarged subarachnoid 
space and lateral ventricles 
in two.  Normal in one. 
Mikami, 1999 Mild atrophy in three  
Guerrini, 2001  Normal (six) 
Labauge, 2002  Normal (five) 
Van Rootselaar, 2002  
Slight cerebellar atrophy 
(two) 
Normal (two) 
De Falco, 2003  Normal (nine) 
Van Rootselaar, 2004 Atrophy, particularly 
cerebellum  
Manabe, 2002  Normal 
Striano, 2004  Normal 
Saka, 2000  Normal 
Guerrini, 2001  Normal (six) 
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The EEG shows generalized spike and wave discharges108;111. and photosensitivity is often 
present108;109;115.  Recordings suggested origin of the movement in the sensorimotor area, 
possibly in hyperexcitable motor cortex107 and results of  electrophysiological testing appear 
to be uniformly compatible with cortical reflex myoclonus107;108;111;115.  Electrophysiological 
features of the European family with mental retardation were similar to those found in the 
families reported from Japan, including photosensitivity on EEG112. 
 
1.6.3.7 Pathology 
In the Japanese literature, normal findings were reported in three patients with myoclonus 
and epilepsy, some of whom had “myoclonic tremor” (121cited in 110). 
Van Rootselaar reported on a case of FCTE in which there was extensive mineralization of 
vessel walls and neurons in the globus pallidus.  The cerebellum showed Purkinje cell loss 
with Bergmann gliosis, atrophy of the molecular layer and abnormal Purkinje cell 
morphology.  Gliosis of the cerebellar white matter and cell loss and gliosis of the dentate 
nucleus were present122. 
 
1.6.3.8 Genetics 
Linkage analysis of known studies is presented in Table 3. 
Table 3.  Linkage analysis  in FAME and related families. 
 
1.6.3.9 Management 
Myoclonus, including finger tremor, and seizures were effectively treated with a combination 
of clonazepam and valproic acid108;115. 
Reference Origin 
2p11.1-q12.2 
FAME 2 
8q24 FAME 1 
Plaster, 1999 Japan 
 + 
Mikami, 1999 Japan 
 + 
Guerrini, 2001 Tuscany + - 
De Falco, 2003 Naples + - 
Labauge, 2002 Southern Spain 
 - 
Van Rootselaar 2002; 
Bouwer, 2002 
Netherlands - - 
Striano, 2004 Italy + (Lod score 1.55) - 
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1.6.4 HEREDITARY DENTATORUBROPALLIDOLUYSIAN ATROPHY 
1.6.4.1 Diagnosis 
Systemic degenerations of the extrapyramidal nuclei have been classified by Jellinger into 4 
groups123: 
1. Pure pallidal atrophy (PA), with lesions found only in the efferent pallidal system. 
2. Pure pallidoluysian atrophy (PLA). 
3. Pallidal degeneration with involvement of the striatum or Substantia Nigra (PLNA). 
4. Combinations of the first 3 types with other “cerebrospinal degenerations” such as 
pallidoluysiodentate atrophy (PLDA). 
Myoclonic epilepsy has not been associated with PA, PLA or PLNA, but is described in the 
group of PLDA.  
There are two early reports of pathological system degenerations of the pallido-Luysian and 
dentato-rubral pathways:  
1. In 1946 Titica and Van Bogaert described a patient with progressive dementia and 
“hemiballismus”, described as “ involuntary contorting movements of the left arm and 
grimacing”, associated with visual loss124.  His older sister had cataracts, marked 
intention tremor, and progressive ataxia.   
2. Smith described a patient with dysarthria, choreoathetosis and cerebellar signs125.  
Autopsy showed changes predominantly in the cerebellofugal and extrapyramidal 
systems with marked neuronal loss in the dentate nuclei, loss of Purkinje cells, and 
marked demyelination of the subthalamic nuclei and the globus pallidus.   
 
Although two cases of familial PME from Japan were described in 1965, with pathology 
involving the brainstem and cerebellum 126 , the condition known as DRPLA, and 
characterized by AD inheritance, was first described in Japan in 1977.  There were four 
cases from three separate Japanese families with AD myoclonic epilepsy, with pathological 
findings of degeneration of the dentate nuclei, superior cerebellar peduncles, and the pallido-
luysian system (127 cited in 128).  DRPLA was first described in the Western literature in 1978 
by Takahata129. 
 
1.10.2 Clinical Manifestations 
In 1982, Naito described five different families with myoclonus, epilepsy, ataxia, dementia 
and choreoathetosis, all of whom had degeneration of the dentatorubral and pallidoluysian 
systems2.  He noted that this was a new neurologic disease, “hereditary dentatorubral-
pallidoluysian atrophy”, with the following unique features2: 
(1) A PME syndrome with or without cerebellar ataxia or choreathetosis or both. 
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(2) Pathological findings of dentatorubral-pallidoluysian atrophy. 
(3) AD heredity.   
Iizuka et al expanded the clinical phenotype, and distinguished two clinical types of DRPLA 
(1984) in addition to PME128:  
(1) Ataxo-choreoathetoid type: ataxia was prominent in the ataxo-choreoathetoid type in the 
early stages of the illness, and choreoathetoid movements more prominent with disease 
progression.  Disturbances of external ocular momements were commonly observed128.  
(2) Pseudo-Huntington type: Choreic movenents and dementia were always predominant, 
and ataxia was mild or latent throughout the course. 
 
The disorder has been most commonly reported from Japan, but cases have been described 
in Europe130.  Age of onset varies from childhood to late adulthood.  The differential 
diagnosis includes Huntington’s disease, Parkinson’s disease, mitochondrial 
encephalopathies and cerebellar ataxias131.  Myoclonus, epilepsy and cerebellar features, 
which include ataxia, postural and intention tremor, are characteristic of DRPLA130.  
Hyperkinetic involuntary movements and rigidity may be related to involvement of the 
pallidofugal system, and may be difficult to distinguish from Huntington disease, possibly 
since they may mask the cerebellar signs130.  
In general, patients with disease of early onset have a more rapid progression and manifest 
as PME, whereas those presenting later have cerebellar ataxia, choreoathetosis and 
dementia, although there are exceptions to this in families of non-Japanese descent2 132. 
 
1.6.4.3 Inheritance 
DRPLA is inherited as an autosomal dominant disorder, and in common with many triplet 
codon repeat disorders, there is a correlation between repeat number and age of onset of 
the illlness133 and anticipation is present129. 
 
1.6.4.4 Special Investigations 
MRI may demonstrate atrophy of the cerebellum and brainstem, correlating with the size of 
the trincucleotide CAG repeat expansion 134.  T-2 weighted high intensity signal change is 
also in the white matter and brainstem135. 
 
1.6.4.5 Neuropathology 
There is neuronal loss in the cortex, thalamus and chromatolytic changes in the neurons of 
the pons, locus ceruleus, hypoglossal and dorsal vagal nuclei.  In the cerebellum, the 
dentate nuclei showed neuronal loss and chromatolytic changes, and reduction in the 
number of Purkinje cells129.  Some patients also showed neuronal loss in the globus pallidus 
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and gliosis of the subthalamic nucleus129;129.  Patients may have severe degeneration of the 
dentate and axonal loss in the superior cerebellar peduncle2;136. 
 
1.6.4.6 Genetics 
The gene locus for DRPLA is located at chromosome 12p13.31 and the gene codes for a 
protein termed atrophin 1.  DRPLA is due to expansion of an unstable trinucleotide (CAG) 
repeat137.  In the Japanese population the number of repeats is highly polymorphic with a 
distinct, bimodal distribution of normal and expanded alleles133.  In normal individuals allele 
sizes vary between 7 and 23 copies, whereas patients with DRPLA have expansions in the 
range of 49 to 75 repeats138. 
 
1.6.4.7 Epidemiology  
DRPLA is described worldwide, although is commonest in Japan, where the incidence is 0.2-
0.7 per 100 000 139;140. 
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1.6.5 NEURONAL CEROID LIPOFUSCINOSES 
NCL consists of a group of genetically determined neurodegenerative disorders 
characterized by the accumulation of abnormal amounts of fluorescent lipopigments, which 
include lipofuscin and ceroid, within neuronal perikarya141;142.  
The disorder was initially classified as a form of amaurotic familial idiocy due to the presence 
of visual loss and dementia.  The histological accompaniment of amaurotic  familial idiocy 
was widespread distention of neurons by lipid material.  With time, infantile amaurotic familial 
idiocy (Tay-Sachs disease) was separated from late infantile/juvenile amaurotic familial 
idiocy (NCL).  The adult variant of NCL was recognized in 1925. 
 
There are four clinical and genetic subtypes 143 
1. The infantile type does not present as a PME syndrome47. 
2. The late infantile form (Janský-Bielschowsky disease) is an AR disorder that starts 
between the ages of 2 and 4 years with a wide range of seizure types including atypical 
absence, atonic and tonic-clonic seizures68.  Shortly after the onset of seizures, ataxia, 
dementia and stimulus-sensitive myoclonic seizures develop, with myoclonus being a 
prominent feature, including “myoclonic status epilepticus” 143142.  The subsequent course is 
rapid and is characterized by resistant epilepsy, spasticity and blindness 142 143.  Death 
typically occurs between 6 to 9 years142 144. 
3. The juvenile type (Spielmeyer-Vogt-Sjögren Disease), more commonly known as Batten’s 
disease145, develops between the age of 4 and 10 years.  As with most forms of NCL, visual 
failure is usually the first symptom, and subsequently seizures, dysarthria and dementia 
develop, often with severe rigidity143.  A wide variety of seizures types are seen, including 
myoclonic, tonic-clonic and absence seizures 49.  Optic atrophy, macular degeneration and 
attenuation of retinal vessels may occur 47.  Life expectancy ranges between 5 and 13 years 
143
.  
4. The adult form (Kuf's Disease) is uncommon and more clinically heterogeneous 144. The 
onset is typically about the age of 30 years but may range from adolescence141 until the 5th 
decade146.  It can present as a PME, although cases may also present with a picture of 
dementia and extrapyramidal or cerebellar disturbance143.  A case of progressive cerebellar 
ataxia, associated with atrophy and fasciculations, without cognitive impairment and 
commencing at the age of 43 has also been described147.  Blindness is notably absent, and 
the optic fundi are normal, although retinal storage of lipofuscin can occur148.  The clinical 
course from onset to death is approximately 15 years 141 .   
 58 
 
1.6.5.1 Diagnosis 
Diagnosis presently requires the demonstration of characteristic inclusions by electron 
microscopy, typically of both skin and muscle142. 
 
1.6.5.2 Inheritance 
The disorder has AR inheritance. However, one family with adult onset and AD inheritance 
has been described: 11 members of a four generation family from New Jersey of English 
origin with PME developed a disorder in their 4th decade characterized by dementia, 
nystagmus, myoclonus, and associated generalized tonic-clonic seizures.  Progressive 
cerebellar ataxia was present, and the average duration of illness was 7 years3. 
The genetics of the various forms of NCL demonstrates that they are heterogeneous 
disorders with common pathologic and clinical features (Table 5).   
   
1.6.5.3 Myoclonus 
In the AD form of NCL, presenting as PME, myoclonus was associated with tremor and 
voluntary movement increased the severity of myoclonus and could elicit massive 
myoclonias3.  In the juvenile form of NCL, myoclonus is described as fragmental, segmental 
and massive49.  In Kuf’s disease it is described as “elementary or complex, of variable 
extent, and occurs in irregular paroxysms, sometimes synchronous in all affected muscles, 
resulting in universal myoclonic discharges”22. 
 
1.6.5.4 Pathophysiology 
Widespread accumulation of autofluorescent lipopigment inclusions in various organs is a 
characteristic feature.  The inclusions, which under the electron microscope appear as 
fingerprint profiles, or as curvilinear and granulomatous bodies, may not always be detected 
or correctly interpreted, leading to missed diagnoses149.  Early investigators were struck by 
the widespread nature of abnormal neurons, and Zeman et al stated “in our collective 
material there was no type of neuron,nor any topographical region consistently exempt from 
lipopigment accumulation” 143.  However, the most severe nerve cell loss occurs in the 
cerebellar cortex. 
The curvilinear profiles, which are comprised of lamellae showing alternate light and dark 
lines, are contained in a membrane-bound cytosome, as are fingerprint profiles142.  The 
lipopigment accumulates at a much earlier age than lipofuscin of aging, and differs from it in 
that it predominantly contains ceroid.  Pronounced and selective neuronal vulnerability and 
total loss of small pigment-laden stellate cells, a local circuit neuron, has been demonstrated 
in the cortex of patients with juvenile neuronal ceroid lipofuscinosis150.   
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1.6.5.5 Special Investigations 
Assay of urinary sediment dolichols, which are lipid intermediates in the biosynthesis of 
glycoproteins, shows levels that are ten times higher than controls, and are particularly 
elevated in the infantile and late infantile forms 151.  Findings of special investigations are 
outlined in Table 4. 
The clinical suspicion of NCL may be supported by electrophysiologic studies with the late 
infantile and juvenile types having characteristic findings on the EEG, electroretinography 
and VEP examination47.   
Table 4 Histological and Immunochemical Diagnosis (After Pearlman and Naidu, 
2004) 
 
CLN1 CLN2 CNL5 CNL3 CNL4 
Tissue Skin Skin Skin Skin Skin 
Diagnosis Rectal Rectal Rectal Rectal Rectal 
Electron Micrograph Conjunctiva Conjunctiva Conjunctiva Conjunctiva Muscle 
Inclusions Granular Curvilinear Curvilinear Fingerprint/ 
Curvilinear 
Fingerprint/ 
Granular 
Macular degeneration + + + + - 
EEG-isoelectric 1.5-2 years - - - - 
Visual evoked potential - +++ +++ - - 
MRI-brain atrophy ++ + + + + 
Hypointensity,thalamus, 
and basal ganglia T2-
weighted images 
+ + + - - 
 
Diagnosis requires the demonstration of characteristic inclusions by electron microscopy.  
These can be found most simply in eccrine secretory cells, as well as in neurons, appendix, 
skeletal muscle and rectal mucosa142;148;148.  The inclusions take various forms with 
curvilinear profiles being characteristic of a late infantile NCL, and fingerprint profiles being 
usual in the juvenile and adult forms, although a number of variations occur142.  In Kuf’s 
disease there is restricted, rather than generalized, neuronal involvement.  The electron-
microscopic evaluation of the skin may miss inclusions, and rectal biopsy has a higher rate 
of diagnostic success, although it is not commonly studied145. 
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1.6.5.6 Neuropathology 
In the dominant form of NCL, neurons from brainstem, frontal cortex, thalamus and 
cerebellum showed extensive PAS positive granule accumulation with neuronal loss in the 
substantia nigra.  There was severe loss of Purkinje cells in the cerebellum and diffuse 
demyelination of the cerebellar and cerebral hemispheric white matter3;3.  In infantile NCL, 
cortical neuronal loss and astrogliosis are seen, with a reduction in the density of white 
matter fibres.  The basal ganglia showed similar changes, and there was variable Purkinje 
cell loss in the cerebellum with the dentate nucleus showing a large number of lipid flakes in 
degenerated neurons152.  In a case of Kuf’s disease, severe neuronal dropout was observed 
thoughout the cortex, with remaining neurons loaded with ceroid- lipofuscin granules.  In the 
basal ganglia, basal ganglia, and the cerebellum had Purkinje cell loss and all neurons in the 
dentate were distended with ceroid- lipofuscin148.  In a case with onset at age 49, 
widespread distention of neurons with lipofuscin was noted in the cortex, basal ganglia and 
spinal cord, with widespread Purkinje cell loss and neuronal loss in the dentate, without 
evident neuronal loss in the cerebral cortex146 
 
1.6.5.7 Genetics 
Loci for the various forms of NCL are outlined in Table 5. 
Table 5 Genetic Information of NCL Variants (after Schiffman, 2004 and Gardiner, 
2002) 
Variant Gene 
Name 
Gene Product Chromosome 
Infantile CLN1 Palmitoyl protein thioesterase 1p32 
Late infantile CLN2 Tripeptidyl peptidase 11p15 
Late infantile 
Finnish variant 
CLN5 "Battenin" 13q21.1-q32 
Late infantile 
variant 
CLN6 
  
Juvenile CLN3 Endosomal/lysosomal transmembrane 
protein 
16p12 
Adult  CLN4   
 
1.6.5.8 Epidemiology 
The NCL group of disorders appears to be panethnic, with a special predilection for the 
infantile subtype in Finland. The frequency is reported to be as high as 1:12,000 to 1:25,000 
live births153, and in Finland the infantile form alone has an incidence of 1:13,000 live births. 
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1.6.6 GM2 GANGLIOSIDOSES 
Tay-Sachs disease, the prototype of the lysosomal sphingolipid storage disorders, is a 
hereditary disorder involving the accumulation of a ganglioside, GM2.  The enzymatic 
defect in Tay-Sachs disease is a deficiency of the lysosomal enzyme beta-hexosaminidase 
A (HEX A or GM2 gangliosidase)154, which is responsible for the cleavage of a terminal N-
acetylgalactosamine from the GM2 ganglioside. 
 
1.6.6.1 Diagnosis 
Diagnosis is on clinical grounds with confirmation by biochemical analysis of beta-
hexosaminidase A in serum, leucocytes and skin. 
 
1.6.6.2 Inheritance 
All of the variant forms of GM2 gangliosidosis are inherited as an AR trait. 
 
1.6.6.3 Myoclonus 
Watson and Denny-Brown described three families with familial amaurotic familial idiocy, in 
which myoclonus was present with movement or sudden stimuli155.  In addition, seizures 
were precipitated by passive movement, sound and light in one case.  In the third case a 
sudden passive movement would result in violent, clonic contractions of the muscle at first 
confined to the joint moved, but spreading rapidly if passive stretch was repeated.  Sudden 
loud sounds or light flashes led to symmetrical clonic flexion movements of both upper and 
lower limbs and if this was repeated at a particular rate, the clonic response became self-
sustained and resulted in a generalized seizures. 
 
1.6.6.4 Clinical manifestations 
Infantile onset  
The infantile onset form is characterized by an excessive startle response.  As the disease 
progresses, motor development slows and the children are unable to learn to sit, with 
associated axial hypotonia, increased tone, hyperreflexia and macular cherry-red spots156.  
During the second year of life, macrocephaly becomes apparent, presumably caused by 
intraneuronal storage of gangliosides and other lipids, and concomitantly, seizures may 
develop which can be induced by auditory stimuli.  Myoclonus is characteristic of the initial 
stages 22.  Between the second and third years of age the children become severely 
cognitively impaired, decerebrate, blind, and unable to respond to most stimuli.  
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Late-onset.  
The late-onset (juvenile/adult) variant of GM2 gangliosidosis, and has an indolent clinical 
presentation.  Although this variant has been called the "adult-onset variant," the illness 
usually begins in adolescence.  Early gross motor development is normal, although 
affected individuals are are often considered clumsy and awkward as children.  An 
intention tremor, frequently seen in the first decade, may be the first indication of a 
neurologic problem.  Dysarthria also develops early, and difficulties in school may also be 
apparent.  Myoclonus or seizures may be prominent early symptoms 22;68.  Dementia, 
ataxia, spasticity and dystonia present later68;156.  During adolescence, proximal muscle 
weakness begins with fasciculations and atrophy that has an appearance of juvenile-onset 
spinal muscular atrophy157.  Development of a broad-based ataxic gait usually follows, 
making walking even more difficult.  Patients have may present in adulthood with 
depression, visual hallucinations, paranoid delusions and catatonic states158 159.  
 
1.6.6.4 Special Investigations 
Enzyme analysis remains the most effective means of diagnosing patients with GM2 
gangliosidosis.  Although neuroradiological studies may be normal at first, the CT head 
scans in children with GM2 gangliosidosis eventually show low density in the basal ganglia 
and white matter, and increased signal intensity on T2-weighted MRI 160.  Late-onset forms 
of GM2 gangliosidosis have prominent cerebellar atrophy, especially of the vermis, but a 
normal-appearing cerebral cortex on CT or MRI scans, despite cognitive decline and 
psychosis158. 
Initially, the EEG in Tay-Sachs disease will frequently show slowing, but when seizures 
develop multifocal spikes may appear.  Watson and Denny-Brown’s case showed 
generalized synchronous and asynchronous bilateral spike and slow wave activity on a 
generally slow background with periodic bursts of slow waves155.  
Electron microscopic analysis of skin, conjunctiva, and rectal mucosa biopsies frequently 
shows storage of membranous cytoplasmic bodies or other electron-dense storage material 
within nerve cells and myelinated and unmyelinated axons161.  Neuropathological findings 
characteristically are ballooning of neurons, with massive intralysosomal accumulations of 
lipophilic membranous bodies. 
 
1.6.6.5 Neuropathology 
A child with seizures and myoclonus came to autopsy, where all neurons were seen to be 
distended with lipid granules; there was extensive degeneration of cerebral cortex, and 
involvement of basal ganglia including globus pallidus, putamen and thalamus.  In the 
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cerebellum, there was diffuse atrophy, with a virtually absent granular cell layer, marked 
reduction in Purkinje cells, and widespread gliosis162. 
 
1.6.6.6 Epidemiology 
Tay-Sachs disease is inherited as an AR disorder.  People of Eastern or Central European 
Jewish ancestry have a predilection for this disease, but other populations, specifically 
French-Canadians, also have a higher than average incidence of the disease.  The carrier 
frequency is estimated to be 1 in 31 in the Jewish population and 1 in 277 in non-Jewish 
populations163.  
   
1.6.6.7 Management 
Valproic acid appears to be the most efficacious anticonvulsant, and clonazepam and other 
benzodiazepines may prove effective in controlling severe irritability and psychiatric 
symptoms159. 
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1.6.7 SIALIDOSIS 
The sialidoses are the least common of the major forms of PME68.  The term "sialidosis" 
refers to lysosomal enzyme defects arising from a  deficiency of neuraminidase (sialidase), 
the enzyme which cleaves the terminal sialyl linkages of several oligosaccharides and 
glycoproteins164.  Deficiency of the enzyme results in intralysosomal storage of glycoproteins 
in neuronal cells165.  Sialidoses have also been referred to as mucolipidosis I, since the first 
patients described with this enzyme abnormality shared features of both the 
mucopolysaccharidoses and the sphingolipidoses 165.  Subsequently a separate group of 
patients, the cherry-red spot-myoclonus syndrome, was described.  These patients 
presented in adolescence and adulthood, and are now referred to as sialidosis type I 166 167.  
 
1.6.7.1 Diagnosis 
The disorder is characterized by: 
1. Visual loss. 
2. A cherry-red spot on fundoscopy. 
3. Myoclonus, often associated with simultaneous polyspike and wave discharge on 
EEG. 
4. No mental deterioration. 
 
1.6.7.2 Inheritance 
The various forms of sialidosis are inherited in an AR manner 164. 
 
1.6.7.3 Myoclonus 
Stimulation, movement, or emotion usually induces the myoclonus 166.  As the disease 
progresses, the myoclonus may interfere with walking and sitting, and become so severe 
that it results in impaired bulbar function 47, particularly since the myoclonus is resistant to 
therapy49.  Generalized seizures in two patients have been noted to be the climax of a series 
of myoclonic jerks 166. 
 
1.6.7.4 Clinical Manifestations 
The primary neuraminidase deficiencies can be divided into two groups 164. 
Sialidosis-type I (primary neuraminidase deficiency without dysmorphism): 
The illness begins in adolescence (range 8-29 years) and patients usually have normal 
growth, physical appearance, and intellect168.  This form is associated with the myoclonus-
cherry-red spot phenotype, with severe myoclonus, progressive visual failure, tonic-clonic 
seizures and ataxia68;169.  Lens opacities and a mild peripheral neuropathy may occur 68.   
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Sialidosis-type II:  
Congenital, infantile and juvenile types occur, with mental retardation being the predominant 
feature of the first two types 169.  Patients are more severely affected than in type I, with early 
onset of a progressive mucopolysaccharidosis-like phenotype, with short stature, bony 
abnormalities, lens opacities, hearing loss and visceromegaly164;169.  This condition occurs 
predominantly in Japan68.  In addition, during adolescence most patients develop macular 
cherry-red spots associated with progressive decline in visual acuity.  This is associated with 
myoclonus and ataxia, tonic-clonic seizures, as well as dementia 68. 
 
Andermann described four members of three sibships from Quebec, who developed a 
tremor of the fingers, progressing to severe action and spontaneous myoclonus in the late 
teens and associated with clonic seizures170.  Renal failure developed rapidly three to four 
years after the onset of neurologic symptoms in three patients; in the fourth, it preceded the 
neurologic syndrome.  Assays of leukocyte alpha-neuraminidase revealed almost complete 
absence of activity. 
 
1.6.7.5 Pathophysiology 
A deficiency of neuraminidase results in excessive amounts of urinary and tissue 
concentrations of compounds containing N-acetylneuraminic acid. 
 
1.6.7.6 Special Investigations 
The presence of cherry-red spots in the macular region of the fundus and a downhill clinical 
course may make the sialidoses difficult to distinguish from Tay-Sachs disease or other 
lysosomal storage disorders. 
X-rays may show dysostosis multiplex, and vacuolated lymphocytes and bone marrow foam 
cells may be seen169.  Analysis of the oligosaccharides in urine distinguish sialidoses from 
other disorders of oligosaccharide metabolism, such as mannosidosis, fucosidosis or 
aspartylglycosaminuria.   
 
1.6.7.7 Pathology 
Allegranza reported a case characterized by myoclonus and GTCS, with features of cortical 
myoclonus171.  PAS positive material stained virtually the entire neuronal population of the 
brain and spinal cord.  In the olivary nuclei and dentate nucleus it formed an homogenous 
mass, being finely granular in other neurons.  The cerebral white matter was preserved.  
There was moderate neuronal loss in the substantia nigra, and there was loss of Purkinje 
cells with rarefaction of the granular layer.  In the spinal cord, the dorsal column nuclei 
showed severe neuronal loss. 
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1.6.7.8 Genetics 
Sialidoses arise from mutations in the neuraminidase gene172. 
 
1.6.7.9 Management 
The myoclonus is poorly controlled by medication. 
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1.6.8 MITOCHONDRIAL DISEASE   
The identification of mitochondrial diseases, and particularly MERRF, as a cause of PME68 
also led to a major controversy as to the causes and usefulness of the Ramsay-Hunt 
syndrome (discussed in section 1.5.)  MERRF is historically unique in two senses: it was the 
first disease in which maternal inheritance was clearly demonstrated, indicating a defect of 
mitochondrial DNA, and it was also the first disorder in which a molecular defect was 
associated with epilepsy173. 
 
1.6.8.1 Diagnosis 
The place of mitochondrial disorders as a cause of the PME syndrome was highlighted in a 
review of patients from the Montreal Neurological Institute by Berkovic46.  Eighty-four cases 
of PME in 53 sibships were studied.  Thirteen patients had MERRF comprising one family 
with multiple affected members and seven sporadic cases.  Myoclonus was usually the first 
symptom.  Myoclonus and ataxia were the central features in 11 cases, these patients 
having all previously been diagnosed as having RHS.  Clinical evidence of myopathy was 
usually absent or mild, but was sometimes prominent.  Less frequent features included optic 
atrophy, hearing loss, neuropathy, pes cavus, short stature, endocrine abnormalities and 
subcutaneous cervical lipomas. 
 
1.6.8.2 Inheritance 
The disorder is maternally inherited. 
 
1.6.8.3 Clinical Manifestations 
Onset is usually in childhood, although adult onset is not uncommon, with the mean age 
being 21 years (range 5-42 years)174.  Myoclonus and ataxia are constant features of 
MERFF, and tonic-clonic seizures are usual, with other features including short stature, 
hearing loss, optic atrophy, neuropathy, and migraine175 176-178.   
The prognosis of the disorder is variable, and mildly affected cases may not progress 173.  
Although dementia may occur, and significant neurological deficits such as cortical blindness 
are described, MERRF usually has a relatively long course and only mild behavioural and 
cognitive deficits 174.  The disease may vary in its extent in particular families, and otherwise 
asymptomatic older relatives may, for example, only have hearing loss173.   
It is possible that some reports of PME associated with Friedreich’s ataxia represent cases 
of MERRF.  Prominent amongst these are the twins originally reported by Ramsay-Hunt, 
who had myoclonus, ataxia, absent reflexes, pes cavus and loss of sensation in the legs 
(see Section 1.5.1).  Similarly, a report by Ziegler et al entitled Myoclonic Epilepsia Partialis 
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Continua and Friedreich Ataxia describes a patient who had myoclonus, generalized 
seizures and spike and wave discharges on EEG179.    
 
Similarly, the May-White Syndrome is a familial disorder with variable penetrance which 
causes PME associated with deafness and ataxia 53;180, and has been associated with a 
mitochondrial myopathy68.  
 
1.6.8.4 Special Investigations 
Lactate levels in serum or CSF may be elevated68, and skeletal muscle classically shows 
ragged-red fibers.  However, the latter are not a reliable marker and are not invariably found 
in affected members of well-studied families173.   
 
1.6.8.5 Pathology 
Baraitser reported on a 74 year old patient with a history of myoclonus, ataxia and 
deafness180.  The basal ganglia and brainstem were normal, apart from some gliosis of the 
inferior olive; there were foci of laminar necrosis in the pericallosal gyrus and loss of the 
pyramidal cells in Ammon’s horn.  In the cerebellum, there was neuronal loss in the dentate 
nucleus, reduction in white matter volume and mild reduction in Purkinje cells.  There was 
moderate pallor of the gracile tract in the spinal cord. 
Skre reported on a family with myoclonic epilepsy and dementia, associated with peripheral 
neuropathy and external ophthalmoplegia.  There was diffuse atrophy of the cerebral 
cortex181.  There was diffuse atrophy of the cerebral cortex, with demyelination of white 
matter, sponginess of the thalamus and minor changes in the striatum.  In the brainstem, 
there was degeneration of the pontine and red nuclei.  The cerebellum showed loss of 
Purkinje cells, myelin loss in the white matter and some atrophy of the dentate nucleus.  In 
the spinal cord, there was marked atrophy of the dorsal columns, with atrophy of anterior 
horn cells and Clarke’s columns.  Berkovic reported findings from three cases of MERRF: 
the cortex was normal, but the brainstem showed diffuse gliosis, and neuronal loss in the red 
nucleus and inferior olive46.  In the cerebellum, there was mild loss of Purkinje cells, 
considerable loss of neurons in the dentate nucleus and astrocytic gliosis throughout the 
white matter, densely around the dentate nucleus.  In the spinal cord, there was pallor of the 
dorsal columns.   
 
1.6.8.6 Genetics 
Molecular defects include the A8344G mutation of the tRNALys gene of mitochondrial DNA 
182
.  This mutation is also sometimes a cause of Leigh’s syndrome.  Two other mutations 
associated with MERRF are also in the tRNALys gene (T8356C and G8363A)138.  The gene 
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symbol is MTTK (previously MERRF).  Mutations associated with myoclonic seizures are 
also found in the tRNALeu gene, which is usually linked with mitochondrial encephalopathy, 
lactic acidosis and strokes183. 
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1.6.9 NEUROSERPIN MUTATIONS 
The protein neuroserpin has recently been found to be involved in the pathogenesis of a 
novel form of PME4.  Two families have been described, one from New York184, and one 
from Indiana185.   
 
1.6.9.1 Diagnosis  
The pathological hallmark is an eosinophilic inclusion body found in neurons, termed the 
neuroserpin body (NB).  Neuroserpin is a member of a large family of serine protease 
inhibitors. 
Berkovic has also reported on five cases of atypical inclusion body PME, a condition which 
may be similar to that described due to neuroserpin mutations186 187. 
 
1.6.9.2 Inheritance 
Inheritance follows an AD pattern.  In the report of Takao et al, the proband’s mother 
presented at age 25 with PME and died at age 37 years, and his brother was also affected 
with PME185.  A paternal uncle and sibling of a paternal grandmother died of epilepsy with 
psychosis and pathologically confirmed Alzheimer disease respectively. The pedigree of this 
family consisted of 46 members over 7 generations. 
 
1.6.9.3 Clinical Manifestations 
The proband of the Indiana family had generalized seizures followed by action myoclonus, 
associated with a decline in work performance and memory185.  Various seizure types were 
noted, including myoclonic, complex partial and tonic-clonic, often refractory to medical 
treatment, with several episodes of status epilepticus. 
On examination, dysarthria and nystagmus were present, with hyperreflexia, except for 
absent ankle reflexes and distal sensory loss.  Myoclonus was noted in the extremities. 
Severe dementia developed by age 38, five years before death. 
As noted in Takao’s report, the proband’s mother had PME, and the proband had action 
myoclonus, and generalized seizures at night185.  The seizures subsequently worsened and 
included myoclonic and complex partial seizures.  Subsequently, he developed nystagmus, 
dysarthria, cognitive decline, hyperreflexia and a sensorimotor neuropathy.   
The individuals with the S49P mutation (New York family) presented at a later age, around 
the fifth decade, and developed dementia4;184, whereas members from both the Indiana and 
Oregon families, who have the S52R mutation, developed PME associated with dementia188 
4
. 
 
 71 
1.6.9.4 Pathophysiology 
Neuroserpin is a serine protease inhibitor mainly expressed in the central nervous system, 
and is a regulatory element of extracellular proteolytic events, inhibiting the activity of a 
tissue plasminogen activator.  Mutations are associated with polymerization of the protein. 
 
1.6.9.5 Special Investigations 
The proband of the Indiana family’s EEG showed frequent spike and wave complexes.  
Nerve conduction studies demonstrated a distal axonopathy.  MRI showed mild cerebellar 
atrophy at the age of 35. 
 
1.6.9.6 Pathology 
The most striking finding is the presence of NBs in neuronal perikarya and neuropil within 
the gray matter of cortex and spinal cord, with striking cortical pathology as well as 
involvement of subcortical nuclei 185.  
There was moderate neuronal loss in the cerebral cortex with numerous NBs.  The basal 
ganglia showed mild neuronal loss and gliosis associated with NBs.  In the brainstem, there 
was neuronal loss in the substantia nigra and locus ceruleus and in the cerebellum, 
moderate loss of Purkinje cells, and mild gliosis of the cerebellar white matter.  Gliosis was 
also noted in the dentate nucleus, although the cerebellar cortex and dentate were virtually 
free of NBs.  NBs were seen in the spinal cord, in Clarke’s nucleus, the posterior columns 
and anterior horn cells.  Takao et al. commented that the distribution of NBs involved 
practically all cortical layers of both association and projection cortices as well as multiple 
subcortical neuronal populations, making a specific clinicopathologic correlation relevant to 
the myoclonus difficult, with relative sparing of cerebellar cortex and dentate nucleus.   
 
1.6.9.7 Genetics 
Three families have been reported.  Mutations cause either a proline for serine substitution 
at residue 49 or an arginine for serine substitution at codon 52 in exon 2.   
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1.6.10 HALLERVORDEN-SPATZ SYNDROME (HSS) 
HSS is a rare cause of PME 68;189.  Myoclonus is generally uncommon in HSS and other 
similar conditions which are associated with axonal spheroids and excessive pigment in the 
basal ganglia190. 
 
HSS typically starts in childhood and adolescence and manifests with choreathetosis, 
dystonia, rigidity, bulbar dysfunction, and dementia, although onset may occasionally be in 
adulthood190.  The Hallervorden-Spatz eponym has unpleasant connotations due to 
Hallevorden’s involvement in euthanasia programs conducted in Nazi Germany, and 
suggestions have been made that the term “Panthothenate kinase associated 
neurodegeneration” replace HSS191.  However,mutations of the PANK-2 gene are not 
invariably found, indicating both genetic heterogeneity as well as nosological difficulties in 
using the term PANK-2 to replace HSP, and the term “neurodegeneration with brain iron 
accumulation type 1” has been proposed for this subgroup192. 
 
1.6.10.1 Diagnosis 
Obligate features (from Swaiman193): 
1. Onset during the first two decades of life. 
2. Progression of signs and symptoms. 
3. Evidence of extrapyramidal dysfunction, including one or more of the following: 
Dystonia, rigidity, and choreoathetosis.  
 
Corroborative features193: 
1. Corticospinal tract involvement. 
2. Progressive intellectual impairment. 
3. Retinitis pigmentosa or optic atrophy. 
4. Positive family history consistent with AR inheritance. 
5. Hypodense areas on MRI involving the basal ganglia, particularly the substantia nigra 
(most obvious in children during the first decade of life). 
6. Abnormal cytosomes in circulating lymphocytes or sea-blue histiocytes in bone 
marrow194. 
 
1.6.10.2 Inheritance 
The range of clinical presentations, and the fact that PANK-2 mutations are not always 
found, suggests that there are several conditions that are either genetically distinct or 
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represent allelic variants.  When familial, the condition appears to be inherited as an AR 
condition, with consanguinity present in some instances. 
 
1.6.10.3 Clinical manifestations 
Clinical manifestations of HSS vary, and the clinical course varies between rapid progression 
to death over 2 years to a more protracted one193. 
In a review, Dooling and E.P. Richardson summarized the clinical features and postmortem 
examinations of 64 individuals with possible HSS195.  Both clinical and pathological features 
were required in order to make the diagnosis, and they identified three groups of patients.  
Their group III patients are of interest with respect to the differential diagnosis of PME, since 
they were defined as having pathological changes similar to the typical cases but clinically 
had a wide range of presentations including childhood mental retardation, alcoholism and 
“senility”, as well as cases manifesting with myoclonus, ataxia, tremor, seizures, and 
spasticity.  Gilman and Barret reported the case of a girl who died at age 17 years, with a 9 
year history of progressive cerebellar signs, hyperreflexia and focal myoclonus of the right 
arm and seizures.  Autopsy showed rusty discolouration of the globus pallidus190. 
 
The adult type is rare, presenting typically with a problem of a movement disorder, the 
nature of which may be more varied than in the early-onset types. At times athetosis, 
chorea, and myoclonus may predominate; nevertheless, dystonia is the most frequently 
associated movement disorder.  Megalencephaly, mental retardation and dopa responsive 
Parkinsonism with HSS196 have been described, although there is typically a poor response 
to levodopa192.  Atypical presentations associated with PANK mutations will usually have 
palilalia, dysarthria, perseverative behaviour and dystonia with progressive dementia and 
freezing similar to that seen in Parkinson’s disease197. 
 
1.6.10.4 Pathophysiology 
Pantothenate kinase is a regulatory enzyme in the pathway leading to synthesis of 
coenzyme A; its product reacts with cysteine.  PANK2 mutations lead to loss of function and 
accumulation of cysteine, an iron chelator.  Excess cysteine may react with accumulated 
iron, leading to oxidative stress and neurodegeneration. 
 
In the normal brain, iron is increased in the globus pallidus, SNc and SNr, red nucleus, and 
cerebellar dentate nucleus.  In HSS there is increased iron content in the globus pallidus and 
SNr, with the rust-brown pigmentation of these regions being a striking neuropathologic 
feature.  The iron granules are located in large astrocytes, microglial cells, and neurons.  
There are asymmetric partially destructive lesions of the globus pallidus, especially the GPi.  
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Spheroids, which are large round structures containing pigment granules and surrounded by 
glia, are presumed to represent swollen axons.  In HSS, they exist in large numbers in white 
and gray matter, as well as the subthalamic nucleus, pallidum and substantia nigra, an 
appearance suggestive of neuroaxonal dystrophy193.   
Other pathological features associated with Hallervorden-Spatz syndrome include 
neurofibrillary tangles (NFT) and Lewy bodies in a case associated with myoclonus. Lewy 
bodies are seen in the substantia nigra, substantia innominata, dorsal nucleus of vagus, and 
locus ceruleus and showed immunostaining with -synuclein198 199.  
  
1.6.10.5 Special Investigations 
MRI studies demonstrate hypodensity in the basal ganglia, most pronounced in the globus 
pallidus due to the paramagnetic effect of iron and associated T2 shortening200. HSS 
patients often manifest an area of higher signal intensity in the central or anteromedial part 
of the globus pallidus, termed the  "eye of the tiger" 200, which correlates strongly with the 
presence of a PANK2 mutation197. 
 
1.6.10.6 Neuropathology 
In a case reported by Yakovlev in 1942 (with pes cavus and maternal inheritance raising the 
possibility of a mitochondrial disorder) as a “case of myoclonus epilepsy with atrophy of 
brainstem and Hallervorden-Spatz type of pathologic change in the pallidum, substantia 
nigra and dentate nucleus189.  There was marked atrophy of the globus pallidus, status 
marmoratus of the putamen and iron pigement in the pallidum, substantia nigra and dentate 
nuclei, and widespread atrophy in the cerebellum with Purkinje cell loss and atrophy and 
gliosis of the dentate nucleus; in the brainstem there was atrophy of the olive and pallor of 
the medial lemniscus, spinocerebellar fibers and nuclei and tracts of Goll. 
 
1.6.10.7 Genetics 
PANK2 mutations are associated with all cases of classic HSS and one third of cases with 
atypical disease197. 
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1.6.11 JUVENILE NEUROAXONAL DYSTROPHY 
Neuroaxonal dystrophy, typically a disease of infancy or childhood and may rarely present in 
late childhood or adolescence as a PME68.  Additional clinical features include dementia, 
ataxia, chorea, and lower motor neuron involvement201;202 
 
Two familial cases of neuroaxonal dystrophy with PME were reported by Scheithauer, who 
distinguished them from HSS since there was no iron deposition in the globus pallidus or 
substantia nigra 203.  Dorfman et al described two brothers with PME associated with 
cerebellar ataxia and cognitive decline that commenced in the second decade201.  The age 
of onset and rate of progression would favour HSS, but pathology was typical of neuroaxonal 
dystrophy.  These cases may represent a transitional state between the two conditions, and 
the authors therefore proposed the term juvenile neuroaxonal dystrophy to illustrate this.   
 
Infantile neuroaxonal dystrophy includes a broad category of patients with variable clinical 
presentations.  The onset of illness is usually at the end of the first or beginning of the 
second year of life.  Infantile neuroaxonal dystrophy and HSS may be variants of 
neuroaxonal dystrophy, since similar pathological findings are found in the two conditions201.  
However, HSS usually starts later, and progresses more slowly, and the presence of iron 
containing pigment in the basal ganglia is uncommon in neuroaxonal dystrophy201.   
 
1.6.11.1 Diagnosis 
The neuropathological hallmark of this disease is the presence of spheroids, which are 
dystrophic axonal swellings found in great abundance throughout the nervous system of 
affected individuals. 
 
1.6.11.2 Myoclonus  
The two patients of Dorfman et al developed myoclonic jerks of the upper body, particularly 
in the morning.  In one, myoclonus became more severe and was associated with 
generalized tonic-clonic and absence seizures.  The myoclonus could be precipitated by any 
muscle activity and was associated with a progressive dementing illness and ataxia.  
Myoclonus in the other patient was described as being a severe action type of myoclonus, 
which interfered with any purposeful movement and was sometimes so violent that he would 
be thrown to the ground201.  
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1.6.11.3 Clinical Manifestations 
Infantile neuroaxonal dystrophy is characterized by delayed milestones and subsequently 
combinations of pyramidal tract signs, dystonia, rigidity with dementia and seizures, lower 
motor neuron involvement, and early visual disturbances. 
 
1.6.11.4 Pathophysiology 
Similar spheroids to those of neuroaxonal dystrophy are also found in HSS.  Although seen 
in other diseases, including ataxia-telangiectasia and Tay-Sachs disease, spheroids are 
particularly numerous in infantile neuroaxonal dystrophy and HSS and may reflect the 
primary pathophysiological process.  However, in HSS the dystrophic axonal swellings are 
largely confined to the basal ganglia, whereas they are widespread in neuroaxonal 
dystrophy201.  However there are transitional cases in which intermediate clinical and 
neuropathological features are found201.  Cerebellar atrophy and degeneration of the 
posterior columns, pyramidal tracts, spinocerebellar tracts and optic pathways are also noted 
190
. 
 
1.6.11.5 Special Investigations 
Infantile neuroaxonal dystrophy is characterized by typical spheroids in cortical or peripheral 
(skin and conjunctival) biopsies.  In the cases of Dorfman et al, the EEG showed a slowed 
background, with frequent occipital spikes, rhythmic delta and a photoparoxysmal response.  
The amplitudes of evoked potentials were increased in size, suggesting that myoclonus may 
have been of cortical origin201. 
 
1.6.11.6 Neuropathology 
Scheithauer reported on the case of two siblings with neuroaxonal dystrophy203.  They 
developed myoclonus associated with other seizure types, associated with ataxia and 
dementia.  Dystrophic swellings were noted throughout the cortex, and dense spheroid 
accumulation in the external globus pallidus and thalamus, and to a lesser extent in the 
caudate nucleus, and putamen.  Similarly, there was dense spheroid accumulation in 
substantia nigra and red nucleus and the dentate nucleus.  There was marked cerebellar 
atrophy, with virtually complete Purkinje cell loss and gliosis of the entire cerebellum, 
including the white matter.   
Wakabayashi reported a case with a spastic tetraparesis, who developed myoclonus and 
dementia and GTCS198.  Pigmented, iron positive granules were found scattered throughout 
the neuropil and round blood vessels.  Numerous axonal spheroids were present throughout 
the nervous system.  There was virtually complete absence of cerebral, neostriatal and 
globus pallidus neurons.  Similarly, there was moderate loss of Purkinje cells and granule 
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cells and prominent axonal spheroids in the dentate nucleus.  There was marked neuronal 
dropout in the substantia nigra.   
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1.6.12  COELIAC DISEASE 
An extensive clinical and pathological review of 16 cases of coeliac disease from 
Birmingham reported the presence of dementia, peripheral neuropathy and spinal cord 
dysfunction 204.  In addition, many patients had ataxia, in some of whom there was also 
position sense loss204. 
 
1.6.12.1 Clinical Manifestations 
The first report of myoclonus associated with coeliac disease was that of Finelli et al in 1980 
205
.  They described a 56 year old man who developed generalized ataxia with nystagmus.  
Despite a gluten free diet, his condition deteriorated and he developed rhythmic tremor of 
the eyelids, chin and palate.  
Bhatia et al reported four patients with progressive myoclonic ataxia associated with coeliac 
disease 206.  
 
1.6.12.2 Myoclonus 
Bhatia et al’s cases had action myoclonus, stimulus sensitive myoclonus and two had 
seizures206. 
 
1.6.12.3 Special Investigations 
Electrophysiology appears typical of cortical myoclonus206.  
 
1.6.12.4 Neuropathology 
In Finelli’s case, at autopsy there was marked cerebellar atrophy with loss of neurons in the 
dentate nucleus and marked Purkinje cell loss205.  
In Bhatia et al’s report, autopsy of one patient revealed atrophy of the cerebellar 
hemispheres 206.  Histology of the cerebral cortex was normal, as were the basal ganglia and 
thalamus.  There was marked loss of Purkinje cells in the cerebellum with marked Bergmann 
astrocytosis.  There was astrocytosis of the internal granular cell layer and  of the dentate 
nucleus, and olives with mild neuronal loss in the latter. 
In a case of celiac disease, associated with GTCS and ataxia, in the cerebellum there was 
neuronal atrophy in the dentate nucleus and astrocytic hypertrophy, with focal Purkinje cell 
loss throughout the cerebellar cortex.  Neuronal atrophy with perivascular cuffing with 
lymphocytes was seen in the olivary nuclei204.   
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1.6.13 BIOTIN DEFICIENCY 
1.6.13.1 Diagnosis 
This is a form of myoclonus characterized by biotin deficiency 
 
1.6.13.2 Myoclonus 
Low amplitude spontaneous and action-induced multifocal myoclonus.    
 
1.6.13.3 Clinical Manifestations 
Bressman and Fahn described a female patient who had some unsteadiness of her trunk as 
an adolescent and in her third decade became aware of jerking movements of the trunk as 
well as increasing deafness and difficulty walking 207.  A year later seizures developed and 
subsequently she developed a sustained right hemiparesis after a right focal seizure.  On 
examination, she had saccadic pursuit, slowed saccades and sensori-neural hearing loss.  
There was marked limb and gait ataxia and myoclonus present. 
 
1.6.13.4 Special Investigations 
Biotin levels. 
 
1.6.13.5 Pathophysiology 
This disorder probably falls in a group of biotin-responsive multiple carboxylase deficiencies 
(MCD).   Late onset or juvenile MCD typically appears in the first months of life and clinical 
features include skin rash, ataxia and hearing loss 208.  The likely cause of the disorder is a 
deficiency of Biotinidase. 
 
1.6.13..6 Management 
Patient responded to biotin supplements 
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1.6.14 GAUCHER DISEASE (GD) 
The condition of non-infantile, neuronopathic Gaucher’s Disease is characterized by the 
features of PME.  
 
GD is a lysosomal storage disorder resulting from deficient activity of glucocerebrosidase 
and the accumulation of its substrate, glucocerebroside, made up of a long chain amino 
alcohol (sphingosine), a long chain fatty acid and a molecule of glucose 209.  The storage 
material occurs primarily in cells of the macrophage-monocyte system, resulting in a 
multisystem disease with progressive visceromegaly and gradual replacement of the marrow 
with distinctive lipid-laden macrophages, the Gaucher cells210. 
 
There are three subtypes, with types 2 and 3 having neurologic involvement.  Type 2 
disease progresses rapidly, resulting in death in early childhood 209 and is characterised by 
bulbar palsy, hepatosplenomegaly, spasticity and seizures 211. 
  
Type 3 disease (the juvenile form) has been subclassified into types 3a and 3b.  Patients 
with type 3a disease have progressive neurologic deterioration, often with recurrent 
myoclonic and generalized tonic-clonic seizures and moderate hepatosplenomegaly210.  
Neurological signs include horizontal supranuclear gaze palsy, dementia, spasticity and 
ataxia 209.  Type 3b is characterized by significant hepatosplenomegaly and supranuclear 
gaze palsies, the latter being the sole neurological sign 209.  A family in which two siblings 
with slowly progressive, late onset myoclonus, intention tremor and gaze palsies has been 
described211.  PME as a result of Gaucher’s disease has been described in an adult, 
commencing at the age of 17212. 
 
1.6.14.1 Diagnosis 
Diagnosis is confirmed by markedly reduced ß-glucosidase activity towards the substrate, 
glucosylceramide. 
 
1.6.14.2 Myoclonus 
Myoclonus is described as being progressive, refractory to medication and stimulus 
sensitive211. Typically, jerks begin in the limbs and become progressively more stimulus 
sensitive, reacting to noise or touch.  Negative myoclonus may also be observed.  Both 
myoclonic and generalized seizures may occur. 
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1.6.14.3 Clinical Manifestations 
Progressive neurological deterioration, with frequent myoclonic seizures and 
hepatosplenomegaly. 
 
1.6.14.4 Special Investigations 
EEG may show spike and wave discharges, either multifocal or diffuse 212  213;214SEPs may 
be significantly increased in amplitude in patients with type 3 Gaucher disease 215. 
 
1.6.14.5 Pathophysiology 
In type 3 GD there is neuronal loss in cortical and subcortical structures 209, and Gaucher 
cells may be present in brain parenchyma 214. 
 
1.6.14.6 Neuropathology 
Verghese reported on a case with onset of Gaucher disease in the second year of life, with 
stimulus sensitive myoclonus and normal EEG.  Cerebral cortex was normal, as were the 
basal ganglia and brainstem, excepting for Alzheimer type 2 astrocytes in the SN, and the 
inferior olivary nucleus.  There was marked loss of neurons in the cerebellar dentate nucleus 
with many of the residual neurons showing pyknosis and nuclear condensation.  The fiber 
loss was selective to the dentatorubrothalamic pathway with loss of fibers in the superior 
cerebellar peduncle but not in the cerebellar white matter or the other peduncles210.  Conradi 
reported on  a young child with severe myoclonus and spike and wave activity on EEG214.  
The cerebral cortex and white matter showed focal alterations consisting of intra-
parenchymal and perivascular accumulation of Gaucher’s cells.  The dorsal tegmentum, 
pons and medulla showed Gaucher’s cells and astrocytosis and astrogliosis around 
capillaries to varying degrees214.  There was a slight loss of Purkinje cells and the granular 
cell layer was affected by a focal, severe loss of granule and Golgi cells, as well as 
astrogliosis and intra-parenchymal Gaucher’s cells214.  The dentate nucleus showed a 
severe loss of neurons with astrocytosis and astrogliosis. 
Winkelman described two siblings with Gaucher disease, one of whom had myoclonus which 
worsened prior to a seizure211.  Cerebral cortex and brainstem were normal, although 
collections of Gaucher cells were widely disseminated in the basal ganglia and subcortical 
white matter211.  .  Relatively diffuse involvement of the brainstem was present, with 
neuronophagia and nests of microglia.  The inferior olive showed diffuse astrogliosis, and 
there was severe disease of the dentate, fastigial, and emboliform nuclei, with preservation 
of the Purkinje cell and granule cell layer211.  
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1.6.14.7 Genetics  
Mutations in the glucocerebrosidase gene include point mutations, insertions and 
substitutions209.  
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1.6.15 ANGELMAN SYNDROME 
An example of myoclonus associated with tremulous activity is that of Angelman syndrome.  
Patients display rapid jerking resulting in a coarse distal tremor, with associated 
electrophysiological features of cortical myoclonus216. 
 
1.6.15.1 Diagnosis 
Angelman syndrome is a condition of severe mental retardation with characteristic facies, 
seizures and a “puppetlike” motor pattern, consisting of ataxic gait, jerky limb movements 
and tremulousness216. 
 
1.6.15.2 Inheritance 
Paternal deletion of chromosome 15q11-13 is associated with 60 % of cases217. 
 
1.6.15.3 Myoclonus 
Patients studied by long-term video-EEG and EMG monitoring demonstrated very rapid 
jerking of variable amplitude. Myoclonus was brought out by voluntary movement and also 
occurred at rest in prolonged runs. Muscle bursts typically started in the face or hand and 
then spread, with recruitment of muscles in a rostrocaudal sequence. Myoclonus was 
associated with rhythmic 5 to 10 Hz sinusoidal or sharp activity (Figure 3), seen in the 
contralateral hemisphere or bilaterally, but EEG activity was not time-locked to the 
myoclonus.  
 
  
Figure 3.  Rhythmic sinusoidal activity (from Guerrini et al., 1996).  
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1.6.15.4 Clinical Manifestations 
Manifestations include severe mental retardation, microcephaly, inappropriate laughter, and 
seizures. 
 
1.6.15.5 Pathophysiology 
The majority of patients have a deletion of chromosome 15q11-13217. This is associated with 
a deletion of GABAA receptor genes (β3, α5, γ3). However, myoclonus is expressed similarly 
in patients without deletions 216. 
 
1.6.15.6 Special Investigations 
SEPs were not enlarged and the C-reflexes were not present216.. However, JLA 
demonstrated a premyoclonus transient216. 
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1.6.16 RETT SYNDROME 
Rett syndrome is associated with dementia, and occurs in female children.  There is a 
characteristic pattern with specific stages.  Although development initially occurs normally, it 
ceases to advance around the age of one year.  Thereafter, regression occurs, with 
development of dementia 1.5 years after the start of the illness. 
 
1.6.16.1 Diagnosis 
The condition is characterized by dementia, with associated features of autism, seizures, 
acquired microcephaly and truncal ataxia.  The majority of patients tend to become 
bradykinetic.  Myoclonus occurs in about half of patients older than 4 years. 
 
1.6.16.2 Myoclonus 
In a study by Guerrini, nine out of ten patients had myoclonus218.  The myoclonus was 
multifocal and varied greatly in severity, occurred at rest, and was enhanced by voluntary 
movement.  Bilateral or generalized myoclonus was not recorded. 
 
1.6.16.3 Special Investigations 
EEG showed slow background activity, with a 4-6 Hz rhythmic sinusoidal pattern typical of 
Rett syndrome.  Myoclonus was only occasionally time-locked with spike discharges.  
However, all nine patients with myoclonus had a reproducible premyoclonic spike recorded 
by JLA. 
SEPs showed a significant increase in the amplitudes of the N20-P30 and P30-N35 
complexes.  The C reflex was reported as being hyperexcitable in all patients218.  . 
 
1.6.16.4 Genetics 
In 5 of 21 sporadic patients with Rett syndrome, Amir et al identified three de novo missense 
mutations in the gene encoding methyl-CpG-binding protein-2219.  
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1.7. ANATOMY OF MYOCLONUS 
1.7.1 ANATOMY OF THE BASAL GANGLIA 
The functional unit of the striatum is made up of the caudate nucleus and putamen, 
separated from each other by the fibers of the internal capsule.  The putamen and globus 
pallidus (GP) form the lentiform nucleus.  The GP is divided into external and internal 
segments, the GPe and GPi respectively. 
Basal ganglia output comprises three different components (Figure 4):  
(1) A dorsal division, the lenticular fasciculus.  
(2) A middle division, the fasciculus subthalamicus, which projects through the internal 
capsule to the subthalamic nucleus. 
(3) A ventral division, the ansa lenticularis220. 
 
Figure 4. Projections of the GPi via the LF (lenticular fasciculus)and AL (ansa 
lenticularis) (Figure from Parent and Parent, 2004220). 
 
The dorsal lenticular fasciculus fibers cross through the internal capsule and then sweeps 
caudally to reach the ansa lenticularis in Forel's field H.  In so doing, they merge into field H2 
of Forel;which is the area along the course of the lenticular fasciculus where the fibers of the 
fasciculus merge with the dorsal aspect of the subthalamic nucleus and the ventral aspect of 
the zona incerta (Figure 5).  The ansa lenticularis courses ventromedially around the 
posterior limb of the internal capsule and then enters Forel's field H.  Ultimately, the ansa 
lenticularis and lenticular fasciculus merge to form the thalamic fasciculus (Forel's field H1) 
located dorsal to the zona incerta. 
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In addition, Forel’s Field H contains dentatothalamic and rubrothalamic fibers which merge 
with pallidofugal fibers.  This region is therefore also called the prerubral field or the 
tegmental field. 
 
Figure 5. Anatomy of the subthalamic region (from Loyola University Medical 
Education Network 221) 
1.7.2 ANATOMY OF THE SUBTHALAMIC REGION 
The subthalamus is located between the H2 field of Forel and the internal capsule, and 
consists largely of the upward continuation of the tegmentum of the midbrain. It is found 
ventrolaterally to the thalamus, and separates the thalamus from the internal capsule.  
Caudally, the red nucleus and substantia nigra extend upwards into the subthalamic region, 
and the floor of the third ventricle lies medial. The zona incerta lies between Forel’s fields H2 
inferiorly and Field H1 medially.   
1.7.3 ANATOMY OF THE CEREBELLUM AND CEREBELLAR OUTPUTS 
The major efferent pathway of the dentate, emboliform and globose nuclei is through the 
hilum of the dentate and then to the brainstem via the superior cerebellar peduncle. 
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1.7.4 ANATOMY OF THE SUBSTANTIA NIGRA 
The substantia nigra has two divisions, the pars reticulata (SNr) and pars compacta (SNc).  
The SNc has dopaminergic projections to the striatum, and the SNr serves as an outflow 
nucleus for the basal ganglia. 
1.7.5 ANATOMY OF THE THALAMUS, AND THALAMIC CONNECTIONS:  
The divisions of the thalamus are derived from the distribution of its major afferent systems.  
The ventral thalamus is divided into ventral anterior (VA), principal ventral medial (VMp), 
ventral lateral (VL), and ventral posterior lateral (VPL) thalamic nuclei.  The VA has two 
components, magno- and parvocellular, termed the VAmc and VA respectively222. 
The VL and VPL nuclei are each subdivided into anterior and posterior subnuclei, termed 
VLa and VLp, and VPLa and VPLp (Figure 6)223.  VL is also divided into the ventro-oralis 
anterior and posterior of Hassler (Voa and Vop) 224, noting that VLa is probably equivalent to 
Voa and Vop223.  
Olszewski gives a broadly similar breakdown, excepting that VL is divided into pars oralis 
(VLo), pars caudalis (VLc), pars medialis (VLm), pars postrema (VLps), and area X (Figure 
6).  VPL is divided into oral and caudal subnuclei, VPLo and VPLc.  (VPLo, VLc, VLps and 
area X were termed VLp by Jones)223. 
 
According to the model grouping proposed by Morel, the ventral thalamus is grouped into 
two divisions 225 .  Anteriorly, the schema is largely unchanged, comprising the VA, VL and 
VM nuclei.  VA has a magnocellular subdivision (VAmc), VL is again divided into anterior 
and posterior components, but VLp is further subdivided into dorsal (VLpd), ventral (VLpv) 
and paralamellar (VLpv).  However, the ventral posterior nucleus (VP) is divided into three 
main nuclei: the traditional ventral posterior lateral (VPL), ventral posterior medial (VPM) and 
ventral posterior inferior (VPI).  VPL nucleus is divided into a pars oralis and caudalis. 
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Figure 6. Comparison of monkey motor thalamus: nomenclature of Walker (A), Ilinksy 
(B), Olszewski (C) and Jones (D).  (data derived from table 1, Macchi and 
Jones, 1987). 
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Figure 7. Input to Motor Thalamus: green is pallidal input, brown is cerebellar input 
and blue is lemniscal input223. 
  
Figure 8. Connections of the thalamus (from Hamani et al., 2006). 
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1.7.5.1 Input to Thalamus (Figures 6,7,8 and Table 6) 
Table 6. Connections of the thalamus (taken from Hamani et al.222 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7.5.1.1 Substantia Nigra: the substantia nigra projects to VAmc and VA223. 
 
1.7.5.1.2 Basal Ganglia: According to the scheme of Jones, basal ganglia output is to the VA 
and VLa (this corresponds to Voa, Vop and Lpo of Hassler)223.  In the scheme of Olszewski, 
basal ganglia projections are to VLo and most of VA222. 
 
1.7.5.1.3 Cerebellum: The major cerebellar input is to VLp.  In the scheme of Olszewski, the 
input from the cerebellum is to VLc, VLps, area X and VPLo, noting that these nuclei and 
VLp correspond to one another223.  In Hassler’s scheme, Vop receives cerebellar inputs; and 
there is no consensus as to whether Vop lies in cerebellar or pallidal territory 222.  The Vim 
nucleus, a common site of functional surgery, is included in VLp. 
 
1.7.5.1.4 Sensory: According to Jones; the VPL is a sensory nucleus, with the VPLa 
receiving deep lemniscal afferents, and the VPLp superficial sensory lemniscal fibers (Figure 
9).  In Olszewski’s schema, VPLc is the region which receives lemniscal fibers, containing 
muscle reflex afferents226.  Spinothalamic fibers project only to ventral VPLo,  
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Figure 9. Diagram indicating thalamic lemniscal input from VPLc to cortical areas 3a, 
3b, 1 and 2.  Terminology of Olszewski (Figure from Jones, 1983226). 
1.7.5.2 Thalamic Output: 
1.7.5.2.1 Substantia Nigra: The region of thalamus that receives afferents from the 
substantia nigra projects to the SMA. 
 
1.7.5.1.2 Basal Ganglia: VA and VLa innervate the SMA and preSMA; however, primary 
motor cortex and prefrontal motor cortex are also supplied from pallidal territory. 
 
1.7.5.1.3 Cerebellum: VLc and VPLo both project to area 4, suggesting they form a common 
cerebellar relay nucleus 226.  The thalamic regions receiving cerebellar input also supply the 
preSMA, the SMA and the premotor cortex.  
 
1.7.5.1.4 Sensory: According to Jones, the caudal division of ventral posterior lateral nucleus 
(VPLc) and its trigeminal counterpart (VPM) projects to sensory cortex226.  Group 1 afferents 
from muscle receptors project to VPLc; and these appear to project to area 3a, and to a 
lesser degree, area 2 (Figure 9) 226.  The cutaneous core of VPLc projects only to areas 3b 
and 1 and does not project to motor cortex.  (Discussed further in Section 1.8.13). 
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1.7.6 ANATOMY OF SENSORY CORTEX 
Area 3a is characterized by a zone of attenuated layer IV granule cells intervening between 
the thick granularity of area 3b and the giant pyramidal cells of area 4226.  (Discussed further 
in Section 4.13). 
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1.8 PHYSIOLOGY OF MYOCLONUS 
This chapter reviews in detail the relationship of myoclonus to epilepsy and the physiology of 
myoclonus, both cortical and subcortical, including animal studies. 
 
In view of their importance to the diagnosis of cortical myoclonus, detailed overviews are 
included of the SEP, JLA, long latency reflexes and excitability cycles.  Particularly after the 
advent of JLA, myoclonus was classified into cortical and reticular reflex forms.  If myoclonus 
was associated with a brief EMG discharge, had a premyoclonus spike on JLA, enlarged 
SEP and easily elicited C reflex it would be termed cortical myoclonus.  With regard to 
localization of myoclonus, cortical myoclonus was imputed to be of cortical origin and 
reticular reflex myoclonus considered to arise in the brainstem reticular formation.  
 
However, as Dawson pointed out as early as 1946,  “the disturbances in the EEG in 
myoclonic epilepsy are so large and so widespread that it seems highly unlikely that of 
cortex or basal structures, pyramidal or other efferent systems, any one will be active in 
isolation”227.  Hallett also noted that although most cases of myoclonus with brief EMG 
discharges reported in the literature apparently fitted the cortical or reticular formation 
mechanism, or both, many cases did not 228. 
 
It is perhaps unnecessary to comment on the integral relationship between the subcortical 
structures and the cortex, in particular thalamo-cortical interactions.  However, the question 
as to whether myoclonus is predominantly cortical in origin or is significantly influenced by 
subcortical structures is a key feature of this thesis, and hence the question needs to be 
explored in some detail.  The notion that myoclonus may be of subcortical origin is not new:  
Van Bougaaart noted that  “this generalization of synchronous slow waves, followed by 
generalization of spikes, allows the hypotheses that cortical instability is primarily determined 
by instability in some subcortical mechanism with diffuse effect, responsible for the slow 
waves”229.  Subsequently, Watson and Denny-Brown described a case of myoclonus in a 
patient with lipid storage disease, and neuronal damage in the thalamus and dentate nuclei, 
and concluded  that “instability in the diffuse neuronal subcortical system is an essential part 
of an epileptic process of generalized myoclonic seizures” 230.   
 
As will be seen in the discussion of the nosology of myoclonus, there are a number of 
dificulties that arise when trying to classify myoclonus, and this becomes exaggerated when 
attempting to dissect out the underlying pathophysiology, particularly with regard to 
separating cortical from subcortical causes.  Obvious (but not trivial) examples of this include 
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Hallett et al’s observation that in some patients with Epilepsia Partialis Continua (EPC), 
where myoclonus virtually by definition should arise from motor cortex, pathological 
examination of the cortex may reveal a normal appearance231.  In patients with PME, the 
pathology is frequently not cortical, but can be found elsewhere, such as the cerebellum 60. 
 
A neat summation of the viewpoint that myoclonus is not of cortical origin is that of Halliday, 
writing in 1980 “ Myoclonic epilepsy appears to reflect a disordered function of this system 
(the medullary reticular formation), associated with an abnormal epileptic discharge in the 
medullary reticular formation.  The enhanced cortical evoked potentials and the associated 
disorders of the background rhythm of the EEG are no doubt a secondary result of this 
disordered function, and appear to be mediated by the ascending fibres relaying in the 
midline thalamic nuclei (nucelus reticularis thalami) which in turn modulate SEP amplitude at 
the level of VPL and VPM” 232. 
 
Similarly, Chauvel in his review of seizures of frontal lobe origin, commented that “Recent 
issues in motor system physiology place the primary motor cortex in a key position inside a 
large ensemble of related cortical areas, interconnected with feedback loops, of efferent 
projecting thalamic, cerebellar and brainstem structures, of efferent projecting pathways to 
subcortical nuclei (as relays of internal loops), and to the spinal cord through more or less 
direct interneuronal networks.  Whether a circumscribed pathology, unique or multiple, 
produces disturbances of a system as a whole or disconnects part of it, thus leading to a 
functionally autonomous subsystem, it most likely underlies the distinctive features of the 
clinical patterns.  Such complexity prompts us to consider that, facing each individual case of 
apparently typical ‘cortical myoclonus’, no a priori statement about a primary role of the 
motor cortex can be put forward before having obtained convincing electrical-clinical 
correlations.  Alternative possibilities of subcortical pacemakers, as well as cooperative 
cortico-subcortical mechanism, cannot be easily ruled out.  The same is obviously true for 
the reverse situation, i.e. demonstrating the non-cortical origin of myoclonus” 233. 
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1.8.1 NOSOLOGY OF MYOCLONUS  
Largely because myoclonus is the result of disturbances on many levels of the nervous 
system, it tends to defy classification and attempts to classify myoclonus tend to be 
oversimplistic, as exemplified by statements such as this one: "When the alteration occurs 
predominantly at cerebral levels they are called seizures; when motoneurons are involved 
fasciculations result; and when the stratum of origin is interneuronal in brainstem or spinal 
cord, the term is myoclonus” 234.  A crucial question concerns the existence of a myoclonus 
centre, a concept which first held sway with the publication of Hodskins and Yakovlev’s 
paper on myoclonus in 1930, where the majority of patients had pathological evidence of 
neuronal loss in the dentate nucleus of the cerebellum 235.  Since then, the pendulum has 
swung back again, and although today the concept of a myoclonus centre might be risible, it 
is nevertheless true that the current literature usually implies or explicitly states that 
myoclonus is of cortical origin.  In effect, the myoclonus centre has moved from the 
cerebellum to the cortex.  Of course, it may be that myoclonus results from abnormal 
conditions arising diffusely within a neural network, rather than the dysfunction of a single 
specific structure 236. 
 
Pathological classifications 
Hodskins and Yakovlev proposed a pathological classification 235: 
1. Myoclonus associated with epilepsy involved the dentate system, midbrain and basal 
ganglia. 
2. Myoclonus not associated with epilepsy involved only the dentate system. 
In 1950 van Bogaert proposed a classification according to the site of presumptive 
pathologic involvemen 229:  
1. Cortical: Jacksonian epilepsy or epilepsia partialis continua (EPC) 
2. Central gray substance:  Unverricht-Lundborg disease. 
3. Bulbo-ponto-cerebellar formation: palatal myoclonus, paramyoclonus, or dyssnergia 
myoclonus cerebellaris of Ramsay-Hunt. 
Phenomenonological classification 
Denny-Brown proposed dividing myoclonus into four groups, and was the first (1956) to note 
the presence of stimulus sensitive myoclonus in a classification of PME 237. 
1. Spontaneous epileptic myoclonus (in patients with idiopathic epilepsy). 
2. Stimulus-sensitive myoclonus (in patients with familial myoclonic epilepsy, lipidoses 
or Lafora body disease). 
3. Palatal myoclonus. 
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4. Bulbar myoclonus, which varied from rhythmical myoclonus to isolated twitches, and 
was exemplified by patients with Creutzfeld-Jakob disease. 
Similarly to Denny-Brown, Bonduelle classified myoclonus into epileptic and brainstem 
types:22 
1. Epileptic: bilateral, synchronous and synergistic, best seen in the myoclonus associated 
with childhood absence.  
2. Brainstem myoclonias: the appearance of this myoclonus was either simple or complex, 
rhythmic or arrhythmic, and asynchronous. This myoclonus was believed to involve the 
extrapyramidal system, including the corpus striatum, the subthalamic nucleus, substantia 
nigra, red nucleus, dentate nucleus and inferior olive. 
Bonduelle observed that "no single specific lesion can be accepted as the cause of the 
myoclonic syndrome and that modern thought has abandoned the idea of a ‘myoclonic 
centre’ in the brainstem " 22. 
 
Another approach to the phenomena associated with myoclonus was that of Rothwell 238: 
1. Sponaneous myoclonus: myoclonus occurring at rest 
2. Action myoclonus: myoclonus present during attempted voluntary movement 
3. Reflex myoclonus: myoclonus triggered by sensory stimuli. 
Physiological classifications 
In his review of 1967 239, Halliday divided myoclonus into three groups, using an approach 
that extrapolated from the results of neurophysiological tests to give rise to anatomical 
localization, an approach which continues to be used up until the present: 
1. Pyramidal. 
2. Extrapyramidal. 
3. Segmental. 
The first group, pyramidal, was characterized by myoclonus of brief duration which  followed 
a cortical discharge by a fixed time period.  The cortical discharge could be focal or diffuse, 
but typically involved the contralateral motor area.  This condition was associated with 
enhanced cortical potentials and myoclonic jerks had a fixed temporal relationship to 
peripheral stimuli 239.   
The second group, extrapyramidal, was characterized by the absence of a cortical 
discharge, with a less tight connection between the timing of cortical potentials and EMG 
bursts.  The cortical potentials could occur at the same time as the myoclonic jerk or 
subsequently to it, and the myoclonic jerk was of longer duration.  Examples of this group 
were SSPE and Creutzfeldt-Jakob disease (CJD) 239.  
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In an important advance, Shibasaki subsequently described the technique of back-averaging 
and divided groups of myoclonus into pyramidal or non-pyramidal based on the presence or 
absence of a cortical discharge occurring prior to the myoclonus 240.   
Shibasaki has also classified myoclonus into two groups according to whether they were 
stimulus sensitive or not 241.  However, if the purpose of classifications is to distinguish 
conditions from one another, this distinction is not particularly useful, since virtually all 
myoclonus, particularly if related to PME or cortical lesions, falls into a stimulus sensitive 
category, a point made by Shibasaki in a subsequent monograph 242.  The non-stimulus 
sensitive myoclonias (CJD, SSPE, spinal myoclonus) are typically identified by their own 
unique clinical and historical characteristics, and the myoclonus associated with these 
conditions is often distinctive, all of these features being more striking than their lack of 
stimulus sensitivity. 
Anatomical classifications 
The most recent classification is anatomical, and divides myoclonus into cortical and 
subcortical and overlaps with Halliday’s extrapyramidal-pyramidal dichotomy 242  (Table 7). 
Examples of cortical myoclonus include disorders associated with PME, as well as JME 
(juvenile myoclonic epilepsy), post-anoxic myoclonus, Alzheimer’s disease, CJD, metabolic 
encephalopathies, olivoponto cerebellar atrophy, cortical-basal ganglionic degeneration and 
Rett syndrome. 
Table 7. Distinguishing features between cortical, subcortical and spinal 
myoclonus. (derived from Shibasaki, 2000) 
 Cortical Subcortical Spinal 
Movement Shock-like Less shock-like Can be shock-like 
Condition Posture, movement Rest Rest 
Rhythmicity 
Irregular, but often 
appears rhythmic 
Tends to be periodic Periodic or rhythmic 
Stimulus 
sensitivity 
Highly sensitive Not sensitive Can be sensitive 
 
Subcortical myoclonus includes essential myoclonus, periodic myoclonus, dystonic 
myoclonus, reticular reflex myoclonus, startle syndrome, and palatal tremor.   
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1.8.2 DEFINITIONS OF TYPES OF MYOCLONUS 
In a natural succession to the previous classifications, a greater concentration on 
neurophysiological testing gave rise to a more specific classification of myoclonus.  This 
consisted of: 
• Myoclonus with its origin in the brainstem, termed reticular reflex myoclonus 243.  
• Myoclonus with neurophysiological features suggestive of a cortical origin, termed 
cortical reflex myoclonus 228;244.   
 
However, as Hallett et al noted in their paper on cortical reflex myoclonus, “although most 
cases of myoclonus with brief EMG discharges reported in the literature apparently fit the 
cortical or reticular formation mechanism, or both, many cases do not” 228.  In a similar vein, 
referring to patients with pyramidal myoclonus, Halliday has commented: “The fact that jerks 
depending on cortical spike discharges occur in these patients does not necessarily mean 
that all their jerks are determined in this way.  The cortical spikes occur on a background of 
raised excitability, and there is no reason to suppose that this is confined to the neurons or 
afferent pathways.  Indeed, such excitability changes are only likely to be at all localized in 
the relatively unusual cases of epilepsia partialis continuans associated with a Rolandic 
focus” 239. 
 
Focal reflex myoclonus  
This term was first used by Sutton and Mayer in 1974 in a patient with hemiplegia associated 
with myoclonus, in whom there were focal jerks preceded by a cortical spike 245.  
 
Reticular reflex myoclonus243:  
This is characterized by the following features:  
1. The myoclonic jerk is generalized. 
2. Jerks can be triggered by peripheral sensory stimuli. 
3. Cortical EEG correlate is not time-locked to the EMG event. 
4. Muscles are activated up the brainstem and down the spinal cord 238. 
5. The EMG correlate is a brief burst lasting 10-30 msec 16. 
 
Cortical reflex myoclonus228 
This condition has been defined as238: 
1. A focal, sensitive area, commonly on the hand and forearm, stimulation of which 
evokes the myoclonic jerk. 
2. Focal muscle jerk limited to a few muscles in the same part of the body. 
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3. Short burst of EMG activity (10-30 msec). 
4. Muscles are activated in sequence passing down the brainstem and spinal cord. 
5. Enlarged SEP frequently present. 
6. If spontaneous or action myoclonus is present, a cortical EEG correlate is present, 
time-locked to the event. 
7. Latency of the SEP is about half the latency of the reflex muscle jerk: for example in 
the upper limb, SEP latency is 18-25 msec, and that of the reflex jerk is 36-50 msec. 
 
Cortical Myoclonus 
An important question revolves around the issue of whether the term cortical myoclonus is 
similar to or synonymous with cortical reflex myoclonus.  Currently it would generally be 
accepted that cortical reflex myoclonus, with its emphasis on a focal stimulus-sensitive area, 
is a subset of a larger group of cortical myoclonus 242.  As Shibasaki wrote, “most myoclonic 
jerks of cortical origin are stimulus sensitive, being elicited by stimuli of a single or multiple 
modalities, and and thus called ‘reflex myoclonus“242.   
 
However, it is uncertain whether the clinical phenomena of focal myoclonus and generalized 
forms of myoclonus are underpinned by the same underlying pathophysiological processes.  
The term used initially was cortical reflex myoclonus and had been introduced by Chadwick 
and Hallett to describe the myoclonus in patients who had a cerebral anoxic event228;244.  
This corresponded to the syndrome of Lance and Adams246, in which, typically following a 
cerebral hypoxic event, in which myoclonus could be seen associated with voluntary 
movement246.   
Features of the syndrome of cortical myoclonus included: 
1. Enhanced SEPs. 
2. Enhanced Long latency reflexes. 
3. Myoclonus was evoked by stretch. 
4. Cortical events could be triggered by myoclonus228.  
 
Hallett subsequently described cortical reflex myoclonus247 as a “fragment of focal or partial 
epilepsy.  Each myoclonic jerk typically involves only a few adjacent muscles for example, 
only an antagonist pair.”  The difficulty with reconciling cortical reflex myoclonus as being a 
generalized condition, as initially described in the patients with cerebral anoxia228, with the 
concept that cortical reflex myoclonus is focal (a fragment of epilepsy), is apparent.  The 
answer may lie in Hallett’s proposal that most myoclonus is neither focal nor generalized, but 
multifocal: “Many or all muscles in the body can be affected by different jerks, so that the 
myoclonus is ‘multifocal’ ” 247.   
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Obeso, Rothwell and Marsden expanded the concept of cortical reflex myoclonus in their 
article entitled “The Spectrum of Cortical Myoclonus: from focal reflex jerks to spontaneous 
motor epilepsy“60.  Citing Dawson’s case of cortical reflex myoclonus248, the case of EPC 
described by Kugelberg249, and their previous reports on reticular reflex myoclonus and 
cortical reflex myoclonus228, they concluded that there was “evidence of muscle jerking 
arising in the motor cortex”60.  In particular, they noted that jerk locked averaging “went a 
long way to clarify the mystery of the relationship of the EEG to myoclonic jerks.  Many 
previous observers had found it difficult to interpret the significance of the presence or 
absence of spike discharges in the EEG, and their time relation to myoclonic twitches.  It 
was not until it was possible to establish whether such EEG spikes were time-locked to the 
muscle jerks, or whether any other form of EEG abnormality could be averaged in relation to 
muscle twitches, that the true significance of cortical discharge in relation to myoclonus 
could be appreciated”60.   
 
Cortical myoclonus was believed to arise from the cortex based on the following 
observations: “ (1) spike discharges in the routine EEG preceding the muscle EMG bursts 
responsible for the myoclonus, as in many cases of typical epilepsia partialis continua; (2) 
the discovery of an EEG potential preceding the EMG bursts responsible for the myoclonus 
by the technique of back-averaging; (3) the provocation of myoclonus by external stimuli, 
which also caused abnormal cerebral evoked potentials recorded from the surface of the 
scalp over the sensorimotor cortex or elsewhere”60.   
 
However, it is not clear from this discussion whether all or only some of these three features 
are necessary for a diagnosis of cortical myoclonus, and the authors themselves performed 
back averaging in less than half of their cases.  This article is notable, since for the first time 
it introduced the entity termed cortical myoclonus to describe a group of conditions which 
were not always clearly associated with well defined cortical lesions or with cortical reflex 
myoclonus.  Of their eleven cases, three had focal myoclonus and were stimulus sensitive 
(touch and pinprick), one had focal myoclonus and was not stimulus sensitive, and two 
others had multifocal myoclonus and had touch or pinprick induced myoclonus.  The 
diagnoses included probable multi-system atrophy (two), Ramsay-Hunt syndrome (three), 
posttraumatic myoclonus (one), early onset cerebellar ataxia with retained reflexes (one), 
EPC (one), possible corticobasal degeneration (one) and unknown (two).  Of the eleven 
cases, seven had clinical and CT evidence of cerebellar damage, although the conclusion 
remained that "all these patients described appear to have myoclonus as a result of 
abnormal electrical discharges arising from the cerebral cortex"60.   
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Shibasaki and Obeso independently proposed that spontaneous myoclonus is not 
spontaneous at all, but is triggered by subclinical stimuli 60;250, an idea first put forward by 
Watson and Denny-Brown in 1955: “since some small natural movement of the patient often 
precipitated myoclonic jerks in the part that was moved, it is clearly possible that 
“spontaneity” of appearance was related to the variable pattern of stimulus inherent in the 
milieu of the living organism”230.  However, at least one report would suggest that this is not 
the case, since experimentally a distinction may be made between spontaneous and 
induced myoclonus (the frontal cortical areas are activated with peripheral stimulation, but 
this is not seen in spontaneous myoclonus251). 
 
Subequently, in their review of myoclonus in the Handbook of Clinical Neurology, Hallett, 
Marsden and Fahn231 proposed a phenomenonological classification based on the 
distribution of myoclonus (focal, multifocal or generalized) and the source of the “responsible 
electrical discharge” (cortical, brainstem, spinal). 
 
Focal myoclonus included cortical myoclonus, and the term was characterized by jerks 
limited to a few muscles, sometimes induced by modality specific stimuli. Associated 
electrophysiological features included 231 : 
1. Brief EMG burst (30-60 msec). 
2. Myoclonus time-locked to a cortical event, typically a focal positive-negative transient 
over sensorimotor cortex contralateral to the jerk. 
3. The transient preceded the jerks by about 20 msec. 
4. Giant SEP. 
5. C-reflexes.  
6. Muscles activated in a sequence passing down the brainstem and spinal cord. 
 
Multifocal myoclonus was described as “while each jerk is focal, multiple sites in the body 
might be affected by different jerks.”  Generalized myoclonus was described as “each jerk 
affects much of the body”.  Multifocal and generalized myoclonus could occur in the same 
patient, had similar etiologies and were considered synonymous with “epileptic myoclonus”.  
The causes of epileptic myoclonus were largely the group of diseases associated with PME.  
The four subtypes of epileptic myoclonus included cortical myoclonus, reticular myoclonus, 
combined cortical and reticular myoclonus, and primary generalized epileptic myoclonus 
(section 1.8.9). 
 
Cortical myoclonus was described as being identical to focal myoclonus excepting that it was 
multifocal, and that, as opposed to a focal region of cortex being hyperexcitable, in multifocal 
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myoclonus there was “generalized cortical excitability”231.  The neurophysiological findings 
were identical to focal myoclonus.  
 
To recap, the myoclonus of PME was defined as a subtype of epileptic myoclonus and was 
associated with cortical myoclonus.  In the development of these descriptions and 
classifications it appears that a well-defined entity, stimulus induced focal myoclonus, had 
become the basis for conceptualizing virtually all forms of myoclonus, other than reticular 
reflex myoclonus, CJD or SSPE.  The primary reason for this appears to be that cortical 
reflex myoclonus and other forms of myoclonus of cerebral origin shared abnormalities on 
neurophysiological testing.  Since the neurophysiology was similar, cortical reflex myoclonus 
was termed focal cortical myoclonus, and other forms of myoclonus were viewed as 
multifocal cortical myoclonus.  This would be illustrated by a patient with EPC having the 
same mechanism of myoclonus as a patient with PME.  Indeed, Marsden accepted cases of 
PME and post-anoxic myoclonus as being cortical reflex myoclonus, saying that cortical 
reflex myoclonus occurred in “progressive myoclonic encephalopathies and in a number of 
other diffuse degenerative disease”16.  In contradistinction, authors such as Halliday have 
drawn a distinction between “focalized myoclonus, i.e., between the type of jerking seen in 
epilepsia partialis continua, which clearly has a constant primary focal distribution (even if it 
may spread from the focus by a jacksonian march)” and “the generalized diffuse myoclonus 
that is so characteristic of many of the progressive myoclonic epileptic patients”252.  
Historically, the underpinning for the notion of myoclonus arising from the cortex may have 
rested on Marsden’s report of 1973 entitled “Is the human stretch reflex cortical rather than 
spinal“ in which he proposed that myoclonus was the result of hyperactive stretch reflexes 
which involved the cortex253.  The derivation of the terms cortical reflex myoclonus and 
reticular reflex myoclonus follow directly from this proposal, their names reflecting the 
importance that Marsden’s group attached to their findings from working on the human 
stretch reflex. 
 
It needs to be emphasized that the current literature universally accepts cortical myoclonus 
as being defined by electrophysiological criteria that are identical with those which Hallett, 
Marsden and Fahn originally used to define focal cortical myoclonus231.  What is less clear is 
whether most forms of PME truly represent “multifocal cortical reflex myoclonus”.   
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1.8.3 MYOCLONUS AND EPILEPSY 
Myoclonus is often considered to be a fragment of epilepsy, and as a part of the approach to 
the physiological classification of myoclonus, it is perhaps easiest to begin with defining focal 
and generalized epilepsies.  Focal motor seizures are jerks of part of the body, related to a 
discharge in a corresponding area of motor cortex.  Recurrent jerks are known as EPC.  In a 
process termed secondary generalization, the focal cortical discharge may spread, resulting 
in a secondarily generalized seizure.   
 
In contradistinction, primary generalized epilepsies are likely to be genetic in origin, and 
current understanding is that the generalized spike and wave activity which is the hallmark of 
such epilepsies is due to abnormal discharges arising from thalamo-cortical connections 254.  
Typical clinical manifestations of generalized epilepsies include myoclonus, absence 
seizures and generalized tonic-clonic seizures.  The EEG in these cases shows spike and 
wave discharges, typically with symmetrical involvement of both hemispheres, but not 
infrequently asymmetrical.  Myoclonus in primary generalized epilepsy is typically 
symmetrical, but may be frequently asymmetrical or focal. 
 
In addition, there is a group of epileptic conditions termed secondarily generalized 
epilepsies, a prominent example being the Lennox Gastaut syndrome.  These disorders 
have EEG features of generalized spike and wave, but are characterized by progression and 
cognitive decline, features which overlap with the disorders associated with PME.  Similarly 
to the question of the origin of generalized myoclonic jerks in PME, it is unclear if the 
epileptic discharges in the secondarily generalized epilepsies are multifocal (arising from 
multiple discrete focal areas of abnormality) or are generalized, arising from thalamo-cortical 
interactions, as occurs in primary generalized or idiopathic epilepsies.   Given that absence 
seizures are the basis of the model for thalamo-cortical interactions that characterize primary 
generalized epilepsy, it is salient to point out that 2-3 Hz spike and wave discharges as seen 
in absence seizures are also described in secondary generalized encephalopathies255. 
 
With regard to myoclonus and primary generalized epilepsies, in the case of absence 
seizures, Gibbs et al observed that patients often had associated "motor movements of a 
clonic sort" 256.  Subsequently, Jasper reported that when clonic movements occurred in 
absence seizures, the latency between the spike and wave discharge and the movement 
was variable, raising the possibility of autonomous subcortical centers being responsible257.  
Tassinari noted that in patients with myoclonic absence the EEG showed a wave of positive 
polarity, the amplitude of which correlated with the myoclonic jerks.  Each positive transient 
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was followed by a single jerk with a constant latency, ranging from 15-40 msec for more 
proximal muscles and 50-70 msec for more distal muscles 258.  Hallett et al, referring to these 
cases of myoclonic absence, raised the possibility that the spike and wave discharge time-
locked to the jerk “might be due to a brainstem discharge diffusely activating cortex to 
provoke a cortically determined generalized myoclonus”228. 
 
There appears to be some overlap in the neurophysiology of patients with primary 
generalized seizures disorders and PME.  Thus, in JME, a form of primary generalized 
epilepsy which is characterized by myoclonus and generalized seizures, the amplitudes of 
the SEP are significantly higher than in patients with other forms of idiopathic generalized 
epilepsy259.  Enlarged SEPs are held to be a feature of cortical myoclonus, and similarly, JLA 
of myoclonus in JME showed a positive-negative EEG transient260, as may be seen in 
cortical myoclonus.  The myoclonus in JME was related to bursts of polyspikes, not spike 
and wave activity, and the JLA transient also resembled a burst of polyspikes 260.  The 
authors proposed that “a wide cortical area is responsible for the PSW discharges, but that 
myoclonic events arise when PS (polyspike) frequency approaches that of central motor 
rhythm, and when paroxysmal activity reaches a critical threshold at which it activates the 
motor cortex”260.  An additional area of overlap between PME and the idiopathic generalized 
epilepsies is photosensitivity on EEG, which may be blocked by apomorphine in both 
conditions261.   
 
Although these findings would suggest diffuse cortical excitability is associated with the 
myoclonus in JME, paradoxically in patients with IGE and absence seizures, when magnetic 
stimulation of the cortex time locked to spike-wave discharges is used, the resulting motor 
evoked potential (MEP) is reduced in amplitude, and threshold to stimulation is elevated, 
implying decreased cortical excitability262.  Other reports have found reported enhanced 
visual evoked responses during spike-wave discharges, particularly in fronto-central regions 
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.  Experiments in primates showed a reduction in VEP amplitude during spike and wave 
activity, although there was a similar gradient to humans, in that there was enhancement of 
the response frontally as compared with occipital response 263.   
 
With regard to similarities between cortical reflex myoclonus and epilepsy, there is a single 
case report of two sisters who had both JME and reflex writing epileptic jerks264.  However, 
although the myoclonic jerks in these patients might arise on the basis of peripheral sensory 
stimulation (as in cortical reflex myoclonus), other mechanisms related to higher order 
cognitive processing are also potentially implicated, given that the reflex seizures worsened 
with tasks of greater semantic difficulty or phonetic complexity.
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1.8.4 FUNDAMENTAL PATTERNS OF MYOCLONUS: ANIMAL STUDIES 
Although the induction of myolconus has been widely studied in animals, it should be noted 
that the use of agents known to precipitate myoclonus, and to a lesser degree lesion 
experiments, are both unlikely to correspond to the situation where a chronic 
neurodegenerative condition results in myoclonus. 
 
Noting that enlarged evoked responses are a hallmark of cortical myoclonus, if visual, 
auditory or touch stimuli are applied to an animal which has been given the GABA antagonist 
Metrazol, large cortical evoked potentials will occur.  Additionally, high voltage symmetrical 
spike and wave activity, sometimes developing into 3 Hz spike and wave, the typical 
frequency of absence seizures, is seen265.  Myoclonus and generalized seizures may 
develop, depending on the frequency of photic stimulation used265.  Catechol (1,2 -
dihydroxybenzene) administration results in enhanced responses from thalamic sensory 
relay nuclei and cortex, and once the cortical response reaches threshold amplitude, 
myoclonus can result266. 
 
Similarly, jerks induced by chlorolose may be evoked by light touch and are associated with 
a discharge in the motor cortex 267, followed by a burst in the pyramidal tract 268.  These jerks 
are abolished by ablation of the motor area, and temporarily also by transient carotid 
occlusion 268, suggesting that cortex is implicated in the development of myoclonus252.  
However, subcortical pathways appear also to be utilized since although cortical ablations 
markedly reduced visual evoked responses and myoclonus in cats given Metrazol 265;269, 
both myoclonus and generalized spike and wave activity, albeit of prolonged latency, could 
still be elicited265.  The motor cortex is therefore not indispensable for the generation of 
myoclonus, although it does affect the threshold required to generate myoclonus239.   
 
Early investigators proposed that there were two systems resulting in myoclonus239;265:   
1. A pathway giving rise to a short latency, low threshold response, ascending in the 
lemniscal system to the primary cortical sensory areas, resulting in a large evoked 
response.  Subsequently, the discharge travelled from motor cortex via  the 
corticospinal tract. 
2. A pathways resulting in a longer latency, higher threshold response which depends 
on subcortical pathways and could persist despite ablation of both the sensory and 
motor areas.  It is likely that the second mechanism was mediated via the thalamic 
reticular nuclei270.  In decorticate animals this response arose from the reticular 
formation of the brainstem 267;271. 
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However, the two systems are not discrete and may interact, as exemplified by myoclonus 
initiated in the motor cortex that may descend either in the corticospinal system or by the 
non-somatopically organized corticoreticulospinal route252.  Similarly, catechol may not only 
produce a stimulus induced corticospinal reflex and increase the cortical evoked response, 
but may also result in a spino-bulbo-spinal reflex, the origin of which is probably the nucleus 
reticularis gigantocellularis (NRG)272.  In addition, both chloralose and pentylenetetrazol 
activate cortical and subcortical mechanisms, and their use will give rise to myoclonus which 
persists even if the corticospinal tracts have been lesioned at the level of the medulla, 
indicative of the involvement of non-pyramidal pathways in the generation of myoclonus252.  
Similarly, decorticate and decerebrate cats may develop generalized myoclonus in response 
to peripheral stimulation under chloralose anaesthesia271.   
 
More precise localization of the origin of myoclonus to the reticular formation can be 
demonstrated experimentally.  Infusions of urea result in irregular spikes seen in the 
brainstem reticular formation, particularly in the medullary reticular formation in the NRG273.  
This results in stimulus sensitive myoclonus which becomes more generalized until finally a 
tonic-clonic convulsion occurs273.  Dichloro-Diphenyl-Trichloroethane (DDT)-induced 
myoclonus has a similar origin274.  When DDT is injected into the NRG, myoclonus develops 
and is then followed by unilateral spikes, stimulus sensitive myoclonus and periodic runs of 
EEG spikes.  Two hours after injection, when the cortical EEG had became normal, 
myoclonus persisted.  DDT was also able to produce generalized myoclonus from injections 
in the cerebellar nuclei, inferior olive and red nucleus, but not the ventral thalamus274.  This 
model appears robust, since cobalt injected into the medulla gives similar findings of 
myoclonus and irregular bilateral spike and wave on EEG 275.  
 
In primates, Denny Brown demonstrated that stimulus-sensitive myoclonus developed a 
month after ablation of the postcentral or precentral cortex, and worsened after removal of 
the cerebellum276.  In baboons, myoclonus may be induced by ablation of the cerebellar 
vermis277.  The myoclonus involved proximal muscles, was brief, bilateral, symmetric and 
synchronous, and resembled an exaggerated startle response.  It was of late onset and was 
both light-sensitive and spontaneous, and could be elicited by passive movements or touch if 
the animal was awake278. 
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1.8.5 MYOCLONUS AND SUBCORTICAL LESIONS 
Given that myoclonus may be divided into subcortical and cortical forms, this section reviews 
the literature concerning subcortical lesions and myoclonus. 
 
Lance & Adams (1963) pointed out that myoclonus had been observed in anencephalic 
infants, indicating that cortex in humans is not required for the generation of myoclonus. 
 
Thalamic Lesions 
Following hypoxia, in rats with myoclonus, extensive neuropathological changes are noted in 
the region of the Nucleus Reticularis Thalami (NRT) 279.  Injection of GABAA antagonists into 
the NRT in rodent models produced spontaneous, rhythmic myoclonus ipsilateral to the side 
of the injection, whereas GABAB antagonists failed to show similar results.  JLA showed a 
central/frontal negative potential in these cases279.  Long latencies, of greater than 100 
msec, were noted between the EEG and EMG responses suggesting that “extrapyramidal, 
rather than pyramidal, systems are involved in the myoclonus triggered through the NRT”236. 
 
Matsumoto et al postulated that disruption of GABAA receptor function in the NRT triggered 
myoclonus through a circuit involving the cortex279.  Since there are no direct efferents from 
the NRT to the cortex and there was a delay between the injection and the onset of 
movements, other thalamic relays are probably involved, with progressive recruitment of 
cortical neurons resulting in myoclonus279.   
 
In humans, thalamic lesions comprising extensive neuronal loss and gliosis are reported in 
post-hypoxic patients with myoclonus280.   
 
With regard to specific regions of the thalamus, and their involvement in the production of 
myoclonus, Hassler noted that single stimuli in the Voa nucleus produced jerks in the 
contralateral limb.  He observed further that “stereotaxic coagulation of Vop produced a good 
effect in myoclonic syndromes”281.  However, Fahn reported on a case of cortical myoclonus 
following cardiac arrest in whom bilateral thalamotomies failed to control myoclonus 282.  
Lance and Adams viewed intention or action myoclonus induced by hypoxia, not as pure 
cortical myoclonus, but rather resulting from “synchronous and repetitive firing of 
thalamocortical neurons”246. 
 
Milhorat described the effect of medial thalamectomies in monkeys, which was likely to have 
involved the intralaminar nuclei, and resulted in the development of myoclonus, both 
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spontaneous and elicited by pentylenetetrazol283.  This was associated with the development 
of ipsilateral paroxysmal bursts of spikes.  Recurrent stimuli resulted in the development of 
focal seizures. 
 
Munchau et al described a patient with an infarction in the right posterolateral thalamus, who 
developed severe postural and kinetic tremor, with dystonic posturing and myoclonic jerks284.  
Using paired-pulse transcranial magnetic stimulation, they demonstrated a reduction of 
cortico-cortical inhibition, and proposed that this was due to damage to the loop connecting 
basal ganglia with thalamus and cortex or as a result of abnormal input to the reticular 
nucleus of thalamus.  Similarly, in a patient with a lesion of the dorsomedian and intralaminar 
thalamic nuclei, the normal short latency afferent inhibition induced by a peripheral 
stimulation was attenuated, resulting in a larger evoked response to magnetic stimulation285.  
This would suggest that thalamic lesions result in a loss of the normal thalamic enhancement 
of cortical inhibitory networks. 
 
In a patient with PME and photic myoclonus as a result of MERRF, regional cerebral blood 
flow was measured by positron emission tomography at rest and during myoclonus provoked 
by photic stimulation.  During photic stimulation, there was significantly increased activity in 
the thalami, occipital cortex, supplementary motor cortex and right primary motor cortex286.  
When myoclonus was present, there was significant increased activity in the SMA, as 
opposed to when absent, and the authors proposed a thalamic focus for photic myoclonus in 
MERRF, with projection to precentral motor cortex by thalamo-cortical connections. 
 
Globus Pallidus 
Ono et al reported a patient with myoclonus due to manganese toxicity with high intensity 
signals in the globus pallidus.  There were no features of cortical myoclonus 
neurophysiologically and the duration of the EMG burst associated with myoclonus was 100-
500 msec287, a feature of extrapyramidal myoclonus. 
 
Caudate 
In rodents, injections into the caudate using GABAA antagonists (picrotoxin) or GABAA 
channel blockers resulted in myoclonus, which typically progressed to focal seizures288.  
Injections in the GP, thalamus and cortex failed to evoke myoclonus.  However, in order to 
evoke myoclonus, the cannula had to pass through sensorimotor cortex, and it appeared 
that this combination of a caudate lesion and damage to cortex was necessary for 
myoclonus to develop 288.  However, spikes were seen initially in the caudate nucleus and 
subsequently in cortex288.   
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Similarly, patients with Huntington disease with stimulus sensitive myoclonus have been 
described, in whom generalized and multifocal myoclonus were found289.  Neuropathology of 
a single case showed marked neuronal loss and gliosis in the caudate nucleus, with atrophy 
and gliosis in the globus pallidus and putamen.  The cerebral cortex and cerebellum 
appeared normal.  Mild astrocytosis was present in the thalamus, subthalamic nucleus and 
red nucleus.  In another case, there was generalized cortical atrophy, marked neuronal loss 
and gliosis in the caudate and anterior putamen and lesser involvement of the thalamus, with 
minimal changes in the red nucleus, subthalamic nucleus and dentate nuclei.  
In these cases, the EMG duration of myoclonus was short, late responses were detected 
after median nerve stimulation and back-averaging showed a positive-negative wave 
preceding the myoclonus by 20 msec, all features of cortical myoclonus (Figure 10)289.  
Myoclonus could be induced by flash, magnetic stimulation and peripheral nerve stimulation, 
and magnetic stimulation resulted in repetitive myoclonus.  The SEPs were not enlarged, 
although there was a widespread positive wave corresponding to P30-N40.  The first burst of 
myoclonus induced by peripheral nerve stimulation occurred at 40 msec, a relatively short 
latency, given that cortical reflex myoclonus has a latency of about 50 msec289.  The authors 
comment that the “short latency of reflex myoclonus in HD is unusual for classic cortical 
reflex myoclonus, and might support a subcortical site of origin.  Although there are two 
crucial differences between the myoclonus in HD and typical cortical reflex myoclonus, 
several observations in the present patients point towards a cortical origin for their 
myoclonus.  The presence of spike and wave discharges on the EEG and a backaveraged 
cortical potential preceding the myoclonus is characteristic of a cortical origin.  Cortical 
hyperexcitability is also suggested by the repetitive responses to magnetic brain stimulation, 
and by the repetitive cortical potentials that followed peripheral nerve or flash stimuli”289.  The 
authors postulated that the repetitive reflex jerks (Figure 11) might be related to abnormal 
thalamocortical influences due to striatal degeneration. 
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Figure 10. JLA demonstrating a cortical potential in a case of Huntington disease.  
The potential occurrs prior to the myoclonic spike by 18 msec; repetitive 
cortical waves followed and were time locked to the repetitive myoclonus 
(taken from Case 3 of Thompson et al., 1994a). 
          
 
 
 
 
 
 
 
 
Figure 11. Simultaneous recording of EEG and EMG during action myoclonus in 
patient with Huntington disease.  Bursts of myoclonus are associated with 
repetitive spike and wave EEG discharges (from Thompson et al., 1994a). 
 
Similarly, in corticobasal degeneration, a condition characterized pathologically by neuronal 
degeneration in the cortex, basal ganglia and thalamus, stimulus sensitive myoclonus was 
described in two cases, in which the myoclonus was characterised by trains of repetitive, 
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synchronous discharges, often accompanied by repetitive long latency responses.  The 
SEPs showed reduced N20-P25 responses, but C reflexes were present, JLA revealed a 
small positive potential and myoclonus duration was 20-40 msec, compatible with cortical 
myoclonus290. 
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1.8.6 MYOCLONUS AND CORTICAL LESIONS 
Since myoclonus may be divided into cortical and subcortical forms, this section reviews 
literature reporting on pure cortical lesions associated with myoclonus (Table 8).  The 
classical example of cortical myoclonus is that arising from a focal cortical lesion.  However, 
cortical myoclonus may exist without associated structural change in the cortex253, and 
somewhat unexpectedly, lesions are not necessarily located in motor cortex.  
Table 8. Case reports of myoclonus associated with cortical lesions.  
 
On an experimental basis, Chauvel induced a chronic epileptogenic focus in primates, 
resulting in periods of EPC and Jacksonian type seizures291.  Weak peripheral stimuli 
produced an evoked biphasic positive negative potential over the primary motor area, but 
stronger stimuli resulted in the superimposition of a large amplitude (1-2 mV) potential, 
resembling an epileptic spike.   
 
REFERENCE SEIZURE TYPE CORTICAL 
REGION 
STIMULUS 
 
STRUCTURAL 
ABNORMALITY 
Dawson, 
1947b 
Focal myoclonus 3 cm anterior 
to central 
sulcus 
Tendon reflex 
Pressure 
None 
Forster, 1949 
Focal Motor 
Reflex Epilepsy 
Precentral 
gyrus 
Touch Post-central 
Kugelberg, 
1954  
Focal Motor 
Focal myoclonus 
Precentral 
gyrus 
 
Leg movement 
Tendon jerk 
Electrical 
stimulation 
Precentral gyrus 
 (presumed) 
Cowan, 1986 EPC Parietal  Parietal Cortex 
Vignal, 1988 Reflex Epilepsy 
Parietal  
Rolandic  
Touch  (MRI normal) 
Volkmann, 
1998 
EPC Parietal  None 
Ashby, 1999 Focal myoclonus Motor cortex   
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With regard to individual case reports, in 1947 Dawson described focal myoclonus in a 
patient, and was the first patient to be described with giant evoked potentials, and who 
subsequently came to autopsy, where no lesion could be demonstrated, although 
neurophysiological testing had suggested that the myoclonus originated from anterior to the 
motor strip248. 
 
Subsequently, in 1949 Forster reported a case of a patient with a vascular naevus of the 
Rolandic fissure, associated with atrophy of the post-central gyrus, associated with focal 
motor seizures and reflex epilepsy which was induced by touch to the left shoulder.  Tapping 
the shoulder also produced a large evoked potential over the right vertex centrally.  The 
precentral gyrus was found to be excitable based on its response to direct electrical 
stimulation, and the excitable region lay directly in front of the area producing the enlarged 
evoked potentials 292. 
 
Kugelberg and Widen described a case of EPC with focal myoclonus with a spike focus in 
the central head regions.  Each spike was followed by a discharge 27-34 msec later in the 
tibialis anterior muscle249.  Spikes were spontaneous or could be induced by passive or 
active motion of the leg, tendon jerk, or electrical stimulation.  Electrical stimulation of the 
tibial nerve resulted in a cortical spike with a latency of 30 msec.  A small region of cortical 
hyperexcitability was identified by direct cortical recording localized to the medial surface of 
the precentral gyrus, and spike potentials were noted to phase reverse 0.5-1 mm below the 
cortical surface and disappear a few mm deeper.  Myoclonus ceased following corticectomy.   
 
Vignal 293 reported on a case of reflex partial seizures characterized by the patient being able 
to provoke a seizure by pseudorhythmic tapping over his chest, in the same region where he 
experienced a sensory aura prior to his spontaneous seizures.  MRI and standard scalp 
SEPs were normal.  Peripheral stimulation resulted in rhythmic polyspikes over the central 
region and vertex, followed by widespread flattening of the EEG, associated with tonic 
contraction of the left arm, flexion of the body, contraction of the left leg and then the right 
side.  Depth electrodes showed that tapping induced slow waves with brief overlapping rapid 
discharges in the parietal sensory cortex and rolandic motor cortex.   
 
Volkmann et al. reported on a patient with EPC.  SEPs were not enlarged, and MRI was 
normal, although previously one hemisphere was swollen, suggestive of Rasmussen’s 
encephalitis294.  Using magnetoencephalography (MEG) and source localization of dipoles, 
interictal spikes were localized to the inferior parietal lobule, which was concordant with PET 
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data.  JLA of MEG waveforms showed a single deflection with a latency of 31 msec, which 
could be localized to the anterior border of the region giving rise to interictal spikes.   
 
Ashby reported a case of a patient with celiac disease with focal myoclonus, evoked by 
action or sensory stimuli295.  MRI showed areas of increased signal in the white matter.  At 
electrocorticography, bursts of high frequency (25-30 Hz) spikes were recorded from motor 
cortex associated with myoclonic jerks.  With more severe myoclonus the bursts of spikes 
evolved into electographic seizures.  SEPs showed an initial response over the sensory 
cortex, followed by a large potential in the leg area of the motor cortex.  With JLA, the 
latency from the first major deflection to myoclonus was 35 msec.  Stimulation over the 
cortex resulted in a series of myoclonic jerks, and it was concluded that both myoclonus and 
the giant evoked potential arose from motor cortex.  At electrocorticography the multiple 
spike bursts were found to be electropositive, indicating that neurons were depolarized at the 
level of the cell body.   
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1.8.7 RETICULAR REFLEX MYOCLONUS 
Reticular reflex myoclonus refers to myoclonus of brainstem origin, believed to originate in 
the reticular system, but as with cortical myoclonus, this form of myoclonus may also arise 
as a result of peripheral stimulation.   
 
However, the characteristic features of the entity of reticular reflex myoclonus are rather 
unclear, since only a few patients have been described296.  There appears to be a spectrum 
from reticular reflex myoclonus to cortical reflex myoclonus: on one extreme there are cases 
of generalized myoclonus of brainstem origin without any of the usual manifestations of 
cortical reflex myoclonus (normal SEP, normal EEG, no C reflex, brief EMG duration of 
myoclonus), and on the other, there are cases which appear to overlap with cortical 
myoclonus since the EEG is abnormal and a C reflex is present. 
 
The definition of reticular reflex myoclonus includes297: 
1. Generalized myoclonus. 
2. Absence of JLA related spike. 
3. Evidence of caudo-rostral spread of the discharge from the brainstem. 
 
Generalized myoclonus is typically defined as synchronous jerks of the whole body, although 
reports of reticular reflex myoclonus have shown that jerks display a gradient of onset, 
depending on the distance of affected muscle groups from brainstem centres297.  Hallett et 
al, referring to generalized myoclonus, stated that it involved “jerks affecting much, if not all, 
of the body musculature; effective stimuli anywhere in the body would produce a similar 
jerk”228.  
 
Although it is a rare phenomenon296, the causes of reticular reflex myoclonus are the same 
as the causes of cortical reflex myoclonus, which appears to far more common247.  In 
reticular reflex myoclonus, the myoclonus can be spontaneous or induced by action and 
sensory stimulation, and the stimulus is often modality specific, as is seen in cortical 
myoclonus231.  Hallett et al proposed that the pattern of muscle activation, which was 
widespread with flexor and proximal muscle group predominance, was consistent with an 
origin in the polysynaptic reticular formation and the reticulospinal tract 231.   
Reticular reflex myoclonus has often been associated with the spino-bulbo-spinal reflex 
described by Shimamura298, who showed that stimulation of the dorsal root afferents resulted 
in an impulse which subsequently relayed in the caudal medulla, and then re-entered the 
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cord.  Ascending pathways conducted signals rapidly, whereas descending fibers had 
relatively slower conduction times.  
 
The majority of patients with brainstem myoclonus probably have their myoclonus mediated 
through a system similar to that involved in the startle response.  A typical startle reaction 
consists of a generalized flexion response, although activity can also be recorded in 
extensor muscles296.  The latency of the response is relatively long and variable, and the 
pattern of muscle recruitment is typically that of sternocleidomastoid activation initially 
followed by other cranial muscles (Figure 12) 299 296.  Startle reflexes are believed to 
commence in the caudal brainstem and spread rostrally and caudally.  As with the spino-
bulbo-spinal reflex, the spinal efferent conduction velocity is at a relatively low speed 300.  
Distal responses are delayed compared with proximal ones, suggesting there is a 
preferential activation of axial and proximal muscles 296.  However, the orbicularis oculi often 
appears to be activated before the sternocleidomastoid, a feature which is incompatible with 
rostro-caudal activation of brainstem structures.  This phenomenon may represent a blink 
response followed by a startle response300.  
               
Figure 12. Three superimposed trials of an abnormal startle response elicited by taps 
to the head in a patient with hyperekplexia.  EMG activity is seen first in 
sternocleidomastoid, and then in orbicularis oculi, masseter, trunk and 
limb muscles.  From Brown et al., 1991d. 
Chadwick and co-workers were the first group to describe patients in whom stimuli resulted 
in generalized, predominantly proximal myoclonic jerks244.  The EEG showed spike-wave 
activity, but the SEPs were normal, and there was no spike prior to myoclonus.  The 
myoclonus appeared to propagate upwards from the brainstem244.  Hallett and colleagues 
subsequently described a 55 year-old man who developed spontaneous and stimulus 
sensitive myoclonus after cardiorespiratory arrest, and proposed the term “Reticular Reflex 
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Myoclonus”243.  However, this patient was atypica, since that the conduction time of the 
efferent stimulus was very rapid296.  Myoclonus was present at rest, and was made worse by 
attempted voluntary and passive movement243.  On EMG, the duration of the jerks varied 
from 10-30 msec (although jerks of brief duration are more typically a feature of cortical 
myoclonus, see page 99)243.  The EEG showed very frequent spikes, usually but not always 
associated with the myoclonic jerks243.  The EEG abnormalities suggest there was cortical 
involvement, as might be expected following diffuse cerebral anoxia, which seems credible, 
given the history of cardiac arrest. 
 
The EEG spikes were not time-locked to the EMG discharges and data on the relationship 
between the EEG and myoclonus had to be derived from series of single trials243.  (Shibasaki 
has commented that variable latency seems characteristic of reticular reflex myoclonus, and 
that averaging of responses is less useful than examining individual responses 241).  The 
SEP was not enlarged, but a C reflex was present243.  Myoclonic jerks could be precipitated 
by a variety of sensory stimuli243.  Spontaneous jerks of the lower cranial nerve musculature 
(sternocleidomastoid and trapezius) usually preceded the cortical spike, whereas those of 
the upper cranial nerve musculature (orbicularis oris and masseter) followed the spike (see 
Figure 13)243.   
               
Figure 13. Figure showing a spontaneous myoclonic jerk in a case of reticular reflex 
myoclonus.  There is activation of cranial nerves in a caudal-rostral 
direction.  From Hallett et al, 1977. 
The authors derived central conduction times based on the latencies of the jerks and 
peripheral conduction times243.  From this they deduced that activation of cranial nerves was 
upward and arose in the medulla243.  As Rothwell noted, the critical factor that suggested a 
brainstem origin was the order of muscle activation: the sternocleidomastoid initially, 
followed by orbicularis oris 7 msec later, and then the masseter 9 msec after that296.  As 
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opposed to the findings in the spino-bulbo-spinal reflex of Shimamura, afferent cord 
conduction time was long (14 msec), whereas efferent cord conduction time was short (2 
msec)243.  However, the derived latencies and conclusions appear unlikely to be correct.  
The 7th nerve nucleus was activated 10 msec after the trapezius, and the 5th nerve nucleus 
19 msec after trapezius.  The authors state “Thus the signal producing the myoclonus 
seemed to travel (rather slowly) up the brain stem”243.  However, the signal took 10 msec 
from the cervical cord to the 7th nerve nucleus (the authors appear to have wrongly assumed 
that the nucleus for sternocleidomastoid was in the brainstem, the correct location extending 
from the lower medulla to the upper cervical spinal cord), but then took 9 msec to travel from 
the 5th to the 7th nucleus, although both nuclei are located in the pons.  The difference in 
afferent and efferent conduction times in the cord, of 14msec and 2 msec respectively 
seems unlikely to be correct., since a latency of 2 msec is equivalent to a velocity of 250 
m/sec.  In the case quoted by Rothwell244, the latencies of the afferent and efferent cord 
conduction were similar.  These differences prompted Rothwell et al to surmise that there 
might be more than one form of reticular reflex myoclonus238. 
 
Hallett et al’s case, although termed reticular reflex myoclonus, had at at least three features 
suggestive of cortical involvement, namely the presence of a C reflex, the brief EMG 
discharges, and frequent cortical spikes243.  Similarly, Brown reported a case of a 65 year old 
man who developed features of both cortical and reticular reflex myoclonus after cerebral 
anoxia.  Myoclonus was both spontaneous and generalized after somaesthetic and auditory 
stimulation, and multifocal action myoclonus was present during voluntary movements297.  
The EEG showed frequent generalized polyspikes, often associated with myoclonus.  The 
EMG bursts were of 25-100 msec duration; and with JLA there was a positive-negative spike 
maximal over the vertex and contralateral hand area, with a latency between the positive 
spike and myoclonus of 10 msec297.  Cortical SEPs were not enlarged.  EMG activity was 
first noted in sternocleidomas toid and later in more rostral cranial nerves.  In addition, the 
R1 component of the blink reflex was delayed, suggesting brainstem dysfunction297. 
 
More typical cases include that of a patient with generalized jerks in response to tendon tap 
and electrical nerve stimulation described by Rothwell238.  The SEPs were of normal size, 
and the jerks began in the brainstem and spread rostrally and caudally238.  Similarly, 
Shibasaki described a patient with generalized myoclonus of brainstem origin, associated 
with a midbrain infarct and in whom the myoclonus was induced by stimuli such as sound or 
tapping (Figure 14)301.  Somatosensory evoked potentials showed a small, long duration 
potential at C3 obtained at 31.8 msec.  There was no sponaneous myoclonus, and the C 
reflex and EEG were normal.  Afferent conduction velocity was rapid, whereas efferent 
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conduction was slow, as in the spino-bulbo-spinal reflex298.  However, midbrain lesions 
should typically not affect centers involved in the startle reflex, nor the reticular formation that 
has previously been implicated in experimental animals in brainstem myoclonus (see 
Section 1.8.4). 
 
Figure 14. Myoclonus recorded over the biceps in response to stimuli at the chin, 
forearm and ankle in a case of generalized myoclonus associated with a 
brainstem infarction.  Five traces recorded from each site.  Note the 
variable latencies of response.  Figure from Shibasaki, 1988.   
A similar case was described by Oguro et al. in a patient with post-hypoxic myoclonus and 
CT scan evidence of diffuse subcortical change.  Myoclonus could be elicited by auditory 
stimuli and taps to the body.  There were no EEG spikes or potentials noted with JLA, and 
N20 wave of the SEP was prolonged and of low amplitude.  Myoclonus was generalized and 
symmetrical and presumed to be of brainstem origin, with efferent conduction of 14 msec for 
the spinal cord302. 
 
A clear illustration of a borderline case between reticular reflex and cortical myoclonus was 
described in the Japanese literature.  A patient with persistent generalized myoclonus was 
found to have a brainstem lesion on MRI associated with herpes encephalitis.  The EEG was 
slowed, and SEPs were enlarged and C reflexes were enhanced303.  The converse situation 
was described by Shibasaki in a patient with CJD in whom photic stimulation resulted in 
large amplitude evoked responses diffusely.  However, SEPs were not enhanced and C 
reflexes were absent, illustrative of a dissociation between a reduction in cortical inhibition 
and the production of enlarged SEPs. 
 
Given that the startle response and presumably reticular reflex myoclonus are of brainstem 
origin, an interesting observation has been made that startle seizures (typically tonic motor 
seizures triggered by auditory or somatosensory stimuli) have been shown by depth 
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electrodes to commence in the motor cortex or supplementary motor area233.  These 
seizures are typically seen in children with extensive hemispheric injury, usually of an 
ischaemic nature.  Frequently, there appears to be a sensory stimulus which triggers the 
motor attack, this stimulus sometimes being localized to a limb233.  Epileptiform discharges 
are known to arise in the reticular formation of the lower brainstem and may influence 
sensory input to the cortex 304.  Similarly, it is possible that myoclonus of brainstem origin 
may arise from reflex jerks arising in the somatosensory cortex, which may trigger responses 
in the reticular formation mediated via the spino-bulbo-spinal reflex arc 271;272.  Noting that 
both generalized myoclonus as well as spike and wave discharges on EEG may arise from 
the brainstem reticular formation, Halliday stressed that the medullary reticular formation 
ascends to the midline thalamic nuclei, and may modulate afferent inpulses in the specific 
nuclei232.  In animal experiments, stimulation of the intralaminar thalamic nuclei enhanced 
the EMG response to a corticospinal volley, although this response may survive ablation of 
motor cortex, suggesting that the enhancement results from a projection to spinal motor 
neurons rather than cortex 305. 
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1.8.8 CORTICAL REFLEX MYOCLONUS AND CORTICAL MYOCLONUS 
Synchronous frontal polyspike discharges and associated myoclonic jerks were first 
recorded in 1938 in a patient with PME 306.  Subseqently, in 1946, Dawson reported on the 
relationship between EEG spikes and myoclonus in two patients who had a buildup of 
generalized, irregular, myoclonic jerks over one to two hours which culminated in a 
generalized seizure227.  These cases would probably correspond to the current definition of 
cortical reflex myoclonus, since eliciting tendon jerks resulted in myoclonus.  In these 
patients, the interictal EEG showed mild diffuse slowing with single or multiple epileptogenic 
spikes.  During episodes of myoclonic jerking, bursts of spikes were seen on the EEG at 
frequencies of 8-13 Hz.  As is shown in Figure 15, the longer the EEG discharge, the more 
prolonged were the myoclonic jerks.  
 
Figure 15. Example of cortical reflex myoclonus.  Four recordings (marked a,b,c,d) of 
simultaneously recorded EMG (top two traces) and EEG (bottom two 
traces) (from Dawson, 1946). 
In addition, eliciting the knee reflex resulted in a myoclonic jerk 80-180 msec later (Figure 
16).  There was no EEG correlate at this stage, which was in the initial period before the 
seizure. 
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Figure 16. Case of cortical reflex myoclonus.  A myoclonic jerk (arrow) is elicited by 
the knee jerk, indicated by KJ.  The figure shows three examples, recording 
from extensor (“EXT”) and flexor (“FLEX”) muscle groups (from Dawson, 
1946). 
At a later stage, prior to the onset of the seizure, a tendon tap or sudden noise would induce 
a generalized myoclonic jerk (Figure 17).  This was associated with a group of “spike 
potentials” on EEG.  These were seen 130-150 msec after the jerk, and were larger over the 
hemisphere contralateral to the site of stimulation. 
 
 
 
 
 
 
 
 
 
Figure 17. Case of cortical reflex myoclonus.  Two examples of a tendon tap 
(indicated in the figure as TJ) eliciting EEG activity and a generalized 
myoclonic jerk.  (from Dawson, 1946). 
The entity of Cortical Reflex Myoclonus was described by Hallett et al243 although Sutton and 
Mayer had previously described a similar condition in a report entitled Focal Reflex 
Myoclonus245.  All three cases were likely to be post anoxic in nature, and therefore had 
features of Lance-Adams syndrome 246.  All had generalized tonic-clonic seizures and all had 
myoclonus which was precipitated by voluntary movement, and by various modalities (Table 
9).  One patient also had myoclonus evoked by touch, and of the three patients described in 
Hallett et al’s original paper, probably only this patient would currently be defined as having 
cortical reflex myoclonus 238;307.   
The myoclonus often resulted in an irregular, coarse, distal tremor on action, as noted 
previously by Chadwick 244.  EEG showed generalized bursts of irregular spike and wave 
and polyspike and wave activity in Case 1, a few small sharp waves intermittently in Case 2, 
and irregular diffuse slow wave activity with occasional  sharp waves in Case 3.   
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Table 9. Clinical characteristics of patients with cortical myoclonus; from Hallett et 
al, 1979. 
 Age Event 
Myoclonus 
at rest 
Myoclonus 
Action 
Myoclonus 
Passive 
movements 
Myoclonus 
Discrete 
sensory 
stimuli 
1 47 Severe 
Head 
Injury  
- + + - 
2 37 Cerebral 
Anoxia 
- + + - 
3 79 Syncope  
- +  - 
 
The myoclonic jerks lasted 10-30 msec.  As opposed to reticular reflex myoclonus, 
myoclonus appeared to travel in a purely rostro-caudal direction down the brainstem and 
spinal cord (Figure 18).  However, as can be seen from the figure, given the difficulty of 
establishing the precise latency of onset, determining the order of activation of muscles is 
difficult. 
 
 
Figure 18. Case of cortical myoclonus: following a tap to the jaw “the monosynaptic 
reflex (jaw jerk) is following by the myoclonic response in orbicularis oris 
and sternocleidomastoid” (from Hallett et al. 1979). 
All three patients had enlarged SEPs, of maximal amplitude over the contralateral hand 
area.  Deuschl found subsequenlty that early SEP components (N20/P25/N33) were normal 
in the Lance-Adams syndrome 307, and Fahn has described a similar case of post-anoxic 
myoclonus with generalized spike and wave on the EEG, and abnormal poorly formed 
SEPs282.   
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Jerk-locked averaging showed a single positive wave of highest amplitude at the hand areas 
of both hemispheres.  There were long-latency responses at 40 msec, and the EEG 
response to stretch was a series of repetitive negative transients in the contralateral 
hemisphere over the hand area. 
 
Hallett et al contrasted their description of cortical reflex myoclonus with three uncommon 
forms of myoclonus, namely ballistic-overflow myoclonus, segmental myoclonus, and 
myoclonus of SSPE, and drew the following conclusions: 
1. They termed the condition cortical reflex myoclonus: defined as “myoclonus in which a 
brief EMG burst, synchronous in agonist and antagonist muscles, causes the involuntary 
muscle jerk and is time-locked to a cortical event”228. 
2. Cortical reflex myoclonus was focal or multifocal, and similar jerks were seen in 
“epilepsia partialis continua or focal epilepsy”, and arose from a focal cortical discharge 
activating a focal muscle contraction228. 
3. Cortical reflex myoclonus might arise from hyperactivity of a component of the long-
latency stretch reflex. 
 
Other than cerebral anoxia, typical cortical reflex myoclonus has also been described in the 
following conditions308. 
1. RHS (Obeso, 1985, Deuschl 1987). 
2. Spino-cerebellar degeneration (Obeso 1985) 
3. Olivopontocerebellar atrophy and multiple system atrophy (Obeso 1985; Chen 1992; 
Rodriguez 1994). 
4. Cerebral anoxia (Hallett 1979 Deuschl 1987).) 
5. Metabolic degenerations such as NCL, Sialidoses and the cherry red spot myoclonus 
syndrome(Shibasaki 1985; Deuschl 1987). 
6. Alzheimer’s disease (Ugawa 1991). 
7. Mitochondrial disease (So 1989;Deuschl 1991,  Mima 1997). 
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1.8.9 PRIMARY GENERALIZED EPILEPTIC MYOCLONUS 
Noting that primary generalized epilepsies refer to idiopathic epilepsies, classically 
associated with a normal neurological examination, and with a generalized spike and wave 
pattern on EEG, Wilkins et al. described primary generalized epileptic myoclonus113;309.  
They examined eleven patients with myoclonus and “chronic epileptic/myoclonic disorders”.  
Patients were selected on the basis of the similarity of their JLA data.  Six patients had 
Lennox-Gastaut syndrome, two had Alzheimer’s disease, and there were single cases of 
PME, “degenerative disease” and typical petit mal.   
 
Clinically, the patients had minipolymyoclonus and generalized, synchronized, whole body 
jerks, which were stated to resemble those of reticular reflex myoclonus.  However, 
myoclonus was sometimes restricted to individual muscles but was seen often in antagonist 
pairs or other muscles of the same limb.  Bilateral synchronous discharges were frequently 
found. EMG bursts were between 10 and 50 msec in duration and were often recorded in 
rapid sequential patterns causing tremulousness.  EEG showed absent alpha and diffuse 
theta in nine patients; the majority had atypical or typical spike and wave discharges. 
 
In seven patients, JLA showed a frontal or frontocentral negative cerebral potential, of 100-
250 msec duration, and commencing 5-500 msec before the jerk.  In the other four cases the 
jerk was preceded by a shorter duration potential of 30-100 msec, which was time-locked to 
between 40 and 60 msec before onset of EMG.  In one patient with Lennox-Gastaut 
syndrome, JLA showed an 8 Hz bifrontal rhythmn (Figure 19).   
 
As opposed to other studies, this group of patients were singular in that no clear JLA 
associated spike was detected, but instead a diffuse frontal negativity.  The authors 
suggested that the pathophysiological process was the same as that of primary generalized 
epilepsy, since they felt their patients all had the latter condition, although this group of 
patients would not currently be considered to have primary generalized epilepsy, excepting 
for the one case of typical petit mal.  Guerrini has pointed out that this condition is perhaps 
incorrectly named since many of the patients would currently be viewed as having 
generalized symptomatic, non-genetic epilepsies8. 
 
The authors speculated on subcortical and cortical interactions in the genesis of the JLA-
associated frontal negativity, but noted that “the cortical event always precedes the 
myoclonus”, indicating they believed that the frontal negativity caused the myoclonus.  
However, unlike cortical reflex myoclonus, there was “loose coupling between EMG and 
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EEG events”113.  Bilateral simultaneous EMG bursts also distinguished this condition from 
multifocal cortical myoclonus.  Barrett has suggested that a possible mechanism for the 
multiple small twitches seen was “individual small areas of motor cortex become 
hyperexcitable and generated multiple small spikes leading to tremulous activity in distal 
muscles”310, although this is the same mechanism proposed for multifocal cortical myoclonus 
put forward by Hallett, Marsden and Fahn (Section 1.8.2)231.   
 
               
Figure 19. JLA demonstrating an 8 Hz bifrontal rhythmn in primary generalized 
epileptic myoclonus.113 
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1.8.10 PHYSIOLOGY OF CORTICAL TREMOR 
The group of conditions discussed in section 2.3 (Cortical tremor, FAME and ADCME) are 
frequently characterized by tremulous movements, termed cortical tremor.  The consensus 
statement of the Movement Disorders society 311 defines cortical tremor as a specific form of 
rhythmic myoclonus, consisting of: 
1. High frequency, irregular tremor-like postural and kinetic myoclonus almost 
indistinguishable from high-frequency postural tremor. 
2. Synchronous, short, high-frequency jerks (7-18 Hz) on EMG 
 
In 1993, Toro et al from the Human Motor Control section of the NIH reported on the detailed 
physiology of a number of patients who had cortical tremor.  They described ten patients, 
three of whom had postural tremor, seven had action myoclonus, of whom two had sensory 
reflex myoclonus.  Of the five remaining patients with action myoclonus, the underlying 
etiologies were Lafora body disease, postonoxic myoclonus, PME and Baltic myoclonus in 
two.  JLA showed a positive-negative transient in seven patients and a more complex series 
of wavelets in three others, with a latency from the peak of the positive cortical discharge to 
myoclonus of 22 ± 11msec.  The five patients with action-induced myoclonus had giant 
SEPs and C-reflexes.  All patients had abnormal rhythmic bursting seen on EMG during 
voluntary contraction, usually with synchronous activity in the agonist and antagonist 
muscles.  The authors proposed that the abnormality lay in the motor cortex and that 
descending corticospinal volleys resulted in the rhythmic EMG pattern.  They also noted that 
cortical neurons firing in excessive synchrony may lead to the sensori-motor cortex 
oscillating between activation and inhibition312. 
  
Ikeda reported two patients who appeared clinically to have essential tremor, but 
electrophysiologically were characterised by the features of cortical reflex myoclonus (clinical 
features are discussed in Section 2.3)107.  The patients had rare seizures and ‘fine shivering-
like twitching’ in the fingers and hands which were worsened by posture holding or 
movement of the hands.  Surface EMG at rest showed irregular discharges involving 
muscles of the arms in either a synchronous or asynchronous fashion.  EMG bursts were 
typically of 50 msec duration.  With regard to SEPs, the amplitudes of the P25 and N33 
responses were both significantly elevated.  C-reflexes were enhanced, and JLA 
demonstrated a positive-negative biphasic EEG discharge (Figure 20).   
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Figure 20. JLA in a patient with cortical tremor showing that the positive peak is 
maximal at the right sensorimotor area (arrow), and precedes the 
myoclonus by a latency of 15.4 msec (two superimposed sets) (from Ikeda 
et al., 1980). 
EEG showed occasional generalised poly-spike and wave complexes and generalised 
intermittent slow activity in one patient and a slow background and generalised intermittent 
4-6 Hz slow activity without distinct epileptiform discharges in the other.  The authors noted 
that this involuntary movement resembled polyminimyoclonus as originally reported by 
Spiro313 and subsequently by Wilkins et al309.  They proposed that small areas of motor 
cortex were hyper-excitable and generated numerous small spikes in a multifocal manner, 
thereby causing frequent low amplitude twitches in the hands.  There was a degree of 
rhythmicity on posturing and on voluntary muscle contraction resembling tremor, and the 
condition was therefore termed cortical tremor107. 
 
Terada in 1997 reported on familial cortical myoclonic tremor as a form of cortical reflex 
myoclonus108.  The authors considered that their cases had the same condition as that 
reported by Ikeda.  Neurophysiologic testing demonstrated that there was an arrhythmic 8-
10 Hz discharge involving the arms, sometimes synchronous and sometimes not.  The EEG 
showed generalised spike and wave discharges in four patients and photoparoxysmal 
responses in all of these.  SEPs demonstrated N20 responses within normal limits in all 
patients, and abnormally enlarged subsequent components in all except for one.  C-
responses were elicited, both ipsi- and contralaterally in all patients.  JLA demonstrated a 
positive-negative biphasic spike prior to myoclonus in three patients (Figure 21), maximal at 
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the central region contralateral to the side of EMG recording.  The latency from the positive 
EEG spike to the EMG discharge was approximately 30msec108.   
      
Figure 21. JLA in a case of cortical tremor shows a positive-negative biphasic spike 
maximal at the right central area (arrow), preceding EMG onset in the first 
doral interosseous muscle by about 30 msec (fromTerada et al., 1997) 
Okino et al described four patients with familial benign myoclonus epilepsy of adult onset, 
characterized by myoclonus and rare seizures, in which the EEG showed frequent 
generalized polyspikes111.  Surface EMG showed synchronous bursts occurring irregularly.  
Evoked potential studies showed a normal N20, but enlarged P25 and N33 in two patients.  
One patient had normal sized evoked potential responses and one had borderline increased 
responses.  Long-loop C reflexes were easily obtained, with latencies ranging from 32 to 45 
msec.  JLA demonstrated a positive-negative EEG potential in two of 4 patients, with a 
latency of 23 msec.  In two patients the myoclonus was “too fine and rare to obtain a trigger 
burst”. 
 
Okuma et al published two reports on familial cortical tremor with epilepsy.  The first report 
concerned a family with an autosomal dominant condition comprising rare seizures and 
postural tremulous movements of the fingers110.  The proband also developed arrhythmic 
oscillations in the legs on standing, resembling orthostatic tremor.  EEG showed a slight 
excess of theta activity with both multifocal spikes and spike and polyspike and wave 
discharges in the proband, a photoparoxysmal response with mild excess theta in a second 
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patient, and focal sharp waves and generalised spike and wave complexes in a third  
Surface EMG showed rhythmic bursts at a frequency of 7-9 Hz of 10-50 msec duration in the 
forearm flexors and extensors, and similar bursts were recorded in the legs when the patient 
stood.  In these two patients SEPs were enlarged in both and C-reflexes were obtained in 
one110.  JLA demonstrated a positive spike with a latency of 16 msec prior to myoclonus 
recorded from the forearm extensor muscles and 18 msec prior to myoclonus in the 
quadriceps myoclonus.   
 
The second report concerned three families with seven affected members 115.  The proband 
had an EEG which showed spike and polyspike and wave complexes and a 
photoparoxysmal response.  Surface EMG showed rhythmic bursts of 10-50 msec duration 
at a frequency of 8-10 Hz in forearm flexors and extensors.  SEPs demonstrated giant 
potentials and C-reflexes were present.  JLA demonstrated a positive spike with a latency of 
15 msec preceding myoclonus in extensor muscles of the forearm.  The three other patients 
examined had identical neurophysiology of enlarged N20-P25 and P25-N33 components of 
the SEP, C-reflexes and spike and polyspike discharges on EEG.  Two of the four patients 
had a photoparoxysmal response115. 
 
Uyama reported in abstract form on 27 affected patients with FAME, with 
electrophysiological features of cortical myoclonus116;  Subsequently, Plaster and Uyama 
reported on linkage to the FAME 1 locus5.  EEG showed generalised spikes or multiple 
spikes and slow waves on EEG and there was photosensitivity in 67% of patients.  Studies 
of evoked potentials and C reflexes were compatible with cortical reflex myoclonus5. 
 
In the report by Mikami of 17 affected patients from a single family with BAFME, the EEG 
was abnormal in all patients and most patients had generalised polyspike and wave 
complexes6.  The P25 and N33 components of the SEP were enlarged in all patients.  JLA 
demonstrated a positive spike preceding myoclonus in four patients and C-reflexes were 
recorded in all patients.   
 
A five generation family with autosomal dominant inheritance was described from Turkey in 
which myoclonus started in the third or fourth decades, associated with migraine120.  EEG 
showed generalised spike and multiple spike and wave complexes.  Photic stimulation could 
provoke myoclonic jerks and resulted in a photoparoxysmal response on EEG.   
Two Italian families were described with BAFME with linkage to the FAME 2 locus9.  These 
families had cortical tremor, and rare seizures in about half the patients.  The EEG was 
normal in six, and showed spike and wave activity in ten, with a photoparoxysmal response 
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in eight of these.  JLA showed a positive-negative premyoclonic spike or a “more complex 
series of wavelets” (Figure 22).  Ten patients showed giant SEPs, and in the remaining five, 
SEPs were normal.  C reflexes were observed in all but one patient. 
 
Figure 22. Patient with BAFME, in whom JLA showed “a series of waves with a 
premyoclonic positive-negative potential” (from de Falco et al., 2003). 
Labauge et al reported on a family with FAME, with features of cortical myoclonus7.  Surface 
EMG showed rhythmic 10-13 Hz bursts.  The P25-N33 waves of the SEP were enlarged, but 
reached a value of 8.5 V in three of five patients (a figure of 8.5 V is usually considered to 
represent the upper limit of normal for these responses250) .  C reflexes were present in all 
patients, and JLA demonstrated a biphasic positive-negative discharge. 
 
Similarly, Striano et al reported an additional family with BAFME10.  Of five patients 
examined, all had abnormal EEGs, with a photoparoxysmal response in two.  Giant SEPs 
were present in three, and all had a C reflex  JLA showed a positive-negative spike or series 
of wavelets related to myoclonus.   
 
In a further family with BAFME, associated with night blindness, the SEP showed a marked 
increase in the P25 and N33 components, and C-reflexes were enhanced.  JLA 
demonstrated a positive spike, or a series of wavelets, preceding the myoclonus by 20 
msec, which arose from the centro-parietal region114. 
 
Van Rooteselaar reported a Dutch family with FCTE with 13 affected members117.  The 
cortical tremor was irregular with a frequency of 10-16 Hz.  JLA could either not be done, or 
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showed no cortical potentials.  SEPs showed P25-N33 amplitudes that were within normal 
limits (3.8-6.5V) in three of five patients, the remaining two having enlarged responses.  C 
reflexes were obtained in four of five patients.  EEG was only done in five patients, of whom 
two had normal recordings.   
 
Elia reported on three patients from a family with possible mitochondrial inheritance pattern 
where the predominant clinical features were postural and action tremor, seizures, and 
mental retardation in one patient.  EEG revealed spikes over the posterior regions of both 
hemispheres and diffuse sharp waves in one patient, a 7Hz background with diffuse spike 
and wave complexes and posterior spikes in another, a slow background with diffuse slow 
waves or spike and wave complexes in the third patient, and rare spikes mostly over the left 
posterior regions in the fourth patient.  IPS resulted in photoparoxysmal activity in all 
patients.  Surface EMG demonstrated prominently synchronous contractions of agonist and 
antagonist muscles at a frequency of 8-10 Hz.  SEPs showed giant P25-N40 waves and C-
reflexes were enhanced.  JLA (Figure 23) demonstrated a positive wave immediately prior to 
the myoclonic jerk. 
          
Figure 23. JLA in a patient with familial cortical tremor and mental retardation 
reportedly showing “a positive deflection preceding the electromyographic 
burst of 27 msec” (from Elia, 1998). 
Guerrini et al reported on a family with seizures and myoclonus, termed Autosomal 
Dominant Cortical Myoclonus with Epilepsy (ADCME) 8.  The interictal EEG showed a 
normal background; six of seven patients had focal temporal or frontotemporal spikes or 
spike and wave discharges, and photic stimulation resulted in a photoparoxysmal response.  
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EMG showed synchronous agonist and antagonist contraction at a mean frequency of 12 
Hz.  The amplitude of the N20 response was normal, but there was a significant increase in 
the N20-N30 amplitudes and the P30-N35 amplitudes, and flash VEP showed a significant 
increase in the amplitude of the greatest positive peak.  All patients had C reflexes, with a 
contralateral response after 8 msec.  Back-averaging generated a series of waves, with a 
similar frequency to the myoclonus (Figure 24).  The largest response was a positive-
negative biphasic transient, and the positive peak occurred 21 msec before the EMG of wrist 
extensors.  However, as the authors pointed out:  “as both myoclonus-related EMG and EEG 
activities were rhythmic, it was difficult to establish with absolute certainty from back-
averages which of the various waves time-locked to the EMG discharge bore the most fixed 
temporal relationship to the EMG trigger”8.   
 
 
Figure 24. JLA in three patients with ADCME8.  Arrows indicate the peaks from where 
the latencies were measured (common average reference). RAPD= right 
abductor pollicis brevis; LWE= left wrist extensor (from Guerrini et al., 
2001. 
Frequency analysis demonstrated significant peaks in coherence between EEG and EMG 
over the contralateral rolandic area in five of seven patients studied, with the frequency of 
coherence ranging from 8-25 Hz (Figure 25).  Phase spectra showed that EEG activity 
preceded EMG activity, although the EMG lag (8-15 msec) was shorter than that seen with 
back-averaging and was brief for even the fastest cortical pathways.   
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Figure 25. Frequency analysis in a patient from Guerrini et al.’s report of ADCME 
(2001).  The thin lines in A, B & C indicate 95 % confidence limits.  A shows 
coherence between the EMG of the wrist extensor and the F4-C4 EEG.  B 
shows the phase spectrum with linear phase coherence at the frequencies 
where there is strong coherence.  C shows cumulant density estimates 
(equivalent to the cross-correlation between signals). 
Regarding reports in which JLA showed a series of waves, it should be noted that oscillatory 
activity in the motor areas of the human cortex is prominent in the primary sensorimotor area 
where activities of 10 and 20 Hz are seen314.  This rhythm may be a basic feature of motor 
cortex function and may explain the facilitation of EEG-EMG events in the 20 Hz range.  In 
patients with cortical tremor, there have been a number of reports of activity of similar 
frequency associated with myoclonus.  Ugawa reported on four patients, two with benign 
familial myoclonus epilepsy, one with tuberculous meningitis and a patient with negative 
myoclonus secondary to hepatic encephalopathy.  In the patients with positive myoclonus, 
JLA showed a 20 Hz EEG rhythm preceding the myoclonus, and in the patient with negative 
myoclonus (Figure 26), silent period averaging showed a 16 Hz EEG oscillation over the 
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contralateral motor cortex315.  Toro et al. also reported that JLA showed a positive-negative 
transient in seven patients and a more complex series of wavelets in three others in their 
initial report on cortical myoclonus312. 
 
Figure 26. JLA from report of Ugawa(2003); 489 trials averaged showing 20 Hz 
oscillatory activity, maximal at the C3 electrode. 
Similarly, sinusoidal cortical discharges associated with JLA have been reported in an HIV 
positive patient who presented with action myoclonus of the left leg.  CT showed white 
matter lesions of the right internal capsule and left temporal lobe, and likely diagnoses were 
either HIV encephalopathy or PML316.  Although SEP amplitudes were not enlarged, the 
EEG showed bursts of polyspike and wave acitivity of high frequency (40-55 Hz) over the 
sensorimotor cortex.  JLA demonstrated a high amplitude positive-negative-positive complex 
of maximal amplitude over the vertex (Figure 27).   
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Figure 27. JLA showing a high amplitude positive-negative-positive complex of 
maximal amplitude over the vertex (from Kapoor et al., 1991). 
Rhythmic myoclonus has also been reported in an HIV positive patient presenting with 
ataxia, associated with multiple areas of signal abnormality in the white matter317.  EMG 
recordings showed that the movements were of 50 msec duration and had a frequency of 10 
Hz.  EEG showed a slow background with intermittent runs of high amplitude activity in the 
alpha range in the frontocentral and vertex regions.  JLA resulted in “a complex shape that 
included multiple waves due to the rhythmic recurrence of the jerks and EEG waves”.  A 
positive peak preceded the jerks by 12-18 msec.  Autoregressive spectral analysis 
determined that there was coherence between rhythmic EEG discharges and EMG bursts, 
with a peak at a frequency of 10.8 Hz317.  The authors proposed that since rhythmic activity 
was visible on EEG, and significant coherence was demonstrable, the oscillations were 
generated by large, synchronous discharges of hyperexcitable cortical neurons317.  
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Rhythmic 25 or 50 Hz cortical and muscle discharges have been described in cortical 
myoclonus.  Myoclonus was first induced and then often occurred in series of bursts (Figure 
28-A).  The EEG correlate was often a rhythmic series of giant positive spike and slow 
negative wave complexes318.  The intervals between spikes and bursts of myoclonus were 
similar, being about 20 msec.  On back-averaging, frequency histograms of the cortical spike 
to EMG burst were derived from the individual jerk-locked events (not averaged); the 
majority of the histograms demonstrating the existence of more than one peak (Figure 28-B).   
          
Figure 28. A shows recurrent cortical potentials (P1, P’,P’’)) followed by myoclonus 
(C, C’, C’’), B shows histograms of the interval between EEG spike and 
muscle response (C reflex).  the top graph demonstrating two peaks, the 
middle three peaks, and the bottom graph shows the spike to EMG 
intervals during voluntary action.  From Brown and Marsden, 1986. 
In PME, patients have been shown to have low voltage 20 Hz arrhythmic EEG activity 
coupled to myoclonic jerks of a similar frequency, possibly related to a loss of cortical 
inhibition and therefore increasing entrainment of neurons319.  Figure 29 shows the results 
from a patient with PME and shows rhythmic EEG activity at 20 Hz, associated with muscle 
jerks in the right ECR.  The next trace shows another PME patient with rhythmic EEG activity 
at 20 Hz coupled to muscle jerks of the right ECR at rest.   
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Figure 29. 20 Hz rhythmic EEG activity associated with myoclonus at rest.  The 
recording is a polygraphic one comprising EEG and EMG. 
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1.8.11 LONG LATENCY REFLEXES AND C REFLEXES 
This section concerns transcortical reflexes, of importance since the current division of 
myoclonus into cortical and reticular reflex myoclonus is based on the concept that 
myoclonus is due to an enhanced transcortical reflex, and that cortical myoclonus has a long 
latency reflex as an integral feature.  Inherent in the concept of long latency reflexes, is that 
the physiological responses interconnecting sensory input to motor output must relate to the 
potential ability of the motor cortex to adjust its output in response to changing peripheral 
sensory input320.  The somatosensory system needs to be tightly linked with the motor 
system for the generation of discrete, coordinated movements such as hand-mouth 
coordination and fine tactile discrimination321.   
 
As opposed to the monosynaptic stretch reflex which occurs at rest, stretching a muscle 
which is actively contracting will result in a long latency stretch reflex322, and it has been 
suggested that this may represent a transcortical servo loop which acts to control motor 
output during movement 323.  In normal subjects, peripheral nerve stimulation facilitates 
subsequent motor evoked potentials at latencies which are compatible with a peripheral 
input reaching sensory cortex followed by cortical motor discharge, supportive evidence for 
the existence of long latency reflexes324.   
 
The terminology used is somewhat confusing: responses to electrical stimuli or joint 
displacements are termed M1 or E1, and correspond to the tendon reflex; this is also known 
as the long latency response 1 (LLR 1).  The long latency component at a latency of 40 
msec is usually also termed a C reflex, which is synonomous with M2 or LLR II325.  A later 
component is termed M3 (LLR III), and typically has a latency of about 90 msec326.  Typically 
in PME and similar conditions, a C reflex may be identified, with latencies ranging from 31 to 
58 msec241, often associated with an enlarged SEP and other features of cortical 
myoclonus327.   
 
Cortical reflexes were studied by Evarts in monkeys328, by noting responses in motor and 
sensory cortices during a task in which a sudden force displaced a limb.  Typically, sensory 
cortex neurons discharged at 10 msec, and pyramidal neurons 4 msec later.  There were 
EMG responses in muscle at 12 msec, compatible with a monosynaptic stretch reflex, and a 
second phase was seen at 30-40 msec and a third at 80 msec.  Evarts believed that the 
second phase was not a pure reflex, but that there was a learnt component, and that motor 
set was also involved, both features of voluntary movement328, a finding confirmed by 
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others326, although the subject of controversy325.  In a primate model of EPC and secondarily 
generalized seizures induced by subpial injections of alumina cream, Chauvel described 
succesive bursts in the injured hemisphere after peripheral stimulation stimulation329.   
1. The first corresponded to the monosynaptic reflex;  
2. The second component had a latency of 40 msec (termed E1). 
3. A third response had a latency of 80 msec, and duration of 70-90 msec (termed E2). 
Direct cortical stimulation in the region of the focus (hindlimb area) resulted in two EMG 
bursts, the first with a latency of 12 msec and the second with a latency of 40-50 msec.  
Chauvel et al suggested that the E1 and E2 reflexes were transcortical in nature and that the 
E1 reflex was analagous to a long-loop reflex.  Furthermore, they postulated that 
transcortical reflexes could trigger short myoclonic jerks and maintain longer seizures, 
stating that “the neuronal organization of the mammalian motor cortex is indeed such that a 
cell receiving afferent impulses of muscular origin projects in turn to the very same muscle 
from which these impulses originate”329. 
 
In humans, Marsden et al. suggested that there were different pathways for the tendon reflex 
and the stretch reflex, having noted that responses to stretch and other stimuli in muscles 
occurred at about twice the latency as was seen in tendon jerks, and proposed that they 
arose from a transcortical stretch reflex pathway253.  They also examined a patient in whom 
stretch of the thumb resulted in a myoclonic jerk of the whole arm, with a latency of 50 msec.  
Marsden subsequently demonstrated that posterior column lesions could abolish late 
respones, noting that the posterior column was physiologically an appropriate pathway for 
the rapid transfer of spindle information to the cortex330.  In patients with DRPLA, in whom 
SEPs are not enlarged, but have prolonged latencies, the amplitude of the LLR 2 was 
significantly smaller than controls, possibly related to degeneration of the medial lemniscus, 
with consequent reduction in cortical input331.  Similarly, lesions of the cortex itself could also 
abolish the servo response to displacement of the thumb; the initial component at around 40 
msec was frequently lost, often with persistence of later components, for example, at 55 
msec, or in the case of a patient with a lesion of the sensory cortex, at 75 msec332.  As a 
result of these findings, Marsden’s group theorized that cortical myoclonus was the result of 
exaggerated long loop reflexes, perhaps triggered by poorly discernible peripheral 
stimuli60;247.  However, the experimental setup for determing long latency reflexes was 
hampered by mechanical problems such as the inability of torque motors to generate 
discrete stimuli (rather producing stimuli lasting 100 msec or more), and that mechanical 
stimuli activate not only muscle stretch receptors but also multiple sensory receptors 326 .   
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Moreover, there are other theories to account for the presence of long latency reflexes being 
distinct from the tendon reflex.  These include dispersed spindle afferent volleys and 
mediation of the stretch reflex by slowly conducting afferents such as group II secondary 
spindle afferents322.  Similarly, with regard to the finding of abolition of long latency reflexes 
by lesions, the long latency pathway may involve slowly conducting polysynaptic spinal 
routes which are subject to descending influence from supraspinal structures, and removal 
of a hypothetical facilitatory influence on this pathway could explain the absence of long 
latency responses in the patients322.  In addition, the relationship between the responses that 
Marsden et al obtained from muscle stretch and the C reflex seen in cortical myoclonus is 
unclear.  These responses arise from different stimuli, stretch and electrical stimulation of 
peripheral nerve respectively, and electrical stimulation of the peripheral nerve does not 
usually elicit a tendon reflex.  Despite these caveats, there is likely to be involvement of long-
loop pathways involving the motor cortex for distal hand and fingers muscles333.  However, 
this has not been shown to be the case for proximal muscles in the arm, and Chen has 
reported that for proximal muscles, the estimated central delay is too short for a transcortical 
reflex334.  Additionally, in the legs, long latency responses do not appear to be analogous to 
those demonstrated in the human hand325.   
 
With regard to the original hypothesis of long latency reflexes being intimately involved in a 
servo loop linking motor and sensory responses, long latency components appear to be 
inadequate in the production of an effective control of limb position, and it seems unlikely 
that long latency reflexes form part of an error-feedback system to restore the position of a 
limb after its displacement326.  An additional difficulty is that although afferents to the motor 
cortex may be involved in cortical reflexes, the nature of the afferents (whether direct or 
mediated through the sensory cortex) is unclear.  Marsden wrote in 1973 that “such a 
transcortical stretch reflex derives its recent plausibility from the discovery that impulses from 
muscle stretch receptors (muscle spindles) have a rapid pathway to the cerebral cortex.  
First found in lower mammals, this pathway has been traced in the baboon to a cortical area 
in the depths of the central sulcus, immediately next door to the motor area”.  However, the 
existence of a short latency input, if any, to the motor cortex is uncertain (see discussion, 
Section 1.8.13).  The situation may be summed up in this quote by Butler,: “a preoccupation 
in the literature with long-loop reflexes has, in our opinion, placed excessive emphasis on 
the shortest latency input.  Most skilled movements are pre-programmed and it is more likely 
that sensory input is used to detail the progress of a movement and its outcome, rather than 
to provide input to allow the cortex to respond to perturbations”335. 
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Concerning the more specific role of these reflexes and myoclonus, subsequent to 
Marsden’s reports on long latency reflexes, he and Hallett published their paper on cortical 
reflex myoclonus (Section 1.8.8) reporting that in normal subjects, the long-latency 
responses to stretch started at about 40 msec and lasted till about 90 msec (Figure 30).  In 
addition, they reported that long latency responses often appeared to be composed of two 
parts, termed A and B.  The early A response began 40 msec after the onset of muscle 
stretch, whereas the B component had a latency of 50-60 msec.   
     
Figure 30. EEG and EMG responses to stretch of the thumb.  SP indicates the spinal 
monosynaptic reflex and LL indicates the onset of the long latency reflex” 
Figure from Hallett et al., 1979.   
Although a feature of cortical reflex myoclonus, remarkably, given the presumptive cortical 
origin of long latency reflexes, Shibasaki reports that these reflexes may also be enhanced 
in reticular reflex myoclonus, although the latter is ascribed to brainstem dysfunction242. 
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1.8.12 CORTICAL EXCITABILITY 
A critical question regarding the pathophysiology of myoclonus is whether the cerebral 
cortex is abnormally disinhibited and therefore, hyperexcitable.  In certain cases, where the 
cortex has less inhibition than normal, peripheral stimuli may lead directly to myoclonus, or 
recurrent peripheral stimulation may be required in order to bring cortex to a threshold above 
which myoclonus will occur.  As Adrian and Moruzzi put it “to cause movement the cortex 
must be stimulated many times at short intervals in order to build up the requisite degree of 
facilitation.  This is a process which takes place in the cortex itself and is associated with a 
progressive increase in the size of the potential wave following each shock” 268.   
 
Early examples of this phenomenon included Dawson’s case in whom it was noted that 
myoclonus could gradually increase over days and culminate in a generalized seizure227.  
With reference to this patient, Hallliday noted  the "frequent occurrence of recruitment in the 
muscle jerks, suggesting that the train of cortical spikes, which had a frequency of about 8-
13 per sec, had to build up to a state of excitability in the intervening pathways by repetitive 
firing”252.  In an analogous fashion, Dawson observed that, following a series of tendon taps, 
initial stimuli produced focal jerks without apparent EEG change, while subsequent stimuli 
produced generalized EEG spikes and generalized myoclonus 227.  Similarly, Watson and 
Denny Brown, in a patient with PME due to lipidosis, recognized a sustained afterdischarge 
resulting from stimulation in various modalities at a favourable rhythm and duration of 
stimulus336.  With repetition of a stimulus at a favourable rate, there was a spread of cortical 
discharge and the evoked slow wave was detected in an area larger than that of evoked 
spikes.  Likewise, in a patient with infantile hemiplegia and stimulus sensitive myoclonus 
studied by Fullerton and Giblin, myoclonus showed recruitment as determined by an 
increase in amplitude when stimuli were given at a frequency of 1 Hz239.   
 
The effects of peripheral stimulation allow inferences to be drawn regarding the potentially 
different states of cortical excitability.  Similarly, the determination of excitability cyles, in 
which stimuli may be given in pairs, and the interval between stimuli varied is a useful 
experimental technique in assessing cortical excitation.  Shibasaki has proposed that 
demonstration of enhanced excitability following a single stimulus is evidence for cortical 
involvement in producing reflex myoclonus242.  An increase in the degree of cortical 
excitability may account for successive SEP peaks and C reflexes seen after a single 
stimulus, a phenomenon described in a number of reports in patients with PME 228;318), and 
corticobasal degeneration 289.   
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With regard to excitability cycles, in Dawson’s initial study of the normal SEP in man, he 
found that the amplitude of the response to the second of a set of paired stimuli could be 
facilitated by as much as 50 to 70 % during the facilitatory period lasted from 60 to 100 msec 
and again from 120 and 160 msec, with a period of depression from 10 to 30 msec (Table 
10)248.  The response of the second stimulus is believed to correlate with the level of cortical 
excitability241.  Sutton and Mayer found mild facilitation with interstimulus intervals (ISI) from 
32 to 63 msec, and again from 130 to 250 msec (Table 10)245.  
Table 10. Results of experiments of excitability cyles in patients with myoclonus. 
 Enhancement (ISI) Attenuation (ISI) 
Dawson, 1947b 60 –100 10 - 30; 120 -160 
Sutton & Mayer, 1974 32 - 63; 130 - 250  
Seyal, 1991 40 – 200 <40; 300 - 500 
 
Seyal described two patients with cortical reflex myoclonus, with giant SEPs and C-reflexes: 
in one, seizures could be brought on by movement; in the other, taps over the hand resulted 
in spikes in the opposite centroparietal region and rhythmic myoclonus could be induced by 
stimulation of the foot337.  At ISIs of less than 40 msec, the SEP amplitudes following the 
second stimulus were decreased compared to those following the first stimulus; whereas at 
ISIs of 40-200 msec, the SEP amplitudes were increased; a second period of attenuation 
occurred at ISIs of 300-500 msec (Table 10)337.  The excitability cycle of the C-reflex 
paralleled that of the SEPs.  These excitability cycles are abnormal, since in normal 
individuals no enhancement of SEPs occurs until an ISI of 200 msec338. 
 
Shibasaki used a different technique: using stimuli at varying intervals after myoclonic 
discharges, he was able to obtain a cortical excitability curve by comparing the amplitude of 
the evoked potential following myoclonus with that obtained irrespective of myoclonus339.  
There was enhancement of the N33 evoked response and the C reflex for 20 msec after the 
myoclonus339.  When a pair of shocks was used to elicit the SEP in a patient with PME, giant 
SEP and C reflexes were observed to be enhanced with ISI of 35 msec but attenuated at an 
interval of 65 msec250.  Ugawa examined cortical excitability by studying the recovery 
function of the SEP, which was investigated by the paired stimulation technique in which 
paired stimuli are given at various time invervals.  The SEP obtained by the second stimulus 
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was obtained by subtracting the SEP evoked by the first stimulus from the result of the 
paired stimulus340.  .  At short interstimulus intervals, in patients with Alzheimer’s disease 
with myoclonus, galactosialidosis, and in PME (not specified), the SEP- recovery curve was 
abnormal, suggestive of cortical excitability being present.  There was a dissociation 
between the SEP amplitude and the SEP-function, since some patients had an abnormal 
SEP-recovery curve, although their SEPs were not enlarged, and vice versa340.  
 
Using JLA, Brown et al demonstrated interhemispheric and transcallosal spread of 
myoclonic activity in patients with myoclonus who developed bilateral jerks even when only 
one limb was stimulated, and proposed that this represented abnormal excitation of cortex 
which might be relevant to the development of seizures in these patients341.  Subsequently, it 
was shown that patients with multifocal myoclonus have lower cortico-cortico inhibition and 
transcallosal inhibition in the event that they have bilateral or generalized jerks compared to 
the group which does not have generalized jerks 342. 
 
Cortical excitability may also assessed by use of magnetic stimulation.  Reutens et al 
demonstrated increased cortical excitability in idiopathic generalised epilepsy343;344.  In two of 
three patients with PME (MERRF and Unverricht-Lundborg), with peripheral stimulation, 
motor evoked potentials were facilitated at ISIs between20 and 60 msec, suggesting that 
cortex was abnormally excitable345.  Similarly, in a patient with focal myoclonus associated 
with celiac disease, the threshold to magnetic stimulation was reduced over the affected 
hemisphere295. 
 
In a group of patients with DRPLA, peripheral nerve stimulation preceding magnetic 
stimulation facilitated motor evoked potentials in some patients, although somewhat 
paradoxically, these patients had SEPs which were not enlarged, and had prolonged 
latencies, with a reduction in long latency responses.  The authors proposed that this 
dissociation was the result of activation of different populations of cortical pyramidal 
neurons331.  In patients with ADCME, the resting motor threshold intensity was significantly 
reduced (even though patients were on antiepileptic drug treatment), and the post MEP 
silent period during rhythmic EMG bursting was markedly shortened compared with controls, 
both findings suggesting loss of cortical inhibition8. 
 
In Unverricht-Lundborg disease Silen et al. have shown that patients have reduced cortical 
inhibition, as demonstrated by lack of the normal rebound response (stimuli normally elicited 
a small transient decrease, followed by a strong increase ("rebound") of the 20 Hz 
component of the mu rhythm following peripheral stimulation) 346.   
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Similary, in cases of Unverricht-Lundborg disease with myoclonus but no seizures, the 
responses of the primary somatosensory cortex, as determined by the size of evoked 
potentials, were only slightly enhanced or were normal, and no ipsilateral responses were 
seen, whereas in those patients with seizures, SEPs were enlarged.  This suggests that in 
the group of patients without seizures the motor cortex was less excitable and had less 
disturbed transcallosal conduction347.  The same authors also used MEG to examine the 
cortical drive on spinal motor neurones in Unverricht-Lundborg disease, and demonstrated 
enhanced cortex-muscle coherence during isometric contraction, as compared to normal 
subjects348.  The authors suggested that abnormal coherence may be due to reduced 
inhibition in motor cortex or altered cerebello-thalamo cortical output.  However, Karhu 
reported that cortical inhibition in Unverricht-Lundborg disease was normal, as studied by the 
response of the neuromagnetic somatosensory evoked field to a paired stimulus paradigm of 
median and ulnar nerves and by altering the ISI349. 
 
Hanajima used a paired-pulse magnetic stimulation technique to study cortico-cortical 
inhibition of the motor cortex: normal results are inhibition at short intervals and facilitation at 
long intervals350.  Patients with PME had reduced inhibition at short intervals, perhaps 
associated with an alteration in the excitability of cortical inhibitory interneurons.  Similarly, 
normal inhibition was lost in patients with lesions affecting either the basal ganglia or their 
connections with motor cortex, whereas patients with lesions in the sensory cortex or 
thalamus had normal findings.  Using magnetic stimulation over the hand areas of the 
cortex, one being the conditioning stimulus, and the other the test stimulus, Hanajima 
demonstrated facilitation at early ISIs of 4-6 msec, with no late inhibition, whereas normally 
there is late inhibition at ISIs of 8-20 msec and no facilitation, the findings being suggestive 
of impaired cortical inhibition in affected patients351.   
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1.8.13 NORMAL SEP 
Electrical stimulation of peripheral nerves activates a large number of large diameter fibers, 
predominantly cutaneous afferents of Group I and II in type352.  Group I and II afferents are 
derived from cutaneous receptors, muscle spindles (primary and secondary endings), Golgi 
tendon organs and joint capsule receptors.  However, there is controversy over the degree 
to which cortical SEPs are the result of stimulation of Group II cutaneous and/or joint 
afferents, or to Group I and II muscle afferents353.  
 
The afferents for the SEP are conducted along the dorsal columns, medial lemnisci and the 
caudal division of the ventral posterior lateral nucleus of  the thalamus (discussed in greater 
detail in Section 3.5.2)354,226;232.  With regard to the role of thalamic nuclei in the evoked 
potential, in man lesions of the VPL encroaching on VPM reduced the evoked potential, 
whereas lesions of VL had no effect, suggesting that the evoked potential is mediated 
through the VPL and VPM nuclei, and not VL355.  Stimulation peripherally results in 
responses at latencies of 7-20 msec in N ventralis posterior, depending on the region of the 
body stimulated356.   
 
In patients with cortical reflex myoclonus the short latency between stimulus and response 
suggested that the cortical event arose synchronously with or shortly after the afferent 
volley’s arrival at the cortex 248.  This would necessitate a direct sensory input to motor 
cortex, termed a short latency afferent, or rapid projection from sensory to motor cortex.  
However, the nature of the peripheral projections to motor and sensory cortices is complex.  
In cats, there are direct short latency cutaneous and muscle afferents projections to the 
motor cortex via the VPL nucleus 357.  In primates, short latency somatosensory afferents 
projecting to area 4 have been recorded226;358; with area 4 receiving input from cutaneous 
and deep receptors, but most area 4 neurons are predominatly responsive to joint movement 
or deep pressure359 358.   
 
Moreover, somatosensory projections to area 4 of motor cortex are sparse compared with 
those to area 3b of sensory cortex.  Although SEPs have been recorded in area 4 of motor 
cortex in cats and monkeys360, removal of the hand area of somatosensory cortex abolishes 
the SEP, indicating that the motor component of the SEP is likely to be trivial or non-
existent361.  However, Goldring found smaller and later potentials than those recorded from 
somatosensory cortex, suggesting that potentials from motor cortex could contribute to the 
P25-N35 component of the SEP in some cases, although it is unclear whether these could 
be derived from sensory cortex or not362.  
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Although the motor cortex appears likely to receive short latency input from deep forelimb 
afferents, it is unclear how this occurs.  Posterior column input appears to be involved, since 
cervical cord lesions result in lack of responsiveness of area 4 neurons to peripheral 
stimuli363.  However, the posterior columns project to VPLc, and there is no anatomic 
evidence of a projection from VPLc to motor cortex364.  On the contrary, group I muscle and 
muscle spindle afferents pass via the posterior columns through the shell of VPLc and 
project to area 3a 365 and cutaneous afferents project via the central core of VPLc to areas 
3b and 1226.  VPLc and its subcomponent, VPm, project to areas 3a, 3b, 1, and 2 (Figure 
9)226.  Group I and II afferent projections likely reach area 3b prior to reaching area 1361.  
Area 3b projects posteriorly to areas 1 and 2, and anteriorly to area 3a.  Area 3a, which 
receives Group I afferents and projects to area 1, resembles a zone of attenuated layer IV 
granule cells intervening between the pyramidal cells of area 4 and the thick granular cell 
layer of area 3b, and is therefore an overlap zone, functionally sensory rather than motor 
cortex 226;366.   
 
Only area 2 of somatosensory cortex projects forward to area 4226.  However, cooling of this 
region does not reduce the responses of motor cortex to passive joint movement363;365, 
indicating that the origin of short latency inputs to motor cortex is unlikely to be transmitted 
via area 2.   
 
An alternative pathway of short latency inputs to motor cortex would involve VPLo, which 
receives cerebellar inputs and projects to motor cortex 364.  However, the role of this nucleus 
in cortical projections of afferent input from muscle and joints is unclear, since it does not 
receive a projection from the dorsal columns 367.  Furthermore, when compared to VPLo 
neurons in the cerebellar thalamus, VPLc neurons fire at shorter latency, have more discrete 
and lower threshold sensory fields and have fields which resemble those of motor cortex, 
making it more likely that VPLc neurons are likely to be responsible for the short latency 
input 335.  There may be overlap between terminations of the medial lemniscus and 
cerebellum at the VPLo and VPLc border, but this is controversial 367.  Different populations 
of neurons in this boundary zone have been identified which project to either motor or 
sensory cortex 359.  
 
It remains unclear how short-latency lemniscal inputs reach motor cortex, and if they do so 
via VPLo 367 226.  The cerebellum can also supply sensory input to the motor cortex, and 
cerebellar thalamic neurons have sensory fields, although the response is weaker than that 
seen in VPLc 335.  However, cerebellar sensory information is likely to contribute only to later 
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motor cortical responses to peripheral stimuli since sensory input to limb perturbation arrives 
in the cerebellar thalamic nuclei 16 msec after responses in VPL to the same stimulus 335.   
Furthermore, many cerebellar thalamic neurons fire too late for a monosynaptic connection 
from the interpositus nuclei to provide the source for the short latency input.  For example, 
interpositus neurons respond with latencies of 20-40 msec368, whereas neurons in cerebellar 
thalamus respond at latencies of 48 msec 335.  Only the earliest firing cells in the cerebellum 
could contribute to the short latency motor cortical response, which has a latency of 20-50 
msec following displacement of a limb328. 
 
With regard to the neurophysiology of the evoked potential at cellular level, activation of 
mammalian somatosensory cortex generates a surface positive-negative sequence, the sum 
of slow postsynaptic potentials, often termed the primary evoked response369.  The primary 
positivity is believed to represent depolarization of pyramidal cell bodies and proximal apical 
dendrites, whereas the primary negativity is believed to reflect later depolarization of distal 
apical dendrites 360;370.  Pyramidal cells perpendicular to the cortex therefore give rise to a 
dipole with opposite polarities at the surface of the cortex and lower cortical levels; this being 
termed a radial dipole.  In contrast, a tangential dipole consists of neurons in the wall of a 
sulcus, resulting in a potential field of opposite polarities on either side of the sulcus.  Such a 
dipole is detectable by MEG, which allows for a determination of the direction of the 
intracellular current flow, that is, the site of depolarization in the apical dendrites of large 
pyramidal cells242. 
 
Dawson had initially recorded a positive-negative deflection, corresponding to the primary 
evoked response 371.  Subsequently, cortical recordings by Giblin showed a similar positive-
negative response (Figure 31) and it was concluded that mammalian and human responses 
were similar, with respect to the polarity and relationship of the primary positivity and 
negativity372.  Giblin described an initial positivity, P25, largest in the region medial to where 
N20 was recorded, and the conclusion was that P25 was the primary positivity of 
somatosensory cortex 361.  However, Broughton noted the polarities of the primary response 
were inverted in man compared to the usual mammalian responses, since the major initial 
response was N20/P20, followed by P30/N30, and proposed that in man the primary cortical 
SEP generator could be located deep in the posterior wall of the central sulcus373. 
 
In the normal SEP, the primary triphasic complex is believed to represent the cortical 
response to the afferent volley 374.  Waves have been labelled as follows: 
N20: First cortical negative wave at 20 msec, also termed N1 
P25: Following positive potential at 25-32 msec, also termed P1 
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N30: Subsequent negative potential at 33-40 msec, also termed N2374 
 
                  
Figure 31. These responses show SEPs: A and B are scalp recordings; C was 
recorded from the cortical surface of the postcentral gyrus (from Giblin, 
1964).   
However, the origin of the normal human SEP is somewhat controversial.  With reference  to 
Figure 32, based on Allison’s work (1991) it seems likely that the typical waveforms seen in 
human cortex are: 
P20-N30: corresponding to the hand area of motor cortex; location 1 (Figure 32-C), recorded 
from  motor cortex and frontal scalp. 
P25-N35: corresponding to the medial portion of hand area of somatosensory cortex near 
the central sulcus, but also recorded at smaller amplitudes from the motor cortex near the 
central sulcus: location 2 (Figure 32-C). 
N20-P30: largest in the lateral portion of the hand area of somatosensory cortex and 
adjacent parietal cortex: location 3 (Figure 32-C). 
 
These potentials appear to be generated in somatosensory cortex in area 3b and 1, and not 
elsewhere361.  Depth probe recordings have recorded the largest P20-N30 potential at one to 
two cm beneath the cortical surface360, which is compatible with the major axis of a dipole 
generator sited in area 3b 361.  Similarly, MEG recordings have shown a tangential source 2-
3 cm beneath the scalp in the region of the somatosensory cortex 375;376.  Recordings of both 
MEGs and SEPs confirm that they are produced by a single tangential generator; the 
direction of intracellular current flow detected in magnetic recordings being consistent with 
initial depolarizion of neurons in somatosensory cortex, but not motor cortex 361: MEG 
demonstrates that area 3b is the major contributor to the 20 msec and 30 msec potentials.   
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Figure 32. A shows position of the electrodes over the scalp (oblique view).  B shows 
the SEPs recorded from the electrodes in A (note the polarities are 
reversed compared with usual conventions).  C shows the cortical surface 
of the hemisphere, where CS is the central sulcus.  D shows SEPs 
recorded from the cortical surface (from Allison, 1991) 
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1.8.14 PATHOLOGICALLY ENLARGED SEPS 
A central tenet of the current classification of myoclonus into cortical and subcortical types is 
that in cortical myoclonus the SEPs are enlarged.  However, particularly given that 
subcortical structures are involved pathologically, it is important to try and establish the basis 
for our understanding of enlarged evoked potentials as being of cortical origin.  Summed 
excitatory postsynaptic potentials (EPSPs) give rise to the P1-N2 wave either due to 
abnormal afferent inputs, or because of a primary disorder of cortical inhibitory interneurons 
or a secondary failure of inhibition from other subcortical structures374.  As Dawson wrote in 
1947: “If in fact the initial wave in the response to stimulation in the myoclonic subject… is 
associated with the arrival of the afferent volley at the cortex and not with any subsequent 
cortical activity, as is suggested by the short latency and polarity of the response, then the 
cause of the great difference in size between the responses in the healthy and the myoclonic 
subjects must be sought below the cortex, possibly at the level of the thalamus” 248. 
 
Halliday observed that “in a sense it is to the phenomenon of myoclonus that we owe the 
discovery of the somatosensory evoked response in the human cortex”239.  Having 
demonstrated that peripheral electrical stimulation in a patient with myoclonus brought about 
changes in cortical potentials, Dawson went on to describe SEPs in normal individuals371.  A 
few months later, Dawson noted that SEPs could be enlarged some five to ten times in focal 
myoclonus, the first example of the intimate relationship of myoclonus with abnormal SEPs 
248
.  The subject had a complaint that when he put weight on his toes, his foot began to 
shake and seizures occurred preceded by altered sensation of the left arm.  Generalized 
myoclonic jerks were elicited by evoking tendon reflexes and active or passive movements.  
During myoclonic jerks the EEG showed groups of polyspikes (fast focal sinusoidal 
discharge) occurring every few seconds.. 
 
Features of the SEPs associated with myoclonus include:  
• Focal limb myoclonus is associated with unilaterally enlarged SEPs374.  In this case 
the myoclonus is usually a combination of cortical reflex myoclonus and spontaneous 
myoclonus, worsened by action374.  This form of focal myoclonus is typically limited to an 
abnormality of a small cortical area. 
• Bilaterally enlarged SEPs are seen with multifocal or generalized myoclonus 374.  
Myoclonus is typically worsened by action, but spontaneous and cortical reflex 
myoclonus are often present.  Reflex jerks may be present on stimulation, as may 
generalized myoclonus.  The pathophysiology is that of a generalized encephalopathy, 
or due to loss of inhibition, frequently associated with cerebellar disease 374. 
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However, patients may have enlarged SEPs without myoclonus; 252 374. and conversely, 
myoclonus is not necessarily associated with enlarged SEPs230;239;374;377.  Myoclonus may 
only be present if the SEP reaches a particular amplitude 239, and large SEPs may be 
present only when actual jerking is taking place in focal myoclonus374. 
 
There is experimental evidence for subcortical activity being expressed as an evoked 
potential, and as early as 1964, Giblin recorded a negative potential at a latency of 17 msec, 
and concluded that “since this negative wave precedes the positive wave of the primary, it 
can only be due to presynaptic potentials in thalamocortical projection fibres” 372.  
Subsequently, a diffuse negativity at N18 was noted to persist despite thalamic or 
suprathalamic lesions which aborted N20 and later potentials 378, and was therefore 
interpreted as being of thalamic or brainstem origin.  However, animal recordings have 
shown that evoked potentials recorded in VPL appear at the cortical surface as a positive 
inflection on the rising phase of the primary positive wave; this early potential having a 
subcortical source since it increases in amplitude at increasing depth from cortical surface, 
as opposed to the primary positive-negative complex which inverts in polarity in deep cortical 
layers 373. 
 
An autopsied case with an absent N19 was shown to have diffuse cortical atrophy with 
normal thalamus and thalamocortical radiation, suggesting that potentials with latencies of 
19 msec and later are of cortical origin 379.  Direct recordings from the Vop nucleus of the 
thalamus showed that the latencies of thalamic potentials were shorter than N20, “consistent 
with a cortical origin for N20”379.   
 
In recordings made during stereotactic thalamotomy, carried out under local anaesthesia, 
the nucleus ventro-caudalis, which lies in the sensory territory of thalamus, was found to 
have the clearest responses to stimulation, and its response was invariably related to the 
initial negative response of the cortical SEP, which occurred 1-2 msec later (Figure 33).  It 
was concluded that this cortical response represented the afferent volley of the thalamo-
cortical fibres380.  Similarly, Pagni reported a cortical positive wave at 15-20 msec, about 2 
msec later than the thalamic response 381. 
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Figure 33. Recordings during stereotactic thalamotomy; SEP recorded 
simultaneously with the thalamic recording; electrical stimuli consisted of 
0.1 msec rectangular pulses at random intervals from 1-1.5 seconds, 
usually over median nerve.  VC nucleus of thalamus showed clearest 
responses to stimulation: a single positive deflection, at a latency of 12.2 
msec to onset and 17.5 msec to peak (P1), related to the initial negative 
response (IN) of the cortical SEP (Cx), which occurred 1-2 msec later (from 
Fukushima, 1976). 
Cortical responses as a result of activation of subcortical structures, as exemplified by the 
SEP, are not unique to thalamo-cortical interactions.  Further examples of subcortical 
structures giving rise to evoked potentials include the subthalamic nucleus and the lateral 
geniculate body: 
1. Stimulation of the subthalamic nucleus results in both positive and negative 
potentials at latencies of 19 and 23 msec respectively at the medial-posterior frontal 
regions on EEG.  The more prolonged latency is believed to be related to stimulation 
of the premotor cortex 382.   
2.  When recording the VEP, flash stimulation in the primate produces a broadly frontal 
negative response, N25.  In the lateral geniculate body, early current sinks in the 
parvocellular lamina 3 and magnocellular lamina 2 generate the initial part of N25, 
and the peak and later parts of this wave arise from depolarization of cells in lamina 6 
383
.   
A critical point in the argument that myoclonus is of cortical origin is the apparent 
dissociation between the amplitude of the N1 response, which is of normal amplitude 
250;377;384;385
 and the subsequent P1 and N2 responses which are enlarged.  Although there is 
uncertainty as to whether the waves seen in giant SEPs are analogous to those seen in 
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normal SEPs, the latency and distribution of the first negative cortical response is equivalent 
to the N20 of normal individuals 238;250;377;385;386.   
 
Although giant evoked potentials are typically recorded from sites corresponding to 
somatosensory cortex, their origin may be more widespread, or they may arise from other 
cortical areas or represent abnormal input from subcortical structures.  However, since the 
N1/N20 response classically represents the thalamic afferent volley357;387, it is assumed that 
the abnormal enlarged responses of PME and similar conditions are not related to thalamic 
or other forms of abnormal input, but that the cortical area from which the evoked potentials 
are recorded is itself abnormal.   
 
However, the N1 response in cases of PME is not always of normal size.  Shibasaki initially 
reported that the amplitude of the N1 and P19 were within normal limits or slightly larger than 
normal 250;384, and Rothwell reported a slight increase in size in two patients377, noting that 
"some patients have an enhanced N1 response in the SEP, which may indicate that the 
afferent volley reaching the cortex is enlarged"238.  Jones reported a case with an enhanced, 
asymmetrical N20 response, and commented that “ it is puzzling that the majority of studies 
should find little evidence for enhancement of N20, since this component is widely believed 
to be generated at suprathalamic level, but recent experience suggests that N20 may be 
affected more often than previously thought”304.  The use of MEG has demonstrated an 
enlarged N20m in patients with Lafora body disease, Familial Cortical Myoclonic Tremor 388, 
and in Unverricht-Lundborg disease349 potentially indicating that the ‘subcortical structures 
may also play some role in the pathogenesis of myoclonus’ 388.  Similarly, N1 amplitudes are 
enhanced in CBD, more so in the hemisphere not associated with myoclonus308, although 
not always 334.  However, in another study of patients with Unverricht-Lundborg disease 
using MEG, the amplitudes of cortical evoked responses at 20 msecs were not larger than 
controls389, and Mima found normal sized N1 responses in patients with MERRF and a 
second case of Familial Cortical Myoclonic Tremor388.   
 
To an extent, as much as there is controversy as to the size of the N20 response, it is 
equally uncertain whether the subsequent enlarged responses are due purely to cortical 
activity, or whether they are affected by subcortical input.  There may be subsequent 
processing of the input seen at N1 or the later arrival of an enlarged slower conducting 
afferent input, which is then responsible for the development of the enlarged P1 238.   
 
The fundamental basis of the origin of the N20 is unknown  and it is reported both as being 
generated by postsynaptic potentials of pyramidal neurons of area 3b of somatosensory 
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cortex390, as well as being due to “presynaptic activity originating from the primary sensory 
cortex”384.  An evoked potential is a summation of a number of complex cortical events, 
many of which are poorly understood: “the possibilities for addition and subtraction of action 
currents for so many derivations make it clear that a single physiological unit of which the 
gross evoked potential is the integral must be a constantly changing will-of-the-wisp.  This is 
not to say that an evoked potential is not a function of the numbers and rates of discharge of 
single cells, but rather that the function is a difficult one to solve precisely, especially when 
different members of the population may be simultaneously active in different ways”370. 
 
However, animal models of evoked potentials have been described.  A study of local cortical 
micro-circuits in rodents using current source density analysis allowed three phases to be 
discerned in the primary evoked field potential (Figure 34):  in the first phase, thalamic 
afferents depolarize layer III and V pyramidal cells 391.   A second phase was determined 
largely by intracortical projections, and in the third phase, spikes were generated in layer V 
pyramidal cells, presumed to be excited by thalamo-cortical input (sink f in Figure 34).  This 
finding suggests that, at least in rodents, a detailed analysis of the components of the 
evoked response indicates that thalamic afferents play a role in determining the cortical 
evoked response in most or all of the components of the evoked potential that are noted to 
be enlarged in cortical myoclonus.  It should be emphasized that there are considerable 
similarities between humans, primates, cats and rodents, certainly with regard to the primary 
response, which corresponds to the N20/P20 component in humans 392.   
 
            
 
 
 
 
 
 
Figure 34. Note: N1 in this figure does not correspond to human N1, but corresponds 
to human P1.  A: Depicting termination of specific thalamo-cortical 
afferents (spec aff) in the border of layers Vb/VI and layers IIIb-IV.  B: 
Sequence of sink-source configuration, depicted in two pyramidal cells 
with cell bodies in layers III and V.  Sinks (net inward current) are hatched 
and sources (net outward current) are dotted. 
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It is pertinent to note that although only 5% to 20% of the excitatory synapses onto layer 4 
neurons in the cortex are thalamocortical, since these connections are more powerful than 
intracortical connections, a small number of thalamocortical axons may dominate the activity 
of cortical layer 4 cells during sensory inflow393; in addition, layer 4 networks may amplify the 
thalamocortical input 394.   
 
One indication that the process underpinning evoked potentials in humans is more complex 
than it would appear at first sight is that in patients with myoclonus the amplitudes of the 
positive and negative waves vary independently 239, suggesting that neuronal populations in 
cortex are behaving differently.  Thalamotomies in humans involving VL and part of VPL 
reduced evoked responses at latencies of 19.2 and 24.3 msec suggesting that “the two wave 
forms are related, both being reduced by the same thalamic lesion”355.  Evidence supporting 
Rothwell’s hypothesis that subsequent processing takes place after arrival of the afferent 
volley is potentially seen in Unverricht-Lundborg disease, where the N1 response is 
significantly delayed349. 
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1.8.15 LOCALIZATION OF THE SEP  
This section reviews current understanding of the localization of the giant evoked potentials 
associated with myoclonus.  In the setting of an abnormally disinhibited cerebral cortex, giant 
potentials may not necessarily arise by the same mechanisms as the evoked potential in a 
normal subject.   
 
Dawson observed that evoked responses were largest over the hemisphere contralateral to 
the site of stimulation and were topographic, in the sense that the potentials corresponded to 
the arm or leg area of the cortex.  These potentials were thought to arise from central or 
post-central cerebral cortex371.  However, SEPs may be widespread, and not limited to 
somatosensory cortex, as seen in patients with PME, sialidosis and uraemia,  where giant 
SEPs can be widespread, involving the central, parietal and frontal regions, 384.   
 
In part related to the belief that the generator of the SEP and the C reflex were identical (see 
page 163, Rothwell et al. proposed that giant SEPs could be considered to represent an 
abnormal synchronous discharge of motor cortex pyramidal tract neurons which could 
activate the spinal motoneurons via a monosynaptic fast conducting pathway 377.  Moroever, 
they also noted that the postcentral cortex could give rise to pyramidal tract neurons.  
Similarly, Obeso et al suggested that "the giant SEP might represent the discharge of those 
cortical neurons responsible for activating the anterior horn cells innervating the jerking 
muscles" 374, although given that there is no clinical evidence of impaired cortical motor 
function such as weakness or incoordination, the source of the SEP is unlikely to be in the 
motor cortex374.   
 
In Dawson’s case, the source of the abnormal evoked potential was recorded 3 cm anterior 
to the central sulcus 248, and in a case of Rothwell’s was found to lie in the sensory cortex by 
electrocorticography 377.  These cases suggest that the giant SEP reflects abnormal cortical 
function outside of the motor area, with involvement of regions such as the supplementary 
motor area or the somatosensory cortex 377.  A further example of this potential mechanism 
is seen in patients with multisystem atrophy with photic reflex and action myoclonus where 
photic stimulation induces a normal VEP, followed by a discharge which phase reverses 
between temperofrontal and prerolandic electrodes 395.  Brain mapping of giant SEPs 
suggested neuronal sources in the rolandic (sensorimotor) region, and it was proposed that 
following a normal occipital potential, the excitatory volley projected to premotor cortex 395.  
In a more complex case of cortical reflex myoclonus, electrocorticography showed bursts of 
spikes associated with myoclonic bursts, with the source of spikes corresponding to the leg 
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area of motor cortex295.  This region was resected, with improvement in myoclonus.  The 
earliest SEPs were recorded over sensory cortex, but the giant SEP was recorded from 
motor cortex, about 3 msec after the sensory cortex SEP.  Stimulation of sensory cortex did 
not result in myoclonic jerks, whereas stimulation of the motor cortex did result in 
myoclonus295. 
 
Certainly, the majority of cases appear to have abnormal EPs arising from sensory cortex, 
for example, in Cowan’s case of EPC, a large parietal cortex excision including the region 
responsible for generation of the giant SEPs resulted in abolition of reflex myoclonus386.  
Obeso suggested that in cases where the abnormal SEP was localized posterior to the 
central sulcus, the motor cortex could be physiologically normal, and driven by abnormal 
inputs from sensory cortex 60.  An example of this mechanism would be the case of cortical 
reflex myoclonus described by Rosen, in whom myoclonus could be evoked by touch, 
vibration and stretch, presumed to be due to a zone of increased excitability in the left 
sensori-motor regionit was postulated that an initial positive wave at a latency of 20 msec 
represented abnormal excitation of area 3a (the primary projection area for muscle spindle 
afferents), followed by abnormal excitation 20 msec later of a larger area involving the motor 
cortex396.   
 
With the use of MEG, it can be shown that the the equivalent current dipole of the 
somatosensory evoked magnetic fields (N20m) is localized in the posterior bank of the 
central sulcus, probably area 3b 242.   Largely, MEG in patients with myoclonus has 
complemented previously documented findings for the giant SEP and the normal evoked 
potential.   
 
 
 161 
1.8.16 LOCALIZATION & LATENCY OF THE JLA SPIKE 
A cardinal feature of cortical myoclonus is the presence of a spike detemined by JLA.  The 
modern approach to the classification of myoclonus was initiated by Shibasaki in 1975 when 
he described the technique of back averaging240.   
 
In Shibasaki’s initial report there were two cases (lipidosis and idiopathic RHS) in whom 
clear spikes could be demonstrated with JLA.  The spikes were biphasic, of positive-negative 
polarity and preceded myoclonic jerks in the upper limb by 10-17 msec (Figure 35)240.  JLA 
was therefore able to establish that myoclonus was closely related to an EEG spike, as 
opposed to routine EMG-EEG recordings where this association was usually not evident.  
Shibasaki, with reference to Halliday’s classification of myoclonus into pyramidal and 
extrapyramidal, thought that the spike demonstrated by JLA corresponded to the pyramidal 
group, whereas those without a spike were of the extrapyramidal type240.  As noted 
previously (page 101), JLA allowed a number of cases to be termed cortical myoclonus or 
cortical reflex myoclonus60.   
 
Figure 35. Averaged recording of case of RHS, showing a focus of the spike posterior 
to the right central region, related to myoclonus of the left biceps. 
Calibration: 10V for amplitude and 100 msec for time (from Shibasaki and 
Kuroiwa, 1975 ).  Upward deflection indicates negativity. 
In subsequent papers, in 1978 and 1985, Shibasaki looked at larger groups of patients with 
myoclonus, and found similar results250;385.  JLA showed positive-negative “sharp potentials” 
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related to myoclonic discharges in patients with PME.  The second phase of the biphasic 
potential of negative polarity was termed the “spike potential”.  The latency from the onset 
(the preceding positive peak) to a myoclonic discharge in the arm varied from 7 to 15 
msec385.  The onset was defined as commencing at the preceding positive peak (Figure 35 
and 36).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Averaged recording in a case of PME showing a spike at the right central 
electrodes, related to myoclonus of the left hand (from Shibasaki et al., 
1988)).  
The decision to use the positive peak relates to the work of Lance and Adams in patients 
with hypoxic myoclonus, since they reported that “measurement of the latency between 
cortical spike and muscle potential must take the positive cortical deflection as its starting 
point, for this would represent the time at which a descending volley might be initiated in the 
pyramidal tract”246.  Lance and Adams noted that work in animals had shown that stimulation 
of the specific relay nuclei of the thalamus resulted in a cortical discharge, initially positive 
and subsequently of negative polarity.  A descending discharge could be recorded in the 
corticospinal tract, and commenced “at the same time as the early positive component of the 
cerebral complex”397. 
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Figure 37. A: JLA showing cortical spike with latency of 12 msec from spike to onset 
of myoclonus (interval y).  B: SEP showing enlarged N33 response.  Time 
interval from P25 (early positive peak) to C reflex is 14 msec (interval x).  
Figure from Shibasaki, 1978.  
Given that peripheral stimulation resulted in giant evoked potentials and a subsequent 
myoclonic jerk (C reflex), and that JLA is dependant on recording from myoclonus, it is 
perhaps not suprising that a possible relationship between the spike seen with JLA and giant 
evoked potentials was proposed (examples are seen in Figure 37 and Figure 38 307;385.  Not 
only were the wave forms of the myoclonus-related spike and the N33 of the SEP similar, 
but also the latency from the JLA associated spike potential to myoclonus was similar to that 
from the N33 wave of the SEP to the C reflex385.  Further evidence for a relationship 
between the giant evoked potential and the JLA spike was that the N33 component of the 
SEP phase reversed at the area corresponding to the contralateral precentral hand area, as 
did the JLA recorded EEG spike, although the SEP was more widely distributed250.  Obeso 
et al noted that the potential seen with JLA and SEPs shared "the same morphology, 
topography, and time relation to the myoclonic jerking"374.  The proposal was made that the 
myoclonus related spike and giant SEP which precede spontaneous myoclonus and reflex-
evoked myoclonus respectively were directly related250.  Shibasaki concluded that the 
“myoclonus-related spike and the giant SEP seen in those cases of “cortical reflex 
myoclonus” have common physiological mechanisms, although they may not be identical 
“
327
, and proposed that the myoclonus was of cortical origin385.   
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Figure 38. Patient with Lance-Adams syndrome.  A shows SEP and C reflexes.  B 
shows JLA with spike and myoclonic jerks.  C shows the two traces 
superimposed.  Figure from Deusch et al., 1987. 
However, it appears unlikely that the giant SEP of reflex-evoked myoclonus and the cortical 
spike determined by JLA are indeed similar.  As previously noted (page 153), the giant SEP 
and myoclonus are often dissociated, with giant SEPs not present in all patients with cortical 
reflex myoclonus, and some patients having giant SEPs without myoclonus250;374.   
 
Furthermore, the frontal and parietal distributions of SEPs and premyoclonus spikes in 
patients with cortical reflex myoclonus also differ251.  A dissociation may be detected 
between the SEP and the myoclonic jerk, in that anti-myclonic drugs can reduce the 
frequency and severity of jerks, whereas the amplitude of the SEP is unaffected or even 
increased337;377.  Similarly, in patients with focal myoclonus taking 5-hydroxytryptophan, 
there was a dissociation between SEP size and C-reflexes, since the latter disappeared on 
treatment, whereas SEPs did not337.   
 
A further problem with the application of JLA to determine the nature of the myoclonic 
discharge lies in establishing the latency from the premyoclonus spike to the onset of 
myoclonus.  The JLA spike is believed to arise from the motor cortex in cortical myoclonus 
on the basis of a latency of aproximately 20 msec, which is similar to that obtained from 
direct stimulation of human motor cortex, where the latency from electrical stimulation of the 
cortex to motor response is about 22 msec238 (Figure 39), or the latency obtained by 
transcranial magnetic stimulation, which varies from 23.5 msec334 to 22.6 msec 308.  Mean 
latencies of 19.8 msec and 21.3 msec for contracted and uncontracted for thenar muscles 
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were obtained by Day.398 with the latency from time of cortical stimulation to response in the 
thumb being 19.2 msec 399. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Example of JLA, where a positive wave is reported to precede the jerk by 
20 msec ( from Obeso, 1985). 
Shibasaki, who described JLA in relation to myoclonus, found that the positive peak of the 
spike preceded the onset of myoclonus with latencies ranging from 10-17 msec, 7-15 msec 
and 6-22 msec in his three initial reports 240;241;385.  In the first of these, he proposed that 
these short latencies were indicative of “a deep origin for both the cortical paroxysmal 
activity and the myoclonic jerk”, since the conduction of impulses from the motor cortex to a 
muscle of the contralateral arm was known to take approximately 25 msec”240.  Since then 
there have been many reports demonstrating a lack of consistent correlation between 
cortical spikes and muscle jerks, or discrepancies in the expected latency differences.  A 
summary of the results from JLA in a number of articles is presented in Table 11.  In 
ADCME, Guerrini et al. found that analysis of phase spectra showed that EEG activity 
preceded EMG activity, although the EMG lag (8-15 msec) was shorter than that seen with 
back-averaging and was brief for even the fastest cortical pathways.  When Brown et al drew 
up frequency histograms in rhythmic myoclonus of the cortical spike to EMG burst, they 
noted several different peaks (Figure 28): one of these peaks had a latency of only 17 msec 
and was 5 msec shorter than the conduction time to FDI measured by magnetic stimulation 
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of the motor cortex in that patient; the authors comment “thus the descending motor volley 
must, in some trials, have left the cortex 5 msec or so before the peak positivity of the giant 
spike”318.   
 
Furthermore, the configuration of the spike is rather variable (Figures 35, 36 & 39), and 
determining the latency from the spike to onset of myoclonus may be difficult (Figures 36 & 
39).  In addition, problems with JLA including the arbitrary nature of the trigger level and that 
high-frequency myoclonus may prevent analyses400.  Shibasaki also noted ‘jerk-locked 
averaging might be associated with a considerable time jitter between the actual onset of 
myoclonic EMG discharge and the trigger pulse which was obtained from that EMG, 
resulting in a poorly synchronized averaging, whereas SEP is consistently time-locked to the 
stimulus onset”401. 
 
Noting that the MEP latency is inversely proportional to the amplitude, and that experiments 
using magnetic stimulation of the cortex would therefore tend to overestimate the speed of 
cortico-muscular conduction402, Cantello et al used magnetic stimulation to evoke a potential 
of the same amplitude as the spontaneous myoclonic discharge, and found a 
corticomuscular conduction time of 23 msec403.  The interval between the initial positive 
wave and myoclonus obtained with JLA ranged from 13.3 to 16.3 msec, and the authors 
inferred that the origin of the abnormal potential was therefore subcortical 403.   
 
With regard to the origin of the JLA associated spike, it should first be noted that direct 
recordings have been obtained in patients with myoclonus.  In a patient with anoxic induced 
myoclonus, spontaneous myoclonus was preceded by a cortical spike with a latency 
compatible with discharge down the corticospinal tract.  Recordings from the VL nucleus 
showed that discharges followed the cortical spike and were simultaneous with the muscle 
jerks.  Peripheral stimuli led to a motor cortical response, with or without myoclonus, without 
an associated VL response, and stereotaxic lesions of VL had no effect on myoclonus404.  
However, VL lies in the cerebellar territory of the thalamus, and it is unlikely that short 
latency afferents project via this nucleus to sensorimotor cortex (see discussion page 149).  
Two cases of Unverricht-Lundborg syndrome have been studied with depth electrodes in the 
sensorimotor cortex, GPi, VL and VPL nuclei of thalamus, internal capsule and red nucleus.  
Myoclonus always followed a cortical spike recorded from sensorimotor cortex contralateral 
to the myoclonus, with a fixed latency381.  Stimulation of the VP nucleus of thalamus (the 
principal sensory nucleus, comprising the VPL and VPm405) evoked a bilateral myoclonic 
jerk, “mediated through the sensorimotor cortex” 381.  
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Similarly, Tassinari studied two cases of Unverricht-Lundborg syndrome with depth 
electrodes in the sensorimotor cortex, GPi, VL and centromedian nuclei of thalamus, and red 
nucleus.  He reported that spike discharges in the thalamus occurred independently of 
paroxysmal activity in the cortex, and action myoclonus was not necessarily associated with 
ventrolateral thalamic nucleus discharges406.  As can be seen in Figure 40 reporting 
Tassinari’s findings, action myoclonus was associated with spike discharges in the 
ventrolateral thalamic nuclei and red nucleus, and possibly in the motor cortex.   
 
Figure 40. Surface EEG Enlarged sections of that seen on the left: paroxysmal activity 
noted in the first three channels  “doubtful activity was observed in the left 
rolandic cortex”.  Figure redrawn from Tassinari, 1998 
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Table 11. Results of JLA from various sources 
Reference Conditions Wave type Location Muscle Peak used 
for latency 
Latency (msec) 
Shibasaki, 1988 Cortical reflex or cortical Positive Negative  Corresponding to 
muscle from where 
recorded 
  6 to 22 
Obeso, 1985 Case 8 (Hallett 79) Positive Negative Sensorimotor cortex  Positive 17 
 Case 9 focal myoclonus Positive Negative Widespread  Positive 22 
 Case 11 Positive Negative Sensorimotor cortex  Positive 20 
 Case 10 EPC Negative Midline Rolandic Quadriceps  30 
Guerit, 1994 Focal myoclonus Positive Negative    53 
Guerit, 1994 Focal myoclonus Positive Negative   Negative  27 
Terao, 1997 Focal myoclonus Positive Negative  Tibialis Anterior Positive 24.4 
Uesaka, 1996 EPC Positive Negative  ECR Positive 31.6 
    ECR Negative  15.8 
    ECR Positive 9.6 
    ECR Negative  25.5 
Ochi407 EPC   Wrist extensor Positive 20.0 
Volmann, 1998 (MEG) EPC Single  deflection Inferior Parietal Flex Dig Sup N/A 31 (normal TMS time 
of 17.2 msec in 11 
year old) 
Rothwell, 1984      17-22 
Tobimatsu, 1985 Sialidosis   Thenar Positive 23.8-31.1 
Tobimatsu, 1985 Sialidosis   EDC Positive 16.8 
Brunt, 1985 Sialidosis   APB Positive 14 
 Sialidosis   EDC Positive 8 
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Table 11 continued. Results of JLA from various sources 
Reference Conditions Wave type Location Muscle Peak used 
for latency 
Latency (msec) 
Deuschl, 1987 NCL   Thenar Positive 17 
Shibasaki, 1975 Lipidosis Positive Negative Central Extensor Indicis  17 
    Brachio-radialis  10 
Deuschl, 1987 PME   Thenar Positive 16 
 PME   Thenar Positive 16 
 PME   Thenar Positive 15 
 PME   Thenar Positive 17 
Shibasaki, 1978 PME  Positive Negative  Dorsal 
Interossei 
Positive 12 
    Biceps Positive 7 
    FCU Positive 14 
    Brachiorad Positive 15 
    Extensor Indicis Positive 10 
    FCU Positive 13 
    Biceps Positive 9-12 
    Brachiorad Positive 9 
    Biceps Positive 8-12 
    Deltoid Positive 7-14 
Shibasaki, 1986 PME    Positive 6-22 
Brunt, 1985 PME   APB Positive 13 
 PME   APB Positive 15.8 
Mima, 1988 PME Positive  ECR Negative  14.3 
 PME Positive  ECR Negative  14.3 
 FAME Positive  ECR Negative  14.3 
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Table 11 continued. Results of JLA from various sources 
Reference Conditions Wave type Location Muscle Peak used 
for latency 
Latency (msec) 
Uesaka, 1996 Familial myoclonic 
epilepsy (4 cases) 
Present  FDI  16.2 
Elia, 1998 Familial cortical 
myoclonus 
Positive Fronto-centro midline  Positive 25-30 
Ikeda, 1990 Cortical Tremor   Extensor indicis  15.4 
Ikeda, 1990 Cortical Tremor   Extensor indicis  20.8 
    FDI  24.0 
Shibasaki, 1975 RHS Positive Negative Little posterior to central 
region 
biceps ?Negative  13 
    FCU ?Negative  13 
Deuschl, 1987 RHS   Thenar Negative  19 
Obeso, 1985 RHS Positive Negative Sensorimotor cortex Positive  20 
Kunesch, 1991 RHS     80 
Deuschl, 1991 MERRF   Present   
Brown, 1996 PMA (coeliac)   Forearm 
extensor 
Positive 15 
Brown, 1999 Coeliac disease   ADM  27 
 PMA   F Ext  14 
Wilkins, 1984 Alzheimer’s disease Negative  Contralateral central 
area 
  20 to 40 
Mima, 1988 Alzheimer’s disease     28 
Panzica, 2001 JME Positive Negative Frontal Deltoid Positive 10.25 
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Table 11 continued. Results of JLA from various sources 
Reference Conditions Wave type Location Muscle Peak used 
for latency 
Latency (msec) 
Mima, 1988 LGS Negative (standard 
JLA) 
Contralateral central 
area (standard JLA) 
  65 (standard JLA and 
MEG) 
Deuschl, 1987 Lance Adams   Thenar Positive 20 
 Lance Adams   Biceps Positive 8 
 Lance Adams   Biceps Positive 9 
 Lance Adams   Biceps Positive 10 
 Lance Adams   Biceps Positive 9 
Brunt, 1985 Lance Adams   APB Positive 13.2 
Uesaka, 1996 Lance Adams Present     
Mima, 1988 CBD   DIO Positive 15 
Brunt, 1985 CBD Small Positive F3-C3  APB Positive  18 
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2 METHODS 
2.1 IDENTIFICATION OF AFFECTED CASES 
The proband of family A (A-III-8) was identified from a search for patients with idiopathic 
generalized epilepsies (IGE) (Figure 41), and that for family B (B-IV-3) was referred with 
epilepsy from a psychiatric ward at Tygerberg hospital (Figure 42).  Participants were 
examined and underwent MRI and routine neurophysiological investigations including EEG, 
visual evoked potentials (VEP) and somatosensory evoked potentials (SEP) and nerve 
conduction studies.  In addition, jerk locked averaging was performed, and the response to 
magnetic stimulation was determined.  Pathology of the fixed brain of subject  A-III-9 was 
obtained. 
 
 
Figure 41. Family tree for Family A. 
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Figure 42. Family tree for Family B. 
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2.2 NEUROPHYSIOLOGY 
Ethical approval was obtained from the University of Stellenbosch for neurophysiological 
investigations. 
2.2.1 EEG 
EEGs were obtained after the application of electrodes and conducting jelly, using the 
International 10-20 system.   
 
2.2.2 NERVE CONDUCTION STUDIES 
Standard techniques were used408,  and peroneal and tibial motor responses and sural 
sensory responses were recorded.  Duration of myoclonus and synchronicity of discharges 
was also recorded. 
 
2.2.3 EVOKED POTENTIALS 
For SEPs, the median nerve at the wrist was stimulated, and upper limb SEPs were 
recorded at the contralateral scalp (C3’ and C4’: 2 cm posterior to C3 and C4 on the 
international 10-20 system).  Stimulation rate was 3 Hz, with a duration of 0.2 msec.  Digital 
averaging was performed using 200 rectified samples; the filters were set at a high cut of 
500 Hz, and a low cut of 10 Hz.  The latencies of the N20, P25 and N33 peaks, and the 
interpeak amplitudes of N20-P25 and P25-N33 were recorded, as were the N20 amplitudes.  
Averaging was typically performed three times to ensure reproducibility.  For VEPs, 
responses were measured using checkerboard pattern-reversal stimuli.  The stimulation 
frequency was 2 Hz, with filters set to a high cut of 50 Hz and low cut of 20 Hz.  Digital 
averaging was performed using 100 rectified samples.   
 
2.2.4 C REFLEXES. 
Long-loop reflexes were obtained by stimulation of the median nerve while recording over 
the thenar muscle, with EMG monitoring to ensure that the muscle was relaxed.   
 
2.2.5 JERK-LOCKED AVERAGING. 
Jerk-locked averaging was performed on a Neuropack electromyograph (Nihon Koden, 
Japan).  EEG recordings were obtained from the C4I-Cz derivation with filter settings of 50 
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Hz and 0.05 Hz for high and low cut.  EMG filter settings were 3 KHz and 5 Hz for high and 
low cut.  Some patients had additional derivations recorded, such as C4-Fz. Recordings 
were obtained from the thenar eminence, a site where regular myoclonic jerks occurred, and 
where jerks could be obtained regularly and reliably at rest.  Jerks occurred frequently but 
were well defined.  Movement artefact did not present problems since the jerks were of low 
amplitude.   
 
2.2.6 MAGNETIC STIMULATION 
For magnetic stimulation surface EMG was recorded from the right abductor pollicis brevis 
muscle (Figure 43).  The study was performed at rest, silence being monitored on the EMG.  
A Magstim 200 stimulator (The Magstim Company, Dyfed, United Kingdom) was used with a 
double circular 7 cm coil.  Based on handedness, the dominant cortex was stimulated in the 
region of the hand area.  The threshold for motor stimulation was determined from a trial of 
10, being the minimum percentage of the stimulator output required to produce a response 
in half the trials, at a sensitivity of 200 µV/div.   
The trigger input socket of the Magstim was synchronized to the electromyograph, the 
trigger mode of which was set to random.  Paired stimuli were administered to the median 
nerve, with a stimulus interval of 8 msec, with the duration of the first and second stimuli 
being 0.5 msec345.  The strength of the stimulus was maintained at a point which was 
subthreshold for evoking a compound muscle action potential (CMAP).  MEPs were 
recorded with filter settings of 3 KHz and 2 Hz for the high and low cut.  The delay to the 
time of triggering the Magstim varied from 10 msec through to 70 msec in increments of 10, 
with the delay being measured from the first of the 2 paired stimuli.  For each time period, 8 
shocks were administered, and between shocks the MEP amplitude was measured from 
onset to peak.  At each stimulus interval from 10 to 70 msec, two runs were done, one at 
20% above threshold (termed low level stimulus), and one at maximum power (termed high 
level stimulus), this being defined as that power which was determined to give the maximum 
MEP.  Three participants were examined and compared with a control group of 28 subjects.  
Three additional subjects were excluded since responses could only be obtained at 
maximum power. 
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Figure 43. To illustrate the method of magnetic stimulation.  Paired stimuli were given 
peripherally.  These serve to trigger a magnetic stimulus, in this example 
with a delay of 20 msec, and this results in an evoked potential. 
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2.3 MAGNETIC RESONANCE IMAGING  
MRI was obtained in 10 subjects, using standard sagittal and axial T1, axial T2/Proton 
Density and coronal T2, and in more recent studies, FLAIR sequences. 
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2.4 PATHOLOGY  
Patient A-III-9 was reported to have died at night following a seizure.  The precise cause of 
death is unknown.  Post mortem was obtained approximately 14 hours after death, limited to 
the brain.   
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2.5 GENOTYPING AND LINKAGE ANALYSIS 
Ethical approval was obtained from the University of Stellenbosch for extraction and analysis 
of DNA. 
Eight blood samples were collected from Family A, including II-3, 4, 6, III-4, 5, 7, 8, 10, and 
19 blood samples from Family B, including III-1, 11, IV-3, 5, 6, 8, 9, 10, 11, 16, 23, 24, 25, 
26, V-9, 10, 12, 13, 14.  Genomic DNA was extracted from peripheral blood leukocytes by a 
standard phenol extraction method.  Three microsatellite markers (D21S2040, D21S1912, 
and D21S1959) from the EPM1 locus (chromosome 21q22.3)409 were studied, as was a 
CAG repeat in the DRPLA gene (chromosome 12p13.31)137, and seven microsatellite 
markers (D8S1784, D8S1830, D8S1779, D8S547, D8S1694, D8S342, and D8S1826) 
across the FAME1 locus (chromosome 8q23.3-q24.1), and ten microsatellite markers 
(D2S139, D2S2180, D2S1387, D2S2333, D2S2161, D2S388, D2S2216, D2S2264, D2S135, 
and D2S1897) from the FAME2 locus (chromosome 2p11.1-q12.2).  The markers on FAME1 
and FAME2 loci were selected from those listed on the genetic map at the Marshfield 
Medical Clinical Website (http://research.marshfieldclinic.org/ genetics/home/index.asp).  
The microsatellite markers were amplified by PCR with one primer pair for each 
microsatellite marker. PCR products were separated by electrophoresis on a CEQ 8000 
Genetic Analysis System and analyzed with Fragment Analysis software (Beckman Coulter, 
CA) per the manufacturer’s instructions.  The MLINK program was used to run the two-point 
linkage analysis with the following model: autosomal dominant inheritance, frequency of the 
dominant allele of the causative gene being 0.0001, and penetrance being 0.9. 
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3. RESULTS 
3.1 CLINICAL CHARACTERISTICS 
Two families were identified from the Western Cape province of South Africa, an area also 
known by its Afrikaans name of  the “Swartland” –black land, due to the appearance of the 
dark vegetation of the region.  The affected families are of mixed ancestry, predominantly 
representing intermarriage between the Khoisan and early settlers of Caucasian origin.  The 
disease is likely to have originated in a common ancestor in the two families in the 
Namaqualand area of the Northern Cape.  It is then postulated that migration in a southerly 
direction took place to the small towns of the Swartland where the participants were 
identified (Figure 44).  The proband of family A was identified in Moorreesburg, a small town 
whose existence is largely related to the activities of the wheat farms in the area.  All the 
affected members of family A still live in Moorreesburg.  The proband of family B lives in 
Atlantis, a city established in the latter days of apartheid with the purpose of establishing a 
city for people of mixed ancestry on the principal of separate development.  The proband’s 
cousin lives on a farm two kilometres from Moorreesburg, and the proband’s mother’s 
extended family lived and died on farms in the Moorressburg area.   
                                  
Figure 44. Map showing the towns of the Swartland region mentioned in the text.  
Calvinia is present in the top right of the figure. 
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Four generations were reported to have been affected in family B: a granddaughter aged 74 
at the time of interview reported that her grandmother had tremor and fits, and had largely 
been bed-bound although able to walk.  The grandmother had lived in Calvinia, and was 
probably born between 1870 and 1880.  Calvinia is 330 kilometres from Moorreessburg.  
Many participants were uncertain of their birth dates, of where they grew up and of the 
whereabouts of close family members.  Marked alcohol abuse, frequent movement from one 
farm to another and impoverished social circumstances with minimal education were the 
rule, features probably related to the conditions of farm workers in the area, rather than a 
reaction to disease.  Although a common ancestor could not be identified, the rarity of the 
disorder and the geographical proximity of the families makes it highly likely that they are 
related.  A high mortality of older generations due to homicide and other causes and the lack 
of birth records has made the task of linking the two families more difficult. 
 
During the study, seventeen affected individuals were identified, with the oldest affected at 
the age of 31 (B-IV-3), and the youngest at 13 years (A-IV-1), with a median age of onset of 
20 years.  The core syndrome of the illness consisted of GTCS and myoclonus.   
Myoclonus comprised both positive and negative myoclonus of the whole body, 
predominantly involving the upper limbs and trunk, as well as tremulousness of the hands, 
brought out by maintenance of outstretched limb posture.  Although myoclonic jerks were 
observed in the legs these were considerably less than in the arms.  Blepharospasm was 
also noted, but no other jerks of the face were seen.  Additional features, such as 
nystagmus, abnormal pursuit, dysarthria and hyperreflexia were observed (Table 12).  
Eleven participants had combinations of truncal and limb ataxia.  Eleven participants had 
either hyperreflexia, an extensor plantar response, or both. Two participants (B-IV-25 and B-
V-10) were observed to have prominent, high amplitude positive and negative myoclonus 
resulting in occasional falls, in both of whom myoclonus responded to valproate and 
clonazepam.  Seven participants reported runs of myoclonus prior to a generalized tonic-
clonic seizure.  In four participants myoclonus was either very slight or absent, although 
tremor was present in all except B-V-11, whose status was determined by generalized spike 
discharges on EEG. 
 
Patient A-III-9 died following a seizure at the age of 31, B-IV-3 died at the age of 39, and B-
V-10 died at the age of 35 years.  The disorder may affect life expectancy for the usual 
reasons seen in poorly controlled epilepsy.  It is unclear whether, in addition, as a result 
primarily of an associated neurodegenerative process, there is increased mortality.  It 
appears that similarly to Unverricht-Lundborg disease, this condition may have been 
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worsened by phenytoin74.  Certainly, in all participants in whom reasonable compliance 
occurred and response could be assessed (six patients), there was considerable 
improvement on valproate. 
 
A number of participants were noted at the time of presentation to have cognitive 
impairment.  The father of the proband of family A, who was severely disabled, answered 
questions slowly and with difficulty, and had an MMSE of 16.  In addition, patient B-V-10 was 
severely demented, patient B-IV-26 had an MMSE of 9, although she also had a history of 
severe alcohol abuse and had callosal agenesis, and her two affected sisters had MMSE 
scores of 15 and 16.   
 
Some participants also had considerable neurological disability at the time of presentation, 
or were observed to have a decline in function during the course of the study.  The proband 
of family B, who developed the disease relatively late at the age of 31, felt that the illness 
was progressive, and led to impaired functioning at home, to the extent that she was no 
longer able to care for herself.  She died eight years after onset of her illness.  Patient B-IV-
23 was noted to become forgetful and developed dysarthria.  Patient B-V-10 was noted to be 
demented and ataxic at the time of her initial presentation at the age of 29, and both 
conditions deteriorated over the next five years.  Patient A-II-6 had prominent dysarthria, 
ataxia and cognitive impairment when initially assessed at the age of 46, and reported 
progression of his condition, particularly truncal ataxia.  His nephew, A-III-5, was noted to 
have a clear decline in coordination with gait ataxia.   
 
Many participants also reported that their affected parents were neurologically impaired and 
died young: B-III-9 and B-III-12 were reported to have been affected in their early thirties and 
died in their late thirties.  B-III-9 had visual hallucinations, complained of strange smells, and 
was admitted to a mental institution. B-IV-19 died at the age of 45 following a seizure, had 
frequent seizures, unsteadiness of gait and confusion at times. Patient B-II-1 had tremor, 
many seizures, and drowned after he ran into a farm dam following a seizure. Patient B-III-
21 had seizures every 2-3 weeks and walked as though she were intoxicated. 
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Table 12. Clinical features of Families A and B (+ Present /- Absent/nd not done) 
Patient Onset MMSE Seizure Frequency Nystagmus Dysarthria Ataxia 
Hyperreflexia/ 
Babinski 
A-II-6 22 16 Rare _ + + + 
A-III-4 20 28 Rare _ _ + _ 
A-III-5 18 9 2-3/month _ _ + _ 
A-III-7 14 nd 1/month + + _ + 
A-III-8 18 27 2/month _ _ + _ 
A-III-9 20 nd 1/month _ + + + 
A-III-10 23 26 Rare + _ + + 
A-IV-1 13 30 None _ _ _ _ 
B-IV-3 31 nd Seldom _ _ _ _ 
B-IV-6 20 28 2-3/month _ _ + + 
B-IV-10 25 nd 2-3/month _ _ + + 
B-IV-23 17 15 1-2/year _ + + + 
B-IV-25 19 16 Rare _ _ + + 
B-IV-26 30 9 Rare _ _ _ + 
B-V-10 25 Unable Very 
frequent + + + + 
B-V-13 19 18 Rare _ _ _ + 
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3.2 NEUROPHYSIOLOGY 
Results of investigations are presented in Table 13. 
3.2.1 EEG (Details of individual recordings in Table 19, Appendix 2) 
Patients A-III-5, A-IV-1, B-V-11, and B-V-13 only underwent EEG studies.  16 participants 
had a total of 26 recordings.  All of the participants had at least one abnormal study, except 
for one (A-III-7), who did not have an EEG.  In family A, seven participants had either an 
abnormal background or intermittent bursts of slow activity (theta and delta bursts).  Four 
participants had polyspike and wave activity (PSW), and the remainder had clear 
epileptogenic activity (independent focal spikes (1), single burst of PSW (1), and left frontal 
spike (1).  In family B, seven participants had an abnormal background or intermittent bursts 
of slowing.  Two had a normal background (both with recurrent bursts of PSW).  Six 
participants had abundant PSW activity and one had brief frontal spike discharges.   
One patient (B-V-13) had no spike or PSW discharges (total of 3 EEGs), but had a markedly 
abnormal background.   
Patient B-V-11, with no history of myoclonus or epilepsy, had a normal EEG on one 
occasion, and a second EEG that showed a single burst of polyspike and wave.  
Subsequent long term recordings showed abundant generalized spike and wave activity.   
With regard to photic responses, one patient, B-IV-25, had a photoparoxysmal response 
associated with clinical myoclonus, although three other subsequent EEGs did not show this 
response. Another patient, B-V-10, had jerks associated with photic stimulation, and the 
study was terminated.  Two further EEGs in this patient did not show a photoparoxysmal 
response. 
 
Unaffected family members: Individual B-V-9 had right temporal spikes and right temporal 
delta, a normal neurological examination, and seizures which were controlled with phenytoin, 
and was classified as unaffected. Ten unaffected family members had 16 EEGs, which were 
normal, as indicated in Figures 41 and 42.  
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Table 13. Results of investigations in Family A and Family B (• Present /ο Absent/nd 
not done)  
 
 
*: Photoparoxysmal response with associated clinical myoclonias 
**: Had jerks associated with IPS, but study was terminated 
 
Patient Abnormal 
EEG 
Photic 
response 
Enlarged 
SEP 
Abnormal C 
response 
Symmetrical 
myoclonus 
JLA 
spikes 
A-II-6 • ο • • Rare _ 
A-III-4 • ο • • nd nd 
A-III-5 • ο   nd nd 
A-III-7 • ο   nd nd 
A-III-8 • ο  • At times + 
A-III-9 • ο  • At times + 
A-III-10 • ο   No + 
A-IV-1 • ο   nd nd 
B-IV-3 • ο ο • Variable + 
B-IV-6 • ο  • nd + 
B-IV-10* • ο • • Frequent + 
B-IV-23 • ο • • At times + 
B-IV-25** • • • • At times nd 
B-IV-26 • ο • • No nd 
B-V-10 • ο • • No nd 
B-V-11 • ο   nd nd 
B-V-13 • ο •  nd nd 
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3.2.2 NERVE CONDUCTION STUDIES (Details of recordings in Table 20, Appendix 2) 
11 participants had nerve conduction studies: in nine, the sural, peroneal and tibial latencies, 
amplitudes and velocities were normal, and in two, only the sural was examined and was 
normal.   
Myoclonic jerks were examined in nine participants, and the duration of the EMG discharge 
was less than 50 msec in all (Table 21, Appendix 2).   
Synchronicity was recorded in eight participants, and showed variable results (Table 21, 
Appendix 2), and Figures 65 and 66, Appendix 2.   
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3.2.3 EVOKED POTENTIALS (Details of evoked potentials in a control group in Appendix 1) 
 
With regard to evoked potentials, of eleven participants examined, eight had enlarged SEPs 
(N20-P25 > 8.6 µV; P25-N33 >8.4 µV250) (Table 14); average values for our laboratory were 
3.7 µV and 2.6 µV respectively, Table 22, Appendix 2).  The latencies of SEPs were normal. 
VEPs were normal in amplitude and latency.  An example of an enlarged evoked potential is 
shown in Figure 45. 
Table 14. Amplitudes of evoked potentials, measured in µV.  Successive recordings 
separated by a /. 
        Patient Amplitude 
N20 
Amplitude  
N20-P25 
Amplitude 
P25-N33 
A-II-6 1.1 /1.1 /1.56 /1.32 8.5 /3.7 19.5 /7.3 
A-III-4 1.8 /1/ 0.9 12.5/9.7/7.4 25.4 /22.7/ 15.3 
A-III-8 10.4 6.3 /8.0/ 6.2 13.6/14.1/12.6 
A-III-10 1.0 /0.8   
B-IV-3 0.4 /0.8/ 0.5 2.3 /1.4/ 1.7 2.9/3.6/4.6 
B-IV-10 0.9 8.5 11.5 
B-IV-23 0.7 /2.5 9.5 /10.8 18.0 /18.3 
B-IV-25  7.8 /9.2/ 9.0/ 8.9 14.7 /14.2 
B-IV-26 3 /3.7/ 3 9.4 /10.4/ 10.5 10.4/8.7/ 9.2 
B-V-10 3.7/ 3.5 14.5/ 13.5 30/ 31.3 
B-V-13 4.5 15.7/ 14.9 14.2/ 15.7 
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Figure 45. Enlarged SEP (Median nerve stimulation, patient A-III-8); vertical axis 5µV. 
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3.2.4 LATE RESPONSES  
11 participants were examined for late responses by stimulation of the median nerve.  At low 
stimulation currents late responses were easily evoked and replicated, with latencies of 
between 36.2 to 46.6 msec.  Examples of late potentials are shown in Figures 46 and 47.  
(Further details may be found in Table 23,  Appendix 2). 
    
Figure 46. Late response in patient B-IV-3 (distal and proximal median nerve 
stimulation; horizontal time base of 10 msec/division). 
     
Figure 47. Late response in patient A-III-8 C. (Series of stimuli at increasing current 
strength, compound muscle action potential at left of figure; horizontal 
time base of 10 msec/division) 
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3.2.5 JERK-LOCKED AVERAGING. 
In the majority of participants studied, jerk-locked averaging showed a 8-10 Hz frequency 
spindle time locked to the jerk (Figure 48).  Similar examples from other participants are 
shown in Figures 49, 50 and 54.  Recording from the right upper limb showed that this 
activity phase reversed at C3-P3, with some waves exhibiting electronegative phase-
reversal at C3 on parasagittal and coronal montages and the C3-P3 derivation being 
relatively isoelectric (Figures 51 - 53).   
                   
Figure 48. Jerk locked averaging.  Seven superimposed averages from patient B-IV-
23, each of 100 averages. Vertical division of 10V/division.  Horizontal 
division of 100 msec/division. 
                
 
 
 
 
 
 
 
Figure 49. Jerk locked averaging.  Three superimposed averages from patient A-III-10. 
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Figure 50. JLA in patient B-IV-10 : averaged records showing group of waves 
associated with myoclonic jerks.  Horizontal division of 200 msec/division. 
 
 
 
Figure 51. A: Bipolar parasagittal montage.  JLA from patient A-III-8, recording from 
right thenar eminence.  Electrodes labeled according to the International 
10-20 system.  EMG record corresponds to X1-X2.  Vertical division of 5 
V/division.  Horizontal division of 100 msec/division. 
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Figure 52. B: Coronal montage JLA from patient A-III-8, recording from right thenar 
eminence.  Electrodes labeled according to the International 10-20 system.  
EMG record corresponds to X1-X2.  Vertical division of 5 V/division. 
Horizontal division of 100 msec/division. 
 
 
Figure 53. C: Referential montage to ipsilateral ear.  JLA from patient A-III-8, 
recording from right thenar eminence.  Electrodes labeled according to the 
International 10-20 system.  EMG record corresponds to X1-X2.  Vertical 
division of 5 V/division. Horizontal division of 100 msec/division. 
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Figure 54. Jerk locked averaging from patient B-IV-3, recording from right thenar 
eminence.  Horizontal division of 20 msec/division.  
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3.2.6 MAGNETIC STIMULATION. 
For magnetic stimulation, a comparison was performed between three participants and 28 
controls, recruited from staff and medical students.  Using the package Statsgraphics 
(Manugistics, Inc), men and women in the control group overall showed no significant 
differences, although at individual duration times, there were significant differences; 
therefore the male controls were removed from subsequent analyses used to examine 
differences between the ten female controls and the three female participants.  Repeated 
Measures ANOVA for low level stimuli and high level stimuli showed effects for group and 
duration and the group x duration interaction which were highly significant.   
 
Statistical analysis of the results of the magnetic stimulation findings is found in Appendix 2.  
Individual results of the magnetic stimulation in participants and controls for low and high 
level stimuli are available in Appendix 3. 
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3.3 PATHOLOGY 
Patient A-III-8: biopsies of the axillary apocrine glands and palmar eccrine glands did not 
show any abnormal storage material or evidence of neuronal ceroid lipofuscinosis on routine 
histology or electron microscopy.  A muscle biopsy was normal.   
 
Patient A-III-9: Examination of brain: macroscopically, the gyral pattern was within normal 
limits and there was no cerebral atrophy.  Sections showed normal sized ventricles, a well-
defined cortical ribbon and unremarkable central grey matter.  The substantia nigra and the 
locus ceruleus appeared well pigmented, and the mamillary bodies and red nuclei appeared 
normal. The brainstem structures did not appear atrophic and there was no evidence of 
cerebellar atrophy, involving either the lateral lobes or vermis.  Regarding histology, the 
brain was extensively sampled in an attempt to assess the presence of neuronal loss and 
gliosis. The most obvious changes were seen in the sections of the cerebellum where there 
was focal Purkinje cell loss, with early Bergman gliosis and the presence of torpedoes 
(especially evident in silver stains)  (Figures 55 and 58).  In addition, the dentate nucleus 
showed patchy neuronal loss and neuronal atrophy, with occasional "ghost cells" and 
neurons with large eosinophilic, hyaline cytoplasmic inclusions (Figures 56 and 57).  The 
hilus showed some myelin pallor and scattered microglial clusters were noted in the middle 
cerebellar peduncle.  The superior cerebellar peduncles appeared atrophic.  The olives 
showed mild neuronal loss and some evidence of astrocytosis on glial fibrillary acid protein 
stain. 
 
Sections of the basal ganglia show mild neuronal loss and astrocytic gliosis in the external 
segment of the pallidum, while there was probable atrophy of large striatal neurones and 
lipofuscin accumulation.  The subthalamic nucleus showed no obvious neuronal loss, but a 
single microglial cluster was noted.  The substantia nigra was normal.  Sections of the 
neocortex from many areas show no obvious neuronal loss and normal lamination appeared 
to be maintained. The centrum semiovale showed some pallor of myelin staining. 
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Figure 55. Cerebellar cortex. A. showing loss of Purkinje cells (Palmgren silver stain x 
100); B. Early Bergmann Gliosis (hematoxylin and eosin staining x 100). 
 
 
 
Figure 56. Dentate nucleus. A. Equivocal neuronal inclusion of uncerrtain 
significance, associated with neuronal loss without significant gliosis;  
B. Inclusion Body. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
A B 
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Figure 57. Dentate nucleus. A. Relatively normal neurons; B. Dying neuron 
surrounded by reactive cells (astrocytes and microglia); hematoxylin and 
eosin staining x 400. 
 
 
 
Figure 58. Cerebellar cortex. A. Purkinje cell with axonal swelling torpedo 
(hematoxylin and eosin staining x 200) B. Purkinje cell with axonal swelling 
torpedo (Palmgren silver stain x 400) 
 
 
 
A B 
A B 
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3.4 MAGNETIC RESONANCE IMAGING  
Eight of the ten participants showed cerebellar atrophy, varying from mild to severe in the 
oldest patient (Figure 59-62).  The atrophy was typically characterised by widening of major 
fissures and vermal atrophy.  STIR sequences were performed in participants B-V-10, B-IV-
23 and B-IV-26 and showed normal hippocampal formations.  Individual findings are 
summarised in Table 15.   
In addition, patient B-IV-26 also had partial callosal agenesis of the genu and body of the 
corpus callosum.  Patient A-II-6 had bilateral T2/FLAIR hyperintense signal change in the 
basis pontis, a focal cortical defect in the left opercular cortex and lacunar infarctions in the 
right striatum and thalami (Figure 62-B).  Patient B-IV-23 had periventricular T2 and FLAIR 
signal change, with multiple basal ganglia lacunes, and a single brainstem lacune (Figure 
61, A, C, D & E).  Patient B-V-10 had an area of T2/FLAIR hyperintense signal in the 
periventricular white matter (Figure 62-F).  Two studies were normal (A-III-8, B-V-13) (Figure 
59, 60). 
Table 15. Results of MRI studies. 
A-II-6 Focal cortical defect in the left opercular cortex, and focal, circumscribed 
T2 hyperintensities (T1 hypointense) in the right striatum and the thalamus 
bilaterally.  Mild dilatation of the lateral and third ventricles. Striking 
widening of the fissures of the posterior fossa with marked cerebellar 
atrophy and bilateral T2/FLAIR hyperintense signal change in the basis 
pontis with dilatation of the IVth ventricle 
A-III-4 Cerebellar atrophy; marked increase in CSF signal in cerebellar 
hemisphere, folia and posterior fossa cisterns.  
A-III-8 Normal (repeat studies in 1992 and 1998) 
B-IV-6 Cerebellar atrophy, predominantly with widening of major fissures and 
vermal atrophy 
B-IV-10 Cerebellar atrophy, predominantly with widening of major fissures and 
vermal atrophy 
B-V-13 Normal 
B-V-10 Generalized atrophy, marked in cerebellum; lacune in paraventricular white 
matter. 
B-IV-25 Cerebellar Atrophy with widening of major fissures and vermal atrophy 
B-IV-23 Extensive cavitation of the striatum, thalamus and pons with T2-FLAIR 
hyperintensity.   
B-IV-26 Cerebellar Atrophy.  Callosal agenesis. 
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Figure 59. T1 weighted Axial Studies at level of midbrain and pons illustrating 
moderate cerebellar atrophy involving the vermis and anterior lobe.  A A-III-
8 (normal) ; B B-IV-25; C A-II-6;D B-IV-10 
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Figure 60. T2 weighted axial studies illustrating mild to moderate degrees of 
cerebellar atrophy. A B-IV-6;  B B-V-13 ;  C B-IV-23;  D B-IV-25;  E B-IV-26;    
F A-III-4;  G B-IV-10. 
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Figure 61. T1 weighted sagittal sequences showing mild to severe degrees of 
cerebellar atrophy. A B-V-13; B B-IV-23; C B-IV-26; D B-V-10. 
 
A B 
C D 
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Figure 62. MRI demonstrating lacunes and white matter changes.  A: patient B-IV-23 
(coronal T2), C (axial T2), D (axial FLAIR), E (axial T1): extensive cavitation 
of the striatum, thalamus and pons with T2-FLAIR hyperintensity.  B: 
patient A-II-6 (coronal T2) showing lacunar infarctions in the striatum and 
thalamus.  F: patient B-V-10 (coronal T2) showing areas of periventricular 
T2 hyperintensity. 
 203 
3.5 GENETICS 
In family A, the generation of strongly negative two-point LOD scores at three markers tightly 
linked to the EPM1 locus excluded this candidate locus from involvement with FAME 3.  The 
DRPLA locus was also eliminated as a candidate locus in this family, both by the generation 
of a strongly negative LOD score and the absence of expansion of the triplet repeat in the 
atrophin gene.  These loci were not analyzed in family B. 
 
Analysis of genotypes for markers at the FAME 1 and FAME 2 loci on chromosomes 8 and 2 
excluded these as the region containing the same locus in family B.  In the smaller family A 
the chromosome 2 locus was excluded, however, the chromosome 8 locus could not be 
excluded in family A since there was a shared haplotype among the five affected samples 
that were available for genotyping.  
 
The results of the lods score for families A and B at various recombinant fractions are listed 
in Appendix 4. 
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4. DISCUSSION 
The disorder described in this thesis was first identified as part of a search for patients with 
juvenile myoclonic epilepsy410, and the core features of the condition remain the presence of 
myoclonus and generalised tonic clonic seizures.  The differential diagnosis of this 
presentation includes the progressive myoclonic epilepsies and familial adult myoclonic 
epilepsy.  However, disorders presenting with seizures and myoclonus also include the 
progressive myoclonic ataxias.  PME and progressive myoclonic ataxias overlap, but are 
typically distinguished by the presence of prominent seizures and cognitive impairment in the 
former. 
 
Results of linkage analysis demonstrated negative lod scores for the two known loci 
associated with FAME, the FAME 1 and FAME 2 loci.  This novel condition was therefore 
assigned the designation FAME 3.  The major distinguishing features between FAME 3 and 
other forms of FAME include progression, age of onset, clinical features and certain special 
investigations, notably MRI. 
 
FAME appears to be a fairly uniform and relatively benign syndrome, characterized by 
myoclonus and rare seizures and mild or no progression of disease, and without associated 
neurological features except tremor5;7;9;10;107.  Progression and neurological impairment 
typically go hand in hand, and, FAME 3 appears on a continuum between PME and PMA on 
the one hand and FAME on the other.  PME and PMA are characterised by significant 
progression and neurological disability, whereas in FAME progression and neurological 
disability are either absent or trivial. 
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4.1 FEATURES OF FAME 3 
4.1.1 PROGRESSION OF DISEASE 
In FAME 3, there is a significant evidence to suggest progression: 
1. Historically, participants reported that their affected parents died young and had 
neurological impairment.  Three of the patients died during this study, at age 31, 35 and 
39. 
2. Participants had evidence of significant neurological impairment at the time of first 
assessment.  For example, patients B-V-10, B-IV-26 and A-II-6 were cognitively impaired 
when first assessed. 
3. At time of presentation, certain patients had evidence of unequivocal neurological 
impairment.  Patient B-V-10 and A-II-6 had significant ataxia when they presented. 
4. During the course of the study, participants’ neurological status was noted to deteriorate.  
Patient A-III-5 was noted to have worsening coordination and to have developed gait 
ataxia.  Patient B-IV-25 became forgetful and developed dysarthria. 
 
There are two important caveats that need to be considered: 
1. Assessment of cognitive state.  The majority of participants in this study had very poor or 
very limited schooling.  Assessment of cognitive function in this situation is extremely 
difficult and there are no well validated mechanisms for obtaining accurate data.  In 
general, the MMSE requires eight years of school education in order for it to be valid.  
Interpretation of borderline or low normal MMSE scores in this study is difficult, but they 
are likely to represent normality.  However, it is likely that scores below 20 are abnormal. 
2. Effect of anti-epileptic agents and alcohol.  Both phenytoin and alcohol are cerebellar 
toxins.  Alcohol is also a cause of fronto-temporal dementia.  Estimation of alcohol 
consumption is difficult, particularly in cases where alcohol abuse may have happened 
several years prior to assessment.  At least one patient was known to have toxic levels 
of phenytoin (A-II-6).  Given these factors, it is possible that either or both dementia and 
signs of cerebellar disease may have been related to extraneous causes other than 
FAME 3.  In addition, Eldridge74 has reported on cases of PME whose condition 
worsened when on phenytoin, and it is possible that phenytoin may have had a similarly 
deleterious effect in these cases.  However, it is unlikely that certain patient’s 
neurological status may be explained on the basis of these factors alone.  For example, 
B-V-10 presented with marked ataxia and gross cognitive decline.  The ataxia was not 
compatible with an alcohol induced phenomenon, in which damage to the anterior lobe 
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of the cerebellum results in truncal ataxia and relative sparing of the upper limbs.  
Similarly, the degree of dementia appeared profound and out of keeping with that seen 
typically as a result of alcohol abuse.  Patient B-IV-25 developed change in her voice as 
a result of worsening myoclonus and was noted to have cognitive decline despite 
reporting no alcohol intake. 
 
In comparison to most families reported, there appears to be a greater degree of progression 
in FAME 3 than in other forms of FAME (Table 16).  In general, the patients from Japan 
appear to be less severly affected than those from Europe11.  Van Rootselaar reported 
moderate functional disability with increasing myoclonus in the elderly, and impaired walking 
in two patients11;117.  Labauge et al reported on slight to moderate progression leading to 
mild to severe handicap with complaints of memory deterioration7.  Certainly, despite claims 
that the disorder is benign, a number of reports have documented some deterioration, but 
this seems to be to a lesser degree than that seen with FAME 3. 
Table 16. Progression in FAME; (documentation of benign course in italics and 
parentheses). 
Reference/ TERM 
  
PROGRESSION 
 
Ikeda, 1990 
Cortical Tremor 
  
  
Patient 1. Developed seizures five years after tremor, and 
then seizures every 1-2 years.  
Had seizures several times a month and finger tremor then 
became pronounced, so that writing was not possible. 
Patient 2.  Fine tremor became worse, and developed 
seizure age 73. 
Okino, 1997 
Familial Benign 
Myoclonus Epilepsy 
Of Adult Onset 
  
   
Patient 1. Developed tremor age 40; this worsened later, 
and spread to legs, and she was unable to walk by herself 
by age 78.  Myoclonus was too severe for her to do anything 
by herself (but relieved by medication). 
Patient 4. Myoclonus gradually worsened, involving limbs 
and face.  His level of consciousness and myoclonus 
frequently deteriorated., but responded to medication. 
Manabe, 2002 
BAFME 
(61 year old had no difficulty in working or daily life) 
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Table 16 continued.  Progression in FAME; (documentation of benign course in italics 
and parentheses). 
Reference/ TERM 
 
PROGRESSION 
 
Okuma, 1997 
FCTE  
(Tremor not progressive; younger brother of 
the proband able to work as engineer 20 
years after first seizure) 
Terada, 1997 
FCMT 
  
  
Tremor became progressively worse; only 
difficulties with skillful finger movements. 
(3/6 patients had from one to three seizures 
throughout clinical course) 
Okuma, 1998 
FCTE  
  
(seizures well controlled) 
Uyama, 1996 
FAME  
No progression, but degree of myoclonus 
increased over 10-15 year follow-up, 
especially in patients over age 70. 
 (Lifespan normal) 
Mikami, 1999 
BAFME  
(No ataxia or dementia over ten years) 
Elia, 1998  
Familial Cortical Tremor, Epilepsy and 
Mental Retardation  
(Tremor did not worsen; seizures became 
rare after treatment with phenobarbital: 
Finger tremor in one patient reported not to 
have worsened since childhood) 
Guerrini, 2001 
ADCME 
Three had resistant complex partial seizures 
(Maximum severity of myoclonus was 
reached within a year of onset) 
Labauge 2002  
FAME   
Increasing myoclonus in elderly; functional 
disability was moderate with impaired skilled 
movements such as writing. Walking was 
impaired in two patients. 
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Table 16 continued.  Progression in FAME; (documentation of benign course in italics 
and parentheses). 
van Rootselaar, 2002 
FCTE  
Slight to moderate progression leading to 
mild to severe handicap; complaints of 
memory deterioration.  Several affected 
relatives with seizures had deterioration of 
memory. 
de Falco, 2003 
BAFME 
 
Seizures develop in 85% of those aged > 25 
years. 
(Tremor was not significantly progressive; 
syndrome described as “nonprogressive”) 
4.1.2 AGE OF ONSET 
The median age of onset of disease in the two familes in this study was 20 years.  This can 
be compared with that reported in other series, in which patients typically have an older age 
of onset (Table 17). 
Table 17. Age of onset (mean age in bold) 
 Onset myoclonus Onset seizure 
+/-50 59 
+/- 35 45 
Ikeda, 1990 
+/- 65 73 
24 
 
Case 1:16 None 
Case 2:30 33 
Manabe, 2002 
Case 3:27 None 
32 35 
Case 1:40 ? 
Case 2: 41 
Case 3:26 26 
Okino, 1997 
Case 4:40 +/-40 
32 27 
Case 1:29 25 
Case 2: 20 
Case 3:? None 
Case 4:32 32 
Okuma, 1997 
Case 5:34 32 
25 29 
Case 1:21 20 
Case 2:25 19 
Case 3:21 20 
Case 4:30 40 
Okuma, 1998 
Case 5:28 48 
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Table 17 continued.  Age of onset (mean age in bold) 
37  
Case 1:24  
Case 2:33  
Case 3:35  
Case 4:40  
Case 5:42  
Terada, 1997 
Case 6:48  
Uyama, 1996/Plaster, 1999  Mean age 37.5 
Mikami, 1999  Mean 30.5 years(range 18-45) 
Case 1:57 None 
Case 2:18 18 
Case 3:12 5 
Elia, 1998 
Case 4:Childhood 5 
23 25 
Case 1:50 59 
Case 2:12 12 
Case 3:15 15 
Case 4:30 34 
Case 5:20 27 
Case 6:20 20 
Case 7:20 15 
Guerrini, 2001 
Case 8:17 20 
Family A:Mean 25.1 (15-40) Mean 42.5 (30-50) De Falco, 2003 
Family B:Mean 18 (11-25)  
Labauge, 2002 41 (30-60) 44.6 (30-67) 
Striano, 2004 14.6 (13-18) 30 
 Case 1:18 - 
 Case 2:14 46 
 Case 3:13 18 
 Case 4:13 25 
 Case 5:15 30 
12-45 (23.5) 42 
Case 1: 63 
Case 2: 44 
Case 3: 37 
Case 4: 43 
Case 5: 52 
Case 6: 44 
Case 7: 43 
Case 8: 42 
Case 9: 20 
Van Rootselaar, 2002 
Case 10: 31 
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4.1.3 SEIZURE FREQUENCY 
Compared with the disease in the South African families, the seizures associated with FAME 
may occur at a later age7 9;107.  Although seizure frequency varied, many patients with FAME 
3 had frequent seizures.  In contrast, most reported families with FAME have had infrequent 
seizures, as presented in Table 18.  For example, in Ikeda’s initial report, one patient had 
only two seizures107.  Similarly, in the family reported by Terada, episodes of loss of 
consciousness were reported to be extremely rare108.  Of European families, that reported by 
de Falco had rare attacks9, and in ADCME, of eight affected patients,  two had only one or 
two isolated GTCS, and three had seizures in remission on treatment, in two of whom 
remission was present for 20 years.  The proband of the family reported by van Rootselaar 
was reported to have rare seizures117. 
4.1.4 NEUROLOGICAL FINDINGS 
Other features which suggest that FAME 3 is unique compared to more benign forms of 
familial myoclonic epilepsy include the presence of dementia and corticospinal and 
cerebellar dysfunction (table 12).  Neurological findings included nystagmus, dysarthria, 
ataxia and corticospinal tract dysfunction manifesting as hyperreflexia and the Babinksi sign.  
These findings may be contrasted with those reported in other forms of FAME, outlined in 
table 19. 
4.1.5 EEG 
The EEG background is normal in ADCME and not infrequently patients with FAME have 
normal EEGs 7;10,117 , whereas abnormal EEG backgrounds and abundant polyspike 
discharges were the rule in the participants described in this report (Table 19, Appendix 2).  
However, as opposed to findings in the South African participants, photosensitivity appears 
to be common in both FAME and ADCME 5,6,8;10.   
4.1.6 MRI 
Further distinctive features included MRI findings of cerebellar atrophy.  An additional 
radiological feature was that three patients had lacunar infarctions in the basal ganglia, 
brainstem and white matter changes, notably in the absence of a history of hypertension.  
The results of neuroradiological tests are reported in Table 15 and are shown in Figures 59-
62.  Interestingly, the family reported by Okino also reported multiple lacunar infarctions in 
one patient and cerebellar hemisphere infarction in another111. 
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In FAME, MRI is generally reported to be normal7;10, whereas cerebellar atrophy, ranging 
from mild to severe, was found in eight of ten patients from the two families reported here.  
Mild cerebellar atrophy on MRI was seen in two of four patients in a Dutch family with FAME, 
and a 68 year old patient from this family had cerebellar degeneration at autopsy122.  
However, this family had typical features of FAME in other respects, with mean age of onset 
of seizures at 43 years, and no other features of neurological disease other than mild 
cognitive impairment11;117.   
4.1.7 NEUROPATHOLOGY 
In FAME 3, pathological findings included Purkinje cell loss and dentate atrophy in the 
cerebellum, and neuronal loss and gliosis in the pallidum and olives (Figures 55-58).  In the 
Japanese literature, normal findings were reported in three patients with myoclonus and 
epilepsy, some of whom had “myoclonic tremor” (121cited in 110).   
 
Van Rootselaar reported on a case of FCTE, in whom linkage was negative for both the 
FAME 1 and 2 loci.  The cerebellum showed Purkinje cell loss with Bergmann gliosis, 
atrophy of the molecular layer and abnormal Purkinje cell morphology.  Gliosis of the 
cerebellar white matter and cell loss and gliosis of the dentate nucleus were present There 
was extensive mineralization of vessel walls and neurons in the globus pallidus122.  A second 
case showed similar features, and some gliosis in the claustrum411. 
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Table 18. Clinical characteristics of patients with FAME and allied conditions. 
Number 
Affected 
 
Reference 
 
Term 
 
Myoclonus 
Description 
 
Tremor 
Description 
 
Enhanced 
by: 
 
Seizures 
 
Cerebellar 
Signs 
Dementia 
 
10 living 
3 dead 
 
Labauge, 
2002 
 
FAME 
 
Sometimes at rest; 
Oscillatory, brief 
and irregular. 
  
Involuntary 
rhythmic 
movements of the 
extremities  
Action 
Posture 
 
8/13 Infrequent 
  (2-5 
seizures/lifetime) 
Absent 
 
Absent 
 
13 definite, 3 
possible from 
one family 
 
van 
Rootselaar, 
2002 
 
FCTE 
  
  
  
Present in fingers, 
arms 
feet and legs 
 
Kinesogenic 
tremor resembling 
essential tremor 
with superimposed 
myoclonus  
 
 Action  
 Stress 
 
(11/16) 
  
 Absent 
 
  
Complaints of 
memory 
deterioration 
 
Slight Cognitive 
impairment 
(short term 
memory and 
attention deficit) 
in 4 (all on AEDs) 
  
2 families 
15 in two 
families 
  
de Falco, 
2003 
  
  
BAFME 
  
  
  
Distal Arrythmic 
Myoclonus of arms 
  
  
Cortical tremor 
  
  
  
Posture 
  
  
  
7/15 Rare (1-5) 
Eight had no 
GTCS 
 Absent 
  
  
  
Absent 
  
  
  
7 
 
Striano, 2004 
BAFME 
 
Continuous, distal 
fine twitches of 
hands  
Cortical tremor 
 
Emotion  
Fatigue  
 
Rare(1-4)  
One had no 
GTCS  
 
Not reported 
 
 1 had IQ of 79 
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Table 18 continued: Clinical characteristics of patients with FAME and allied conditions. 
Number 
Affected 
 
Reference 
 
Term 
 
Myoclonus 
Description 
 
Tremor 
Description 
 
Enhanced 
by: 
 
Seizures 
 
Cerebellar 
Signs 
Dementia 
 
Patient 1. 3/6 
Siblings in one 
family 
Patient 2 No 
family history 
  
  
Ikeda 
1990 
 
Cortical 
Tremor 
  
  
  
  
Fine, shivering- 
like twitchings 
  
  
Posture  
Action 
  
  
Patient 1. 
Several every 
one-two years 
 
Patient 2. Two 
(Age 73,74) 
Absent 
  
  
  
Absent 
  
  
  
4 patients from 3 
different Families 
  
  
  
Okino  
1997 
 
Familial 
benign 
myoclonu
s epilepsy 
of adult 
onset 
  
  
  
Patient 1. 84 year 
old 
mother : marked, 
generalised 
Previously in 
arms and 
Eyelids 
Patient 2,3&4 
Myoclonus of 
limbs and face 
 
 
Movement 
Intention 
  
  
  
Rare 
  
  
  
Absent 
  
  
  
Absent 
  
  
  
5 in 3 generations 
 
 
Manabe 
2002 
  
 
 
BAFME 
  
Myoclonus in 
arms and legs at 
rest 
  
Fine tremor in 
fingers 
  
  
  
  
 
Rare 
   
  
  
  
 
Absent 
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Table 18 continued: Clinical characteristics of patients with FAME and allied conditions. 
 
Number 
Affected 
 
Reference 
 
Term 
 
Myoclonus 
Description 
 
Tremor 
Description 
 
Enhanced 
by: 
 
Seizures 
 
Cerebellar 
Signs 
Dementia 
 
5 in 3 
generations 
 
Okuma 
1997 
 
FCTE 
 
 
 
 
 
Tremulous 
shivering-like 
movements 
 
 
 
Extremely rare, 
1-3 times during 
clinical course. 
 
 
 
 
 
 
6 from 3 
families 
Terada 
1997 
FCMT 
  
  
  
 Rhythmic 
involuntary 
movements in the 
distal arms and 
legs  
 Posture 
Fine 
movements 
  
3 only had 1-3 
events 
Absent 
  
Absent 
 
7 from 3 families 
   
  
Okuma, 1998  FCTE  
Present in arms 
when 
anticonvulsants 
stopped 
Tremulous finger 
movements 
  
  
  
  
  
  
  
Well controlled, 
infrequent 
  
  
27 in four families 
Uyama 
1996  
FAME  
Myoclonus in 
arms 
and legs 
Tremulous finger 
movements 
Fatigue, Photic 
stimuli 
  
Rare 
  
Absent 
  
Absent 
  
17 affected out of 
27 in one family   
Mikami, 1999 
BAFME 
 
Myoclonus of  
extremities  
50% upper body 
50% whole body 
Tremulous finger 
movements 
  
  
 
2 had none  
Infrequent(often 
fewer than 4 
during lifespan) 
  
Absent Absent 
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Table 18 continued: Clinical characteristics of patients with FAME and allied conditions. 
 
Number 
Affected 
 
Reference 
 
Term 
 
Myoclonus 
Description 
 
Tremor 
Description 
 
Enhanced 
by: 
 
Seizures 
 
Cerebellar 
Signs 
Dementia 
 
7 in 6 
Generations of 
one family 
Elia 
1998 
  
Familial 
Cortical 
Tremor, 
Epilepsy 
and Mental 
Retardation 
  
  
Fine tremor 
involving the 
fingers 
  
Stretching 
hands or 
movement  
  
1 had no 
seizures 
Seizures well 
controlled in 2/3 
  
  
Mental 
Retardation in 
two 
  
11 in 5 
generations 
  
  
Guerrini 
2001  
  
  
  
  
ADCME 
  
  
  
  
Distally, at rest 
in severe caes 
Arrythmic, 
multifocal 
proximal arms 
Eyelid 
twitching 
"tremor-like" 
  
  
  
  
Posture 
maintenance 
  
  
  
2 had 1/2 
isolated  
GTCS 
3 had Sz in 
remission 
1 resistant 
GTCS 
2 resistant CPS 
  
  
  
  
  
All had low IQ 
(Two<70) 
 
 
 
 
14 from 4 
families. 
 
Plaster 1999 FAME  
Varying 
degrees of 
myoclonus 
Fine finger 
tremulous 
movements 
  1-4/ lifetime Absent  Absent 
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4.2 GENETICS OF FAME 
Linkage analysis was used to investigate the genetic localization of FAME 3.  If a single 
alteration in a gene, an allele, is responsible for the production of a disease trait, then that 
allele should be present in the DNA of all carriers of the condition.  A marker is a gene of 
sufficiently high prevalence that it is likely to be found in the family under study, and if two 
affected members of that family should have the same allele at the marker locus more often 
than would be expected, this finding increases the probability that there is linkage between 
that marker allele and the trait being investigated, for example, myoclonic epilepsy. 
 
Genes may be said to be closely or loosely linked, depending on their distance apart from 
one another.  A frequent occurrence during meiosis is the process known as crossing over, 
which consists of the exchange of parts between the chromatids of homologous 
chromosomes.  Crossing over of chromosomes between two linked genes results in a new 
combination, known as a recombination, between the two loci.  The frequency with which 
these recombinations increases with increasing distance between two genes. The genetic 
map distance between two genes is defined as the expected number of crossovers occurring 
between them, observable as regions of contact known as chiasmata.   At any given 
meiosis, there is a 1% chance that recombination will occur between two genetic markers 
that are separated in the DNA by one centimorgan, representing approximately ten million 
base pairs of DNA.  Two genes located one centimorgan apart will be passed on  together 
from parent to offspring 99% of the time 412. 
Linkage describes a distance relationship between two genetic loci and quantifies the 
location of a polymorphic marker relative to a gene for a disease 412.  The process of meiosis 
is associated with the separation of alleles so that each gamete ends up with only one of an 
allele-pair.  Linkage analysis is a test to determine whether in this process, known as 
segregation, a trait or disease associates with some known genetic marker within families 
more frequently than would be predicted by Mendel’s law of independent segregation.  The 
probabilities that the observed associations are caused by linkage or arose by chance (no 
linkage) are calculated.  The ratio of these two possibilities is expressed as a logarithm 
(base 10) and is termed the odds ratio for linkage (lod) 413.   
The lod scores either support or reject the hypothesis that the disease locus is near the 
marker locus.  Support for linkage is suggested by positive lod scores, where a result of 
more than 3 is a threshold value for accepting the existence of linkage, representing odds of 
1000 to 1 in favour of linkage, whereas scores of less than -2 are indicative of odds of 10 to 
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1 against linkage.  Since recombination between two loci becomes more likely the further 
apart they are on a chromosome, the genetic distance between the disease locus and a 
given marker locus can be estimated by the recombination frequency (θ) which is the rate of 
recombination between them.  The recombination frequency has an upper limit of 0.5, which 
is equivalent to no linkage (random assortment).  For a given data set at a particular 
recombination fraction tight linkage may be excluded, but this does not exclude linkage at a 
greater.  
Linkage analysis requires the identification of an unequivocal phenotype, a familial clustering 
of this phenotype, and the availability of a sufficient number of adequate informative 
pedigrees.   
Genetic analysis becomes more difficult when the penetrance of the disease phenotype is 
low or when the penetrance is an unknown function of age.  Errors in the assessment of the 
phenotype can obscure linkage findings because they may lead to the mis-scoring of 
recombinant events 414.  Genetic or locus heterogeneity may also obscure linkage findings, if 
a similar phenotype is caused by separate genes in unrelated families, since one family may 
give a positive lod score with a given close marker whereas another family may give a 
strongly negative lod score with the same marker414. 
In general, samples for the establishment of genetic linkage should be obtained from a 
minimum of 10 to 12 affected individuals within a family, for evidence of linkage to be 
demonstrable.  A single large family of a given size provides more potential linkage 
information than does a combination of several smaller families with the same total number 
of individuals415, large families being  better suited for linkage analysis because they contain 
potentially fewer unrelated individuals than do smaller families.  Pedigrees with larger sibship 
sizes are more efficient than those with smaller sibships because the proportion of meioses 
scored per genotype is higher when many offspring are available for inclusion in the 
analysis414. 
In FAME 3, the initial assessment that the phenotype was a pure one of a core syndrome of 
epilepsy and myoclonus was found to be erroneous when patient Patient B-V-11, who was 
asymptomatic, was noted to have a single spike discharge on a standard EEG recording.  
Subsequent long term EEG monitoring established the presence of abundant spike 
discharges.  Similarly, patient B-IV-26, who was a poor historian, was initially felt to be 
asymptomatic until her EEG was noted to be abnormal.  Subsequently, she was noted to 
have mild postural tremor, and on follow-up, reported having a generalized seizure. 
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Five problems in establishing affectedness status were identified: 
1. The disorder is age dependant. For example, the offspring of patient A-III-4 were 
initially presumed to be unaffected.  However, one of them (A-IV-1) developed 
myoclonus at the age of 13.  Given that the age of presentation for FAME 3 is quite 
wide, ranging from early adolescence to the fourth decade, determining the 
affectedness status in family members in their first three decades may be difficult. 
2. Patients may be clinically asymptomatic.  As noted, patients B-V-11 and B-IV-26 
were either normal or had trivial physical findings.  Similarly, when last assessed, 
patient A-III-10 appeared to be normal, although she was on treatment at the time. 
3. Although the vast majority of cases have an abnormal EEG, this may represent a 
circular argument, since the “gold standard” test is an EEG, and affectedness is 
determined by whether the EEG is normal or not.  Patient B-V-11 initially had a 
normal EEG, and a second recording showed a single spike discharge.  The question 
of the optimal duration of EEG recording is unanswerable, and presumably is related 
to age: it is reasonable to assume that the older the patient, the more advanced the 
disease, and the more likely that the EEG will be abnormal.  However, this is 
unproven.  Extrapolating from the experience with patient B-V-11, it is possible that 
some patients classified as asymptomatic on a the basis of a single normal EEG may 
well be abnormal, either because they are too young to manifest the disease, or 
because they are clinically asymptomatic and a single EEG is insufficient to indicated 
affectedness.  If the EEG is to some extent a marker of severity of disease, it seems 
plausible that those patients on the mild end of the spectrum of affectedness might 
have not only minimal or no clinical signs but also a normal or minimally abnormal 
EEG. 
4. One patient (B-V-9) was identified as having focal temporal spikes and focal slowing 
in the temporal region.  Apart from Guerrini’s report of ADCME, in which patients had 
FAME associated with complex partial seizures and focal temporal spikes8, other 
forms of genetic epilepsy have been associated with focal seizure types, for example, 
autosomal dominant nocturnal frontal lobe epilepsy and GEFS plus416;417.  The 
affectedness state of this patient is unknown.  He is believed not to have FAME 3 
since he lacks typical clinical manifestations, and his EEG findings would be unique.  
However, the possibility that some patients may manifest with focal spikes cannot be 
excluded. 
5. In general, determining affectedness on the basis of history was relatively 
straightforward, with many reports being that of individual who were severely 
neurologically impaired, with frequent seizures.  However, mildly affected patients 
may not have been identified by their relatives.  The converse also holds true, in that 
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some patients may have been incorrectly determined to be affected on the basis of 
history.  However, all patients who were affected had abnormal EEGs. Given that 
seizures occur in approximately 10% of the population at some stage, and are likely 
to be more prevalent in a population prone to alcohol abuse and violence, the 
possibility exists that, similarly to patient B-V-9, who is presumed to have epilepsy 
not related to FAME 3, patients may have developed secondary epilepsy on the 
basis of an acquired lesion. 
 
The inheritance pattern of FAME 3 appears to be clearly autosomal dominant, and the 
penetrance of the condition is high.  Affectedness status is determined by multiple factors 
including history, clinical features, EEG and MRI scan.  These factors are largely congruent, 
in that patients would report seizures, have clinical evidence of myoclonus, be shown to 
have a typically abnormal EEG, and MRI would demonstrate cerebellar atrophy. It is 
therefore highly unlikely that patients who were examined and investigated would have been 
incorrectly assigned as having the disease.   
 
The apparent high penetrance of the condition (Figures 41 and 42) may also be an indication 
that determination of affectedness is accurate, with a low false negative rate.  However, an 
exception to this is related to determination of affectedness in the offspring of B-IV-14, where 
of eight individuals, only one was thought to be affected.  The affected individual, B-V-3, had 
died before the study commenced, and of the remaining seven siblings, five had normal 
EEGs.  The most parsimonious explanation is that the positive affectedness status of 
patients B-IV-14 and B-V-3, in both of whom the determination was historical, is incorrect. 
 
Given that FAME 3 overlaps with the group of PME conditions and with FAME, the number 
of candidate loci was limited, since in PME dominant inheritance has only been reported in 
DRPLA2, a single family with Kufs disease3 and mutations in the neuroserpin gene 4.  All of 
these conditions are rare, with the exception of DRPLA, which is, however, uncommon in 
non Japanese populations140;418.  Clinically, all three of these conditions appeared possible 
candidate genes, although neuroserpin gene mutations are typically associated with a 
greater degree of dementia.   
 
Kufs disease is characterized by PAS positive material in cortical neurons.  Similarly, in 
patients carrying mutations in the neuroserpin gene, intraneuronal eosinophilic 
homogeneous bodies are seen in neurons in cerebral cortex.  Sections of cortex from patient 
A-III-9 were normal, excluding both Kufs and neuroserpin mutations as possible causes for 
FAME 3. 
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In the early stages of investigation of the disease, it was felt that Unverricht-Lundborg 
disease was a plausible candidate locus.  In family A, two point LOD scores of -14.24, -12.83 
and –6.82 were generated at the DNA markers D21S2040, D21S1912 and D21S1959419.  
These markers are tightly linked to the EPM1 locus409 and excluded this candidate locus 
from involvement with FAME 3 (Table 31, page 274).   
 
With regard to DRPLA, in family A the two point LOD score derived at the DRPLA locus was 
-14.50.  In addition, there was no evidence of expansion of the triplet repeat in the atrophin 
gene, with two normal sized alleles being present.  The DRPLA locus was therefore 
eliminated as a candidate locus (Table 32, page 275).  The EPM1 and DRPLA loci were not 
analyzed in family B. 
 
In the smaller family A the chromosome 2 locus (FAME 2) was excluded (Table 32, page 
275).  However, the chromosome 8 locus (FAME 1) could not be excluded in family A since 
there was a shared haplotype among the five affected samples that were available for 
genotyping (Table 32, page 275).  
 
In family B, Analysis of genotypes for markers at the FAME 1 and FAME 2 loci on 
chromosomes 8 and 2 excluded these as the regions containing the same locus (Table 33, 
page 276).   
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4.3 CAUSATION OF MYOCLONUS 
 
Myoclonus is a phenomenon that is key to a widely disparate range of conditions, but of 
these, perhaps the overlap between epilepsy and myoclonus is the most striking.  The 
occurrence of epileptic seizures is intrinsic to the definition of PME, and many patients with 
PME describe not only myoclonus and epilepsy, but also that increasing runs of myoclonus 
may terminate in a seizure78;103;104;126;126;166;227;420-422.  In cortical myoclonus, the EEG findings 
of generalized spike and wave, “giant” evoked potentials and enhanced late responses are 
likely to indicate that in this condition the cortex is abnormally excitable, or abnormally 
disinhibited, a feature of idiopathic generalized epilepsies343;345.  Although myoclonus and 
epilepsy may be related independently to increased cortical excitability, their close temporal 
relationship is striking and suggests that the underlying pathophysiology is very similar.   
Thus, with regard to epilepsy, myoclonus has unique features, which include: 
1. Frequent accompaniment by epileptic seizures. 
2. Increasing frequency and amplitude of myoclonus culminating in a generalized 
seizure. 
 
Similarly, with regard to the movement disorder of myoclonus itself, again there are two 
striking characteristics: 
1. Overlap between myoclonus and tremor. 
2. Tendency for myoclonus to be brought out by voluntary movement. 
The relationship between tremor and myoclonus is a complex one.  For example, rhythmic 
myoclonus cannot be distinguished from tremor311.  Apart from the fact that cortical 
myoclonus is described as either rhythmic or irregular, the current definition also explicitly 
states that cortical tremor is not a tremor at all, but is a myoclonic phenomenon311.  
Emphasizing this point, the consensus statement from the Movement Disorder Society on 
tremor notes “It must be emphasized that so-called jerky tremors are often not tremors but 
rather, myoclonus or asterixis”311. 
 
When viewed from either a phenomenonological perspective or a pathophysiological one, 
myoclonus can range from being a type of tremor to a type of epilepsy.  In attempting to 
unravel the cause of myoclonus, it will prove useful to examine both aspects in greater 
detail. 
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4.3.1 MYOCLONUS AND EPILEPSY 
Apart from our understanding of myoclonus and cerebellothalamocortical pathways, 
reviewed in the following section, relatively little is known about many of the basic 
mechanisms of myoclonus.  In contradistinction, the pathophysiology of generalized 
seizures, notably absence seizures, has been explored in greater detail, and this knowledge 
may therefore lead to greater understanding of the pathophysiology of myoclonus.  Absence 
seizures serve as a model for the primary generalized epilepsies as a whole, which may 
present with absence, generalized tonic-clonic seizures or myoclonus.   
 
The major shared EEG correlate between primary generalized epilepsy and FAME is the 
presence of generalized spike and wave discharges.  There are clear distinctions between 
the two conditions, in that the EEG in FAME 3 is associated with a slow background and the 
frequency of the generalized spike and wave discharges is not 3 Hz, as is typically found in 
absence epilepsy.  However, the generalized epilepsies themselves may be best regarded 
as part of a spectrum of epileptic conditions.  One extreme constitutes pure primary 
generalized epilepsy, where the major etiologic factor is an inherited trait that is expressed 
electroencepholographically as generalized spike-wave discharges at 3 Hz or faster.  The 
other extreme is made up of secondary generalized epilepsies where there is diffuse grey 
matter disease, usually due to acquired factors.  Lying between these are a considerable 
number of patients with a heterogeneous mixture of features. 
 
Of greater relevance to the question of the relationship between generalized spike and wave 
discharges in epilepsy and myoclonus are the conditions referred to as borderline 
syndromes with absence.  These include idiopathic myoclonic astatic epilepsy of childhood 
(syndrome of Doose) and epilepsy with myoclonic absences.   
i) Intermediate petit mal is a condition of absence seizures which is clinically similar to 
childhood absence, but is associated with atypical spike and waves.  These are 
irregular, with a frequency of less than 2.5 Hz and are asymmetrical.  The interictal 
EEG has a theta background and frontal bursts of polyspike and wave activity.  The 
condition is characterised by a myoclonic jerks which may be prominent or may be a 
minor symptom amongst daily convulsive seizures, and some patients are mentally 
retarded.  The disorder begins usually between the age of 2 and 5 years and, 
although classified as a generalized cryptogenic or symptomatic epilepsy, there may 
be a large subgroup caused by idiopathic epilepsy or IGE 423. 
ii) Epilepsy with myoclonic absences is a rare condition which usually has its onset at 
the age of seven years, has a male preponderance, and is noteworthy for the 
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presence of mental deterioration.  The seizures consist of absences with prominent 
myoclonus or clonic jerks, frequently associated with tonic contractions.  The ictal 
EEG displays a typical 3 Hz pattern which may be precipitated by hyperventilation.   
Absence seizures are also described in secondary generalized epilepsies, in which case 
there are usually associated tonic and atonic seizures or myoclonus.  Such patients 424 may 
have focal signs, cognitive impairment, and evidence for an acquired aetiology, and the EEG 
has a slow background and the spike and wave discharges are of a frequency of 2 Hz or 
less.  Similarly, absences are described in subacute sclerosing panencephalitis, in which 
they have a frequency of 2.5 Hz with periods of desynchronization 425, and are also seen in 
lysosomal storage diseases 426.  Of note, a case of Batten’s disease, which is one the 
conditions linked to PME, has been described with a 3 Hz spike and wave discharge, 
indicating that typical EEG patterns of primary generalized epilepsy may occur as a 
manifestation of diffuse neuronal disease.  Metabolic encephalopathies such as renal 
failure255  hypoglycaemia and metrizamide use 427 are also reported to cause absence 
seizures, although in the case of the latter, a slow 2 Hz sharp and slow wave pattern was 
noted. 
 
Considerable basic research has been carried out in investigating the pathophysiology of 
absence seizures.  Gloor described the fundamental pathogenesis of the generalized 
epilepsies as an abnormal response pattern of cortical neurones to the afferent 
thalamocortical volleys which are normally involved in the elicitation of spindles428.  This 
aberrant response occurs under conditions of diffuse mild cortical hyperexcitability, and 
results in an increased number of action potentials generated as a result of the afferent input 
from the thalamus.  These findings were based on experimental studies of penicillin-induced 
seizures in the cat, in which thalamic structures were stimulated directly, with the additional 
administration of penicillin either systemically or applied topically to the cortex.  In the cat, 
generalized spike and wave discharges can be produced experimentally by stimulation of 
the midline and intralaminar nuclei of the thalamus.  In humans, direct recordings have 
demonstrated that spike and wave discharges as part of an absence seizure can be 
simultaneously recorded from both cortex and thalamus 429;430. 
 
However, electrical stimulation of human frontal cortex, particularly the mesial aspect, may 
also produce EEG activity indistinguishable from spontaneous spike and wave and attacks, 
and which clinically resemble either simple or complex absences, suggesting that subcortical 
structures may not always be required for the generation of the spike and wave discharge431. 
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In summary, three levels of the central nervous system are involved in the genesis of the 
discharges428: 
i) the cortex, which is hyperexcitable. 
ii) the thalamus, particularly the midline and intralaminar nuclei. 
iii) the brainstem reticular formation, which allows for facilitation of generalized 
discharges if its activity is depressed.  
Oscillatory activity in the thalamus, such as that resulting in sleep spindles, is dependant on 
the intrinsic ability of neurons within the NRT to impose their oscillatory behaviour on 
thalamo-cortical circuitry (Figure 63).  The NRT forms a shell surrounding the dorsal 
thalamus, made up of GABAergic neurons projecting both amongst each other and also to 
the thalamic relay nuclei.  These NRT neurons are stimulated by thalamocortical and 
reciprocal cortico-thalamic projections.   
                             
Figure 63. Thalamo-cortical interactions.  (Redrawn from Chang & Lowenstein, 2003) 
1. Thalamic reticular neurons (in blue) hyperpolarize the thalamic relay 
neurons, acting at GABAB receptors.   
2. Thalamic relay neurons (in green) activate the cortical pyramidal 
neurons. 
3. Cortical pyramidal neurons activate the thalamic reticular neurons in a 
feedforward loop.   
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If the thalamus is inactivated, spike and wave discharges in both the thalamus and cortex 
are abolished432.  In turn, when cortical activity is abolished or suppressed, spike and wave 
discharges are suppressed in the thalamus 433 although spindles continue to be present 434.  
The spike and wave burst appears to be initiated in the cortex with secondary involvement of 
the thalamus, and is seen more clearly in neurons of the specific nuclei435.  Once initiated, 
both thalamus and cortex are essential to the maintenance of the spike and wave 
discharge430.  Studies using time computation histogram techniques of cortical and thalamic 
neurons have demonstrated that firing takes place in an oscillatory, phase-locked manner436; 
intracellular discharges recorded during spike and wave bursts demonstrate a marked 
increase in the firing probability of both thalamic and cortical neurons during the spike, and 
the converse holds true during the slow wave component430.  Corticothalamic neurons fire 
bursts of action potentials during the spike (of the spike and wave discharge) and hence 
entrain thalamic neurons to the oscillatory discharges which underlie the spike and wave 
discharge, with some thalamic cells reciprocally projecting back to cortex437.  In spike and 
wave discharges recorded from thalamus and cortex there is preservation of GABAergic 
function, with preserved IPSPs, thereby contributing to synchronisation of spike and wave 
discharges which are dependant on rhythmically recurring inhibition in both cortex and 
thalamus 438. 
 
4.3.2 MYOCLONUS AS RELATED TO THE MOTOR SYSTEM 
Wolfhart and Hook 422 appear to have been the first authors to observe that myoclonus was 
brought out clearly by action: “at every volitional movement there were violent jerks and 
shakings, sometimes of a tremor type”.  Bonduelle observed that "in a great variety of 
diseases myoclonus may be intensified or elicited by voluntary movement of the affected 
segment of a limb or maintaining the limb in a given posture "22 and also drew attention to 
the "infinite gradation between pure postural tremor, as seen in essential tremor, and the 
major forms of dyskinesia such as the syndrome described by Lance and Adams, methyl 
bromide poisoning and hepatolenticular degeneration"22.   
 
Similarly, Gilbert found that myoclonus occurs upon a background of shifting posture or 
changing direction of movement, and suggested that this implied a relationship to cerebellar 
function439.  Harriman96 and Gilbert440 noted that maneuvers which worsened tremor would 
worsen myoclonus.  Shibasaki also commented on the fact that cortical reflex myoclonus is 
commonly enhanced by posturing and/or volitional movement, possibly suggesting a role for 
the cerebellum in the production of myoclonus401.   
 
 226 
Regarding the role of the cerebellum in myoclonus, Mima reasoned that since most patients 
with PME had cerebellar ataxia, most would also have deficits in the 
cerebellothalamocortical system 441.  However, Ugawa, studying patients with hereditary 
cerebellar ataxia, showed that cortical excitability was normal in these conditions, using a 
technique of a cerebral hemispheric conditioning stimulus followed by magnetic stimulation 
(cortico-cortical inhibition).  Since cortical excitability was normal, it was inferred that 
cerebellar systems did not contribute to cortical excitiability or cortico-cortical inhibition via 
the cerebello-thalamo-cortical pathway.  However, in a different experimental set-up, in 
which electrical stimuli over the posterior fossa were followed by transcortical stimulation, the 
normal degree of cerebellar inhibition of motor cortex was absent in DRPLA and other forms 
of hereditary cerebellar ataxia 442;443.   
 
Other studies have contributed further evidence to suggest a role for the cerebellum in 
patients who develop myoclonus.  In a patient with RHS studied with a 3-dimensional 
positional analysis system, myoclonic jerks were noted to be more frequent when directed to 
a target and appeared to be triggered primarily by external sensory inputs relevant to the 
movement rather than the movement itself444.  Myoclonic jerks followed finger contact with a 
target after about 100 msec: given that many cells in the dentate nucleus respond to visual 
and somatosensory inputs, this long latency might be accounted for by processing in 
cerebellar structures prior to motor cortex activation444.  The authors postulated that loss of 
Purkinje cell inhibition, with consequent abnormally synchronized sensory related inputs 
from cerebellar nuclei, could affect cerebellar projections to the cortical motor regions444.  
Similarly, the bereitschaftpotential, which is generated by activation of the motor cortex 
through dentato-thalamic connections, was found to be absent in some forms of PME (RHS) 
445
.  Silen et al. comment that loss of Purkinje cells in the cerebellum is the major finding in 
patients with Unverricht-Lundborg disease78, and that loss of their inhibitory effect could lead 
to enhanced cerebello–thalamo–cortical output, which might affect the oscillatory activity of 
the motor cortex446. 
 
In keeping with these observations, in 1930, Hodskins and Yakovlev reviewed the literature 
on the pathologic findings in myoclonic epilepsy and found that, in all 12 of the adequately 
studied cases in the literature, a lesion had been found in the dentate nucleus or in its 
efferent pathway, the brachium conjunctivum.  In 7 of the 12 cases,  the dentate nucleus was 
“the point of election of the disease”235.  Obeso et al observed in their review of cortical 
myoclonus that 7 of their 11 patients had radiological evidence of cerebellar damage, and 
considered that “myoclonus was due to abnormal cerebellar input into, perhaps, a normal 
sensorimotor cortex”60.  As was also noted, Dawson’s original case who had presented with 
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giant SEPs, focal myoclonus and seizures, had Purkinje cell loss at postmortem 253.  
Similarly, Brown found that cerebellar pathology seemed to be the only consistent 
pathological finding in many cases of PMA, as well as in the few cases of postanoxic 
myoclonus in which there was histology, contrasting with the "physiological abnormalities 
which seem to be primarily cortical"447.  Correspondingly, features of cortical reflex 
myoclonus such as giant SEPs and C reflexes have been recorded in olivopontocerebellar 
atrophy (in which the pathology primarily involves the brainstem and cerebellum)42 and a 
presumptive cortical origin for visual evoked potentials can be demonstrated in the same 
condition395.  Obeso proposed that features of cortical myoclonus, such as bilaterally 
enlarged SEPs, may be related to loss of inhibition from other centres, such as a loss of 
cerebellar inhibition of the sensorimotor cortex 374. 
 
Lesion studies may be useful in a reductionist approach to the causation of physiological 
phenomena, such as myoclonus.  In the sparse surgical literature on myoclonus, there is a 
single case-report of a lesion of the cerebellar dentate nucleus in a 28 year old patient with 
severe myoclonus.  For the first ten post-operative days the patient was free of myoclonus, 
but thereafter it returned to her arms448.  Laitinen reported on seven patients with PME 
(probably Unverricht-Lundborg disease), who underwent subventrolateral thalamotomy, 
(presumably involving Vim and the cerebellar-thalamic outflow) with an improvement in 
ataxia and intention tremor, but “the effect of surgery on the myoclonias was less marked”.  
In two cases with myoclonus and ataxia who underwent thalamotomy, the myoclonus 
ceased initially, only gradually to return to a lesser degree449.  In a case of neuroaxonal 
dystrophy, ventrolateral thalamotomy did not affect myoclonus203.  Based on the rationale 
that increased Purkinje cell activity should decrease cerebral activity, Cooper performed 
cerebellar stimulation over the cortex of of the anterior lobe of the cerebellum450.  In one 
patient, whose condition was the result of anoxic brain damage, myoclonus gradually 
diminished until the patient was able to sit without involuntary movements; “the flapping 
violent movements of her head, neck and upper extremities ceased and she could feed 
herself, drink from a glass without difficulty, and carry on unaided all activities of daily living, 
except walking”450.  Two other patients also had reported improvement in their condition.   
 
However, there is virtually no indication as to how cerebellar lesions might cause myoclonus.  
Clearcut involvement of the dentato-rubral system need not give rise to myoclonus epilepsy 
125;451
, and the majority of diseases involving the cerebellum are not associated with 
myoclonus, for example, spinocerebellar ataxias and paraneoplastic cerebellar 
degeneration.  Furthermore, the spectrum of conditions giving rise to myoclonus associated 
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with cerebellar pathology is wide and ranges from relatively mild diseases manifesting with 
cortical tremor (FAME, coeliac disease) to severe forms of PME, such as DRPLA.   
 
Similarly to theories invoking a broad framework incorporating cortical and subcortical 
structures in addition to the cerebellum in the genesis of essential tremor452, there is 
theoretical and experimental evidence for interactions between the cortex and subcortical 
structures in myoclonus.  Myoclonus overlaps phenomenologically with tremor, and tremor 
has been frequently associated with various types of myoclonus, notably manifesting as 
cortical tremor, which may be clinically indistinguishable from other types of tremor, such as 
essential tremor.  It is therefore not unreasonable to speculate on the involvement of 
distributed networks in the production of myoclonus, analogous to networks associated with 
tremor, including the cerebellothalamocortical pathway453. 
 
In terms of cortical involvement in the genesis of myoclonus, there is substantial evidence for 
a reduction in cortical inhibition (reviewed in section 1.8.12).  With regard to cortical reflex 
myoclonus, Ashby has proposed that a single stimulus may result in the synchronous 
discharge of many neurons, and recurrent discharge and subsequent after hyperpolarization 
and reexcitation might lead to recurrent myoclonus295.  Decreased inhibition in motor cortex 
could cause an increase in the tendency of neurones to become synchronised.  Similarly, 
Brown has observed that during voluntary motor contraction, motor units are subject to the 
effect of different drives, tending to synchronize the discharges of the motor units at different 
frequencies454.  In line with this, patients with cortical myoclonus and multifocal myoclonus 
have been shown to have coherence of cortical and muscle discharges400.  Coherence 
analysis has also shown stong corticomuscular coherence in familial cortical tremor455.  
Strong intermuscular coherence has also been described which may represent rhythmical 
cortical output to target muscles, leading to tremulous movements in conditions with cortical 
tremor455.   
 
With regard to specific subcortical and cortical interactions, the amplitude of the P30m 
evoked potential and spectral amplitudes of 10 Hz activity are correlated in Unverricht-
Lundborg disease, suggesting that both signals are derived from overlapping neuronal 
populations or have common subcortical input349.  More direct evidence in cases of cortical 
myoclonus consists of coherent oscillatory activity in the 8-27 Hz range obtained from the 
cerebellar thalamus (Vim nucleus) and sensorimotor cortex by recording local field potentials 
and EEG456.  The authors proposed that this activity may represent a mechanism for 
“temporal sampling of movement-related activities within the sensorimotor cortex and 
cerebellar systems…..the sensorimotor cortex would be continuously digitizing activity in the 
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cerebellar thalamus, perhaps via a corticocerebellar-thalamic loop, explaining why 
coherence was present between the cortex and the cerebellar thalamus at rest as well as 
during activity”456.  High frequency cortical oscillations may be of cortical origin, but, in 
particular, the basal ganglia are said to  “have a critical role in supporting and controlling the 
synchronization of cortical activity at high frequencies”454.   
 
Coherence has also been reported between essential tremor and cortical EEG activity457.  
However, as McAuley pointed out with regard to essential tremor (Figure 64) “even a 
simplified scheme of the various neuronal pathways potentially relevant in the generation of 
essential tremor indicates that didactically attempting to attribute its origin to a single lesion 
in a single nucleus by means of simple recording is likely to be difficult, and that it may be 
more realistic to appreciate that tremors probably arise through interactions between central 
and peripheral neuromuscular systems”458.  The findings of coherence between cortical 
activity and tremor or myoclonus do not indicate that the cortex is the origin of either 
activity458.    
 
                           
Figure 64.  Diagram indicating the pathways involved in recording coherence.  
From McAuley 458. 
 
Although Shibasaki initially described a single spike-like discharge when performing JLA 
recordings (Figure 35), many reports have either shown or commented on findings of 
multiple wavelets associated with the EMG burst, as seen also in FAME 3 (Figures 48-53).  
This is a similar pattern to that described initially in primary generalized epileptic myoclonus 
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(Figure 19) and has also been described as a manifestation of ADCME (Figure 25), 
Angelman syndrome (Figure 3), in HIV associated myoclonus (Figure 27), and in familial 
myoclonus epilepsy (Figures 22, 23, 26).  Similar rhythmic myoclonus has also been 
reported with findings from JLA of a complex shape that included multiple waves, and with 
coherence between rhythmic EEG discharges and EMG bursts, with a peak at a frequency 
of 10.8 Hz 317.  The authors proposed that since rhythmic activity was visible on EEG, and 
significant coherence was demonstrable, the oscillations were generated by large, 
synchronous discharges of hyperexcitable cortical neurons317.  Clearly, these discharges are 
related to the myoclonic jerk, but equally, the latency of the discharges is too long for there 
to be a direct relationship between a discharge in the motor cortex and a resultant myoclonic 
jerk, as is postulated to be the case in JLA when simple spikes are detected.   
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4.4 CLASSIFICATION OF MYOCLONUS 
In recent years, the concept of myoclonus as consisting of two major entities, cortical and 
reticular reflex, has been prevalent.  This may largely be for historical reasons, in that the 
dominant group working on myoclonus held that exaggerated long loop reflexes were a 
major factor in the causation of myoclonus228;243;253.  Prior to that finding, the presence of 
enlarged evoked potentials had been noted in myoclonus, and were presumed to be 
indicative of cortical dysfunction.  The additional detection of cortical potentials by jerk locked 
averaging appeared to seal the argument that myoclonus was of cortical origin60.   
These modalities, namely, evoked potentials, long loop reflexes and jerk locked averaging 
had been applied initially in the investigation of discrete cortical lesions presenting with focal 
jerks, and found to be abnormal.  Abnormal results on these tests appeared to indicate 
cortical dysfunction.  Subsequently, this interpretation was extrapolated to incorporate most 
other forms of myoclonus.  The abnormal findings that had implicated the cortex as the site 
of origin of cortical reflex myoclonus in the setting of focal cortical lesions were replicated in 
diffuse myoclonus, leading to the deduction that diffuse myoclonus was also of cortical 
origin. 
However, the problem of the neuropathology of the conditions associated with myoclonus 
has been noted persistently to be relatively inconsistent with the concept of a purely cortical 
process causing myoclonus.  In his review of myoclonus, Symonds pointed out that “the 
involvement of the cerebellum is of particular interest in view of Ramsay Hunt’s 
observations, and of the finding by Greenfield (1953) of an almost complete disappearance 
of the Purkinje cells in the case of reported by Dawson (1946), in which myoclonus was 
proven to be provoked by muscle stretch421.  In general, the predominant neuropathology 
has tended to involve subcortical and cerebellar structures, and to spare the cortex60. 
With respect to the neurophysiological criteria for diagnosing cortical myoclonus, the 
traditional argument has been that since the initial cortical response, N1 or N20, is normal 
and represents the incoming thalamic volley, and that subsequent abnormally enlarged 
responses are indicative of a purely cortical process.  However, as reviewed (section 
1.8.14), the initial response is not always normal, and may be enhanced, although to a 
lesser degree than other components of the SEP242.  Perhaps of greater importance, it 
appears probable that thalamic afferents affect later responses that arise after the N20 
response391.  It seems reasonable to assume that in the setting of an existing state of cortical 
disinhibition, cortical networks will amplify thalamic input.  It is unknown whether the 
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enhanced evoked potential is due purely to abnormal cortical processing of a normal 
thalamic signal subsequent to the arrival of the thalamic volley, or whether the thalamic input 
itself is abnormal or prolonged, and that it is this interaction with an abnormally functioning 
cortex which results in an enlarged evoked response. 
 
Jerk locked averaging is a useful technique, but understanding of the physiological 
processes that result in a spike discharge and bear a precise temporal relationship to a 
subsequent myoclonic jerk is limited.  Many forms of myoclonus have jerks that are of too 
high a frequency to be interpreted.  Although the peak of the positive wave has been 
routinely used to determine the latency from point of cortical discharge to onset of 
myoclonus, it is important to point out that this is an assumption based on recordings in 
primates in which a positive cortical potential is believed to represent the combined 
discharge of pyramidal neurons.  Certainly, in many cases the latency from this peak to the 
onset of myoclonus is too short for the discharge to have originated in the cortex (table 11).  
It is perhaps salient to point out that Shibasaki, when initially describing the phenomenon of 
JLA, assumed that it was a feature of subcortical origin for myoclonus, since the latencies 
were so short, and only subsequently altered his position240.  Whether the difficulty lies in 
determining the actual onset of the myoclonic jerk, which is established by the somewhat 
arbitrary setting of a trigger level, or whether the latency should be fixed from some point 
other than the peak of the positive potential, is unclear.  It is not impossible that the cortical 
spike is an epiphenomenon, and is not directly related to the neuronal discharge that results 
in a myoclonic jerk.  The finding with JLA of a pattern of multiple waves is incompatible with 
a single discrete discharge in the cortex resulting in a single, discrete jerk8;216;316.   
Furthermore, as EP Richardson pointed out, even if JLA demonstrates a cortical potential 
associated with myoclonus, this does not necessarily “preclude the possibility that 
subcortical structures may be crucial in making the cerebral cortex either “myoclonogenic” 
(Gilbert 1963) or “epileptogenic” (Ziegler 1974)” 459.    
 
With regard to long latency reflexes, the physiological role of these reflexes, and their origin, 
remains controversial.  It is unlikely that the long latency reflex forms part of the pathway that 
resulted initially in a giant evoked potential and subsequently in a C reflex, as was initially 
proposed385.  Given that the latency of the long latency reflexes is typically held to be 
approximately 40 msec, it is appropriate to refer to the controversy regarding the origin and 
nature of the short latency input to motor cortex, a pathway which would presumably be 
required if the long latency reflex involved a transcortical loop (reviewed in section 1.8.13).  
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However, there is good evidence from a variety of experimental methods that indicate that 
the cortex is relatively disinhibited, as was demonstrated in this study in FAME 3 by using 
transcranial magnetic stimulation, and seen also in other forms of PME and familial cortical 
tremor345;411.   
 
In view of the known subcortical pathology, it is tempting to speculate on ascending 
projections arising from dysfunctional subcortical structures that may affect cortical inhibition.  
For example, the overall set point of thalamic and cortical excitability is modulated by 
ascending cholinergic pathways that project to the thalamus as well as noradrenergic and 
dopaminergic neurons projecting to the cortical end of the thalamocortical loop where they 
influence bursting cells in layer V of the cerebral cortex 460.  Rhythmic stimulation of the 
thalamus results in the the augmenting response, in which responses in the thalamus, as 
well as areas of the neocortex to which the stimulated thalamic foci project, increase in size 
during the first few stimuli461;462.  Intrathalamic mechanisms might make a major contribution 
to cortical augmenting responses during repetitive thalamic stimulation, and cortical 
feedback could promote augmentation in the thalamus through mechanisms similar to those 
that are involved in the generation of spindles462.  Following stimulation in the VL nucleus, 
activity in thalamic afferents projecting to cortical layer V initiates a sequence of events that 
primes the cortical network and subsequent afferent activity evokes an augmented 
response463.  Thus, as Brookhart and Zanchetti noted in animal experiments in cats, 
recurrent thalamic stimulation may induce an augmenting response, and subsequently a 
discharge could be recorded in the pyramidal tract397. 
 
FAME 3 has features of cortical myoclonus in that evoked potentials are enlarged, long 
latency reflexes are present, and JLA demonstrated a series of waves linked to the 
myoclonic discharge.  However, MRI scans showed cerebellar atrophy, and neuropathology 
was largely restricted to the cerebellum, with Purkinje cell loss, and involvement of the 
dentate nucleus.  
 
FAME 3 is therefore a classical example of a condition in which there are subcortical and 
cerebellar pathological changes in the setting of neurophysiological abnormalities which 
traditionally have been associated with cortical dysfunction.   
 
Although focal cortical lesions may have enhanced SEPs and spikes detected by JLA, there 
is evidence to indicate that these characteristics are not exclusively the domain of 
myoclonus arising from the cortex.  As reviewed, a striking feature of many diseases 
associated with myoclonus is the presence of generalized spike and wave activity, and given 
 234 
the substantial body of work that suggests that these discharges arise from cortico-thalamic 
interactions, it appears likely that similar conclusions may be drawn with regard to FAME 3 
and like conditions.  Given the strong association of myoclonus with epilepsy, the 
phenomenon of increasing myoclonic jerks prior to seizures, and EEG findings of spike and 
wave, it appears likely that myoclonus itself may also be associated with abnormalities in 
cortical-thalamic interactions. 
 
Furthermore, FAME 3 shares many neurophysiological similarities with other forms of PME, 
such as DRPLA and the sialidoses.  The majority of these conditions also have pathological 
changes affecting subcortical structures.  With regard to definitions of myoclonus, it seems 
reasonable to emphasize that on the basis of their differing pathology and the presence of 
epilepsy, conditions such as the PMEs are distinct from pure cortical lesions.  Although PME 
and FAME 3 may share neurophysiological features with those forms of myoclonus which 
arise from a discrete cortical lesion, it appears likely that this similarity is the result of two 
distinct pathophysiological processes meeting at a common point, the cortex. It would seem 
reasonable to argue that definitions of myoclonus, such as cortical and reticular reflex, 
border on being somewhat arbitrary distinctions, and that although neurophysiological 
testing lends support to such groupings, many of the disease processes overlap.  The 
majority of the conditions associated with PME and FAME have pathological and 
physiological findings which are indicative of both subcortical and cortical dysfunction, and 
the usual designation of cortical myoclonus for these conditions appears to be an 
oversimplification. 
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APPENDIX 1: CASE HISTORIES  
FAMILY A 
A-II-2  
This patient, who was born in 1942, and died at the age of 57,  was seen at Groote Schuur 
Hospital in Cape Town on one occasion, and was referred to the neurological service with a 
history of generalized tonic-clonic seizures; CT scan showed previous cerebrovascular 
accident with left parietal infarction and atrophy.  Neurology consultation reported a degree 
of dementia, absent ankle and knee jerks and weakness of the legs with flexion 
contractures. 
He was reported by his children to have had an amputation and subsequently burnt to death, 
probably whilst smoking in bed. He was said to have had many seizures; the onset of his 
illness was reported to have been about the age of 30 years.  He had tremor and visual 
hallucinations. 
A-II-6 
This patient’s illness started at the age of 22 years and was characterized by both 
myoclonus and seizures.  He reported that seizures were rare and tended to occur in the 
morning and that there was an increasing frequency of myoclonus prior to a seizure.  He had 
been on both phenytoin and phenobarbital and had documented toxic levels of both drugs. 
His Minimental State Examination (MMSE) was 16, but it should be noted that he had no 
formal education.  When he was examined at the age of 50, symmetrical tremor of the hands 
was present, which was brought out by action, notably posture holding.  Myoclonus was 
present, with occasional jerks of the upper limbs.  Cranial nerves showed abnormal pursuit 
with dysarthria.  Dysmetria of the legs was present and he had truncal ataxia and difficulty 
walking, which had started in his early thirties.  Knee and ankle reflexes were absent and he 
had distal loss of vibration and joint position sense.  Extensor plantar responses were 
present.   
A-III-4   
This patient’s illness started at the age of 20 years, and was characterized by myoclonus 
and rare seizures, the latter being aggravated by sleep deprivation.  Medication largely 
consisted of a combination of phenytoin and phenobarbital and he reported an improvement 
in his condition using valproate. He was initially assessed in 1991 at the age of 28 years, 
and again in 2002. As of 2005 he was still employed as a labourer in a factory.  He had a 
MMSE of 28.  He had a Standard 4 education.  
On examination, he had no nystagmus, but ocular pursuit was impaired.  Blepharospasm 
was present. Mild dysmetria and tremor of the hands were present. Myoclonus of low 
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amplitude was present in his face and upper limbs. Reflexes and distal sensation were 
normal. 
At re-examination in 2002, there was no appreciable change noted: he had changed his 
medication to sodium valproate in the interim period. 
A-III-5  
This patient’s illness was characterized by the presence of myoclonus and seizures, which 
started at the age of 18 years. Seizures occurred two to three times per month and both 
morning myoclonus and seizures occurred.  He reported exacerbation of his condition by 
sleep deprivation and alcohol.  His medication was limited to a combination of phenytoin and 
phenobarb.  CT scan was normal.  He had a Standard 4 Education, and his MMSE was 9. 
On examination, smooth pursuit was abnormal, and although at initial assessment he was 
normal, a decade later on repeat examination, dysmetria was present, affecting legs more 
than arms: this may have represented an anterior vermis syndrome secondary to alcohol.  
Tremulous movements of the lips and hands were present, as was myoclonus of small 
amplitude largely affecting the upper limbs. 
A-III-7  
This patient had both myoclonus and seizures, commencing at the age of 14 years. She 
reported about one seizure per month, and said that seizures would sometimes be preceded 
by increasing myoclonus, and were exacerbated by sleep deprivation. 
On examination, she was not orientated to time or place and appeared to be demented.  She 
had a Standard 1 education.  Nystagmus and abnormal smooth pursuit were present; she 
was dysarthric and had dysmetria of arms and legs, difficulty walking and truncal ataxia.  
Typical tremor was present. Knee and ankle reflexes were difficult to elicit. Low amplitude 
myoclonic jerks were present in the upper limbs. Blepharospasm was present. 
A-III-8  
(Proband family A): This patient, first seen in 1992 at the age of 28 years, reported the onset 
of myoclonus at the age of 26.  Myoclonus was said to come on at any time; she commented 
that it seemed particularly worse after going out into bright sunshine, and on one occasion, 
after a dance.  She also had generalized seizures, and received a combination of 
phenobarbital and phenytoin for these. Myoclonus was not worse in the morning. She 
reported that she would occasionally experience a series of jerks. She had failed her final 
year of schooling and then left school.  On examination, MMSE was 27 and testing of 
category fluency and motor sequencing tasks was normal.  She had fine tremor of the 
fingers at rest, exacerbated by posture, and intermittent myoclonus, predominantly distally in 
the arms.  Smooth pursuit was normal and there was no nystagmus or dysarthria present. 
There was mild blepharospasm. Examination of the motor and sensory systems was intact 
and there was no evidence of cerebellar dysfunction. 
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CSF lactate was normal and biopsies of muscle, axilla and palmar skin were normal. She 
was seen again at the age of 33 in 1997; a combination of valproic acid and clonazepam 
stopped her myoclonic jerks. At the time of her last assessment she reported having a few 
seizures per month, and complained of intermittent myoclonus.  She commented on an 
increased frequency of jerks prior to a seizure.  On examination, she had fine tremulousness 
of the hands, with a mild intention tremor and mild lower limb ataxia. 
A-III-9   
This patient reported the onset of myoclonus at the age of 20 years. He had nocturnal 
seizures at a frequency of one per month. He reported exacerbation of convulsions from 
alcohol, stating that his convulsions had lasted one to two hours. He had a poor response to 
a combination of phenobarbital and phenytoin and at the time of examination was taking 
phenytoin 300mg at night. 
He had a grade 9 education, but reportedly had progressive intellectual impairment. Pursuit 
was abnormal, and he had dysarthria. Postural tremor of the hands was present. 
Dysmetria was present, but it was unclear whether this related to superimposed myoclonic 
jerks. He had truncal ataxia and extensor plantar responses. He died in 1996, reportedly 
following a seizure and his brain was subsequently examined pathologically (details are 
given in Section 2.3). 
A-III-10 
This patient reported that myoclonus started at the age of 23 years. Her examination was 
normal, apart from mild tremulousness, and rare distal myoclonus. She noted improvement 
with clonazepam. She had a grade 1 education and could not read, but scored 26 on MMSE 
in 2001.  
She lived an isolated life on a farm with her mother, and took sodium valproate religiously 
since 1994. She was reassessed in 2001, and reported very few seizures; her neurological 
examination was normal. 
A-IV-1 
This patient, the daughter of A-III-4, presented in 2005 at the age of 23 with a complaint that 
she had experienced intermittent myoclonic jerks since age 13. She had completed high 
school and had a job as a book-keeper at a school.  Myoclonus involved arms more than 
legs, and was worse in the morning and associated with sleep deprivation.  She had no 
history of seizures.  The myoclonus was mild and did not trouble her particularly; she had 
sought medical attention largely due to her sister’s insistence.  She described a brief 
sensation of absence associated with some myoclonic jerks. On examination she had a fine 
postural tremor of the hands and occasional myoclonic jerks were noted in the shoulders. 
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FAMILY B 
B-I-1  
The great-grandmother of the proband, IV-6, lived near Piketberg, and was also reported as 
having lived in Calvinia by her grandaughter, III-1. She was reported to have had tremor and 
seizures, and although she was able to walk, was said to have been in bed much of the time. 
B-II-1 
This patient is said to have had tremor and numerous seizures and drowned after he ran into 
a dam, round about 1900. He lived “on the other side” of Piketberg. 
B-III-9  
This patient had visual hallucinations, complained of strange smells, and was said to have 
frequent exacerbations and remissions. She was reported to have been admitted to the 
Valkenburg Mental Hospital in Cape Town. She is reported to have died in her thirties. She 
was also reported as having myoclonic jerks starting in her early thirties. 
B-III-12  
This patient is described as having myoclonic jerks and generalized tonic-clonic seizures; 
she was also reported to wander off, disappearing for a few days at a time. She was 
reported by her family members to have had a normal gait, without features of truncal ataxia. 
She died in her late thirties.  
B-III-20  
This patient’s son (seen at the age of 46) said that his mother died at the age of 62, after she 
had set herself alight by accident.  She had myoclonic jerks, and reportedly walked as 
though she was drunk and had postictal confusion.   
B-IV-3:  
(Proband family B): This patient was admitted to the hospital in 1994, initially to the 
psychiatry ward, where she presented with emotional lability and myoclonus.  She reported 
that her illness had started five years previously at the age of 31. The myoclonic jerks came 
in clusters, and there were runs of jerks prior to seizures.  The seizures were said to be 
infrequent. She felt that the illness was progressive, and led to impaired functioning at home.  
According to her sister, she had been very neat, but she was no longer able to care for 
herself. In the psychiatry ward, she was noted to have auditory and visual hallucinations and 
religious delusions.  On examination, she was emotionally labile and disinhibited. She had a 
grade 9 education. Myoclonic jerks were present in her arms and hands and trunk, brought 
out by movement.  She had blepharospasm and facial myoclonus.  Reflexes were brisk 
throughout. Coordination was initially difficult to evaluate because of myoclonus, but 
subsequently appeared normal. Myoclonus responded to clonazepam.  CSF and CT brain 
were normal. Although placed on sodium valproate, her compliance was poor and her 
response was unclear. She died aged 39; the circumstances of her death are unknown. 
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B-IV-6  
This patient reported the onset of myoclonus and seizures at about the age of 20 years. She 
felt at the time of initial assessment, at the age of 30, that her condition was not progressive, 
although it seemed to increase with stress. Myoclonus was present only in her arms and 
hands and resulted in her struggling to carry things, serve up food to her children and shop.  
Myoclonus was typically associated with activity and did not occur at rest.  There was no 
morning myoclonus or seizures and no series of myoclonic jerks prior to a convulsion. Sleep 
deprivation and alcohol did not exacerbate seizures.  
Seizures were characterized by having no warning, although she reported that her neck 
would turn to the right initially; after the event she was confused for a few hours;  seizure 
frequency was 2-3 times per month, although at times she would have clusters of seizures, 
up to 7 per day.  She had a MMSE of 28/30; she had a Standard 4 education. 
When initially examined in 1994 there was no truncal ataxia but 5 years later, she had 
developed truncal ataxia.  Similarly, initially reflexes were normal, but she later developed 
hyperreflexia. In 2000, there were myoclonic jerks of the outstretched hands, with 
intermittent jerks seen all over body, especially the arms, hands, and feet.  The reflexes 
were all brisk, but tone was normal. Postural tremor was present. Sensation was normal. 
There was no blepharospasm. There was mild impairment of finger to nose testing and rapid 
alternating movements were mildly clumsy. She had been treated with phenytoin 300mg, 
phenobarbital 30 nocte and clonazepam 0.5 mg nocte. As with her sister, she appeared to 
be only intermittently compliant with sodium valproate. 
B-IV-10  
This patient reported that her illness started around the birth of her fourth child, about the 
age of 25 years. She reported blepharospasm and tremor of her hands, followed later by 
tonic-clonic seizures, which occurred at a frequency of 2-3 per month. The seizures were 
preceded by runs of myoclonic jerks or by jerks or tonic spasms of the left arm. Seizures 
were not worsened by alchohol, but tended to be more frequent in the evening.  She also 
experienced nocturnal seizures. Myoclonus was not worse in the morning. Sodium valproate 
improved her seizure control, both by history and on comparing spike counts on EEG. She 
had no formal education. 
On examination, she had myoclonic jerks composed predominantly of fine, tremulous 
movements in the arms, particularly the hands, brought out by posture. The hands and 
forearms were involved, but not the legs. There was slight myoclonus of the mouth and chin 
and blepharospasm was present. Reflexes were slightly increased. There was mild 
dysmetria in legs and in the arms, possibly secondary to myoclonus. Rapid alternating 
movements were normal, as were smooth pursuit and saccades. 
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One seizure was witnessed at 9 pm: she was noted to have an increase in myoclonus, 
progressing to massive myoclonic jerks, predominantly of the upper body and with retained 
consciousness, and she was unable to stand and sat on the floor; after a few minutes she 
had a generalized tonic-clonic seizure, followed by post-ictal confusion. 
B-IV-14 
This patient was described as having generalized seizures and myoclonus. He died young. 
B-IV-19  
This patient died at the age of 45, just after a seizure. She had many seizures, and was 
reported to have had an unsteady gait. She was said to have been confused at times. 
B-IV-23  
This patient reported that she did not go to school at all, or that it was limited to Sub A.  She 
was unable to remember when her illness began, but stated that it was long after her two 
children were born; on another occasion she reported jerks starting at age 17, and that her 
first seizure was at the age of 42 years.  She reported if she did not take medication that she 
would get jerks of her body and tremor.  She had approximately 1 – 2 seizures per year.  At 
initial assessment she was taking phenobarbital 60 mg daily.  She was first assessed in the 
year 2000, aged 44: smooth pursuit was mildly abnormal, and there was intention tremor 
present, with mildly brisk reflexes.  Myoclonus was only evident as a fine low amplitude 
tremor of outstretched hands and occasional proximal jerks in the legs. There was no 
blepharospasm or facial jerks. 
Four years later, on examination, minimal tremulousness was present. There was no 
nystagmus and smooth pursuit was normal.  She was mildly dysarthric.  There was no 
blepharospasm. On examination of the motor system, the reflexes were brisk, but tone was 
normal.  The plantar responses were flexor; sensation was intact. On examination of the 
cerebellar system, the heel-shin, finger-nose and tandem gait were normal.  
Her MMSE was 15. She was unable to name the province in which the hospital is found and 
identified the year, season and day of the week incorrectly.  She was unable to perform 
serial sevens or to spell backwards.  Her 3-minute recall was 1 and 0 on two separate 
testing periods.  Language function was intact, but she was unable to read or write and 
unable to copy a diagram.  Regarding category fluency, she was able to name seven 
animals in 1 minute; she was unable to identify any similarities, and verbal fluency was 
limited to three words beginning with S; her series of alternating motor sequences was 
normal. 
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B-IV-25 
This patient, born in 1966, was last examined in November, 2004.  She was born on a farm 
and had two years of schooling.  At the age of 12 she was sent as a servant to Cape Town 
and returned home once a year for the next four years, at the end of which time she fell 
pregnant and returned to the farm. 
She was unable to recall when her illness had begun, except that she had her first seizure 
when her son was three years old, corresponding to an age of 19.  She had been an 
alcoholic, but after repeated physical assaults by her husband because of her drinking, she 
stopped. Myoclonus could occur at any time; she reported an increase of myoclonus prior to 
a seizure.  Her husband reported that she had become somewhat more forgetful in the last 
few years, for example would not know what the date was..  She had very few seizures, but 
had severe myoclonus which was considerably improved by sodium valproate; she reported 
that if her medication ran out, the jerks would return.  She had previously been on 
phenobarbital which had not controlled her seizures, and during which time she had very 
prominent myoclonic jerks.  She had no generalized seizures since being on sodium 
valproate, a period of approximately 12 years.  At the time of last examination in June, 2004, 
she had normal smooth pursuit, without nystagmus.  She was noted to have a fine tremor of 
the hands.  There was no ataxia present and she had minimal tremulousness.  Reflexes 
were brisk, except for absent ankle jerks, and sensation and gait were normal.  She had mild 
difficulty with tandem gait.  She reported deterioration in the form of dysarthria due to 
myoclonus of speech.  She scored 16 on the MMSE. 
B-IV-26  
This patient, the youngest of 11 children, had a history of severe alcohol abuse.  At initial 
assessment she was thought to be normal, but on the basis of her abnormal EEG was given 
an “affected” ascertainment. She reported that she had jerks for a few years, from about the 
age of 30 years. She also complained of intermittent dizziness and that she was unsteady on 
her feet.  She reported having only two generalized seizures.  On examination she had a fine 
postural tremor and intention tremor of the hands. Smooth pursuit was abnormal and 
reflexes were brisk. She had only a grade 2 education. She was unable to give the year, 
season or date, and did not know the name of the country, province or town. She was 
unable to spell backwards and could not read, write or copy a diagram. MMSE score was 9. 
B-V-3 
This affected patient died in her thirties; she was described as having dysarthria, and 
epileptic seizures.  She was admitted to the Stikland mental hospital.  She was reported to 
have times when she was unable to walk and times when she was confused. 
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B-V-10 
This patient was first seen at the age of 29 years in 2000.  On examination she had a MMSE 
score of 10, in part related to her severe myoclonus, but she scored only 4/10 for orientation, 
and was unable to say the names of the days of week backwards. In addition she was 
disinhibited and had difficulty in performing motor sequences.  Medicines included both 
phenytoin and phenobarbital.  She had large amplitude myoclonus of predominantly the 
upper body and a moderate tremor of the hands, and was bed-bound.  She had marked 
dysmetria with intention tremor. She was placed on sodium valproate and clonazepam with 
considerable improvement, but developed pancytopenia and sodium valproate was stopped, 
followed by worsening of myoclonus.  She was last examined in March, 2005; at that time 
she was markedly demented, being unable to give appropriate answers regarding orientation 
to place or time, with prominent perseveration.  She had been off all medication and had 
marked generalized myoclonus, which worsened slightly with posture-holding.  Vertical and 
horizontal nystagmus was present and smooth pursuit was markedly impaired.  All limb 
reflexes were absent. Assessment of cerebellar signs was difficult due to the presence of 
myoclonus.  Nerve conduction studies were normal. She had frequent generalized seizures 
while in the ward.  She developed difficulty swallowing and died at the age of 35 years. 
B-V-13  
This patient reported that her illness started about the age of 19, with myoclonic jerks. 
She had a Standard 5 education.  She was taking sodium valproate, 200mg x 3 daily. She 
reported that she only had myoclonic jerks and had no tonic clonic seizures.  Her medication 
decreased her degree of myoclonic jerks. She reported a total of three seizures in her 
lifetime, the last one being about 3 years previously, at which time she had started taking 
sodium valproate. 
On examination she had minimal tremulousness, present both with posture holding and with 
action.  Ocular pursuit was normal and there was no nystagmus.  Reflexes were increased in 
her arms.  There was a mildly abnormal heel-shin test but tandem gait was normal.  
Regarding her cognitive state, her 3-minute recall and language function were intact.  
However, her orientation was incorrect on all questions, both to time and place except for the 
name of the hospital.  Her total MMSE score was 11/30. 
She was seen again in 2005, at which time she was on sodium valproate CR 500 mg tds. On 
examination, she had minimal postural and intention tremor.  Reflexes were moderately brisk 
and smooth pursuit mildly abnormal. MMSE had improved to 18/30. 
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APPENDIX 2: PHYSIOLOGY OF FAME 3 
Table 19. Results of EEGs in patients and controls 
Subject Year Background Polyspike and Wave Hyperventilation IPS 
AFFECTED 
A-II-6 1999 
10-11 Hz alpha with 
moderate theta and 
scattered delta 
Frequent spike and 
polyspike and wave in 
frontal regions 
No increase in SW No 
A-III-3 1999 Slowed 7 Hz background Frequent bursts of polyspike and wave No increase in SW No 
A-III-4 1991 
9 Hz alpha 
Occasional  theta and 
delta transients 
Independent spike and 
wave from frontal 
regions 
Enhances SW No 
A-III-6 nd     
A-III-7 1992 6-7 widespread theta Frequent bursts at 5 Hz  No increase in SW No 
 1998  Polyspike and wave No increase in SW No 
 1999 Normal Poorly formed bursts No increase in SW No 
A-III-8 1987 “slow activity” Single polyspike and 
wave 
SW discharges 
following HV No 
A-III-9 1994 Poorly formed background Left frontal spike discharges  
Intermittent frontal 
spike discharges No 
A-IV-1 2005 
Normal background with 
occasional scattered theta 
transients; recurrent bursts 
of theta and delta activity 
Generalized frontally 
predominant spike and 
polyspike and wave 
No increase in SW No 
B-IV-3 1989 
Normal alpha with 
intermittent episodic 
rhythmic theta activity 
Brief frontal spike 
discharges No increase in SW No 
 1994 Background of theta and 
abundant delta activity 
Single generalized 
frontally predominant 
spike 
No increase in SW No 
B-IV-6 1994 
8 Hz alpha background; 
intermittent brief bursts of 
theta frontally 
 No increase in SW No 
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Table 19. Results of EEGs in patients and controls 
Subject Year Background Polyspike and Wave Hyperventilation IPS 
B-IV-6 2000 
Well developed alpha, 
moderate amount diffuse 
theta, occasional delta 
transients 
Abundant generalized 
spike and polyspike 
and wave discharges 
No increase in SW No 
B-IV-10 1997 Normal background 
Recurrent bursts of 4-5 
Hz spike and polyspike 
and wave discharges, 
duration 0.5-1 second. 
No increase in SW No 
B-IV-23 2000 Diffuse 7-8 Hz theta 
activity;  
Generalized frontal 
spike and polyspike 
and wave 
No increase in SW No 
B-IV-25 2000 Diffuse 5-6 Hz theta background 
Frequent frontal spike 
and spike and wave No increase in SW * 
 2000 
Slow background, mixture 
of theta and delta  
transients 
Frontal spikes and 
polyspikes No increase in SW No 
 2000 Theta background of 5-6 Hz 
Intermittent bursts of 
Polyspike and wave No increase in SW No 
 2004 
Background alpha activity; 
occasional 0.5-1 sec 
bursts of theta intermixed 
with delta 
Occasional brief bursts 
of S and polyspike and 
wave at 3-4 Hz 
No increase in SW No 
B-IV-26 2003 8 Hz alpha rhythm 
Recurrent bursts of 4-5 
Hz bursts of S and 
polyspike and wave of 
one second duration 
No increase in SW No 
B-V-10 2000 7-8 Hz theta background Frequent frontal bursts 
of polyspike and wave No increase in SW ** 
 2003 6-7 Hz theta 
Frontally predominant 
generalized polyspike 
and wave 
No increase in SW No 
B-V-11 2001 Normal Normal No paroxysmal 
activity No 
  Normal Single SW discharge 
on referential montage 
No paroxysmal 
activity No 
B-V-13 2003 6-7 Hz theta background, 
with delta transients Normal 
No paroxysmal 
activity No 
 2003 6-7 Hz theta background, 
with delta transients Normal 
No paroxysmal 
activity No 
ABNORMAL EEG, PROBABLY NOT AFFECTED 
B-V-9 2000 Normal background; Right posterior temporal delta Spikes at T4 and T6 
No paroxysmal 
activity No 
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Table 19. Results of EEGs in patients and controls 
UNAFFECTED 
Subject Year Background Polyspike and Wave Hyperventilation IPS 
B-IV-16 2000 Normal Normal No paroxysmal 
activity No 
B-IV-22 2004 Normal Normal No paroxysmal 
activity No 
B-IV-24 2000 Normal Normal No paroxysmal 
activity No 
B-V-1 2001 Normal Normal No paroxysmal 
activity No 
B-V-4 2001 Normal Normal No paroxysmal 
activity No 
B-V-4 2005 Normal Normal No paroxysmal 
activity No 
B-V-5 2000 Normal Normal No paroxysmal 
activity No 
B-V-5 2005 Normal Normal No paroxysmal 
activity No 
B-V-6 2000 Normal Normal No paroxysmal 
activity No 
B-V-7 2000 Normal Normal No paroxysmal 
activity No 
B-V-12 2001 Normal Normal No paroxysmal 
activity No 
B-V-12 2003 Normal Normal No paroxysmal 
activity No 
B-V-14 2001 Normal Normal No paroxysmal 
activity No 
B-V-14 2003 Normal Normal No paroxysmal 
activity No 
B-V-14 2003 Normal Normal No paroxysmal 
activity No 
B-V-14 2004 Normal Normal No paroxysmal 
activity No 
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Table 20. Results of nerve conduction studies 
Subject 
 
Peroneal Motor 
(latency, velocity, CMAP mV) 
 
 
Tibial Motor 
(latency, velocity, CMAP mV) 
 
Sural Sensory 
(latency/ amplitude V) 
A-II-6 3.3/49.3/4 2.8/56//8 3.2/10 
A-II-10 3.9/47.1/6.9  4.2/12 
A-III-4 3.1/52/5.7 3.9/56/8.4 3.5/16 
A-III-8 3.3/50/10 4.2/57/4.5 3.9/15 
A-III-9   4.2/14.6 
B-IV-3   3.5/18 
B-IV-10 3.3/51/6.6 3.4/61/6 3.0/27 
B-IV-23 2.7/52.4/4 3/55/9.5 3.1/15 
B-IV-25 3.4/50/3  3.6/18 
B-IV-26 2.8/50/4 3.6/51/9 3.6/17 
B-V-10 3.9/52.6/1 3.6/52.6/7 3.7/10 
 
Table 21. Synchronicity of myoclonic discharges and duration of myoclonus. 
Name Synchronous EMG duration (msec, range) 
A-II-6 rare <50(20-40) 
A-III-3 nd  
A-III-7 at times <50(30-50) 
A-III-8 at times <50 
A-III-9 no 20-40 
B-IV-3 Variable 20-40 
B-IV-10 Frequent 30-50 
B-IV-23 at times <50 
B-IV-25 at times 20-50 
B-IV-26 No nd 
B-V-10 No <50 
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Figure 65. Assessing synchronicity and duration of myoclonus; patient A-III-8. 
 
 
       
Figure 66. Assessing synchronicity and duration of myoclonus; patient B-IV-26. 
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Table 22. Control group for determination of SEP amplitudes (average age 39.5) 
Gender/ Age N19 N1-P1/N19-P25 P1-N2/P25-N33 
Mean Values 1.77 3.73 2.61 
    
M38 0.84 1.82 1.66 
 0.42 2.2 1.48 
 1.18 3.06 0.52 
 0.81 2.36 1.22 
    
M46 3.32 6.64 2.8 
 3.4 5.88 2.52 
 3.24 6.28 2.84 
 3.32 6.27 2.72 
    
M36 2.36 2.62 0.72 
 2.12 2.54 0.88 
 2.02 2.6 0.6 
 2.17 2.59 0.73 
    
M46 1.28 3 3.04 
 1.6 3.2 3 
 1.64 2.96 3.14 
 1.51 3.05 3.06 
    
M42 1.42 2.04 3.1 
 1.82 2.82 2.08 
 1.66 2.12 1.98 
 1.63 2.33 2.39 
    
F42 3.56 7.06 5.96 
 3.08 4.92 5.84 
 3.48 9.96 5.56 
 3.37 7.31 5.79 
    
F33 0.6 3.64 2.08 
 0.72 3.32 3.4 
 0.68 3.32 2.52 
 0.66 3.48 2.67 
    
F40 2.72 3.12 1.96 
 2.1 2.88 1.5 
 2.5 3.2 1.86 
 2.44 3.07 1.77 
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Table 22. Control group for determination of SEP amplitudes (average age 39.5) 
M33 1.44 2.98 1.88 
 1.9 3.9 1.86 
 2.6 3.88 1.7 
 1.98 3.59 1.81 
F21 0.54 3.96 2.72 
 0.6 3.46 3.88 
 0.64 3.68 3.92 
 0.59 3.7 3.51 
    
F50 1.02 1.34 1.2 
 1.9 1.18 1.22 
 1.56 1.3 1.26 
 1.49 1.29 1.23 
    
M52 0.96 3.4 4.12 
 1.06 3.64 4.02 
 1.16 3.38 4.2 
 1.06 3.47 4.11 
    
F30 1.12 4.6 4.16 
 1.04 4.72 3.12 
 1.52 4.44 3.76 
 1.23 4.59 3.68 
    
M32 1.08 4.04 1.52 
 1.16 4.16 1.6 
 1.08 4.36 1.72 
 1.11 4.19 1.61 
    
M52 3.52 4.44 2.6 
 3.12 4.6 2.84 
 2.88 4.84 2.96 
 3.17 4.63 2.8 
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Table 23. Results of C reflex studies 
 
Name Long latency-interval (msec) 
Stimulus 
(mA) 
Amplitudeof 
Response (mV) CMAP 
B-IV-10  36.7  3-6   
 36.2    
 37.3.    
 37.2    
 36.85    
 
A-III-4 48.8 3 0.66 0 
 48.7 4.2 0.62 0.54 
 45.6 6.2 1.11 1.07 
 45.4 8 0.28 3.14 
 47.5 10.4 0.31 4.93 
  12.4 0.49 4.72 
     
 47.7 6.6 0.67 0.16 
 45.3 7.4 0.56 0.53 
 45.8 9 0.17 1.06 
 46.9 10.8 0.86 1.27 
 46.6 15.6 0.7 5.1 
 
A-II-6 49.5 12   
 47.2 12   
 47.3 12   
 47.9 12   
 
A-III-8 37.8  0.03  
 39.2 4.2 2.4 0 
 40.6 8.2 1 1.7 
 38.9 8.6 1.8 3 
 40.7 8.8 1.1 3.8 
  11 . 7 
     
 39.1 5.8 3.1 0 
 38.6 7 3.6 0.3 
 45.2 8.2 1.2 3 
 39.7 8.6 1.7 5.5 
 42.1 10.6 0.2 7.3 
     
B-IV-6 40 4   
 39.1 4 5 Nil 
 40.7 3 3  
 40 26 4.45  
 39.95    
 
 39 10   
 41.5 4.9   
 41 4.9   
 40.5    
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Name Long latency-interval (msec) Stim (mA) 
Amplitudeof 
Response (mV) CMAP 
B-IV-23 39.0 – 41.2    
 
B-IV-25 37.6 – 46.6    
  2.6 0.04  
  3 1.1  
  6.4 0.45  
  7.5 0.25  
  8.5 0.98  
  10 0.2  
  13.4 0.3  
     
B-IV-26 43.6 - 46.3    
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APPENDIX 3: STATISTICAL ANALYSIS OF 
MAGNETIC STIMULATION RESULTS 
Using Statgraphics (Manugistics, Inc), a Repeated Measures ANOVA was used to test the 
effects of high and low stimulus applied to patients and controls.  Given the control subjects 
were both males and females, and the patients tested were only females, the first test was to 
determine whether or not there was a significant difference between males and females in 
the controls.  Repeated measures ANOVA was run on low and then on high stimulus.  On 
comparison there was not a direct significant difference between males and females in the 
full model for low stimulus; however, there was a strong effect within duration levels and a 
Sex x Duration interaction (Table 24).  There was a significant difference between males and 
females at high stimulus, as well as a significant within duration and interaction term (Sex x 
Duration) (Table 25). 
Table 24. (Controls) Summary of Repeated Measures ANOVA for low stimulus at all 
duration levels.  Significant values are denoted by an *, an p-value < 0.05 
level was used as the significance level 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value 
Effect 5818.0 1 5848.025 3.311 0.0702 
Error 374278.1 213 1757.174   
      
Effect d.f. effect MS effect d.f. error MS error F p-value 
Sex 1 5818.025 213 1757.17 3.311 0.0702 
Duration 6 908.170 1278 88.97 10.207 0.0000* 
Sex x 
Duration 
6 273.619 1278 88.97 3.075 0.0054* 
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Table 25. (Controls) Summary of Repeated Measures ANOVA for high stimulus at all 
duration levels.  Significant values are denoted by an *, an p-value < 0.05 
level was used as the significance level.  Significant difference between 
genders at high stimulation. 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value 
Effect 11284.7 1 11284.65 4.984 0.0265 
Error 502634.6 222 2264.12   
      
Effect d.f. effect MS effect d.f. error MS error F p-value 
Sex 1 11284.70 222 2264.12 4.984 0.0265* 
Duration 6 3309.25 1332 123.56 10.207 0.0000* 
Sex x 
Duration 
6 694.24 1332 123.56 3.075 0.0000* 
 
To further explore the difference between males and females, a series of one-way ANOVAs 
were run to compare each duration within the high and low stimuli (Table 26).  These results 
showed that at most individual levels in a low stimulus situation, there are no significant 
differences, however at the high level almost all levels exhibited differences.   
Table 26. (Controls) P-values for one-way ANOVA comparisons between males and 
females at each duration within each stimulus level.  All significant p-
values have an *. 
Duration 
(mSec) 
LOW HIGH 
10 0.5861 0.0037* 
20 0.0010* 0.0024* 
30 0.0038* 0.0226* 
40 0.0378* 0.0048* 
50 0.7702 0.0000* 
60 0.5021 0.0249* 
70 0.0884 0.2260 
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Examining the results from the control group analysis, it was determined that all of the data 
(males and females) from this group could be used to determine if there was a significant 
difference between patients and controls at a low stimulus level.  The analysis to determine if 
the control and patients were significantly different was run using only females from the 
control group. 
A Repeated Measures ANOVA was again used to determine if there was a significant 
difference between patients and controls.  Three runs were completed, one using all the 
control group data at the low level of stimulus, the same analysis using only female controls 
at low level, and female only ‘control’ at the high level of stimulus.  All tests determined that 
there was a highly significant difference between patients and controls(Tables 27 & 28). 
Table 27. Repeated Measures ANOVA for low level stimulus between patients and 
controls, using female only control group data. 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value 
Effect 77224.22 1 77224.22 183.598 0.0000* 
Error 43323.46 103 420.62   
Effect d.f. effect MS effect d.f. error MS error F p-value 
Group 1 77224.22 103 420.61 183.598 0.0000* 
Duration 6 3139.89 618 133.72 23.480 0.0000* 
Group x 
Duration 
6 3235.84 618 133.72 24.198 0.0000* 
Table 28. Repeated Measures ANOVA for high level stimulus between patients and 
controls, using female only control group data. 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value 
Effect 245402.5 1 245402.5 216.944 0.0000* 
Effect d.f. effect MS effect d.f. error MS error F p-value 
Group 1 245402.5 88 1131.17 216.944 0.0000* 
Duration 6 1224.5 528 160.47 7.630 0.0000* 
Group x 
Duration 
6 799.7 825 160.47 4.983 0.0000* 
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The number of controls was much greater than the number of patients, even when only 
comparing female controls.  Therefore, all females in the control group that had missing 
values were omitted from the data, and 3 female controls were chosen to test against the 3 
patients.  The results supported those given above, in that there was a significant difference 
between the patients and the control group for both high and low stimulus levels.  The 
results are reported in Tables 29 and 30. 
Table 29. Repeated Measures ANOVA for low level stimulus between patients and 
controls, using 3 randomly chosen females from the control group data. 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value 
Effect 61438.85 1 61438.85 129.249 0.0000* 
Error 21866.25 46 475.35   
      
Effect d.f. effect MS effect d.f. error MS error F p-value 
Group 1 61438.85 46 475.35 129.249 0.0000* 
Duration 6 2061.71 276 161.98  0.0000* 
Group x 
Duration 
6 2459.70 276 161.98  0.0000* 
 
Table 30. Repeated Measures ANOVA for high level stimulus between patients and 
controls, using 3 randomly chosen females from the control group data. 
Test Sum of 
Squares 
d.f. Mean 
Squares 
F p-value  
Effect 206480.6 1 206480.6 188.021 0.0000*  
Error 50516.2 46 1098.2    
       
Effect d.f. effect MS effect d.f. error MS error F p-value 
Group 1 206480.6 46 1098.2 188.021 0.0000* 
Duration 6 832.0 276 169.7  0.0000* 
Group x 
Duration 
6 321.6 276 169.7  0.0818 
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APPENDIX 4: MAGNETIC STIMULATION  
Patient A-III-10 (Maximum CMAP 13.2 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
3.6  4.7 10.1 4.4 1.35 0.6 0.6 
2.6  4.7 10.3 5 0.6 0.4 1.2 
6  7 10.1 6.4 0.4 0.2 1.8 
4.5  6.9 10.2 3.2 0.4 0.6 3 
4  5.5 6.5 5.9 1 0.4 0.4 
5  6.7 10.4 4.1 3 1.2 0.4 
5  5.2 9.9 2.5 0.7 2.4 0.5 
40 
4.9  10 9.9 4.1 0.3 1 0.5 
 
10 15 20 30 40 50 60 70 
12.6  11 15.6 14.1 8.3 12.4 15.1 
13.9  11 11.9 14.5 10.2 14.8 10 
13.2  12 12.3 14.3 14.3 12.5 10.3 
11.9  10 16.2 17.3 14.1 12.7 9.6 
11.3  10 14.5 12.3 13.2 14.7 9.9 
11.3  10 15 13.7 10.1 16.1 12 
11.3  10 12.6 14.5 9.4 13 17.7 
80 
12.9  10.5 17.7 14.9 11.2 12.7 9.6 
Patient B-IV-3 (Maximum CMAP 10.8 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
6.4  3.4 3.7 5.3 5 3.2 5.4 
6.4  4.8 5.6 5.9 1.7 6.8 3.7 
4.4  4.6 5.7 5.5 3.5 5.6 5.9 
3.8  7 5.9 6.1 4.6 7.7 2.6 
4.4  6.7 5.3 6.5 7.5 4.2 2.7 
6.2  6.2 7.6 3 5.5 6.5 5.9 
5.1  4.7 6 7.7 6.1 5 3 
48 
7.3  6.9 7.9 4.8 6.4 6.9 5.4 
 
10 15 20 30 40 50 60 70 
8.2  8.9 9.3 5.9 8.4 8.1 1.5 
6.8  7.9 8.8 8.1 7.6 10 0.4 
8.6  8.7 8.7 7 7.1 8.6 1.9 
9  9.5 8.2 8.5 8.4 9 6.2 
9.4  9 8.8 9.3 9.2 9.7 8.3 
9.2  10.2 7.1 8.5 9.5 10 10.2 
10.4  9.7 9.2 5.6 8.7 10 7 
75 
8.4  9.1 8.7 7.8 7.2 10 8.5 
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Patient B-IV-6 (Maximum CMAP 10 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
3.2  6.4 6.6 6.1 4.7 4.5 2 
3  4.9 6.1 7.1 3.8 6.7 6.2 
2.8  7 4.8 7.7 2.3 5.5 3.8 
1.5  6.6 5.8 7.2 2.2 5.1 3.7 
3.6  8.7 6.6 6.1 4.1 6.3 4.4 
1.3  6 5.4 3 3.2 4.2 5.6 
4.3  5.6 6.7 3.6 5.5 3.6 3.3 
48 
1.4  7.2 6.9 4.6 2.8 5.7 3 
         
10 15 20 30 40 50 60 70 
8.6  5.6 5.7 5 4.6 4.6 5.1 
6.1  5.7 4.7 5.9 5.7 6.1 4.9 
5.8  6.9 3.8 4.7 7.1 5.9 5.7 
5.2  5.4 8.3 5.7 7 6.1 5.6 
6.1  6.2 6.6 5.3 6.3 5.5 5.9 
6.6  8 5.5 6 5.4 6.1 5.8 
7.3  7.1 5.5 6.2 5.3 4.6 5 
85 
7.1  7.3 5.1 5.9 4.7 4.3 5.6 
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Control 1 (Maximum CMAP 16.7 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
6 0.71 4.1 2.8 4.7 1.9 4 6.6 
4.7 1.37 3.9 2.9 2.8 2.8 4.7 1.9 
2.1 0.63 1.7 1.5 3 2.8 2.9 0.8 
3.7 2.37 3.9 3.2 5.7 3.7 1.8 1.9 
5.5 2.47 2.8 3.6 4.1 2.4 3.6 3.8 
4.2 2.5 1.5 2.5 3.1 2.1 1.1 1.1 
1.2  2.6 2.7 2 6.1 2.1 4.3 
70 
5.4  3.8 6.5 6.2 5.1 2 2.2 
 
10 15 20 30 40 50 60 70 
8.2  7.8 6.8 2.9 4.5 3.1 5 
7.6  7.6 8.3 4.2 4.2 3.3 3.8 
7.2  6.7 7.9 5.4 1.8 1.9 5.6 
5.7  5 6.8 5.2 4.9 5 4.4 
6.7  6.1 7.2 4.1 4.3 3.2 4.2 
5.5  7.7 6.8 6.2 3.8 5.8 5 
3.2  6.1 9.5 4.2 4.1 5 5.6 
95 
3.5  6.6 7 6.7 6 6.1 5.2 
 
 
 
 
Patient Control 2 (Maximum CMAP 14.5 mV) (excluded from analysis) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.64  0.3 0.26 0.2 0.28 0.4 0.25 
0.73  0.26 0.36 0.23 0.41 0.14 0.76 
1.14  0.17 0.21 0.17 0.16 0.1 0.21 
0.68  0.45 0.31 0.18 0.15 0.04 0.18 
1.21  0.81 0.47 0.21 0.37 0.09 0.34 
1.06  0.5 0.41 0.18 0.12 0.06 0.17 
0.93  1.08 0.72 0.11 0.14 0.04 0.27 
100 
1.56  0.5 0.52 0.23 0.07 0.1 0.23 
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Control 3 (Maximum CMAP 18.3 mV) (excluded from analysis) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
2  0.5 1 0.4 2.82 3.9  
1.1  1.2 1.45 1.55 3.46 2.6  
1.4  0.3 0.5 0.65 0.7 4.5  
2.1  0.3 0.89 1.72 2.3 4.2  
2.7  0.9 0.4 0.6 2.3 4.7  
1.8  0.4 0.62 0.95 1.5 3.8  
1.1  1.4 0.29 1.11 3.4 3.5  
95 
1.6  0.8 1.39 1.45 3 5.9  
 
 
Control 4 (Maximum CMAP 12.0 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.14  0.26 0.02 0.2 0.36 0.33  
0.03  0.03 0.09 0.6 0.36 0.28  
0.02  0.22 0.36 0.38 0.36 0.63  
0.1  0.04 0.23 0.43 0.19 0.92  
0.13  0.06 0.1 0.26 0.38 0.26  
0.11  0.05 0.34 0.46 0.55 0.24  
0.04  0.07 0.24 0.32 0.29 0.42  
55 
0.22  0.03 0.02 0.35 0.28 0.91  
 
10  20 30 40 50 60 70 
0.66  1.11 1.18 2.49 2.3 1.5  
0.94  1.08 1.32 1.75 2.82 2.6  
0.82  1.95 1.9 2.21 1.85 3.11  
1.18  1.37 2.17 2.11 2.49 3.5  
0.22  1.1 1.92 0.96 1.66 1.22  
0.65  0.96 2.17 2.17 1.85 4.06  
0.73  0.98 0.96 2.18 2.07 3.2  
75 
2.51  1.78 1.99 2.8 1.46 2.7  
 
 
 
 
 260 
Patient Control 5 (Maximum CMAP 8.9 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.34  0.06 2.46 2.4 1 3.03 1.8 
0.49  0.3 1.63 4.6 0.6 1.9 1.5 
0.2  0.31 3.25 2 1.36 1.6 1.8 
0.56  0.37 1.6 2.3 1.13 1.6 1.1 
0.29  0.46 1 1.8 1.05 2 1.6 
0.3  0.07 2.2 1.5 1.5 1.8 1.5 
0.4  0.34 0.6 1.3 0.84 2.2 1.7 
70 
0.24  0.24 0.8 1.6 0.66 1.9 2.9 
 
10 15 20 30 40 50 60 70 
4.4  3.1 2.01 2.58 1.11 1.37 1.63 
4.5  1.3 2.06 1.52 0.71 1.61 1.18 
4.8  1.8 1.9 2.18 0.83 3 2.06 
4.7  1.1 2.31 1.7 0.59 1.67 1.61 
4.9  1.5 1.88 2.36 1.01 1.74 1.74 
5.2  1.1 1.81 1.63 1.68 1.86 1.54 
4.9  1.9 1.67 2 0.73 1.66 2.54 
80 
4.8  1.6 2.67 1.59 0.77 2.49 1.84 
 
Control 6 (Maximum CMAP 9 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.14 0.24 0.19 0.43 2.25 1.48 1.36  
0.93 0.53 0.16 0.2 0.22 1.23 0.25  
0.24 0.37 0.54 0.31 1.13 0.9 0.74  
0.79 0.38 0.64 0.13 1.26 0.41 0.32  
0.21 0.54 0.13 0.2 0.73 0.37 1.21  
0.47 0.51 0.2 0.38 1.18 0.55 0.24  
0.17 0.54 0.19 1.01 0.57 0.48 0.35  
60 
0.31 0.16 0.25 0.21 0.32 0.45 0.59  
 
10 15 20 30 40 50 60 70 
5.4 2.2 4.9 3.2 3.4 2.5 4.9 6 
4.5 3.8 4.3 5 5.1 5.8 6.6 3.4 
4.7 4 3.8 5 5.9 5.2 4.5 3.5 
4.9 5.1 3.8 6.2 5 5.7 5.9 2.9 
3.7 2.3 2.4 6.2 6.3 3.5 4.2 4.4 
5.4 3 2.2 6.6 6.3 6.4 4.5 4.3 
5.8 3.5 2.8 6.3 7.3 6.3 5.7 2 
85 
5 4.7 1.1 3.3 6.3 4.3 5.3 5.5 
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Control 7 (Maximum CMAP 17.5 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
7  3 4.7 5.8 4.6 6 4 
1.9  3.1 2.4 6.5 4.9 4.4 3.9 
3.4  2.2 3.5 5.7 5.1 3.9 3 
5.1  4 3.7 5.2 4.1 2.9 3.3 
4.8  4.5 2.7 4.4 5.3 5.1 5.3 
3.2  3.1 3.5 5.6 4.4 5.7 3.9 
2.2  3.5 3 5.9 3.5 3.4  
60 
4.7  3.2 5.3 4 1.3 3.4 3.4 
 
10 15 20 30 40 50 60 70 
6.5  3.4 5.9 7.4 6  4 
6.5  5.3 5.3 5.2 3.8  4.8 
5.1  4.2 6 4.5 4.3  3 
7  4.7 4.9 4.9 5.5  4 
7.2  4.7 6.8 3.9 4.7  5.1 
6.7  5.4 5.3 4.9 5  4.1 
6.5  4.6 4.7 5.9 3.8  4.3 
85 
5.1  5.6 6.4 5.2 5  4.9 
 
Control 8 (Maximum CMAP 8.5 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
4.3  3.2 2.7 0.8 1.5 1.4 3.1 
3.2  2.3 1.6 1.03 0.18 4 1 
4.3  2 1.4 2.23 2.6 2.5 0.4 
3.3  1.7 3.4 1.7 0.8 1.1 0.46 
4.1  3.5 2.7 2.16 0.12 3.3 2.34 
3.7  2.6 2.3 2.49 2.4 3.4 1.03 
4.6  2.2 3.4 0.7 0.9 5.7 1.82 
63 
3.7  1.2 3 1 1.6 2 2.34 
 
10 15 20 30 40 50 60 70 
3.5  0.83 0.7 1.5 3.1 3.5 0.6 
5.4  0.8 4.5 2.9 3.8 3.4 4.8 
5.4  4.6 2.1 1.7 3.3 4.8 3.4 
3.9  4.3 3.4 2.8 3.8 1.8 2.9 
5.5  4.2 1.2 3.6 3.8 3.3 0.71 
5.1  2.6 4.1 4.4 3.6 3.2 3.2 
5.5  3.2 0.9 6.3 1.5 0.7 2.9 
85 
5.8  5.2 4.9 3.4 3.9 0.8 1.5 
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Control 9  (Maximum CMAP 9.2 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
7.8 6.6 5.4 7.4 7.9 6.6 6.2 7.2 
6.8 7.1 4.9 7.5 8 7.1 6.7 6.8 
5.5 5.6 5.4 5.5 7.5 7.1 6.9 7 
6.1 6.1 7.4 5.9 7.8 6.8 6.2 7.5 
5.1 5.2 3.7 5 7.6 6.5 7.1 6.3 
6.8 4.8 5.6 5.9 7.1 6.9 6.9 6.9 
6.1 6.7 4.6 7.3 6.6 6.7 6.6 6.2 
65 
7.2  6.2 6.2 7 6.4 7 44 
 
10 15 20 30 40 50 60 70 
4.6 5.4 7.9 5.9 6.7 6.9 6.7 6.8 
5.2 6.5 6.9 6.7 5.1 7 7.4 5.9 
5.8 6.5 6.4 7.8 6.9 6 7.7 7.6 
5.4 6.1 6.2 7.7 6.5 5.4 7.2 8.7 
5.7 7.5 7.8 7.4 6.2 6.6 7 7.9 
5.6 6.9 6.7 7.6 6.6 6.1 7 8.1 
5.7 6 8.3 8 6.3 6.6 7.2 7.9 
85 
5.4 6.6 7.9 6 6.4 7 7.2 8.2 
 
Control 10 (Maximum CMAP 12.4 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
1.6  1 2.4 2.4 1 1.1 2.2 
1.3  3.3 2.8 1.2 1 1.1 1.6 
3.8  3.6 2.7 2.96 1.4 1 1.5 
2.2  2 1 1.42 3.2 1 0.4 
3.5  3.2 2.8 3 0.9 3.7 3.7 
1.4  4 1.5 1.7 1.1 1.4 0.4 
3.4  3 3.5 3.88 1.9 2.1 1.4 
78 
3.3  2 5.1 1.45 2 1.6 2.3 
         
10  20 30 40 50 60 70 
8.4  4.4 2 2.3   2.4 
7.2  4.5 4 1.7   1.7 
1.8  2.1 6.5 1.4   0.9 
3.3  4.1 1.3 2.2   2.8 
5.1  3.1 4.3 1.7   3.3 
6.1  2.1 3.8 1.1   4.6 
3  3.2 2.4 1   3.5 
90 
3.4  4.4 3.1 1.3   0.9 
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Control 11 (Maximum CMAP 16.7 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.96  1.88 1.64 4.81 6.4 1.1 1.89 
2.53  2.38 1.92 6.1 5.4 3.3 1.84 
1.4  2.41 2.39 8.3 7.9 3.9 1.58 
1.4  0.25 1.58 3.7 5.7 0.7 1.16 
0.9  1.44 1.61 7.3 7.4 0.4 1.61 
1.2  1.06 1.89 6.5 3 1 1.29 
1.1  0.45 2.93 7.4 2.7 1.41 3.92 
65 
2.4  0 2.66 4.2 4.6 3.01 2.05 
 
10 15 20 30 40 50 60 70 
3.1  2.6 3 6.1 2.6 3.7 1 
5.7  4.8 1.4 3.5 2.9 2.2 3.9 
4.1  3.4 1.5 3.3 1.58 2.2 2.06 
4.6  2 1.8 4.5 4.1 2.4 4.27 
4.9  1.6 6.7 4.4 2.3 3.2 3.09 
4.7  2.1 1.7 2.7 1.6 2.6 1.76 
3  2.4 4 5.6 2.1 1.8 1.89 
85 
5.1  1.5 2.3 5.3 2.9 2.2 2.48 
 
Control 12  (Maximum CMAP 11.4 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.35  0.18 0.18 0.06 0.15 0.23 0.8 
0.17  0.16 0.35 0.48 0.1 0.44 0.33 
0.32  0.31 0.15 0.26 0.11 0.61 0.67 
0.24  0.11 0.13 0.2 0.17 0.22 0.17 
0.13  0.47 0.09 0.24 0.46 0.92 0.3 
0.35  0.08 0.17 0.3 0.46 0.18 0.28 
0.08  0.65 0.17 0.12 0.16 1.18 0.19 
50 
0.18  0.07 0.22 0.05 0.45 0.84 2.37 
 
10 15 20 30 40 50 60 70 
1.8  0.6 1.58 0.59 0.51 2.27 1.77 
2.1  1.2 2.01 1.28 2.92 1.73 0.42 
3.2  1.36 2.95 1 1.69 0.24 0.21 
2.1  1.13 1.17 1 2.4 2.68 1.39 
2.1  1.58 1.87 2.19 1.42 0.21 1.94 
1.9  1.14 1.88 1.25 1.5 2.31 1.72 
2.8  2.08 1.38 0.73 0.82 1.54 1.33 
85 
1.9  2.75 1.4 1.15 1.51 3.13 1.16 
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Control 13 (Maximum CMAP 9.4 mV) 
Level of magnetic stimulation 
Latencies 
 
 
10 15 20 30 40 50 60 70 
0.27  0.13 0.6 1.95 2.34 2.07 0.6 
2.47  0.7 0.37 1.73 0.16 0.7 1.44 
0.37  0.14 1.75 0.6 0.25 1.51 0.18 
1.14  0.28 1.39 2.44 0.28 0.67 0.37 
1.73  0.2 0.24 1.58 1.03 0.79 0.32 
0.15  0.16 0.27 0.63 3 1.7 1.55 
0.78  0.46 1.61 1.11 1.2 0.56 0.18 
55 
0.96  0.13 2.44 0.22 0.71 0.85 1.91 
 
10 15 20 30 40 50 60 70 
3.72  0.7 4 5 2.9 4.5 3.9 
1.5  1 2.2 3.9 4.4 1.4 1.9 
2.3  0.4 2.3 3.6 2.2 1.7 2.5 
3.1  0.9 2.9 4 3 4.8 2.6 
2.2  0.7 2.3 4.4 4 2.3 4.7 
1.5  1.2 2.1 2.6 4.7 4.6 2.1 
2.1  0.5 3.5 3.9 3.5 4.5 4.3 
85 
1.7  0.2 4.6 3.8 3.2 4.7 4 
 
Control 14  (Maximum CMAP 7.8 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
3.4  1.37 3.4 0.71 0.92 0.84 0.52 
0.69  0.41 3.19 0.48 1.03 0.35 1.03 
4.15  0.14 0.36 0.63 0.19 0.3 0.52 
0.33  1.26 1.84 0.91 0.2 2.3 0.97 
0.67  0.47 0.28 1.84 0.31 1.29 0.88 
0.17  1.37 0.18 0.62 0.2 0.17 0.15 
0.01  1.32 1.01 0.56 0.23 0.97 0.71 
80 
2.48  0.23 0.81 3.17 0.87 0.39 0.77 
 
10 15 20 30 40 50 60 70 
0.35  0.43 0.49     
1.47  0.77 0.6     
1.7  0.57 1.07     
3.71  2.45 0.67     
1.66  2.05 0.46     
1.1  0.91 0.64     
0.68  0.52 1.06     
95 
2  2.89 0.2     
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Control 15  (Maximum CMAP 11.3 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.2  0.43 0.66 1.48 0.74 1.29 2.14 
0.3  0.35 0.36 1.36 0.51 2.04 2.59 
0.95  0.45 0.32 0.31 0.42 1.23 1.29 
0.47  0.43 0.15 0.44 0.8 0.74 0.54 
0.97  0.23 0.31 0.17 0.71 1.07 1.31 
0.26  0.66 0.63 0.45 0.43 0.4 1.5 
0.41  0.29 0.57 0.48 0.67 0.6 2 
60 
0.4  0.29 0.35 0.33 0.48 0.2 1.2 
 
10 15 20 30 40 50 60 70 
2.8  2 1.75 2.7 3.65 4.41 5.4 
3.2  0.8 1.09 2.44 1.49 3.8 5.3 
3.2  1.3 4.28 1.43 1.26 4.1 5.1 
2.5  2.2 1.06 2.2 2.21 4.3 4.2 
4.2  1.84 1.63 3.12 1.83 5.4 6.1 
5.2  2.99 1.14 1.6 2.36 2.4 4.3 
3.8  1.11 2.75 2.67 2.72 5.3 5.2 
85 
3.5  1.86 2.2 1.71 2.95 6.2 6.4 
 
Control 16 (Maximum CMAP 14.3 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.46  0.91 1.02 0.08 0.05 0.49 0.16 
0.46  0.27 0.55 1.14 0.08 0.34 0.65 
1.75  0.72 0.18 0.11 0.68 0.24 0.17 
0.87  0.12 0.49 0.13 0.19 0.23 0.22 
0.7  0.55 0.85 0.69 0.57 0.24 0.26 
1.69  0.1 0.1 0.5 0.88 0.5 0.5 
0.49  0.14 0.44 0.28 0.18 0.17 0.89 
70 
0.26  0.02 0.79 0.18 0.34 0.73 0.18 
 
10 15 20 30 40 50 60 70 
1.2  0.94 0.39 0.57 0.51 0.31 1.3 
2.2  1.34 0.48 0.15 0.18 0.29 1.33 
2.82  0.73 0.53 0.52 0.19 0.56 0.19 
1.95  0.83 4.31 0.53 0.42 0.47 1.2 
1.68  0.67 0.5 0.44 0.45 0.2 0.26 
0.91  1.06 1.15 0.69 0.5 0.31 1.95 
2.18  2.24 0.64 0.63 0.64 0.59 1.01 
95 
2.36  0.93 0.97 0.52 0.59 0.24 0.29 
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Control 17 (Maximum CMAP 12.4 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
8  6.1 10 7.1 3.2 6.2 4.8 
9.6  5.3 3 2.6 1.5 3.2 9.6 
11.1  4.3 8 7.5 5.9 5.4 8.4 
9.9  5.1 9.4 5.4 6.6 5.2 6.3 
8.7  4.1 9.5 4.2 6 9.1 5.7 
8  2 9.4 6 8.5 5 5.8 
6.7  4.7 9 5.2 7.5 6.4 8.5 
70 
6.6  1.9 7.8 5.9 4.6 2.7 9.1 
 
10 15 20 30 40 50 60 70 
10  20 30 40 50 60 70 
9  7.6 5.8 8.4 8.2 6.7 6.9 
8.4  7.7 7.3 7.6 8 9.5 7.8 
10.4  5.6 6.9 6.1 4.5 7.5 8.6 
9.7  7.6 8.2 7.6 6.4 4.3 6.8 
8.6  10.1 6.1 8.1 6.7 6.7 5.9 
10.1  7.7 7 8.3 6.5 9.3 5.5 
9.3  6.6 7.8 7.6 5.8 7.9 7.5 
90 
9.6  6.2 5.4 9 6.3 8.8 5.7 
 
Control 18  (Maximum CMAP 10.0 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.29  0.36 2.09 0.68 0.2 0.27 0.04 
2.28  1 1 0.64 0.96 0.45 0.04 
0.48  1.17 0.46 1.63 0.13 0.29 0.55 
0.83  0.86 0.69 2.8 0.44 0.11 0.18 
0.98  0.95 1.03 0.87 0.15 0.1 0.79 
2.34  3.18 0.51 1.35 0.07 0.11 0.11 
0.38  0.72 0.74 2.67 1.25 0.92 0.04 
66 
0.45  0.76 1.36 0.28 0.47 0.28 0.16 
 
10 15 20 30 40 50 60 70 
2.4  1.3 2.95 0.11 0.25 0.47 0.17 
4.6  3.5 1.37 0.52 0.69 0.24 0.37 
1.2  0.5 1.47 0.27 0.69 0.68 0.37 
1.7  1.9 1.21 0.24 0.27 0.36 0.14 
4.3  1.8 0.48 0.61 0.08 0.58 0.16 
1.4  1.2 0.15 0.29 0.26 0.34 0.28 
2.5  0.8 0.2 0.6 0.67 0.46 0.84 
90 
4.2  1.2 0.11 0.01 0.04 0.14 0.58 
 267 
 
Control 19 (Maximum CMAP 8.3 mV) (excluded from analysis) 
Level of magnetic stimulation 
Latencies 
 
0 10 15 20 30 40 50 60 70 
 
10 15 20 30 40 50 60 70 
0.28  0.33 1.53 0.85 0.13 0.53 0.62 
0.37  0.58 1.87 0.96 1.22 0.62 1.79 
0.25  0.73 0.48 1.21 0.36 1.43 0.41 
0.46  0.56 1.45 0.5 1.02 0.12 0.37 
0.74  0.98 2.29 1.97 1.49 0.71 0.47 
0.24  0.17 2.17 2.19 0.39 2.01 0.54 
0.19  2.41 1.46 0.95 0.18 0.07 0.23 
91 
0.13  1.23 0.62 0.48 0.11 0.7 0.19 
 
 
Control 20  (Maximum CMAP 6.9 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
3.8  3.4 1.8 3 4 2.8 2.9 
2.2  2.6 1.5 3 1.5 3.1 2.3 
2.5  3.2 2 2.8 3.6 2.3 2.9 
3  1.2 1.6 2.4 2.7 2.6 2.6 
4.2  3 1.5 3.7 1.7 3.8 3.3 
1.9  2.8 2.4 2.4 1.9 3.5 3 
2.3  3.4 1.7 3 2.1 2.7 2.2 
 
45 
3.1  2.5 1.9 2.3 1.9 2.9 2.9 
 
10 15 20 30 40 50 60 70 
4.7  4 3.3 3.9 3.6 3.6 4.1 
4.2  2.4 2.8 3.5 4 4.7 4.6 
5.2  3.6 3.4 2.3 4.9 3.9 3.6 
3.9  4.1 4.5 4.7 5.1 4.4 2.7 
5.2  3.1 2.3 3 4.2 4.2 3.2 
4.7  3.7 2.9 2.3 3.7 4.9 3.8 
5.1  4.5 3.3 2.2 3.8 4.2 3.5 
80 
3.6  3.5 3.3 5 4.6 4.6 3.3 
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Control 21 (Maximum CMAP 11.3 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
3.1  2.5 2.6 2.7 2.7 2.9 1.1 
3.4  2.4 4.5 2.2 4.5 3.4 2.1 
4.4  2.4 3.3 3.6 3.8 4.2 1.3 
3  2.4 3.3 5.6 5 1.7 0.3 
3.4  1.9 2.4 3.6 3.7 4.8 1 
3.6  1.8 4.5 4.5 3.3 3.8 1.3 
3  1.4 5.9 3.5 4 3.4 2 
78 
4.8  2.9 4.7 1.4 2.7 2.9 1.6 
 
10 15 20 30 40 50 60 70 
5.3  1.4 2.5 1.1 1.2 3.2 0.6 
2  2 0.7 1.2 2.3 0.8 1.9 
3.1  1.4 0.5 0.8 0.6 1.3 0.8 
4.7  2.6 2.9 2.3 1.8 0.9 0.7 
2.2  1.6 2.4 3.2 2.5 1.1 0.9 
2.4  3.2 1.7 1.1 0.5 0.9 0.4 
3.2  2.1 2.8 1.6 2.5 0.9 0.5 
95 
2.9  2.6 1.2 4 0.3 1.3 1.8 
 
Control 22 (Maximum CMAP 9.8 mV) 
Level of magnetic stimulation 
Latencies 
 
        
10 15 20 30 40 50 60 70 
4.5  3.3 4.1 4.7 5.5 6.5 3.7 
5  3.5 3.5 5.1 4.8 3.9 4.4 
3.7  3.4 3.4 4.2 4 4.2 3.6 
3.8  1.9 3.2 3.7 3.8 4.8 3.5 
2.5  3.4 2.2 5 5.1 3.7 3 
3.3  2.9 1.8 3.8 5 6.2 3.7 
3.5  2.3 3.4 4.6 3.8 5 4 
60 
2.9  2.2 4.8 3.6 3.7 6.4 3.9 
 
10 15 20 30 40 50 60 70 
6.9  4.1 4.9 4.4 5.3 4.6 5 
4.7  4.7 5 5.5 5.5 4.8 4.9 
5.4  5.1 6.3 5.3 5.1 4.7 5.5 
5.2  4.2 5.5 5.9 5.5 4.2 5.7 
4.8  4.6 4.6 5 4.8 4.3 4.6 
5.4  5.4 5.2 4 5 5.2 4.7 
5.4  5.3 4.9 5 5.1 5.7 3.8 
80 
5.6  4.1 4.7 4.9 5 3.9 5.5 
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Control 23 (Maximum CMAP 14.6 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
        
3.5  3.2 2.9 5.5 4.7 3.5 4.5 
4.8  3.1 3 4.6 4.6 3.9 4.5 
5.4  3.2 3.2 5.9 3.2 2.9 4.6 
5.6  2.5 2.4 4.6 4.6 4.2 2.9 
5  2.6 2 3.4 4.7 4.9 4.9 
4.7  2.4 4.1 4.7 3.7 5.1 2.4 
5.4  2.4 4.2 5.6 4.6 4.1 4.6 
55 
6.2   5.6 4.4 4 5.1 4.1 
10 15 20 30 40 50 60 70 
5.4  6.2 5.6 4.1 5 6 4.4 
5.5  3 4.8 4.3 5.8 4.7 5.2 
4.9  3.2 4.5 4.7 6.3 5.1 5 
4.2  2.5 4.9 4.9 5 5.8 5.5 
5.3  2.6 3.1 4.2 6.2 5 5.3 
5.7  2.4 5.5 3.9 4.2 5 4.7 
5.9  2.4 3.8 3.7 3 5.7 5.7 
80 
6.1  2.9 3.6 3.3 3 6.2 5.7 
 
Control 24 (Maximum CMAP 14.2 mV) 
Level of magnetic stimulation 
Latencies 
        
10 15 20 30 40 50 60 70 
1.7  1.3 1.5 2.3 3.3 2.6 1.9 
2.3  2.3 2.6 3.1 3 3.3 2.6 
2.4  2.5 1.4 2.8 3.2 2.3 1.1 
2.2  2.4 1.9 2.6 3.9 2.1 2.2 
4  1.2 1.9 2.6 3.6 2.8 1.4 
2.8  2.4 1.7 2.6 4.1 1.5 1.8 
2.5  1.6 2.2 2.8 3.2 1.2 1.2 
52 
4.7  1.5 3.3 3.1 2.2 2.4 1.3 
10 15 20 30 40 50 60 70 
2.5  1.4 2.2 1.5 3.4 2.3 2.1 
1.9  1.3 1.9 2.3 2.6 2 3.9 
2.7  2.9 1.8 2.3 2.2 2.7 4.5 
1.9  1.7 2.5 2.2 1.9 4.3 3.9 
2.1  2.4 3.3 2.1 1.7 3.2 4.5 
4.1  2 2.8 3.1 2.8 3.5 4.4 
3.5  2.7 2.3 1.7 2.7 3.3 4.3 
82 
4.5  3.3 4.3 2.9 2.9 2.7 2 
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Control 25 (Maximum CMAP 13.3 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
7.2  4.7 4.3 3.9 6 7.3 5.5 
5.5  4.9 2.9 3.7 6.9 5.9 4.8 
7.1  3.9 2.8 4.5 7.4 6.5 4.7 
3.7  5.2 3.5 4.4 6.1 6.2 5.3 
6.5  4.8 2.9 4.9 8.1 5.9 4.6 
3.8  2.9 2.8 4.4 6.4 6.4 6 
6.3  5.2 3.6 4 6.7 5.9 5 
65 
5.6  4.6 2.7 4.3 7.1 5.7 6.3 
10 15 20 30 40 50 60 70 
7.4  8.7 4.7 7.6 8.5 10.8 8.5 
8.4  6.3 7.2 6.4 8.9 10.9 7.6 
9.1  7.3 6.8 7.7 9 10.9 9.1 
8.6  7.2 7.2 7.9 9.3 11.4 8.5 
9.2  7.9 7.6 10.1 7.9 10.7 8.4 
10.3  8.1 9.5 8.2 8.4 12 8.4 
8.2  8 8.5 8 8.2 10.3 8.7 
80 
9.3  6.9 7.3 7.6 9.1 9.9 8.5 
 
 
Control 26 (Maximum CMAP 9.7 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
4.2  3.1 0.7 2.8 3.3 0.9 1.3 
2.1  2.3 1.1 2.7 3.1 1.3 2.4 
2.7  2.2 1.7 2.7 4.6 1 4.7 
3.9  1.6 1.3 1.9 3.8 3.3 4.1 
3.6  1.8 0.7 1.9 1.6 1.2 1.7 
2  1.7 1.5 3.3 3.1 1.4 1.4 
3.3  1.6 0.7 1.6 2.9 1.4 3.5 
49 
1.9  0.9 1.1 3 3 1.8 3.2 
10 15 20 30 40 50 60 70 
7.6  3.8 5 4.5 4.2 4 5.7 
10.4  4.3 3.5 5.4 3.9 7.9 4.2 
7.2  5.3 2.9 5.7 5.7 3.8 5.1 
7.1  6.6 5.2 3.3 5.3 5.8 4.3 
7.3  3.2 4 5.9 5.8 4.4 3.7 
6.7  3.7 7 4 4.2 4.1 6.2 
7.9  3.4 2.9 4.7 4.3 4.4 4 
85 
8.8  3.3 3.6 3.3 4 5 6.6 
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Control 27 (Maximum CMAP 16.6 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
4.6  4.4 4.8 1.86 3.5 2.6 4.1 
3  2.5 3.4 0.35 3.4 2.6 3 
4.1  1.8 2.8 1.62 2 3.3 2.7 
3.7  1.3 3.2 1.3 1.9 1.6 2.5 
3.7  3.3 2.3 2.23 2.2 2.9 2.1 
3.9  3.3 2.4 0.43 1.6 1.3 1.7 
1.8  2 3.4 0.22 2.2 2.3 1.7 
57 
1.6  2.8 1.2 0.78 2.7 2.5 1.4 
 
10 15 20 30 40 50 60 70 
5.6  3.4 5.1 4.9 2.1 4.7 2.8 
5  1.3 2.5 3 3.1 2.1 2.1 
4.1  2.5 2.8 3.7 2.2 1.7 1.6 
3.8  1.4 3.4 3.5 1.7 2.1 1.7 
3.7  2.3 3.8 4.6 2.1 4.1 2.7 
3.3  1.8 4.4 4.4 2.2 3.7 2.3 
2.3  1.6 4.2 3 3.1 2.6 2.3 
85 
3.2  2.3 2.6 3.4 2.1 2.2 1.3 
 
Control 28 (Maximum CMAP 10.9 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
1.79  0.46 1.47 1.34 1.21 0.73 1.71 
1.84  0.7 1.24 0.74 0.3 0.64 2.06 
0.59  0.61 0.58 0.71 0.79 0.81 0.65 
1.36  0.27 2.13 1.04 0.32 0.79 0.51 
0.38  1.37 2.24 1.37 2.27 1.23 1.72 
0.69  0.42 1.02 0.65 1.99 0.74 1.02 
0.67  0.34 2.64 0.53 1.77 0.25 1.16 
55 
0.67  2.19 0.22 1.92 1.34 0.99 1.92 
 
10 15 20 30 40 50 60 70 
4.4 3.6 4.39 2.12 6 1.8 6.7 4.2 
8.5 3.62 2.22 2.41 2 5.2 2.4 2 
4 1.82 2.31 1.8 2.5 3.4 2.8 3.3 
3.4 1.4 1.8 2.7 3.1 3.3 3 1.6 
4 4.1 2.54 1.83 3 3.4 3.1 2.1 
2.5 2.36 1.44 4.71 1.9 6.4 4.3 4.4 
2.9 1.39 1.73 4.4 2.7 5 2 3.1 
85 
3.4 3.14 3.24 2.1 4.4 5 2.2 1.5 
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Control 29  (Maximum CMAP 11.6 mV) 
Level of magnetic stimulation 
Latencies 
10  20 30 40 50 60 70 
1.14  0.97 0.92 1.4 0.52 4.26 2.26 
1.02  0.98 1.19 0.98 0.45 2.05 2.06 
0.46  2.77 2.95 3.3 0.5 0.8 2.27 
1.36  2.75 2.16 3.3 2.07 2.96 0.97 
1.01  0.75 4.01 4.9 0.46 4.93 0.46 
0.58  0.79 4.65 2.97 0.92 2.57 2.53 
0.47  1.63 1.17 2.85 2.3 0.98 0.71 
58 
1.56  0.89 4.92 1.83 0.36 4.3 1.96 
 
10  20 30 40 50 60 70 
4.8  4.3 1.8 3.5 4.7 7.4 5.3 
5.9  4.2 2.9 4.6 4.7 3.9 3.5 
6.1  2.3 3.9 5 5.6 5.7 2.6 
4.7  2.4 3.8 5.3 7.9 4.1 3.1 
3.7  2.8 2.3 4.8 6.1 5.9 3.4 
5.4  3.6 5 5.1 6.4 4.8 2.1 
5.5  3.4 2.1 4.5 7.7 1.8 5.1 
90 
3.5  2.4 3.4 5.8 6.7 5.2 4.5 
 
Control 30  (Maximum CMAP 11.5 mV) 
Level of magnetic stimulation 
Latencies 
10 15 20 30 40 50 60 70 
5.6  3.1 4.5 1.2 2 3.2 1.9 
5.3  3.5 3 2.4 1.7 2.3 2.9 
4.8  2 1.6 1.4 4 3.9 2.7 
5.1  1.4 2.4 2.5 2.2 4.4 4.4 
4.5  3 2.2 2.3 3.8 2.3 2.2 
3.9  2.5 4.7 0.3 3.2 2.9 3.2 
4.8  2.6 3.9 2.3 2.4 4.2 6 
72 
3.9  3.2 2.4 3.2 3.6 3.9 3.5 
 
10 15 20 30 40 50 60 70 
6.2  3.2 3.9 1.9 2.9 3.8 3.8 
5.4  3.2 3.3 3.8 3.3 5.3 5.3 
5.1  3 4.1 3.6 3.5 3.2 3.2 
4.9  2.9 3.8 3 4 3.1 3.1 
4.7  4.1 5 3.1 5.1 4.1 4.1 
5.4  3.3 3.6 3.4 4.2 4.5 4.5 
5.7  3.5 4.1 3.4 4.4 2.7 2.7 
92 
5.7  4.3 2.4 4 3.3 4.2 4.2 
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Control 31   (Maximum CMAP 9 mV) 
Level of magnetic stimulation 
Latencies 
 
10 15 20 30 40 50 60 70 
0.14 0.24 0.43 0.66 1.48 0.74 1.29 2.14 
0.93  0.35 0.36 1.36 0.51 2.04 2.59 
0.24  0.45 0.32 0.31 0.42 1.23 1.29 
0.79  0.43 0.15 0.44 0.8 0.74 0.54 
0.21  0.23 0.31 0.17 0.71 1.07 1.31 
0.47  0.66 0.63 0.45 0.43 0.4 1.5 
0.17  0.29 0.57 0.48 0.67 0.6 2 
60 
0.31  0.29 0.35 0.33 0.48 0.2 1.2 
 
10 15 20 30 40 50 60 70 
2.8  2 1.75 2.7 3.65 4.41 5.4 
3.2  0.8 1.09 2.44 1.49 3.8 5.3 
3.2  1.3 4.28 1.43 1.26 4.1 5.1 
2.5  2.2 1.06 2.2 2.21 4.3 4.2 
4.2  1.84 1.63 3.12 1.83 5.4 6.1 
5.2  2.99 1.14 1.6 2.36 2.4 4.3 
3.8  1.11 2.75 2.67 2.72 5.3 5.2 
85 
3.5  1.86 2.2 1.71 2.95 6.2 6.4 
 
 274 
APPENDIX 5: RESULTS OF LINKAGE 
ANALYSIS 
Table 31. Lod scores for Family A of pairwise Lod score for FAME 3 versus EPM1 
markers and DRPLA (from Thomas419) 
EPM1 markers   
 Marshfield 
Lod 
score 
at  = 
         
Marker (cM) 0.00 0.01 0.02 0.03 0.04 0.05 0.10 0.20 0.30 0.40 
D21S2040  -14.24 -1.92    -0.65 -0.21 0.06 0.08 0.03 
D21S1912 0.5 -12.83 -0.94    -0.29 -0.06 0.09 0.09 0.04 
D21S1950 7.8 -6.82 -0.65    -0.05 0.13 0.18 0.12 0.04 
DRPLA 
DRPLA 
CAG 
Repeat 
 -14.50 -4.13    -2.15 -1.32 -0.58 -0.23 -0.05 
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Table 32. Results for Family A of pairwise Lod score for FAME 3 versus 8q markers and 2p markers 
  Family A  Pairwise Lod score for FAME 3 versus chromosome 8q24 markers 
 Marshfield Lod score 
at  = 
         
Marker (cM) 0.00 0.01 0.02 0.03 0.04 0.05 0.10 0.20 0.30 0.40 
D8S1784  0.70 0.69 0.68 0.67 0.66 0.65 0.58 0.42 0.24 0.07 
D8S1830 1.07 0.60 0.59 0.58 0.56 0.55 0.54 0.48 0.33 0.18 0.05 
D8S1779 4.32 0.59 0.58 0.58 0.57 0.56 0.55 0.50 0.36 0.20 0.06 
D8S547 0.00 0.61 0.60 0.59 0.58 0.57 0.56 0.50 0.35 0.19 0.06 
D8S1694 1.73 0.69 0.68 0.67 0.66 0.65 0.64 0.58 0.42 0.24 0.07 
D8S342 4.73 0.70 0.69 0.68 0.67 0.66 0.65 0.58 0.42 0.24 0.07 
D8S1826 0.00 0.70 0.69 0.68 0.67 0.66 0.65 0.58 0.42 0.24 0.07 
            
: Family A: Pairwise Lod score for FAME 3 versus chromosome 2p11.1-q12.2 markers 
 Marshfield Lod score 
at  = 
         
Marker (cM) 0.00 0.01 0.02 0.03 0.04 0.05 0.10 0.20 0.30 0.40 
D2S139  -2.23 -0.41 -0.14 0.00 0.10 0.17 0.32 0.30 0.17 0.04 
D2S2333 1.60 -6.20 -2.34 -1.77 -1.44 -1.22 -1.05 -0.57 -0.21 -0.08 -0.02 
D2S2161 1.84 -2.60 -0.53 -0.26 -0.11 -0.01 0.06 0.22 0.23 0.13 0.03 
D2S388 2.46 -2.98 -2.17 -1.64 -1.33 -1.11 -0.94 -0.47 -0.14 -0.04 -0.01 
D2S2216 3.75 -6.56 -3.06 -2.46 -2.11 -1.86 -1.66 -1.06 -0.49 -0.20 -0.05 
D2S2264 3.21 -6.13 -2.23 -1.66 -1.34 -1.11 -0.95 -0.48 -0.15 -0.05 -0.01 
D2S135 1.60 -2.41 -2.02 -1.59 -1.30 -1.09 -0.92 -0.45 -0.10 -0.01 0.00 
D2S1897 1.60 -6.13 -2.23 -1.66 -1.34 -1.11 -0.95 -0.48 -0.15 -0.05 -0.01 
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Table 33. Results for Family B of pairwise Lod score for FAME 3 versus 8q markers and 2p markers 
  Family B Pairwise Lod score for FAME 3 versus chromosome 8q24 markers 
 Marshfield Lod score 
at  = 
         
Marker (cM) 0.00 0.01 0.02 0.03 0.04 0.05 0.10 0.20 0.30 0.40 
D8S1784  -12.52 -7.26 -6.11 -5.33 -4.74 -4.25 -2.65 -1.09 -0.37 -0.07 
D8S1830 1.07 -8.26 -3.60 -2.88 -2.42 -2.08 -1.81 -0.96 -0.26 -0.04 -0.01 
D8S1779 4.32 -2.48 -1.06 -0.74 -0.54 -0.40 -0.29 0.02 0.17 0.13 0.04 
D8S547 0.00 -11.72 -5.46 -4.43 -3.79 -3.32 -2.94 -1.77 -0.71 -0.28 -0.11 
D8S1694 1.73 -11.52 -6.09 -5.04 -4.35 -3.82 -3.41 -2.08 -0.84 -0.29 -0.06 
D8S342 4.73 -9.60 -4.42 -3.54 -2.97 -2.54 -2.20 -1.14 -0.30 0.05 0.03 
D8S1826 0.00 -3.33 -1.67 -1.28 -1.03 -0.85 -0.71 -0.29 0.00 0.05 0.03 
Family B: Pairwise Lod score for FAME 3 versus chromosome 2p11.1-q12.2 markers 
 Marshfield Lod score 
at  = 
         
Marker (cM) 0.00 0.01 0.02 0.03 0.04 0.05 0.10 0.20 0.30 0.40 
D2S139  -13.25 -2.68 -1.80 -1.30 -0.94 -0.69 0.00 0.32 0.19 0.00 
D2S2180 1.06 -9.96 -0.47 0.11 0.44 0.65 0.80 1.14 1.03 0.59 0.14 
D2S1387 0.54 -9.32 -1.21 -0.65 -0.34 -0.13 0.02 0.37 0.42 0.23 0.06 
D2S2333 0.00 -4.31 -0.63 -0.28 -0.08 0.05 0.15 0.36 0.32 0.16 0.05 
D2S2161 1.84 0.45 0.50 0.53 0.56 0.58 0.59 0.59 0.48 0.31 0.14 
D2S388 2.46 -9.31 -2.34 -1.51 -1.06 -0.76 -0.54 0.01 0.24 0.17 0.05 
D2S2216 3.75 -8.86 -2.01 -1.38 -1.01 -0.74 -0.54 0.02 0.35 0.30 0.12 
D2S2264 3.21 -11.92 -2.99 -2.15 -1.67 -1.34 -1.10 -0.43 -0.02 -0.02 -0.09 
D2S135 1.60 -4.10 -2.60 -2.20 -1.93 -1.72 -1.54 -0.97 -0.45 -0.22 -0.08 
D2S1897 1.60 -5.58 -2.52 -1.81 -1.37 -1.06 -0.82 -0.14 0.22 0.11 -0.10 
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APPENDIX 6: ETHICAL DILEMMAS 
 
Appropriate ethical consent was obtained for the purposes of this study, both in terms of 
assessing DNA for purposes of linkage and for the purpose of neurophysiological testing. 
 
However, the fact remains that the majority of patients were ill-educated and many of them 
were functionally illiterate.  This results in enormous difficulties for the investigator attempting 
to behave in an ethical fashion.  The majority of patients who provided blood samples were 
likely to be relatively ill informed of the precise reason that they were being asked to give 
samples, since explanations of linkage analysis and understanding the nature of DNA 
analysis were difficult.  It would be an interesting study in itself to return to the participants 
and ask if they knew why they had given blood samples at the time of the study. 
 
Similarly, although participants were informed that the purpose of this research study was to 
establish the cause of the genetic illness in their families, as with virtually all other genetic 
illnesses, the results of such a study would be likely to have no or very little impact on their 
future behaviour.  At the time this study was performed, no gene therapy was available for 
genetic conditions of this nature.  The only likely practical outcome of the genetic analyses 
would be to establish a genetic marker for identifying disease in future generations.  The 
implications of this would be that in those who were affected, they could elect not to have 
children at all, or in the event that a pregnancy occurred, genetic testing could be performed, 
and, if they were so willing, they could elect to undergo abortion.  It should be noted that 
even in conditions with far worse prognoses than FAME 3, such as Huntington’s disease, the 
option of undergoing in utero testing is virtually unheard of in the state sector of the Western 
Cape. 
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